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ADHD in children and adolescents is a neurodevelopmental disorder, which is 
recognized by the clinicians all over the world. ADHD is a clinical diagnosis based 
on reliable history, reports from home and school and a physical examination to rule 
out any other underlying medical conditions. ADHD can cause low self-esteem in the 
child and impair quality of life for the child and the family. It is known that ADHD is 
a chronic illness and that clinicians needed to use chronic illness principles in treating 
it. The last 10 years have seen an increase in the number of medications that have been 
approved for the treatment of ADHD. This book has tried to address some of the issues 
in ADHD.
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A few topics in child mental health have sparked continued interest and controversy. Atten‐
tion Deficit Hyperactivity Disorder (ADHD) is one of them. ADHD is a developmental disor‐
der of behavioural inhibition and self-regulation. Since its first description by George
Frederick Still in 1902, this clinical diagnosis had many name changes as well as changes in the
diagnosis criteria. Despite many researches the exact cause of ADHD is still not known. Epide‐
miological studies have estimated its prevalence between 5% and 10%. Many of our colleagues
doubt if it even exists as an entity. There are stories in TV and media about its over-diagnosis
and treatment with drugs that are life-threatening.
Despite this hue and cry, the diagnosis and management approach have very little changes
over last 30 or 40 years. Despite some fine tuning in diagnosis and management, we still rely
on clinical judgement to make the diagnosis and management plan. Children/ Adolescents
with ADHD perceive the world differently from others. Awareness and understanding of this
increasingly recognised entity is the need of the hour.
ADHD is primarily a condition of brain dysfunction, involving many sites in the brain. There
is much more to ADHD than just hyperactivity. This book aims to encourage further reading
and research in ADHD. ADHD is a combination of “nature” versus “nature”. The topics cov‐
ered in the book plan to improve quality of lives in children with ADHD and in their family
members. This book is intended to provide an overview rather than act as an exhaustive
guide. It is hoped that many readers among mental health professionals all over the world will
find this book to contribute in the field of ADHD. Finally this book would not have been pos‐
sible without the able guidance of Ms Mirna Cvijic, the commissioning editor.
Dr Somnath Banerjee
MBBS, DCH, MRCPCH, MSc community Paediatrics, FRCPCH
Community Paediatrician
East Kent Hospitals University NHS Foundation Trust
Dover, Kent, UK
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1. Introduction
Persistent and severe impairment of psychological development resulting from a high level
of inattentive, restless and impulsive behaviour is classified according to the fourth Diag‐
nostic and Statistical Manual of Mental Disorders (DSM-IV) as attention-deficit/hyperactivi‐
ty disorder (ADHD) [1] and according to the Tenth International Classification of Diseases
(ICD-10) as hyperkinetic disorder (HD) [2]. In both classifications the behaviours to be rec‐
ognized are very much the same, they differ mostly in the ways the symptoms are weighted
and combined into categories. The diagnostic criteria are in general broader in DSM-IV,
which is why ADHD is a more common diagnosis. The ICD-10 diagnosis of HD is a narrow‐
er category, where nearly all cases of HD fulfil the diagnostic criteria for ADHD [3].
Hyperactivity is the most noticeable symptom group in ADHD. Children are running and
climbing excessively, often in very inappropriate situations. They often fidget with their
hands or feet when they should seat still. They are always on the go and often act as if driv‐
en by a motor. Inattention is the second markmal of ADHD. Children often fail to give close
attention to details and make careless mistakes in their schoolwork or in other activities.
They do not seem to listen when spoken to directly, they often do not follow through in‐
structions and they fail to finish their schoolwork or other duties. Also, they have difficulties
organizing their tasks and activities. They are easily distracted by extraneous stimuli and
they tend to be forgetful in their daily activities. The third group of symptoms is impulsivi‐
ty. Children have difficulty waiting their turn and interrupt or intrude on others.
The term hyperactivity in this chapter is restricted to mean the combination of symptoms that
define overactive behaviour. The term ADHD symptoms is used to refer to the combination
of hyperactive, impulsive and inattentive symptoms.
The onset of the disorder is in early childhood, nearly always before the age of 5 and fre‐
quently even earlier. It often persists into adolescence and adult life [4]. Up to 65% of chil‐
© 2013 Gregoric Kumperscak; licensee InTech. This is an open access article distributed under the terms of
the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 2013 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, 
and reproduction in any medium, provided the original work is properly cited.
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dren with ADHD continue to experience symptoms as adults, however they manifest
differently in different age periods. Hyperactivity, for instance, is seldom a problem in
adults. It diminishes through adolescence and causes minimal or manageable problems in
adulthood. Impulsivity, on the other hand, can even increase in adolescence but diminishes
slightly through adulthood. The majority of ADHD problems in adults is caused by inatten‐
tion. Adults with ADHD are disorganized, inaccurate, frequently experiencing difficulties in
their relationships, at work and with finances [5,6].
Early recognition and treatment of ADHD is crucial, since longitudinal studies indicate that
inattentive and restless behaviour is a developmental risk. Untreated ADHD is also a risk
for a range of other mental disorders such as conduct disorder, oppositional defiant disor‐
der, depression, and substance abuse or addiction. Many children with ADHD present with
school difficulties including poor classroom participation and associated learning disabili‐
ties in reading, written expression, or mathematics. As a result, they receive low grades, are
retained in a grade level or do not complete the school at the level they started with [4-6].
Untreated ADHD is not only a burden for a person with the disorder and its family, but also
for a society in many aspects. For example, young adults with ADHD are more likely to be
apprehended for violations of traffic laws and to be cited more often for such violations [7].
The treatment of ADHD must be comprehensive and individually tailored. Psychological in‐
terventions, educational change, medication, education and support for parents and/or
teachers should be available. Multimodal interventions are usually indicated [4-6]. Most
children whose problems are severe enough to receive an ICD-10 diagnosis of HD will need
a medication [3]. There are clear guidelines about ADHD treatment including pharmaco‐
therapy, which, however, will not be discussed further in this chapter. The most prescribed
group of medication are psychostimulants and atomoxetine [8,9].
2. History
ADHD is not some new diagnosis made-up in these times when there is an increasing need
for children to sit longer and learn more. Already back in 1844 H. Hoffman wrote a story
about fidget Philip, and in 1890 W. James talked about the attention disorder as a deficit of
inhibitory control. In 1932 Kramer and Pollnow introduced the term hyperkinetic syndrome.
Only 4 years later (in 1937) the first psychostimulant was available. Strauss and Lethinen
used the term minimal cerebral dysfunction to refer to the same symptomatic condition.
World Health Organisation (WHO) introduced in ICD-8 hyperkinetic syndrome of child‐
hood, to change it in 1992 to hyperkinetic disorder. American Psychiatric Association (APA),
on the other hand, introduced in 1980 the term attention deficit disorder and 7 years later
Attention-deficit/hyperactivity disorder (ADHD) [4-6].
Originally, ADHD was thought to be a transient phenomenon because of the tendency for
symptoms (especially hyperactivity) to diminish as children reached adolescence. It is now
clear that the disorder persists into adolescence and into adulthood, but manifests different‐
ly in each developmental stage [6].
Attention Deficit Hyperactivity Disorder in Children and Adolescents4
3. DSM and ICD categorization
The DSM-IV classification is mostly used in North America and UK, while the ICD-10 is
more commonly used in Europe. DSM-V is to come in a year. There was a tendency to bring
definitions of ADHD and HD closer together, and indeed the criteria for the identification of
inattentive, hyperactive and impulsive symptoms are almost identical (see diagnostic crite‐
ria in Table 1). However, there are still significant differences in the number of criteria in
each domain required for a diagnosis, the role of inattention, the definition of pervasiveness
and the handling of comorbidity. The diagnosis of ADHD requires the presence of six inat‐
tentive or six hyperactive-impulsive symptoms, or both. The diagnosis of HD requires at
least six inattentive and three hyperactive as well as one impulsive symptom. Both ‒ ICD-10
and DSM-IV ‒ stress that the symptoms must be present by age 7 and in at least two settings
(home/school) [1,2].
In DSM-V, the age by which the symptoms should be present is to be changed from 7 to 12
years [10]. One of the reasons for this change is the concern about appropriate criteria for
adults. Population survey data indicated that in adults with ADHD, only half recalled onset
by age 7 but 95% recalled the onset by age 12 [11].
Because of heterogeneity of symptoms in ADHD, three different subtypes are distinguished
in the DSM-IV classification [1]:
• Attention-deficit/hyperactivity disorder, combined type: if both criteria A1 and A2 are
met for the past 6 months
• Attention-deficit/hyperactivity disorder, predominantly inattentive type (ADD): if crite‐
rion A1 is met but criterion A2 is not met for the past 6 months
• Attention-deficit/hyperactivity disorder, predominantly hyperactive-impulsive type: if
criterion A2 is met but criterion A1 is not met for the past 6 months.
HD is a narrower category than ADHD, and it appears that nearly all cases of HD fulfil the
diagnostic criteria of ADHD [3]. Most of the children fulfilling the ADHD diagnostic criteria
are not particularly impaired [6]. On the other hand, children with HD constitute the most
severe 20% of those with ADHD [6]. Both diagnostic schemes (DSM and ICD) have their ad‐
vantages and disadvantages. When assessing an individual child, first the fulfilment of the
ADHD criteria is checked, and if the latter are met, the HD criteria fulfilment is checked as
next. If the diagnostic criteria for HD are met, medication will be included in the treatment
approaches available [3].
Essential components of a full assessment process include a clinical interview, medical ex‐
amination and administration of rating scales to patients, parents and teachers. There are
broad-band instruments that evaluate general behavioural and psychosocial functioning,
among most used one being the Strengths and Difficulties Questionnaire (SDQ), Achenbach
scales and Conners’ Rating Scales (CRS) [8].
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A. Either (1) or (2):
(1) six (or more) of the following symptoms of inattention have persisted for at least 6 months to
a degree that is maladaptive and inconsistent with developmental level:
Inattention
(a) often fails to give close attention to details or makes careless mistakes in schoolwork, work,
or other activities
(b) often has difficulty sustaining attention in tasks or play activities
(c) often does not seem to listen when spoken to directly
(d) often does not follow through on instructions and fails to finish schoolwork, chores, or duties
in the workplace (not due to oppositional behavior or failure to understand instructions)
(e) often has difficulty organizing tasks and activities
(f) often avoids, dislikes, or is reluctant to engage in tasks that require sustained mental effort
(such as schoolwork or homework)
(g) often loses things necessary for tasks or activities (e.g., toys, school assignments, pencils,
books, or tools)
(h) is often easily distracted by extraneous stimuli
(i) is often forgetful in daily activities
(2) six (or more) of the following symptoms of hyperactivity/impulsivity have persisted for at
least 6 months to a degree that is maladaptive and inconsistent with developmental level:
Hyperactivity
(a) often fidgets with hands or feet or squirms in seat
(b) often leaves seat in classroom or in other situations in which remaining seated is expected
(c) often runs about or climbs excessively in situations in which it is inappropriate (in adolescents
or adults, may be limited to subjective feelings of restlessness)
(d) often has difficulty playing or engaging in leisure activities quietly
(e) is often “on the go” or often acts as if “driven by a motor”
(f) often talks excessively
Impulsivity
(g) often blurts out answers before questions have been completed
(h) often has difficulty awaiting turn
(i) often interrupts or intrudes on others (e.g., butts into conversations or games)
B. Some hyperactive-impulsive or inattentive symptoms that caused impairment were present
before age 7 years.
C. Some impairment from the symptoms is present in two or more settings (e.g., at school [or
work] and at home).
D. There must be clear evidence of clinically significant impairment in social, academic, or
occupational functioning.
E. The symptoms do not occur exclusively during the course of a pervasive developmental
disorder, schizophrenia, or other psychotic disorder and are not better accounted for by another
mental disorder (e.g., mood disorder, anxiety disorder, dissociative disorder, or a personality
disorder).
Table 1. Diagnostic criteria according to DSM-IV for attention-deficit/hyperactivity disorder [1].
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4. ADHD through different developmental stages
The only constant of ADHD symptoms is that they are changing in each particular child.
Not only from day to day, but also with development. In pre-school children, hyperactivity
is most obvious and impairing. Inattention becomes more salient once a child confronts
school demands. In adolescence and adulthood, hyperactivity diminishes, and inattention
and impulsiveness become most impairing, especially in social situations.
4.1. ADHD in children
4.1.1. Epidemiology
The prevalence of ADHD depends on the diagnostic measures used. In [12] survey, 10% of
the children in one elementary school in North Carolina had been given the diagnosis of
ADHD and 7% were taking medication [12]. An epidemiological study found a cumulative
incidence of ADHD in the elementary and secondary school population of 7.5% [13]. The
rate of lifetime childhood diagnosis of ADHD in another study [14] was 7.8%, 4.3% were
treated with medication [14]. Prevalence for HD is of course smaller, it is 1‒3% for children
aged 6‒14 years [4].
The ratio males : females is around 3 : 1, the prevalence is highest among school-aged boys,
and lowest in girls. But the prevalence in girls is more stable across the age [6].
4.1.2. Clinical picture
Hyperactivity is the most obvious and impairing symptom in children. At playing, hyperac‐
tive children are more often off-task and spend less time on a particular activity than their
non-hyperactive peers [6]. Hyperactive children are more active through the day [6]. Many
children without ADHD are occasionally hyperactive to some extent and this normal hyper‐
activity should not be confused with the more severe and persistent hyperactivity seen in
ADHD children. In ADHD hyperactivity is frequent, severe and persistent and most impor‐
tantly it interferes with a child’s peer and parental relationships, impeding their school per‐
formance and undermining their psychological well- being [6]. Not to forget that there must
be six symptoms from the hyperactivity domain present plus the criterion C (two or more
settings) plus criterion D (clear evidence of clinically significant impairment in social, aca‐
demic, or occupational functioning) to fulfil DSM-IV diagnostic criteria for ADHD [1].
Lack of hyperactivity, on the other hand, does not mean that a child does not have ADHD.
Inattentiveness is the most overlooked symptom, especially in pre-school children and in
particular in girls. Inattentive children are quiet, day-dreaming, sitting in the last row of the
classroom without bothering/disturbing anyone. They have “dreamy” symptoms, typical for
attention deficit disorder (ADD) [15] such as:
• difficulties in following instructions and organizing tasks
• tendency to avoid tasks
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• forgetfulness and tendency to lose things
Among ADHD subtypes, combined type seems to be the most common (43%), and also the
most severe and persistent one [15]. On the other hand, in [16] study the ADD type emerged
as the most prevalent. This study also revealed lower male : female ratios in ADHD diagno‐
ses than other studies, which implies that females and the ADD subtype could be under‐
diagnosed and/or undertreated [16].
Many children with ADHD present with school difficulties including failure to complete
their homework, poor test preparation and test-taking skills, poor organizational skills, poor
understanding of material, poor classroom participation and failure to ask teachers for need‐
ed help, disruptive behaviour in the classroom, and truancy. Children with ADHD who are
constantly singled out by their teachers and parents to “sit down” and “be quiet,” eventual‐
ly have a negative perception (low self-esteem) of themselves. By age 10, these children are
often behind their peers in terms of social and academic skills [17].
The social and academic impairments of children with ADHD cause stress within the fami‐
ly. Parents can become worried and anxious. Confronted with frustration, anger and self-
blame can present with lower self-esteem as parents and as a family. The family seeks a
social isolation, often self-imposed. It is difficult to determine if these effects are a result of
parenting a child with ADHD or if the parental psychopathology is contributing to the
child’s psychological reaction and disorder [6,17].
As ADHD is among most heritable of psychiatric disorders with a high risk for familial ag‐
gregation, it is quite common that ADHD children have parents with the same disease. This
fact further complicates the assessment, treatment and the course of disease. ADHD parents
may have impairment across a variety of domains, including parenting [18], which could be
the reason why many needed changes in a daily life of a child and family cannot/are harder
to be indorsed. 20% to 40% are likely to have the disorder themselves [19]. Families of chil‐
dren with ADHD display higher rates of alcoholism, substance abuse and depression than
families of children with Down's syndrome [20].
4.1.3. Comorbidity
Over 50% of children with ADHD have also comorbid disorders [4-6]. 35–50% have opposi‐
tional-defiant disorder, 25% conduct disorder, 15% are depressed and 25% have anxiety dis‐
order [6]. Learning disorder occurs in 15–40% of children, particularly among ADD.
Language impairment is present in 15–75% of children with ADHD [21,22].
Epilepsy  is  commoner  in  ADHD  children  compared  with  general  population.  36%  of
children with epilepsy met DSM-IV criteria for ADHD. Neither seizure type nor focus of
electroencephalographic (EEG) discharge predict the occurrence of ADHD, but there is a
tendency for ADHD to occur more frequently in those with generalized seizures [23].
Attention Deficit Hyperactivity Disorder in Children and Adolescents8
4.1.4. Course and prognosis
As normal children develop better impulse control, attention focus, other executive func‐
tions, and ability to remain calm as they mature, so do those with ADHD, just at slower
pace, lagging behind their age mates – usually never reaching them [5]. Various factors have
been suggested as predictors of persistence of ADHD symptoms into adolescence and adult‐
hood (among them family history of ADHD, childhood severity of ADHD, psychiatric co‐
morbidity and psychological adversity, impact of treatment ) [15]. Among all the factors,
studies have found that the childhood ADHD severity is a strongest predictor of persistence
of ADHD into adolescence and adulthood [5,24].
Regarding the impact of treatment (intensity and type) on ADHD outcome, the MTA study
found that neither the type nor intensity of 14 months of treatment for ADHD in childhood
(at age 7.0–9.9 years old) does not predict functioning six-to-eight years later. Rather, early
ADHD symptom trajectory regardless of treatment type is prognostic. This finding implies
that children with behavioural and sociodemographic advantage, with the best response to
any treatment, will have the best long-term prognosis [24]. The same study also found that
as a group, however, despite initial symptom improvement during treatment that is largely
maintained post-treatment, children with combined-type ADHD exhibit significant impair‐
ment in adolescence [24].
Across the life span, unmanaged ADHD can contribute to problems in social and academic
settings that coincide with the child’s developmental level. These are:
• Disruptive behaviour
• Oppositional defiant disorder
• Poor academic performance and learning delay
• Low self-esteem
• Poor social skills
• Parent-child relationship difficulties
• Physical injury
A review study found that children treated with stimulants for as long as 2 years showed
improvement in ADHD symptoms, comorbid oppositional defiant disorder and academic
and school functioning [25].
4.2. ADHD in adolescents
4.2.1. Epidemiology
ADHD does not remit with the onset of puberty. Follow-up studies show that a majority
(60‒85%) of children with ADHD will continue to meet criteria for the disorder during teen‐
age years (ages 13-18 years) [26].
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At adolescence, symptoms of hyperactivity and impulsivity related to ADHD tend to dimin‐
ish in intensity and are replaced with an inner restlessness, unableness to relax and feelings
of unhappiness when not occupied [5]. Impulsivity presents in adolescents as interruptions
of others, quick decisions, multitasking and feeling down when not occupied and feeling up
when something is happening [5]. Inattention presents as disorganization, poor time man‐
agement, not listening to what is being said and as forgetfulness.
The [15] study found variations within ADHD subtypes in children and adolescents in the
clinical population. Combined subtype is the most common one in childhood (43%), but in
adolescence ADD subtype is more common (64%) [15].
Symptoms of ADHD in adolescence most often manifest during instructional or vocational
situations. ADHD adolescents show signs of procrastination and disorganization with
schoolwork. 46.3% of them did not complete high school and 29.3% retained a grade level at
least once and 10.6% have been suspended from school. Feelings of tension, apprehension,
the need for reassurance, irritability, negative self-image, and physical complaints are re‐
ported in more than 70% of ADHD patients [7, 27].
4.2.3. Comorbidity
ADHD in adolescence, especially if not treated can result in further complication (school
suspension and/or expulsion, social exclusion, poor motivation, teen pregnancy, driving ac‐
cidents) and comorbid disorders (substance abuse or dependence, mood disorders, conduct
disorders) [7, 17, 28].
Adolescents with (untreated) ADHD are more prone to substance abuse than their peers. In
a [29] study the cumulative incidence of substance abuse disorders throughout adolescence
was compared in 56 medicated ADHD patients, 19 non-medicated ADHD patients, and 137
non-ADHD control subjects. The analysis was restricted to male subjects older than 15 years
of age. Substance abuse disorder was defined as any diagnosis of any of the following: alco‐
hol abuse/dependence (A/D), marijuana A/D, hallucinogen A/D, stimulant A/D, and cocaine
A/D [29]. Non-medicated ADHD patients were at a significantly higher risk for substance
abuse than either controls or medicated ADHD patients during the follow-up period of 4
years. However, there was no significant difference between medicated ADHD patients and
controls. Medication was found to be associated with an 85% reduction in the risk of sub‐
stance abuse in ADHD patients [29].
ADHD and substance use disorder (SUD) may share also biological  factors.  Familial  as‐
sociation  between  ADHD  and  SUD  is  strong,  which  suggests  that  two  disorders  may
share  genetic  or  other  familial  factors.  The offspring of  SUD parents  are  at  greater  risk
not only for SUD, but also for inattention, impulsivity, aggressiveness, hyperactivity and
ADHD [28].
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4.2.4. Course and prognosis
It  remains  difficult  to  predict  persistence  of  ADHD into  adulthood.  Controlling  for  se‐
verity  and  excluding  treatment,  none  of  the  other  variables  (sociodemographics,  child‐
hood  adversity,  traumatic  life  experiences  and  comorbidity)  significantly  predicted
persistence,  even though they were  significantly  associated with  childhood ADHD [30].
Many studies reported adult persistence was much greater for inattention than for hyper‐
activity/impulsivity [6,30].
4.3. ADHD in adults
4.3.1. Epidemiology
Being diagnosed with ADHD as an adult actually means that the condition has been present
since childhood, it just was not recognized or diagnosed at that time. Many follow-up stud‐
ies consistently documented the persistence of ADHD into adulthood, but the level of per‐
sistence has been inconsistent across studies [4-6, 31].
The first reason is the methodological, which includes changes in informant (patient’s pa‐
rents versus adult patient), use of different instruments to diagnose ADHD in adults, comor‐
bidity and diagnostic criteria [31]. Diagnostic criteria are designed for school-aged children
with regard to the number of symptoms required to meet the diagnostic threshold, which
can be developmentally inappropriate for adults. Adults can suffer significant impairment
even though they have fewer than six of nine symptoms needed for the diagnosis. The sec‐
ond reason is that differences in reported remission rates reflected the definition used for re‐
mission rather than disorder’s course [31].
The persistence of the full syndrome of ADHD in adulthood has been found to be between
2‒8% when self-report is used [31]. When parent report is used, the prevalence increases to
46% [28]. The [30] study reported that 1 in 3 childhood ADHD still met DSM-IV criteria
when aged 18- to 44-years [30]. In [32] study 40% of 18- to 20-year-old “grown up” ADHD
patients met full criteria for ADHD, but 90% had at least five symptoms of ADHD [32].
Taking all studies together, the rates of syndromatic remission of ADHD in adults are quite
in agreement; from 60% [32] to 65%‒70% [33]. But majority of subjects continue to struggle
with substantial number of ADHD symptoms and high levels of dysfunction despite a siza‐
ble rate of syndromatic remission by age 20 [32].
4.3.2. Clinical picture
ADHD symptoms in adults manifest quite differently from the way they manifest in chil‐
dren. Hyperactivity is not impairing any more. It is rare to see ADHD adults fidgeting
and/or running around. But some adult ADHD patients seem jittery and have trouble sitting
still. Some complain of having “ants in their pants” and may experience an irritating need to
pace [34]. Adults can learn through time to manage to settle their hyperactivity through ex‐
ercise or hard physical work. But if they are temporarily immobilized (broken leg, somatic
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illness) and are suddenly deprived of a coping method, their hyperactivity can present as
aggression and/or agitation [34].
Symptoms of inattentiveness and impulsivity in adults manifest as [34]:
• forgetfulness, particularly if it involves remembering tasks or jobs that need to be done.
They are often losing household items.
• unableness to keep track of several things at once
• difficulties in keeping promises or commitments to others
• making decisions impulsively, or on the spur of the moment, without thinking about the
consequences
• frequently misjudge how much time they have – or need – to do something. They express
difficulty with being on time.
• being unable to tear themselves away from something enjoyable to shift to a more urgent,
important task
• they describe themselves having quick temper and low tolerance for frustration
Adults with (untreated) ADHD are at greater risk for further complications compared with
general population: changing jobs and partners, unstable relationships, financial problems,
involvedness in car accidents, injuries, crime, and substance abuse. 16-year follow-up study
found that men who had ADHD as boys were significantly more likely to be financially de‐
pendent on their parents, less likely to graduate from college, and had a lower social class
than controls. These functional deficits are likely to be aggravated by the higher levels of
neuropsychological impairment, which was observed on psychometric tests and on behav‐
ioural measures of executive dysfunction [35].
In Norway study, only 22.2% adult ADHD patients had ordinary work as their source of in‐
come, compared with 72% in the general population [36]. Approximately 48% had junior
high school as their highest degree of education, compared with 29.8% in the general Nor‐
wegian population. Thus, more than half had an educational level not suited for most do‐
mains in the work market. Only 8.9% had a college or university degree, compared with
20.8% in the general population. 33% of ADHD patients were receiving disability pension
and 38% temporary social benefits. Maybe the most interesting founding in this study was
the fact that only 17.4% of participants with adult ADHD had been treated with central
stimulants by the age of 18. Results are suggesting that early recognition and drug treatment
of ADHD might protect against occupational impairment in adulthood [36].
Young adult drivers with ADHD were found to be nearly twice as likely to be cited for un‐
lawful speeding and to be cited more than three times as often as young adult subjects in the
control group. Drivers with ADHD had more than 5 times as many traffic citations on their
records than did controls [7].
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4.3.3. Comorbidity
As in children and adolescents, adult ADHD is often present with comorbid disorders,
which makes an accurate diagnosis even more difficult. Studies suggest that up to 90% of
adult patients with ADHD have one or more comorbid psychiatric disorders [37]. The most
common comorbid disorders in adults are anxiety disorders, affective disorders, substance
abuse and antisocial personality disorder. In [36] study, the most prevalent comorbid disor‐
ders were lifetime depression (37.8%), substance abuse (28.1%) and alcohol abuse (23.3%),
14.6% had anxiety disorder. More than 19% had received a diagnosis of personality disor‐
der. Interesting in this study was that more women then men had comorbid borderline per‐
sonality disorder [36]. It is important to know that comorbid psychiatrics disorders emerge
early on in development in childhood and adolescence [38].
Bipolar disorder coexists with adult ADHD in 6–20% cases. Many ADHD symptoms can be
mistakenly attributed to and overlooked because of bipolar disorder [37]. Interesting results
were found in [39] study, namely that ADHD brings significant impairment to bipolar pa‐
tients, especially in adaptation and social functioning, compared with bipolar patients with‐
out comorbid ADHD. Even more interestingly, the authors failed to detect a significant
impact of substance abuse on those same functional outcomes. This stresses out importance
of making an accurate diagnosis of ADHD also in patients where the symptomatology (im‐
pulsiveness, multitasking, not finishing work, changing partners etc.) can be incorporated in
another diagnosis (bipolar disorder) [39].
The high prevalence of comorbidity complicates the diagnostic process as well as treatment
and some studies indicate that high rates of comorbidity in adult ADHD contribute nega‐
tively to the treatment outcome [40].
Follow-up periods into adulthood showed that stimulant treatment in childhood also was
beneficial for social skills and self-esteem. Higher doses and longer treatment period pre‐
dicted less comorbidity and better social functioning [25].
ADHD in adults have striking similarities with paediatric samples regarding psychiatric
and cognitive impairment [41]. Some study suggest that the effect of stimulants is similar in
paediatric and adult samples, which is a reason to believe that adult patients also will have
long-term positive outcome [42].
5. Case report
8-year-old boy was admitted to Child and Adolescent Psychiatry Unit because he had been
experiencing increasing behavioural problems in the school during the last 3 months. He al‐
so showed slowness in mental tasks, was very impulsive, self-willed, irritable and displayed
enhanced verbal and physical aggression. History of problems revealed delayed schooling be‐
cause of expressive language disorder. He was in the first grade of the primary school at ad‐
mission, while his peers where in the second grade. His mother presented a list of
complaints as if they were copied from the ADHD diagnostic criteria ‒ he was always “on
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illness) and are suddenly deprived of a coping method, their hyperactivity can present as
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the go”, running and climbing whenever possible, when needed to sit still he was fidgeting,
he talked excessively, blurted out answers, he could not await his turn, he intruded on oth‐
ers, did not listen to what was being said, lost things daily, was easily distracted and his
school work was a disaster.
Developmental history revealed a risk pregnancy with malpresentation (not head down posi‐
tion of a fetus). He was the third child, prematurely born, with icterus and apnoeic attacks.
He was lagging in motor development (he walked independently at the age of 20 months)
and in language development (spoke the first words at the age of 3, he visited speech and
language therapist).
Family history was interesting since his father had symptoms of ADHD in his youth. One of
his two brothers uttered the first words at the age of five. General assessment at admission
showed clumsiness and stuttering. Further observations showed that he was easily distracted,
had lapses in attention, was overactive, impulsive and impatient. He usually acted without
thinking, behaved inappropriately, was verbally and physically aggressive towards co-pa‐
tients and medical staff, testing the limits all the time and showing stubbornness. He also
seemed unhappy, sad and angry with sudden changes in mood.
Neuropsychological tests found organic-cerebral dysfunction, psychomotor and visuospatial
disturbances and profound attention deficit with hyperactivity. His IQ at the time of testing
was borderline due to severe inattention and hyperactivity. He presented with diminished
inhibition, showed personally and emotionally less mature compared with his peers and he
has been found as quite egocentric. Basic laboratory tests (including thyroid levels) and EEG
were normal.
The boy fulfilled DSM-IV diagnostic criteria for ADHD – combined type. Because of his
changing mood and aggressive periods which were new in his behaviour, bipolar disorder
was considered as a possible differential diagnosis or comorbid disorder. His hyperactivity exist‐
ed ever since he was born and was not episodic (which is typical for hyperactivity in bipolar
disorder). He was easily distracted and mostly did not finish his tasks ‒ but not because of
flight of ideas, thought racing or delusions as seen in manic episodes. He was impulsive,
blurting answers and interrupting – again not because of pressured speech or impulsive
poor judgment as seen in manic episodes. His school performance was bad because of his
inattention and not because of the loss of interest – as seen in depressed episodes of bipolar
disorder. He was never grandiose and had never any appetite or weight changes often seen
in bipolar patients. He was diagnosed as ADHD combined type with comorbid oppositional-defi‐
ant and expressive language disorder. He received psychostimulants, we educated his parents
and his school teachers about the disorder and advised them about the behavioural manage‐
ment techniques. He continued visiting the speech therapists. He responded well to all in‐
troduced measures and we followed him for about a year when he moved to another city.
Nine years later (as 17-year-old) he was admitted again to our child and adolescent psychia‐
try ward. Parents complained about severe behavioural problems lasting for two years. He
threatened with suicide several times, had constant difficulties with authority, was disre‐
garding his safety and was involved in a series of injuries and accidents. He changed three
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secondary schools, without finishing the first year in any of them. He was staying at home
during the day, but went out in the evening taking his parent’s money. When he took 2000
EUR, they started suspecting drug abuse for the first time
He acted quite aloof at admission. He sat quietly and admitted that he was smoking mari‐
huana regularly for 3 years. He also tried ecstasy and cocaine several times – for the last
time the weekend before. He drank alcohol regularly when he was in a company of others,
otherwise he was too anxious. He had been playing poker for 3 years twice a week. He com‐
plained about his inner restlessness, which disappeared when he was on drugs or at least
when he drank something. He revealed that he had rather poor peer relationships – actually
he had no friends. He was unable to concentrate in school but had no problems concentrat‐
ing at poker game or at other pleasure activities (computer games, TV). He felt that he was a
loser; obviously he would not finish the school and he thought of suicide quite often.
He had been taking the medication for ADHD for two years (from the age of 8 till the age of
10), but stopped during the summer holidays. As he was no longer as hyperactive as before,
his parents decided that he did not need it anymore. With a lot of help of his parents and
instructors he somehow managed to finish the primary school, but at great cost – he strug‐
gled with extremely low self- esteem.
He was depressed and suicidal; anxious and tense but opponent to parents and medical
staff at admission.
Neuropsychological tests at second hospitalization found organic-cerebral dysfunction, psy‐
chomotor and visuospatial disturbances as at the first testing. Actual IQ was discrepant with
above average on verbal and lower borderline on non-verbal scale. Tests revealed executive
deficits with diminished inhibition, planning, controlling and anticipation. Depressive
symptomatic was also found.
He was fulfilling the DSM-IV diagnostic criteria for ADHD – inattentive type and for major de‐
pressive disorder. Again, bipolar disorder was considered as possible diagnosis, but was ex‐
cluded due to a constant pattern of inattention, impulsive and hyperkinetic problems,
without any episodic changes in ADHD or affective symptoms. He was treated with atom‐
oxetine and antidepressants and he attended the program for addicted/at risk adolescents
for a year. He managed to finish the first year of the secondary school. Then he stopped tak‐
ing the medication and attending the program and started with marihuana and occasionally
used other drugs again.
5.1. Discussion
Reported case describes prototypic ADHD child regarding the symptomatic and its chang‐
ing over development, family attitude to medication and family stress, comorbidity in child‐
hood and adolescence, and the course of disease.
It  often  happens  that  parents  endure  with  hyperactivity  symptoms and seek  help  only
when school performance is critical.  In severe ADHD cases, which also fulfil  more strict
ICD-10 diagnostic criteria for HD, the problems in school performance and behaviour are
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obvious already in the first  grade of  primary school  and are so severe that  parents  are
faced with the necessity for special  assessment and treatment.  Comprehensive treatment
that includes education and support to parents and teachers,  and also pharmacotherapy
is  very effective.  As in presented case,  children manage developmental  tasks quite  well
as  long the treatment  is  provided.  Hyperactivity  symptoms diminish with development
and many parents understand this as a signal that the child has grown up of the ADHD
and they stop with the treatment.
But  in  majority  of  ADHD cases,  the  symptoms only present  differently  but  continue to
interfere further in adolescent/adult life as inner restlessness, tension and irritability. Pa‐
tients have low school/work performance, are disorganized, have difficulties in social re‐
lationships,  often abuse drugs,  and are engaged in car  accidences.  As a further burden,
the  majority  of  them also  have comorbid disorders  such as  depression,  anxiety,  bipolar
disorder  and personality  disorder.  The stress  on family  grows and the  vicious  circle  of
self-blame, avoidance of social contacts and low self-esteem repeats.  In such cases,  com‐
prehensive treatment enables better schoolwork, settles inner restlessness and tension, re‐
sulting in lower need for drug abuse.
6. Conclusion
ADHD disorder is predominantly diagnosed in childhood, persisting into adolescence and
adulthood in majority of cases. With development the symptoms change, which is the rea‐
son why many of the adolescent and adult ADHD patients stay unrecognised. High comor‐
bidity in adolescence and adulthood is the second reason for ADHD unrecognition after
childhood. The fact is that it is quite difficult to consider ADHD when patients complain
about depressive symptoms, drug abuse or have a personality disorder. But with careful
personal history which also involves patient’s childhood (interview with patient’s parents)
and with the help of specialized ADHD questionnaires, ADHD can be properly diagnosed.
Comprehensive treatment is crucial in any developmental period. It is essential not only for
reducing the core ADHD symptoms, but also for preventing many consequences of untreat‐
ed ADHD and for ensuring better quality of life for patients and their families.
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1. Introduction
The DSM-5 [1], which should be published in 2013, will in all likelihood have a category
named Neurodevelopmental Disorders, under which ADHD will resort. This shift in nosol‐
ogy lays the foundation of the argument that will be put forward in this chapter, therefore
the following points need to be emphasised and warrants further discussion. Firstly, this
categorisation is based on shared aetiology, rather than shared symptoms or shared devel‐
opmental stage (as was the case with the DSM-IV-TR). Historically, disorders were classified
according to shared aetiology (as was the case with DSMI and DSM-II), as opposed to
shared symptomatology (as was the case with DSM-III and DSM-IVTR). The DSM-5 is to a
greater, or lesser, extent a combination of these as it proposes a change to the categorisation,
but not the symptoms of this disorder.
The second point is that the shared aetiology is a neurobiological based aetiology. The name of
the category implies that these disorders have a common, underlying, neurobiological
cause. The question which arises is to what extent these disorders do have an underlying
neurobiological cause, to what extent this is shared, and even to what extent these causes are
shared within the sub-categories of disorders, for example ADHD. Grouping these disorders
together implies a relatively homogenous group of disorders, and even further that the sub-
categories are homogenous within themselves. The DSM-5 makes provision for 4 sub-cate‐
gories of ADHD, i.e. the Combined, Predominantly Inattentive, Inattentive (Restrictive) and
predominantly Hyperactive/ Impulsive, presentations. Does the grouping of these sub-catego‐
ries necessarily imply that they share the same neurobiological aetiology? The argument
that will be put forward in this chapter is that although they all share a neurobiological
cause, this cause is not common and that the sub- categories may have subtle or gross, dif‐
ferences in these neurobiological factors.
© 2013 Burke and Edge; licensee InTech. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 2013 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, 
and reproduction in any medium, provided the original work is properly cited.
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The name of the category also implies a more fluid and dynamic process that starts in child‐
hood and may, or may not, extend across the lifespan into adulthood. This is in sharp con‐
trast to the more traditional, and rather rigid, distinction between adulthood and childhood
pathologies. This category allows for the straddling between childhood and adulthood path‐
ologies. An important point, which warrants emphasis, is that these disorders typically origi‐
nate in childhood, which may then extend into adulthood. Again, in sharp contrast to the
previous DSM classifications, the DSM-5 makes slightly more provision for ADHD in adult‐
hood. As far as the specific criteria, as well as the sub-categories, are concerned, the criteria
for ADHD in adulthood are rather superficial as it does not include the rather extensive re‐
search that has been done on the clinical manifestation of this disorder in adulthood, nor is it
explicit enough in terms of possible sub-categories of this disorder in adulthood. This cre‐
ates a picture of a rather homogenous disorder in adulthood which either influences, or is
perpetuated by, research on this topic.
As much as many Mental Health professionals would like to accept that the diagnosis of
ADHD in adulthood is a valid one, there is also still much scepticism about both the validity
of this disorder, as well as the clinical picture / diagnostic criteria. Some authors [2] postu‐
late that this scepticism may also be due to extensive, but poorly described, comorbid Axis I
and Axis II disorders. Although some may consider ADHD and Personality Disorders (spe‐
cifically Cluster B) to be co-morbid conditions, there are also those that would argue that
these Personality Disorders are often misdiagnosed as ADHD, or vice versa [3]. The roots of
the dilemma are twofold, i.e. that Personality Disorders are a separate and distinct set of dis‐
orders that do not have a biological underpinning and the arbitrary distinction between
childhood and adult pathology. If one removes both these problematic issues, and rather
view a disorder in terms of the aberrant development of behaviour, (neuro)cognition and
emotion (as opposed to “personality”) over time (rather than in life stages), a different pic‐
ture, i.e. one of either maturational lag or maturational deviance, emerges. The neurodeve‐
lopmental disorders, such as ADHD, are associated with a unique temperament that is
characterised by high novelty seeking, harm avoidance and low reward dependence [3]. The
question that arises is whether the neurodevelopmental and personality disorders are the re‐
sult of the same underlying neurological process, or whether they are parallel processes that
may or may not have reciprocal effects on each other [4]. On a theoretical level, i.e. the ma‐
turational lag theory, these two categories of disorders may be considered together, if it is
indeed that the maturational lag theory holds true for both of them.
2. Neurodevelopment of ADHD
The use of the concept neurodevelopment in the categorisation and organisation of disor‐
ders in the DSM-5 suggests that variant disorders can be arranged according to specific neu‐
rodevelopmental pathways. It is understood that the developmental pathway may account
for the neurobiological underpinnings, and thus aetiological foundation of the syndrome ob‐
served. Two neurodevelopmental models, namely the maturational lag model and the develop‐
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mental deviation model, appear to be particularly relevant to the syndrome of ADHD. In this
section evidence supporting these two views will be reported.
2.1. Maturational lag in ADHD
While some evidence has suggested that the ADHD brain develops in fundamentally differ‐
ent ways to typical ones, other results have argued that they are just the result of a lag in the
normal timetable for development, which is known as the maturational lag model [5]. This
model of ADHD is organised around the notion that that the behaviours of a child with
ADHD is abnormal merely in reference to his or her age [5]. This direction in thinking was
initially based on observations that children with ADHD behave similarly to younger chil‐
dren who are more active, impulsive and exhibit a shorter attention span [6]. According to
this model [5], “if the child was younger, the findings would be regarded as normal” (p.
268). He further postulates that the neurological factors that limit the performance of a child
with ADHD are synonymous to that which typically limits the performance of younger chil‐
dren. Hence, the maturational lag model [5] stipulates that an individual with ADHD
presents with a relative delay in certain aspects of their neurological maturation, but that
maturation will eventually ‘catch up’. On average, the brain of ADHD children matured
about three years later than those of their peers, with 50% of their cortex only reaching maxi‐
mum thickness at age 10 years 6 months as opposed to 7 years and 6 months of those chil‐
dren without ADHD [7]. The lags in maturation seem to differ from one cortical area to the
next, for example, the lag in the prefrontal cortex can be as high as 5 years. In other areas,
the ADHD brain seems to mature faster than in a non-ADHD brain, an example being the
primary motor cortex. These researchers draw the conclusion that their findings support the
hypothesis of maturational lag, not maturational deviance.
Nearly 50 years of electrophysiological (EEG) research in the realm of ADHD suggest that
children and adolescents who present with the disorder display abnormalities in their EEG
[8]. The abnormalities observed are either organised according to the maturational lag or de‐
velopmental deviation model. From an EEG perspective, the maturational lag model sug‐
gests that an individual with ADHD should present with cortical activity that is similar to
that witnessed in younger children [9, 10], since an increase in slow wave activity (delta and
theta) and decreased fast wave activity (alpha and beta) is typical in younger children [11].
A number of researchers [12-16] interpret their findings of increased slow wave activity in
children and adolescents with ADHD during an eyes closed resting condition as evidence of
a maturational lag. Additional EEG support for the maturational lag is presented in Table 1.
2.2. Maturational deviance in ADHD
The second neurodevelopmental model is that of the developmental deviation, also known
as maturational deviance, which proposes that maturation is not necessarily lagging, but
that it is not approaching normality or maturation, and that it is unlikely to do so at any
stage during the lifespan. This model was built on EEG research where 90% of the ADHD
sample presented with aberrances in their EEG activity [17]. Subsequently, the developmen‐
tal deviation model of ADHD came into play, which suggests that ADHD results from ab‐
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The name of the category also implies a more fluid and dynamic process that starts in child‐
hood and may, or may not, extend across the lifespan into adulthood. This is in sharp con‐
trast to the more traditional, and rather rigid, distinction between adulthood and childhood
pathologies. This category allows for the straddling between childhood and adulthood path‐
ologies. An important point, which warrants emphasis, is that these disorders typically origi‐
nate in childhood, which may then extend into adulthood. Again, in sharp contrast to the
previous DSM classifications, the DSM-5 makes slightly more provision for ADHD in adult‐
hood. As far as the specific criteria, as well as the sub-categories, are concerned, the criteria
for ADHD in adulthood are rather superficial as it does not include the rather extensive re‐
search that has been done on the clinical manifestation of this disorder in adulthood, nor is it
explicit enough in terms of possible sub-categories of this disorder in adulthood. This cre‐
ates a picture of a rather homogenous disorder in adulthood which either influences, or is
perpetuated by, research on this topic.
As much as many Mental Health professionals would like to accept that the diagnosis of
ADHD in adulthood is a valid one, there is also still much scepticism about both the validity
of this disorder, as well as the clinical picture / diagnostic criteria. Some authors [2] postu‐
late that this scepticism may also be due to extensive, but poorly described, comorbid Axis I
and Axis II disorders. Although some may consider ADHD and Personality Disorders (spe‐
cifically Cluster B) to be co-morbid conditions, there are also those that would argue that
these Personality Disorders are often misdiagnosed as ADHD, or vice versa [3]. The roots of
the dilemma are twofold, i.e. that Personality Disorders are a separate and distinct set of dis‐
orders that do not have a biological underpinning and the arbitrary distinction between
childhood and adult pathology. If one removes both these problematic issues, and rather
view a disorder in terms of the aberrant development of behaviour, (neuro)cognition and
emotion (as opposed to “personality”) over time (rather than in life stages), a different pic‐
ture, i.e. one of either maturational lag or maturational deviance, emerges. The neurodeve‐
lopmental disorders, such as ADHD, are associated with a unique temperament that is
characterised by high novelty seeking, harm avoidance and low reward dependence [3]. The
question that arises is whether the neurodevelopmental and personality disorders are the re‐
sult of the same underlying neurological process, or whether they are parallel processes that
may or may not have reciprocal effects on each other [4]. On a theoretical level, i.e. the ma‐
turational lag theory, these two categories of disorders may be considered together, if it is
indeed that the maturational lag theory holds true for both of them.
2. Neurodevelopment of ADHD
The use of the concept neurodevelopment in the categorisation and organisation of disor‐
ders in the DSM-5 suggests that variant disorders can be arranged according to specific neu‐
rodevelopmental pathways. It is understood that the developmental pathway may account
for the neurobiological underpinnings, and thus aetiological foundation of the syndrome ob‐
served. Two neurodevelopmental models, namely the maturational lag model and the develop‐
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mental deviation model, appear to be particularly relevant to the syndrome of ADHD. In this
section evidence supporting these two views will be reported.
2.1. Maturational lag in ADHD
While some evidence has suggested that the ADHD brain develops in fundamentally differ‐
ent ways to typical ones, other results have argued that they are just the result of a lag in the
normal timetable for development, which is known as the maturational lag model [5]. This
model of ADHD is organised around the notion that that the behaviours of a child with
ADHD is abnormal merely in reference to his or her age [5]. This direction in thinking was
initially based on observations that children with ADHD behave similarly to younger chil‐
dren who are more active, impulsive and exhibit a shorter attention span [6]. According to
this model [5], “if the child was younger, the findings would be regarded as normal” (p.
268). He further postulates that the neurological factors that limit the performance of a child
with ADHD are synonymous to that which typically limits the performance of younger chil‐
dren. Hence, the maturational lag model [5] stipulates that an individual with ADHD
presents with a relative delay in certain aspects of their neurological maturation, but that
maturation will eventually ‘catch up’. On average, the brain of ADHD children matured
about three years later than those of their peers, with 50% of their cortex only reaching maxi‐
mum thickness at age 10 years 6 months as opposed to 7 years and 6 months of those chil‐
dren without ADHD [7]. The lags in maturation seem to differ from one cortical area to the
next, for example, the lag in the prefrontal cortex can be as high as 5 years. In other areas,
the ADHD brain seems to mature faster than in a non-ADHD brain, an example being the
primary motor cortex. These researchers draw the conclusion that their findings support the
hypothesis of maturational lag, not maturational deviance.
Nearly 50 years of electrophysiological (EEG) research in the realm of ADHD suggest that
children and adolescents who present with the disorder display abnormalities in their EEG
[8]. The abnormalities observed are either organised according to the maturational lag or de‐
velopmental deviation model. From an EEG perspective, the maturational lag model sug‐
gests that an individual with ADHD should present with cortical activity that is similar to
that witnessed in younger children [9, 10], since an increase in slow wave activity (delta and
theta) and decreased fast wave activity (alpha and beta) is typical in younger children [11].
A number of researchers [12-16] interpret their findings of increased slow wave activity in
children and adolescents with ADHD during an eyes closed resting condition as evidence of
a maturational lag. Additional EEG support for the maturational lag is presented in Table 1.
2.2. Maturational deviance in ADHD
The second neurodevelopmental model is that of the developmental deviation, also known
as maturational deviance, which proposes that maturation is not necessarily lagging, but
that it is not approaching normality or maturation, and that it is unlikely to do so at any
stage during the lifespan. This model was built on EEG research where 90% of the ADHD
sample presented with aberrances in their EEG activity [17]. Subsequently, the developmen‐
tal deviation model of ADHD came into play, which suggests that ADHD results from ab‐
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normalities in CNS functioning [9]. It further denotes that the EEGs of children and
adolescents with ADHD symptoms are not considered normal in children of any age and
that it is also not likely to mature in a normal fashion [9]. Additional evidence for this model
is provided by the adult ADHD (ADHD) studies which found that the presence of elevated
slow wave activity, especially theta, persists into adulthood [18-19].
2.3. Summary and conclusion
The research referred to in this section was concerned with the investigation of cortical ac‐
tivity patterns in adults with ADHD via EEG methodologies. The research was specifically
interested in the cortical activity patterns of adults with ADHD symptomatology at frontal,
frontal midline and parietal sites seeing that these areas are often the most heavily implicat‐
ed in ADHD. From existing literature, it can be concluded that there is evidence that sup‐
ports both the maturational lag as well as the maturational deviance models (See Table 1).
EEG Based
Model
Description of Model EEG Findings References
Maturational Lag Individuals with ADHD symptoms
present with cortical activity
patterns that is similar to that
witnessed in younger children
Increased relative and/or absolute slow wave activity
and decreased relative and/or absolute fast wave
activity
Increased frontal relative and/or absolute theta
Increased absolute and/or relative delta in temporal
and parietal sites
Decreased relative and/or absolute alpha and beta
power in temporal and parietal sites
[8 -16, 20 – 27]
Developmental
Deviation
ADHD symptoms result from
abnormalities in CNS functioning.
The EEGs of individuals with ADHD
symptoms are not considered
normal in individuals of any age and
is not likely to mature in a normal
fashion.
Increased absolute and/or relative theta activity in
frontal and frontal midline sites.
Decreased relative alpha activity in parietal and
temporal sites.
Decreased absolute and relative beta activity in frontal,
parietal and temporal sites
Elevated theta/beta and theta/alpha ratios
[9,19,26,28,
29]
Table 1. EEG support for the maturational lag and developmental deviation models
3. Personality disorders
Personality and psychopathology have, throughout the 20th  century, been viewed as sep‐
arate but related domains. Although they have been viewed as related domains, the ex‐
act  relationship  remains  largely  unclear.  In  1980,  within  psychopathology,  clinical
syndromes were separated from personality disorders [34]. Splitting these domains high‐
lighted the  overlap between symptoms of  clinical  and personality  disorders  [34],  which
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is  also the foundation for on-going debates concerning the comorbidity between ADHD
in adulthood and personality disorders. If one adopts a neurobiological /  neurocognitive
approach to personality, then the overlap between temperament, personality and person‐
ality  disorders  becomes  more  evident.  Furthermore,  given  the  mounting  evidence  that
ADHD can  persist  from childhood into  adulthood,  it  also  follows  that  there  should  be
more focus on the relationship between personality  and ADHD [35].  Some authors  [36]
maintain that is important to describe ADHD in adulthood in terms of general personali‐
ty structures as it could contribute to a better conceptualization of the disorder. Further‐
more,  there  are  suggestions  that  there  is  evidence  that  indicates  that  developmental
factors  may contribute  to  ADHD in  ways  that  are  separate  from the  associated  behav‐
iour problems. One could go further by saying that it is important to describe personali‐
ty disorders (from a neurobiological perspective) in adults with ADHD, as this could aid
in  describing a  possible  shared aetiology.  In  fact  one could go as  far  as  to  say that  in‐
complete  descriptions  of  Personality  Disorders  in  ADHD continue  to  place  pressure  on
the  validity  of  the  diagnosis  in  adulthood  [2].  Although  there  have  been  a  number  of
studies that have focused on the relationship between ADHD and personality, some au‐
thors [35] maintain that these studies have focussed on only a narrow range of personali‐
ty  constructs.  Table  2  provides  a  summary  of  personality  constructs  that  have  been




Characteristic of Cluster B Personality
Disorder
Sensation Seeking / External stimulation seeking [38, 39] Antisocial [49]
Behavioural disinhibition / Impulsivity [40, 41] Antisocial and Borderline [45]
Borderline [46, 48, 51]
Self-regulation [40] Borderline, Antisocial and Histrionic [50]
Axis II disorders [52]
Externalizing problem behaviours [42] Antisocial [50]
Emotional lability [41] Borderline [44]
Antisocial and Borderline [45]
Low reward dependence [43] Antisocial [47]
Uncooperativeness [43] Borderline [46]
Table 2. Summary of personality constructs identified in ADHD and possible links with Cluster B disorders
There has traditionally been a great but, arguably unwarranted [43], emphasis on the preva‐
lence of Cluster B personality disorder in adults with ADHD. This study, in effect wants to
investigate whether there is some shared neurodevelopmental process in both of these sets
of disorders. The argument is based on the following postulates:
• ADHD is a neurodevelopmental disorder and is the result of either maturational lag or
maturational deviation
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normalities in CNS functioning [9]. It further denotes that the EEGs of children and
adolescents with ADHD symptoms are not considered normal in children of any age and
that it is also not likely to mature in a normal fashion [9]. Additional evidence for this model
is provided by the adult ADHD (ADHD) studies which found that the presence of elevated
slow wave activity, especially theta, persists into adulthood [18-19].
2.3. Summary and conclusion
The research referred to in this section was concerned with the investigation of cortical ac‐
tivity patterns in adults with ADHD via EEG methodologies. The research was specifically
interested in the cortical activity patterns of adults with ADHD symptomatology at frontal,
frontal midline and parietal sites seeing that these areas are often the most heavily implicat‐
ed in ADHD. From existing literature, it can be concluded that there is evidence that sup‐
ports both the maturational lag as well as the maturational deviance models (See Table 1).
EEG Based
Model
Description of Model EEG Findings References
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and decreased relative and/or absolute fast wave
activity
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[8 -16, 20 – 27]
Developmental
Deviation
ADHD symptoms result from
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The EEGs of individuals with ADHD
symptoms are not considered
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is not likely to mature in a normal
fashion.
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temporal sites.
Decreased absolute and relative beta activity in frontal,
parietal and temporal sites
Elevated theta/beta and theta/alpha ratios
[9,19,26,28,
29]
Table 1. EEG support for the maturational lag and developmental deviation models
3. Personality disorders
Personality and psychopathology have, throughout the 20th  century, been viewed as sep‐
arate but related domains. Although they have been viewed as related domains, the ex‐
act  relationship  remains  largely  unclear.  In  1980,  within  psychopathology,  clinical
syndromes were separated from personality disorders [34]. Splitting these domains high‐
lighted the  overlap between symptoms of  clinical  and personality  disorders  [34],  which
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is  also the foundation for on-going debates concerning the comorbidity between ADHD
in adulthood and personality disorders. If one adopts a neurobiological /  neurocognitive
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in  describing a  possible  shared aetiology.  In  fact  one could go as  far  as  to  say that  in‐
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Table 2. Summary of personality constructs identified in ADHD and possible links with Cluster B disorders
There has traditionally been a great but, arguably unwarranted [43], emphasis on the preva‐
lence of Cluster B personality disorder in adults with ADHD. This study, in effect wants to
investigate whether there is some shared neurodevelopmental process in both of these sets
of disorders. The argument is based on the following postulates:
• ADHD is a neurodevelopmental disorder and is the result of either maturational lag or
maturational deviation
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• In some cases ADHD does not continue beyond adolescence (which is in line with the ma‐
turational lag hypothesis), however
• ADHD may continue into adulthood, which cannot be explained fully by the maturation‐
al lag hypothesis.
• The is a reportedly high prevalence of personality disorders in adults with ADHD
• There is evidence of both maturational lag and deviation processes in personality disorders.
If these postulates are correct, the question that arises is whether these two disorders could
be the result of the same neurodevelopmental process. Most, if not all, of the characteristics
mentioned in Table 2 have an underlying neuropsychological or neurobiological correlate.
These neurobiological correlates may be the result of either a maturational lag or matura‐
tional deviance process, depending on which personality disorder one focuses on. One way
of distinguishing between these two hypotheses, would be to consider the course and prog‐
nosis of the different personality disorders. Regarding the Cluster B personality disorders,
two interesting pictures evolve when reviewing course and prognosis, and these may, argu‐
ably be classified as maturational lag or maturational deviation.
3.1. Maturational lag
The roots of the development of Antisocial Personality Disorder can be traced to early ado‐
lescence (i.e. Conduct Disorder) which then follows an unremitting course, with a variable
outcome. There is some evidence that suggests that the symptoms decrease with age [53].
The fact that the symptoms may decrease with age, is somewhat suggestive of a delayed
maturation process [54]. A further indication of a maturational lag is the fact that there is
excessive theta wave activity, while awake, which is akin to what is evident in younger chil‐
dren [54]. One explanation for this could be the temporal discounting paradigm which
quantifies the ability to favour larger, delayed rewards over smaller, more immediate re‐
wards. Temporal discounting matures with age, along with increased impulse control and
self-regulation. This maturation seems to be associated with changes in activation of the
ventromedial prefrontal cortex, anterior cingulate cortex, ventral striatum, insula, inferior
temporal gyrus and posterior parietal cortex [55].
Although it is reported that adults with a histrionic personality disorder display less symp‐
toms as they age [53], it is uncertain whether this is truly due symptoms diminishing due to
maturation, or whether this is merely due to a decline in energy levels due to aging.
3.2. Maturational deviation
In the case of both borderline and narcissistic personality disorders, the disorders are stable
over time showing neither intensifying or decline in symptoms [53]. Unlike antisocial per‐
sonality disorder, the DSM does not make provision for early identification of these disor‐
ders; however, some research does provide some evidence for the early identification of
specifically borderline personality disorder [56]. Although there is some evidence of epilep‐
tiform activity in borderline personality disorder [57], the prevalence is not high enough to
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substantiate that this disorder is due to abnormal brainwave activity. Abnormal brainwave
activity is only one of the many possible neurobiological factors in this disorder and other
factors such as neurotransmitter systems, the endogenous opioid system [58] and various
sub-cortical areas have been included as possible contributing causes to this disorder. De‐
spite numerous studies thyat have been done, the neurobiology of borderline personality
disorder still remains largely unclear [58]. If there is evidence of neurobiological processes,
and that symptoms do not appear to improve over time, one could deduce that these (nar‐
cissistic and borderline) are due to maturational deviation, rather than maturational lag.
3.2.1. Method
This study formed part of a much larger project, and this study itself was larger than what is
reported here. The research question for this study is focused exclusively on maturational
delay versus maturational deviation. Due to the fact that the existing literature seems to fo‐
cus mainly on Cluster B personality disorders, and that EEG studies in relation to the re‐
search question focus mainly on resting state EEG recordings, this study does the same.
Therefore, although there is more information available than reported here, it will be limited
to what is pertinent to the research question only.
3.2.2. Participants
In order to address the research goals the study utilised purposive sampling methods to
identify the ADHD sample. All participants had to be older than 18 years of age and as far
as the other including characteristics are concerned, the researchers had to utilise their
judgement to identify and select individuals from a target population that qualify for partic‐
ipation in the study, based on the sample characteristics [59]. During the initial phases of the
sampling procedure the researchers verbally marketed the research undertaking to profes‐
sional practitioners (mostly psychiatrists and psychologists). Furthermore participants who
were selected on the basis of purposive sampling also nominated acquaintances whom they
believed may qualify for participation in the research. In the initial phase the target popula‐
tion was broadly defined by observed ADHD type behaviours that may be explained by the
syndrome and may be potentially differentially diagnosed from other clinical conditions.
Participants who were subject to the exclusion criteria were not included in the study. The
list of exclusion criteria are informed by similar EEG studies [18, 60-62] which included:
• Psychoactive medication, with the exception of methylphenidate (ADHD related medica‐
tion), in which case participants were asked to refrain from taking the medication for a
minimum of 24 hours prior to the assessment.
• History of a neurological disorder, head injury or CNS infection.
• History of substance use disorder in the previous two months.
• Evidence of another Axis I or Axis II disorder.
• Current diagnosis of hypothyriodism.
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• In some cases ADHD does not continue beyond adolescence (which is in line with the ma‐
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• There is evidence of both maturational lag and deviation processes in personality disorders.
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ventromedial prefrontal cortex, anterior cingulate cortex, ventral striatum, insula, inferior
temporal gyrus and posterior parietal cortex [55].
Although it is reported that adults with a histrionic personality disorder display less symp‐
toms as they age [53], it is uncertain whether this is truly due symptoms diminishing due to
maturation, or whether this is merely due to a decline in energy levels due to aging.
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In the case of both borderline and narcissistic personality disorders, the disorders are stable
over time showing neither intensifying or decline in symptoms [53]. Unlike antisocial per‐
sonality disorder, the DSM does not make provision for early identification of these disor‐
ders; however, some research does provide some evidence for the early identification of
specifically borderline personality disorder [56]. Although there is some evidence of epilep‐
tiform activity in borderline personality disorder [57], the prevalence is not high enough to
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sub-cortical areas have been included as possible contributing causes to this disorder. De‐
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disorder still remains largely unclear [58]. If there is evidence of neurobiological processes,
and that symptoms do not appear to improve over time, one could deduce that these (nar‐
cissistic and borderline) are due to maturational deviation, rather than maturational lag.
3.2.1. Method
This study formed part of a much larger project, and this study itself was larger than what is
reported here. The research question for this study is focused exclusively on maturational
delay versus maturational deviation. Due to the fact that the existing literature seems to fo‐
cus mainly on Cluster B personality disorders, and that EEG studies in relation to the re‐
search question focus mainly on resting state EEG recordings, this study does the same.
Therefore, although there is more information available than reported here, it will be limited
to what is pertinent to the research question only.
3.2.2. Participants
In order to address the research goals the study utilised purposive sampling methods to
identify the ADHD sample. All participants had to be older than 18 years of age and as far
as the other including characteristics are concerned, the researchers had to utilise their
judgement to identify and select individuals from a target population that qualify for partic‐
ipation in the study, based on the sample characteristics [59]. During the initial phases of the
sampling procedure the researchers verbally marketed the research undertaking to profes‐
sional practitioners (mostly psychiatrists and psychologists). Furthermore participants who
were selected on the basis of purposive sampling also nominated acquaintances whom they
believed may qualify for participation in the research. In the initial phase the target popula‐
tion was broadly defined by observed ADHD type behaviours that may be explained by the
syndrome and may be potentially differentially diagnosed from other clinical conditions.
Participants who were subject to the exclusion criteria were not included in the study. The
list of exclusion criteria are informed by similar EEG studies [18, 60-62] which included:
• Psychoactive medication, with the exception of methylphenidate (ADHD related medica‐
tion), in which case participants were asked to refrain from taking the medication for a
minimum of 24 hours prior to the assessment.
• History of a neurological disorder, head injury or CNS infection.
• History of substance use disorder in the previous two months.
• Evidence of another Axis I or Axis II disorder.
• Current diagnosis of hypothyriodism.
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All participants were subject to the clinical interview, and screened for a ‘best estimate’ di‐
agnosis for ADHD by means of the ASRS-v.I.I. and also with the MCMI-III [63] for differen‐
tial diagnosis of other clinical syndromes. The nature of these assessment tools and rationale
for their use are discussed below. The recruitment of participants resulted in a group of 51
adults with ADHD and a group of 43 adults with no clear indications of a clinical disorder.
For the EEG study an initial 15 potential ADHD research participants were identified from the
bigger pool, however, on further investigation 3 participants were excluded from further anal‐
ysis on the basis that they met the criteria for another clinical condition. Subsequently 12 partic‐
ipants met the operational criteria to constitute the ADHD EEG study population. These
participants were first subject to the EEG assessment before the age- and gender- matched non-
ADHD sample was identified. The reason for this was to ensure that no further participants
needed to be excluded and that the non-ADHD sample could be matched on the characteristics
of the final ADHD sample. Two individuals were further excluded from the study population
on the basis that the one participant experienced excessive drowsiness and another participant
presented with significant muscle movement that may confound the obtained results. Subse‐
quently, 10 participants were included in the research sample for the ADHD group. This sam‐
ple met the necessary operational criteria for the inclusion in the study and produced an EEG
reading that is acceptable according to the quality standards. The mean sample age for the
ADHD group was 34.4 years. The female to male ratio was 3:1.
Following the identification of the research sample for the experimental group the study set
out to identify an age- and gender- matched healthy non-ADHD group. Matched sampling
for this group took place by purposively selecting participants from the initial pool of poten‐
tial participants. The sampling of this group was matched exactly to gender and approxi‐
mately within a four year range of the target age criterion. Subsequently the non-ADHD
research sample that was identified exhibited a mean sample age of 33.6 years with a similar
female to male ratio as the experimental group.
3.2.3. Measurement instruments
One of the main challenges in this study was to accurately identify adults with a diagnosis of
ADHD. Due to the fact that ADHD, specifically in adulthood, is not a widely accepted diagno‐
sis, or in other cases an over diagnosed disorder, one cannot rely only on formal diagnoses
made by Mental Health Professionals. Added to this is the problem of a high rate of self-diag‐
nosis of this disorder amongst adults [64], which brings into question relying only on self-re‐
port questionnaires to identify possible participants. For this reason, over and above the
MCMI-III, a semi-structured interview and a self-report questionnaire were also included.
Semi-Structured Clinical Interview. The interview was conducted by any one of the trained clini‐
cal psychologists that formed part of the research team. The purpose of the interview was to en‐
sure that participants met the sampling characteristics mentioned above and to make certain
that none of the exclusion criteria were present in the respective population. The interview also
obtained information regarding the biographical information of participants. Furthermore it
served as a quick screening conformational tool by exploring the presence or absence of the cri‐
teria for ADHD in adulthood as proposed by a number of authors [65, 66].
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Adult ADHD Self-Report Scale (ASRS). The ASRS is not a diagnostic tool but is used as a
screening device to screen for signs and symptoms of adult ADHD. The Adult ADHD Self-
Report Scale (ASRS) is a self-report 18 question questionnaire which screens adults for
ADHD [67]. The ASRS is based on the criteria listed in the DSM IV, on ADHD [68]. Half of
the questions focus on inattention and half of the questions focus on hyperactivity [69]. It is
a paper pencil questionnaire which is self-scored and only takes 5 minutes to complete [67].
It has a five point Likert scale, where the testee ticks one of five responses, never, rarely,
sometimes, often and very often [67]. The ASRS has demonstrated good reliability and val‐
idity in clinical and community samples [68]. The ASRS also has high-quality predictive
power with values between 57 and 93%, showing that it can predict ADHD[70]. The ASRS
proves good internal consistency with values between 0.75 and 0.89 [69]. Concordance was
calculated by looking at the symptom responses of the ASRS and comparing the responses
to clinical ratings, of which Cohen’s k was used to assess this concordance [67]. The con‐
cordance however varied with a range of.16 to.81, which could be the result of error of
measurement or the experience of the clinicians [67]. The total classification accuracy rated
at 96%, however, the ASRS showed moderate levels of concurrent validity and sensitivity
but high levels of specificity [69].
Millon Clinical Multi-axial Inventory-III. This test is primarily a self-report questionnaire that
assesses a wide range of information about an adult’s personality and emotional adjustment
[71]. Furthermore this instrument was designed as a diagnostic tool that yields information
about personality disorders as well as clinical syndromes [72]. The test consists of 175 ques‐
tions that are forced-choice, true-false items [73]. The MCMI III has 28 sub-scales, of which
are categorized into five different categories [71], i.e. Modifying Indices, Clinical Personality
Patterns, Severe Personality Pathology, Clinical Syndromes, and Severe Syndromes. For the
purposes of this study base rate scores below 75 were considered to be indications of no
clinical significance, 75 – 84 as indicative of the presence of a personality trait, and 85 and
higher as persistent personality traits [73].
The results for the internal consistency was :66 for the compulsive scales and 0.90 for major
depression, and the Cronbach alpha’s for the remaining 26 scales exceeded.80, showing
strong internal consistency [73]. Test-retest reliability scores indicated the lowest score of.82
for debasement and the highest was.96 for somatoform, of which the median test-retest coef‐
ficient was.91, which shows stability of the instrument over time [71].
Construct and concurrent validity is tested by looking at how well the instrument performs in
different populations and how much value it has in the real world [73]. The manner in which
this is achieved was by comparing the MCMI to accepted standards achieved by other tests,
comparing the scales on the MCMI to other scales on different tests [73]. It was identified that
there is a high correlation between the scales of the MCMI-III and seven different tests, namely
the symptom checklist-90, the Beck Depression Inventory, the State-Trait Anxiety Inventory,
the General Behaviour Inventory, the Minnesota Multiphasic Personality Inventory (MMPI),
the Michigan Alcoholism Screening Test and the MCMI-II [71]. The correlations on most of the
scales where good, with some having negative scores, but these items were not related to the
specific scales on the MCMI-III. Further evidence to assess how well the MCMI-III scales meas‐
Neurodevelopmental Pathways of Childhood ADHD into Adulthood: Maturational Lag, Deviation, or Both?
http://dx.doi.org/10.5772/53865
29
All participants were subject to the clinical interview, and screened for a ‘best estimate’ di‐
agnosis for ADHD by means of the ASRS-v.I.I. and also with the MCMI-III [63] for differen‐
tial diagnosis of other clinical syndromes. The nature of these assessment tools and rationale
for their use are discussed below. The recruitment of participants resulted in a group of 51
adults with ADHD and a group of 43 adults with no clear indications of a clinical disorder.
For the EEG study an initial 15 potential ADHD research participants were identified from the
bigger pool, however, on further investigation 3 participants were excluded from further anal‐
ysis on the basis that they met the criteria for another clinical condition. Subsequently 12 partic‐
ipants met the operational criteria to constitute the ADHD EEG study population. These
participants were first subject to the EEG assessment before the age- and gender- matched non-
ADHD sample was identified. The reason for this was to ensure that no further participants
needed to be excluded and that the non-ADHD sample could be matched on the characteristics
of the final ADHD sample. Two individuals were further excluded from the study population
on the basis that the one participant experienced excessive drowsiness and another participant
presented with significant muscle movement that may confound the obtained results. Subse‐
quently, 10 participants were included in the research sample for the ADHD group. This sam‐
ple met the necessary operational criteria for the inclusion in the study and produced an EEG
reading that is acceptable according to the quality standards. The mean sample age for the
ADHD group was 34.4 years. The female to male ratio was 3:1.
Following the identification of the research sample for the experimental group the study set
out to identify an age- and gender- matched healthy non-ADHD group. Matched sampling
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research sample that was identified exhibited a mean sample age of 33.6 years with a similar
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3.2.3. Measurement instruments
One of the main challenges in this study was to accurately identify adults with a diagnosis of
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sis, or in other cases an over diagnosed disorder, one cannot rely only on formal diagnoses
made by Mental Health Professionals. Added to this is the problem of a high rate of self-diag‐
nosis of this disorder amongst adults [64], which brings into question relying only on self-re‐
port questionnaires to identify possible participants. For this reason, over and above the
MCMI-III, a semi-structured interview and a self-report questionnaire were also included.
Semi-Structured Clinical Interview. The interview was conducted by any one of the trained clini‐
cal psychologists that formed part of the research team. The purpose of the interview was to en‐
sure that participants met the sampling characteristics mentioned above and to make certain
that none of the exclusion criteria were present in the respective population. The interview also
obtained information regarding the biographical information of participants. Furthermore it
served as a quick screening conformational tool by exploring the presence or absence of the cri‐
teria for ADHD in adulthood as proposed by a number of authors [65, 66].
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Patterns, Severe Personality Pathology, Clinical Syndromes, and Severe Syndromes. For the
purposes of this study base rate scores below 75 were considered to be indications of no
clinical significance, 75 – 84 as indicative of the presence of a personality trait, and 85 and
higher as persistent personality traits [73].
The results for the internal consistency was :66 for the compulsive scales and 0.90 for major
depression, and the Cronbach alpha’s for the remaining 26 scales exceeded.80, showing
strong internal consistency [73]. Test-retest reliability scores indicated the lowest score of.82
for debasement and the highest was.96 for somatoform, of which the median test-retest coef‐
ficient was.91, which shows stability of the instrument over time [71].
Construct and concurrent validity is tested by looking at how well the instrument performs in
different populations and how much value it has in the real world [73]. The manner in which
this is achieved was by comparing the MCMI to accepted standards achieved by other tests,
comparing the scales on the MCMI to other scales on different tests [73]. It was identified that
there is a high correlation between the scales of the MCMI-III and seven different tests, namely
the symptom checklist-90, the Beck Depression Inventory, the State-Trait Anxiety Inventory,
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scales where good, with some having negative scores, but these items were not related to the
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Neurodevelopmental Pathways of Childhood ADHD into Adulthood: Maturational Lag, Deviation, or Both?
http://dx.doi.org/10.5772/53865
29
ure what they say they measure is by calculating the positive predictive power, which was re‐
markable showing a range of.30 to.80 [71]. The MCMI-III has proven construct validity and
diagnostic validity, by comparing test items with other tests and by comparing clinical judge‐
ment with the results indicated from the scales on the MCMI-III [73].
Biopac MP Systems Hardware. The research question is concerned with the nature of the intra‐
cranial electrical currents of adults with ADHD symptomatology. Therefore EEG recording
is appropriate for this study in that it records the electrical activity of cortical nerve cells in
the brain [74]. It is noteworthy to mention that cortical activity is presented in waveforms
and is measured in terms of amplitude and frequency [75]. Amplitude is expressed in micro‐
volts (µV), EEG power is defined by the square of amplitude (µV2) and frequency is defined
as the number of oscillations, or cycles, within a given time frame, or epoch, and is meas‐
ured in hertz (Hz) [76].
This study employed the Biopac MP Systems Hardware [77] for the assessment of cortical
activity. The system is considered to be commercial EEG equipment utilised in the data ac‐
quisition and analysis for life science research. The recording technique utilised by this sys‐
tem is an ethically approved, non-invasive, safe and painless procedure [78]. In order to
ensure the quality of research, the EEG methods employed in this study are informed by
various other EEG studies that employed quantitative EEG techniques [75] as well as stand‐
ardised guidelines for the technologic recording and quantitative analysis of EEG activity in
the research context [79].
A final matter to consider in this section is the reliability and validity of EEG recordings. Vari‐
ous researchers report that EEG recordings are reliable, in that the intra-individual stability of
EEG is stable over time (over a period of 10 to 90 days) [80,81]. The validity of EEG research de‐
pends on the concepts of sensitivity and specificity [76]. In ADHD research, sensitivity refers to
the percentage of ADHD individuals who present with an abnormal EEG while specificity re‐
veals the percentage of non-ADHD subjects who indicate a normal EEG [76]. In a literature re‐
view of several studies, it was concluded that EEG methods in ADHD research typically
demonstrate good sensitivity (90% to 97%) and sound specificity (84%-94%)[76].
3.2.4. Procedure
All potential participants were required to complete the ASRS and MCMI for screening pur‐
poses. Based on the scores on these instruments they were allocated to different groups, or
where they did not meet the criteria for any of the groups, were excluded from further stud‐
ies. As explained previously, the sample for the EEG study was drawn from this pool. Po‐
tential participants were approached to participate in the EEG study.
Upon arrival to the research laboratory participants were requested to sit in the allocated
chair. The researcher and EEG equipment was situated outside of the participants direct line
of sight. Participants were then oriented to the Biopac MP Systems Hardware equipment,
and was further provided with an opportunity to ask questions. The researcher enquired
about whether participants adhered to the instruction to refrain from the aforementioned
substances 24 hours before the assessment. Participants were informed that during the data
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acquisition phase they will engaged in a three minute eyes-closed task. Participants were al‐
so instructed to remain as physically still as possible in order to limit muscle contamination
throughout the entire assessment, and were requested to avoid speaking during the assess‐
ment as a further attempt to avoid contamination of results.
In the data acquisition phase subjects were fitted with an electrocap in accordance with the
10-20 International system of electrode placement. In order to tap the fronto-parietal atten‐
tion network, electrodes were grouped into three areas: frontal (F3 and F4), frontal midline
(Fz) and parietal (P3 and P4) sites (see Figure 1.). EEG signal for all subjects was recorded
under an eyes-closed condition. Eye movements were monitored by electrodes placed on
the outer canthus of each eye for horizontal movements and by electrodes above the eye for
vertical movements. EEG signal was recorded using AcqKnowledge software and BIOPAC
MP Systems hardware. Impedance was kept below 5Kohm (kΩ) and a sampling rate of
200Hz was applied. Continuous EEG data was reviewed off-line. Segments containing head
and eye movement as well as muscle artefact were removed from further analysis. Subse‐
quently, six two second epochs were extracted for the eyes-closed condition and for each of
the cortical sites investigated and for the four frequency bands: delta (1-4Hz); theta (4-8Hz);
alpha (8-13Hz); and Beta (13-20Hz). EEG data was Fast Fourier transformed (FFT) (Hanning
window) and subsequently log transformed (In).
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ure what they say they measure is by calculating the positive predictive power, which was re‐
markable showing a range of.30 to.80 [71]. The MCMI-III has proven construct validity and
diagnostic validity, by comparing test items with other tests and by comparing clinical judge‐
ment with the results indicated from the scales on the MCMI-III [73].
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cranial electrical currents of adults with ADHD symptomatology. Therefore EEG recording
is appropriate for this study in that it records the electrical activity of cortical nerve cells in
the brain [74]. It is noteworthy to mention that cortical activity is presented in waveforms
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volts (µV), EEG power is defined by the square of amplitude (µV2) and frequency is defined
as the number of oscillations, or cycles, within a given time frame, or epoch, and is meas‐
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the percentage of ADHD individuals who present with an abnormal EEG while specificity re‐
veals the percentage of non-ADHD subjects who indicate a normal EEG [76]. In a literature re‐
view of several studies, it was concluded that EEG methods in ADHD research typically
demonstrate good sensitivity (90% to 97%) and sound specificity (84%-94%)[76].
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All potential participants were required to complete the ASRS and MCMI for screening pur‐
poses. Based on the scores on these instruments they were allocated to different groups, or
where they did not meet the criteria for any of the groups, were excluded from further stud‐
ies. As explained previously, the sample for the EEG study was drawn from this pool. Po‐
tential participants were approached to participate in the EEG study.
Upon arrival to the research laboratory participants were requested to sit in the allocated
chair. The researcher and EEG equipment was situated outside of the participants direct line
of sight. Participants were then oriented to the Biopac MP Systems Hardware equipment,
and was further provided with an opportunity to ask questions. The researcher enquired
about whether participants adhered to the instruction to refrain from the aforementioned
substances 24 hours before the assessment. Participants were informed that during the data
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so instructed to remain as physically still as possible in order to limit muscle contamination
throughout the entire assessment, and were requested to avoid speaking during the assess‐
ment as a further attempt to avoid contamination of results.
In the data acquisition phase subjects were fitted with an electrocap in accordance with the
10-20 International system of electrode placement. In order to tap the fronto-parietal atten‐
tion network, electrodes were grouped into three areas: frontal (F3 and F4), frontal midline
(Fz) and parietal (P3 and P4) sites (see Figure 1.). EEG signal for all subjects was recorded
under an eyes-closed condition. Eye movements were monitored by electrodes placed on
the outer canthus of each eye for horizontal movements and by electrodes above the eye for
vertical movements. EEG signal was recorded using AcqKnowledge software and BIOPAC
MP Systems hardware. Impedance was kept below 5Kohm (kΩ) and a sampling rate of
200Hz was applied. Continuous EEG data was reviewed off-line. Segments containing head
and eye movement as well as muscle artefact were removed from further analysis. Subse‐
quently, six two second epochs were extracted for the eyes-closed condition and for each of
the cortical sites investigated and for the four frequency bands: delta (1-4Hz); theta (4-8Hz);
alpha (8-13Hz); and Beta (13-20Hz). EEG data was Fast Fourier transformed (FFT) (Hanning
window) and subsequently log transformed (In).
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In order to gain a meaningful picture of Personality Disorders in ADHD, and therefore a
better picture of maturational lag versus maturational deviation, the data gained from the
MCMI-III was used in different ways. Firstly the average base rate scores (interval scale)
were compared between the groups, thereafter the scores were categorised into 3 categories
(Ordinal scale), i.e. <75, 75-84 and 85>, where after the groups were compared, and lastly,
based on the categorisation of the data, number of personality disorders per individual, per
group are reported.
Histrionic Narcissistic Antisocial Borderline
ADHD (n=51) Mean 50.6 58.5 61.4 55.4
Std. Dev 23.6 21.7 14.3 21.7
Min 0 15 35 0.0
Max 95 110 90 92.0
Non-ADHD(n=43) Mean 60.1 55.9 43.6 38.4
Std. Dev 23.3 20.8 19.1 22.4
Min 4 15 8 0.0
Max 98 98 82 85.0
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Figure 2. Mean scores of the 4 Cluster B Personality Scales for the 2 groups
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In terms of the average base rate scores, Table 3 and Figure 2 reflected that the two groups
were more or less equal in terms of Narcissism and that the non-ADHD group had a higher
average score on the Histrionic, but significantly lower scores on both the Anti-Social and
Borderline scales (See Tables 3 and 4). Of particular importance is that none of the average
scores were higher than 75, indicating that neither of the two groups displayed typical per‐
sistent personality traits.
Histrionic Narcissistic Antisocial Borderline
Mann-Whitney U 861.0 980.5 502.5 612.5
Wilcoxon W 2187.0 1926.5 1448.5 1558.5
Z -1.791 -.882 -4.521 -3.678
p 0.07 0.38 0.000*** .000***
Where: ***: p<0.001
Table 4. Differences between ADHD and Normal groups for the interpersonal sub-scales
Interpreting only the differences in base rate scores of the MCMI can be misleading, there‐
fore the scores of individuals for each of the scales was categorised into one of three catego‐
ries, i.e. Low (<75), High (75-84) or Significant (84>) (See Table 5).
Low score High score Significant score
<75 75 - 84 85> Total
N N N N
ADHD 42 5 4 51
Histrionic nADHD 30 4 9 43
Total 72 9 13
ADHD 41 3 7 51
Narcissistic nADHD 35 2 6 43
Total 76 5 13 94
ADHD 37 12 2 51
Anti-social nADHD 39 4 0 43
Total 76 16 2 94
ADHD 40 8 3 51
Borderline nADHD 41 1 1 43
Total 81 9 4 94
Table 5. Number of participants per category of Cluster B Personality scores
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Interpreting only the differences in base rate scores of the MCMI can be misleading, there‐
fore the scores of individuals for each of the scales was categorised into one of three catego‐
ries, i.e. Low (<75), High (75-84) or Significant (84>) (See Table 5).
Low score High score Significant score
<75 75 - 84 85> Total
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Histrionic nADHD 30 4 9 43
Total 72 9 13
ADHD 41 3 7 51
Narcissistic nADHD 35 2 6 43
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When investigating the data in this way, the results indicate that there were significant dif‐
ferences between the 2 groups on all of the subscales (See Table 6).
Histrionic Narcissistic Borderline Anti-social
Chi-Square 79.43 96.53 118.5 98.64
Df 2 2 2 2
Significance .000*** .000*** .000*** .000***
Where: ***: p<0.0001
Table 6. Chi Square for differences between the 2 groups
Given these results, a frequency analysis was done to determine how many elevated scores
(85>) an individual participant had (See Table 7).
Number of Personality Disorders ADHD nADHD
0 39 (76.5%) 39 (90.7%)
1 9 (17.6%) 4 (9.3%)
2 2 (3.9%) 0 (0.0%)
3 1 (2%) 0 (0.0%)
Total 51 43
Table 7. Number of Personality Disorders per group
These results, from a maturational deviation perspective are meaningful in that the majority
of the ADHD participants (76%) did not show any evidence of a Cluster B Personality Disor‐
der. If one assumes that ADHD is due to maturational lag, and that Cluster B Personality
Disorders are also due to maturational lag, then these results seriously challenge this as‐
sumption. Given the fact that a higher percentage of ADHD (27.5%) showed indications of
one or more Cluster B Personality Disorders than the non-ADHD group (9.3%), there seems
to be evidence of a possible maturational deviation process.
3.2.5.2. EEG results
This part of the study focussed the brain’s intracranial electrical currents and potentials, in
other words cortical activity, of adults with ADHD, and those with no ADHD symptomatol‐
ogy. The patterns that are of particular concern are the activity (elevation or suppression) of
the four frequency bands (delta, theta, alpha and beta).
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The study focused on two domains of investigation: power spectral and ratio coefficients. Pow‐
er spectral studies concerns the calculation of absolute and relative power estimates [20].
• Power spectral density or the power spectrum “… reflects the ‘frequency content’ of the
signal or the distribution of signal power over frequency” [82, p. 806]. For the power spec‐
tral domain the analysis was concerned with two spectral parameters, i.e.:
• Relative power is determined by the amount of EEG activity in a frequency band divided
by the sum of the other bands [75].
• Absolute power is the amount for one specific frequency band without its relationship to
the other bands [79].
• Ratio coefficients refers to the ratio between power in different frequency bands [20].
These two domains of investigation were selected on the basis that they are the most common
and often preferred means of investigation for ADHD studies [20]. The mean values obtained
for the ADHD and non-ADHD group, per area of the brain investigated and per frequency
cluster were employed in obtaining the values for the domains of investigation. The above‐
mentioned equations were applied and subsequently, the absolute, relative and power ratios
were determined. Note that for this study frequency parameters are set as follows: delta
(1-4Hz); theta (4-8Hz); alpha (8-13Hz); and Beta (13-20Hz). The Greek symbols employed to de‐
note the different waves include: delta as δ; theta as θ; alpha as α; and finally beta as β. As far as
the experimental condition is concerned, the abbreviation of EC is employed.
In order to address the research question a between-subjects analysis of diagnostic group
differences was applied. Seeing that the small sample size was not representative of the
greater population, nonparametric statistical procedures were employed [85]. Subsequently
the Mann-Whitney U-test was applied with the use of SPSS software. The Mann-Whitney U
test is the nonparametric alternative to an independent t-test. The Mann-Whitney U test is
appropriate for the between-subjects analysis because it compares differences between two
independent groups, in this case ADHD with non-ADHD [85].
In Table 8 the absolute mean power (µV2) and Table 9 the relative mean power for the different
frequency bands for the different cortical areas across the different conditions are reported. The
table is formatted in this way as to compare the ADHD sample with the non-ADHD sample ac‐
cording to the four frequency clusters and according to the area of the brain investigated.
The results of the resting EEG reveal elevated ADHD relative theta activity at frontal mid‐
line sites. This finding is consistent with childhood and adolescent research that is sugges‐
tive of a maturational lag and developmental deviation profile. Increased relative theta
activity is also indicated in the ADHD studies of [18,19] as well as Clarke et al. (2008b) at
frontal midline sites. Although it was also expected that theta activity would be elevated in
frontal sites, this was not confirmed in the present study. Moreover, the elevation or de‐
crease of theta activity is not documented widely for parietal sites in ADHD literature. How‐
ever, an interesting observation that was not indicated for the initial expectations for the
current study is the presence of decreased absolute theta for the ADHD sample at parietal
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frontal midline sites. Although it was also expected that theta activity would be elevated in
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sites. The reduction of absolute theta at parietal sites is also not supported in the other six
ADHD studies mentioned [10, 18, 19, 61,31,33].
The results of the resting EEG further reveal elevated theta/beta and theta/alpha ratios at
frontal midline sites. These results are consistent with child and adolescent research that are
suggestive of a developmental deviation profile. These results are also indicated in the
ADHD studies of [18, 19, 33].
The resting EEG of the current study also indicates decreased relative beta power for the
ADHD sample in the frontal midline area. These results are in line with child and adolescent
research that are suggestive of a developmental deviation profile. Of the six ADHD studies
[10, 18, 19, 31,33, 61] identified in the current author’s literature search, none of the authors
confirm such results. Also, although decreased beta power was expected for frontal and
frontal midline sites, the finding was only apparent for the frontal midline area.
ADHD non-ADHD Mann-Whitney U Wilcoxon W Z Between group differences
p
Frontal
δ 0.0191 0.0210 35.5 90.5 -0.78 0.44
θ 0.0549 0.0588 38.0 93.0 -0.57 0.60
α 0.0444 0.0476 34.5 89.5 -0.86 0.40
β 0.0171 0.0178 38.5 93.5 -0.54 0.59
Midline
δ 0.0106 0.0070 34.0 79.0 -0.91 0.40
θ 0.0304 0.0241 35.0 80.0 -0.82 0.45
α 0.0234 0.0206 38.5 83.5 -0.53 0.60
β 0.0082 0.0074 39.5 84.5 -0.454 0.66
Parietal
δ 0.0171 0.0317 20.5 75.5 -2.01 0.04*
θ 0.0459 0.0696 20.5 75.0 -2.05 0.04*
α 0.0358 0.0513 21.0 76.0 -1.96 0.05
β 0.0129 0.0211 19.5 74.5 -2.09 0.04*
Where: *: p<0.05
Table 8. Absolute Mean Power (µV2) for the ADHD (n=10) and the non-ADHD (n=9) Groups
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ADHD non-ADHD Mann-Whitney U Wilcoxon W Z Between group differences
p
Frontal
δ 13.0985 13.5419 39.5 84.5 -0.45 0.50
θ 40.7944 40.6344 39.0 84.0 -0.49 0.66
α 33.4839 33.4904 40.0 85.0 -0.41 0.72
β 12.6232 12.3331 42.0 87.0 -0.25 0.80
Midline
δ 12.6778 11.7963 34.0 79.0 -0.91 0.40
θ 41.9948 40.9362 0.00 45.0 -3.68 0.000***
α 33.6352 35.0017 11.0 64.0 -2.94 0.004**
β 11.6922 12.2656 15.0 70.0 -2.45 0.01**
Parietal
δ 14.0345 16.4011 20.5 75.5 -2.01 0.04*
θ 40.8777 40.1942 30.0 75.0 -1.23 0.24
α 33.1763 31.1389 29.0 74.0 -1.31 0.21
β 11.9112 12.2660 26.0 81.0 -1.55 0.13
Table 9. Relative Mean Power (µV2) for the ADHD (n=10) and the non-ADHD (n=9) Groups
The results of the resting EEG further reveal decreased absolute alpha and beta activity for the
ADHD sample at parietal sites. These findings are observed in child and adolescent research
that are consistent with the maturational lag and developmental deviation profile. The results
however have not been indicated in the six ADHD studies identified in the literature search.
ADHD non-ADHD Mann-Whitney
U
Wilcoxon W Z Between group
differences (p)
Frontal
θ:β 3.28 3.30 42.0 97.0 -0.25 0.84
θ:α 1.23 1.23 39.5 94.5 -0.45 0.66
Midline
θ:β 3.69 3.33 6.0 51.0 -3.19 0.001**
θ:α 1.28 1.17 2.0 47.0 -3.52 0.000***
Parietal
θ:β 3.63 3.98 21.0 66.0 -1.96 0.05
θ:α 1.27 1.34 43.0 98.0 -0.16 0.91
Where ** p<.01 and *** p<.001
Table 10. Mean Power Ratio Values for the ADHD (n=10) and the nADHD (n=9) groups
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[10, 18, 19, 31,33, 61] identified in the current author’s literature search, none of the authors
confirm such results. Also, although decreased beta power was expected for frontal and
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Midline
δ 0.0106 0.0070 34.0 79.0 -0.91 0.40
θ 0.0304 0.0241 35.0 80.0 -0.82 0.45
α 0.0234 0.0206 38.5 83.5 -0.53 0.60
β 0.0082 0.0074 39.5 84.5 -0.454 0.66
Parietal
δ 0.0171 0.0317 20.5 75.5 -2.01 0.04*
θ 0.0459 0.0696 20.5 75.0 -2.05 0.04*
α 0.0358 0.0513 21.0 76.0 -1.96 0.05
β 0.0129 0.0211 19.5 74.5 -2.09 0.04*
Where: *: p<0.05
Table 8. Absolute Mean Power (µV2) for the ADHD (n=10) and the non-ADHD (n=9) Groups
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ADHD non-ADHD Mann-Whitney U Wilcoxon W Z Between group differences
p
Frontal
δ 13.0985 13.5419 39.5 84.5 -0.45 0.50
θ 40.7944 40.6344 39.0 84.0 -0.49 0.66
α 33.4839 33.4904 40.0 85.0 -0.41 0.72
β 12.6232 12.3331 42.0 87.0 -0.25 0.80
Midline
δ 12.6778 11.7963 34.0 79.0 -0.91 0.40
θ 41.9948 40.9362 0.00 45.0 -3.68 0.000***
α 33.6352 35.0017 11.0 64.0 -2.94 0.004**
β 11.6922 12.2656 15.0 70.0 -2.45 0.01**
Parietal
δ 14.0345 16.4011 20.5 75.5 -2.01 0.04*
θ 40.8777 40.1942 30.0 75.0 -1.23 0.24
α 33.1763 31.1389 29.0 74.0 -1.31 0.21
β 11.9112 12.2660 26.0 81.0 -1.55 0.13
Table 9. Relative Mean Power (µV2) for the ADHD (n=10) and the non-ADHD (n=9) Groups
The results of the resting EEG further reveal decreased absolute alpha and beta activity for the
ADHD sample at parietal sites. These findings are observed in child and adolescent research
that are consistent with the maturational lag and developmental deviation profile. The results
however have not been indicated in the six ADHD studies identified in the literature search.
ADHD non-ADHD Mann-Whitney
U
Wilcoxon W Z Between group
differences (p)
Frontal
θ:β 3.28 3.30 42.0 97.0 -0.25 0.84
θ:α 1.23 1.23 39.5 94.5 -0.45 0.66
Midline
θ:β 3.69 3.33 6.0 51.0 -3.19 0.001**
θ:α 1.28 1.17 2.0 47.0 -3.52 0.000***
Parietal
θ:β 3.63 3.98 21.0 66.0 -1.96 0.05
θ:α 1.27 1.34 43.0 98.0 -0.16 0.91
Where ** p<.01 and *** p<.001
Table 10. Mean Power Ratio Values for the ADHD (n=10) and the nADHD (n=9) groups




The current study’s results contribute to the neurobiological and pathophysiological infor‐
mation of ADHD and are important for the advancement of aetiological theorising in the
field. Of particular relevance is the interpretation of data in accordance to the maturational
lag and developmental deviation model. The abovementioned results are consistent with
child and adolescent research that support both models. Hence this brings forth the question
of which model more adequately describes the aetiological bases that may be related to the
phenomenon of ADHD.
Given the overlap between the neurocognitive symptoms between ADHD and Personali‐
ty  Disorders  (specifically  Cluster  B),  the  first  part  of  the  study  investigated  the  preva‐
lence of Personality Disorders in ADHD. The rationale for this was twofold, i.e.  there is
evidence  to  suggest  that  Cluster  B  disorders  may  be  the  result,  as  is  the  case  with
ADHD, of maturational lag, therefore, if this is true, all adults with ADHD should show
signs  of  at  least  one  Cluster  B  personality  disorder.  The  results  of  the  study  indicated
that the majority of the adults with ADHD did not show any significant signs of a Clus‐
ter  B  personality  disorder.  However,  there  were  more  ADHD  adults  showing  signs  of
more than one personality disorder than those adults without ADHD. If  one stays with
the  assumption  that  there  is  a  neurocognitive  component  to  personality  disorders,  this
may be indicative of maturational deviation.
These findings seem to suggest that (1) ADHD cannot be viewed as a homogeneous disor‐
der with the same underlying neurodevelopmental processes, and (2) childhood ADHD
does not necessarily progress into a personality disorder (see Figure 6), therefore there is
room for both an Axis I and Axis II diagnosis in adults with ADHD. One of the problems
considering ADHD as a homogenous disorder is that it may suggest a single course with a
single outcome. Research, however, suggests that there may be multiple outcomes, i.e. re‐
mission in adolescence or continuation into adulthood. If there is an assumption of multiple
outcomes, it should firstly indicate that this is not a homogenous disorder, and secondly it
implies that there are different etiological pathways as well. Before one can draw a final con‐
clusiuon about these statements, it is important to also review the EEG results of the ADHD
participants.
In order to further investigate the maturational  lag vs.  maturational  deviation theory of
ADHD, an EEG study, was done on a smaller sample. The maturational lag model sug‐
gests that ADHD behaviours are a consequence of a neurodevelopmental lag [8].  It  fur‐
ther  denotes  that  individuals  with  ADHD  symptoms  present  with  cortical  activity
patterns that are similar to that witnessed in younger children [8, 20]. Moreover it is ac‐
cepted that  cortical  development is  expected to ‘catch up’  and remit  in  adolescence [6].
The developmental  deviation model  denote that  the cortical  activity of  individuals  with
ADHD symptoms are not considered normal at any age and is not likely to mature in a
normal fashion [20].
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Figure 3. Comparison of normative, maturational lag and maturational deviation models of slow wave activity across
developmental stages
Figure 4. Comparison of normative, maturational lag and maturational deviation models of fast wave activity across
developmental stages
As mentioned already, the results of the current study are in line with the ADHD results of
[10, 18, 19, 33] who indicate elevated slow wave activity and increased theta/beta and theta/
alpha ratios. Seeing that EEG aberrances are clearly indicated in adult samples, it does not
confirm the maturational lag’s assumption that cortical maturation will eventually ‘catch up’
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[6, 20]. Instead, the data suggests that ADHD symptoms do persist for some individuals into
adulthood. The results further support the developmental deviation, which suggests that
ADHD behaviours are related to the disorganisation of wave activity that deviates from nor‐
mal development [17, 20]. The deviation is revealed in the results wherein the cortical activi‐
ty patterns remain aberrant and have not normalised in the ADHD sample. Taken together,
the results of the current study confirms [18] notion that since abnormalities of the EEG per‐
sists into adulthood for the ADHD sample, the data is indicative of a more persistent devel‐
opmental deviation for some individuals with the disorder and that not all individuals who
present with the disorder will eventually outgrow it.
Up to this point the results of the resting EEG suggests that the data obtained is more sugges‐
tive of a developmental deviation than a maturational lag. However, as mentioned already, the
results of the current study indicates increased relative theta and consequently elevated theta/
beta and theta/alpha ratios as well as decreased relative beta at frontal midline sites for the
ADHD sample in comparison with controls. This profile displays an elevation in slow wave ac‐
tivity and a decrease in fast wave activity. Although this profile is clearly indicated in develop‐
mental deviation and maturational lag models,  the maturational lag model provides the
qualitative and aetiological information that links this profile with ADHD behaviours.
EEG support of the maturational lag model reveals in its findings cortical activity patterns that
are similar to that witnessed in younger children [10, 20]. In accordance to Kinsbourne [5], the
father of the model’s ideas, the cortical activity patterns that limit the performance of younger
children are synonymous to that which typically compromises the performance of individuals
with ADHD symptomatology [10,  20].  Recent normative databases suggest that absolute
and/or relative slow wave activity (delta and theta) is elevated in childhood and is the highest
shortly before puberty, where after it declines by 60% and finally slows down in its decline af‐
ter the age of 17 [83, 84] (see Figure 3). Following puberty, fast wave activity (alpha and beta) re‐
portedly increases [86]. Finally, between the ages of 25 to 30 years the cortical thickening and
thinning (myelination) stabilises and the process of growth spurts and oscillations in terms of
cortical activity lessens and normalises [86]. In relation to normative EEG data it is evident that
the increase in slow wave activity and decrease in fast wave activity would be more evident in
younger children before puberty commences. Hence it appears that the ADHD type behav‐
iours of the current ADHD sample may be aetiologically related to the patterns of cortical activ‐
ity that typically limit the performance of younger children.
The abovementioned paragraphs elicit information that has implications for the interpreta‐
tion and advancement of aetiological theorising according to EEG-based models of ADHD.
The developmental deviation denotes that the EEG aberrances observed in individuals with
ADHD symptoms are not normal in individuals of any age [20]. However, as indicated
above, the cortical activity patterns observed in the ADHD sample is synonymous to that
which is often observed in younger children. Hence, the data supports the assumption that
cortical maturation deviates from normal development and that the deviation is more per‐
sistent; however, it does not support the notion that the resting EEG observed is not similar
to patterns witnessed at any particular age. Also, the presence of this profile in ADHD EEG
research does not automatically serve as evidence of a maturational lag. The reason for this
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is because the observation of EEG activity, that is similar to that witnessed in younger chil‐
dren in one point in time, does not suggest that those patterns will eventually ‘catch up’.
A further matter to consider in relation to the resting EEG of the current study is the posteri‐
or-anterior time course of cortical development. It is evident that the results of the current
study yield EEG aberrances in parietal, frontal and frontal midline sites for the ADHD sam‐
ple. As discussed previously, the posterior-anterior time course of cortical development sug‐
gests that the cortical activity in posterior regions mature more rapidly than frontal regions
[87]. When cortical development follows this pathway, delta, theta and alpha develop first
from birth in occipital regions and only appear later in parietal and central regions and final‐
ly in frontal regions [26].
The results of the current study indicate deviations in the EEG for the ADHD from the con‐
trol group that are present in early-maturing (parietal area) and later-maturing (frontal and
frontal midline area) sites. If maturation were seen to ‘catch up’ in the ADHD sample, then
the greatest between- group differences would only have been indicated at frontal sites [26].
Hence, the data is not suggestive of development that is slow to ‘catch up’ but again sug‐
gests that development in the ADHD sample is indicating a more persistent deviation and
disorganisation of wave activity [20, 30]. In Figure 5, a summary is provided of evidence for
both a maturational lag and deviance model.
Figure 5. Cortical Activity Patterns of ADHD in Resting Conditions
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It must be emphasised that this study was exploratory in nature, and in many ways it result‐
ed in more questions than answers. What the study did do however, was to highlight some
problems in our interpretation of quantitative data. The first of these is the problem of the
average. The conclusion drawn from averages does not include a satisfactory explanation for
the variance, i.e. in terms of maturational lag, as the findings suggest that there is a distinct
possibility that some of these reach cortical maturity at the same rate as non-ADHD children
(i.e. those at the higher end of the distribution), and that there are those who may reach this
much longer after the 3 year average (i.e. those at the lower end of the distribution). At both
ends of the distribution, it opens the possibility for maturational deviance as symptoms are
present, but cannot be explained fully by the maturational lag theory (See Figure 6). In line
with this above argument, even within studies, not all cortical areas are affected in the same
way. This is, in essence, not problematic, however, formulating a general maturational lag
model is, as it seems to imply that there is general maturational lag. Furthermore there are
studies that report maturational lag, but include discrepant findings in cortical areas which
are explained asymmetrical maturation. The question that arises is whether this should then
be considered as maturational lag or maturational deviance.
Figure 6. Multiple outcomes of ADHD in adulthood
A common theme which runs through all the studies, and may account for many of the
comments  above,  is  that  ADHD is  often considered to  be  a  homogenous disorder.  It  is
quite possible that maturational lag would best account for a certain sub-group, and de‐
viance for others (See Figure 6). If we are going to gain more insight into the etiology of
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this  disorder,  we need to review our research methodologies.  It  is  argued that many of
the  confounding /  contradictory results  is  the  way in  which studies  are  conceptualised.
In this regard, the sampling of participants needs to be more focused, as current studies
seem to include mainly the combined sub-type of  ADHD [6].If  this  were true,  it  would
not  be  inaccurate  to  state  that  very  little  is  known  about  brain  maturation  in  children
with the inattentive subtype. It is therefore imperative that sampling be done much more
specifically and that subtypes are compared to each other. Furthermore, one needs to de‐
viate from the common practice to exclude participants with both ADHD and comorbid
conditions and rather group these participants together based on disorders that are alike
in both symptomotology and theoretical etiology.
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1. Introduction
Attention deficit hyperactivity disorder (ADHD) is an established neuropsychiatric disorder
in children and adolescents with paediatric or mental health services available across most of
Europe. In spite of major improvements in the availability of services for the diagnosis of
ADHD and several therapeutic options, including medications, psychosocial and psycho-
educational therapies, families of children with ADHD experience considerable emotional and
social burden [1-2]. The presence and severity of the child’s ADHD is a significant predictor
of heightened parental stress and the diagnosis of ADHD can result in impairments in the
Quality of Life in patients and their families [3-4]. Yet, there is a rather limited number of
studies exploring parental perceptions of the diagnosis and overall treatment of this disorder.
An American study determined that primary care physicians generally adhere to practices
specified in the AAP guidelines [1] for the diagnosis and treatment of pediatric ADHD; some
variations existed and improvements were possible. Poor access to mental health services,
limited insurance coverage, and other potential system barriers to the delivery of ADHD care
were noted [5]. An Australian study explored perceptions relating to the diagnosis, treatment
and overall management of the disorder [6] in the families of 278 children with ADHD
identified in a community sample of 11 184 children aged 10-12 years; only 66% of parents
recalled the use of questionnaires or rating scales, drugs were tried in 82% and 66% of the
children were still on them, behavioral intervention in 42% and alternative treatments, mostly
elimination diet and/or fatty acid supplementation, were used in 71%. Overall, 55% of parents
were satisfied or very satisfied with their child's care. The conclusion of this study was that
adherence to recommended diagnostic guidelines was inadequate, behavioral intervention
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was underutilized and non-conventional therapies were widely used and considered helpful
in one-third of the children who used them. A study conducted on 20 low socioeconomic status
mothers with children 5-11 years of age with ADHD taking stimulants, aimed to examine the
effect of a 5-week educational intervention on ADHD [7]. Parental satisfaction and parental
sense of competency improved in mothers who participated in the educational intervention.
Psychosocial and psycho-educational interventions as well as pharmacological treatments are
effective in reducing ADHD symptom frequency and severity [1]. Stimulant medications are
recommended as a first-line modality for treating ADHD [8]. They proved effective in
improving both ADHD core symptoms (inattention, hyperactivity and impulsivity) and the
behavioral problems that frequently accompany the disorder (such as aggressive behavior,
depressive mood, anxiety, tics, impaired social functioning and academic productivity) [9].
Remission of ADHD symptoms via medication provides the best possible chance for educa‐
tional and social re-integration and improved functioning through the utilization of non-
pharmacological interventions [10]. Methylphenidate (MPH), a stimulant, is available in
immediate and extended release forms. Because the half-life of MPH in immediate-release
formulations is short, twice or better thrice daily administration is needed in order to maintain
the desirable therapeutic effect. This obviously creates many practical difficulties during
school days; it affects the patient's emotions (embarrassment in taking medication at school),
it interferes with medical privacy preservation, and contributes to poor compliance with the
therapeutic regimen [10-11]. Once-daily MPH in extended release form is significantly more
effective than short acting MPH based on multiple outcome measures including remission rate
[10,12], with better compliance being a primary factor [13-16].
Satisfaction with medication or any therapeutic intervention is an important factor in the
evaluation of overall treatment outcome in ADHD or any other disorder; it is predictive of
better adherence and compliance to treatment, and prevents premature treatment termination
[17]. It depends primarily on the effectiveness of the drug but it is also influenced by parental
and patient expectations, demographic characteristics, social acceptability of the treatment, the
relationship between patient/parents and physician as well as the physician’s knowledge,
competence and ability to communicate with patients and their families [18]. Cultural factors
are also very important in the acceptability of the treatment [19]. Furthermore, use of stimulant
medication combined with frequent reviews (at least 6 monthly) was more likely to be
associated with overall management satisfaction [6].
The goals of this paper were a. to explore family experiences in seeking diagnosis and treatment
of ADHD in an urban community and b. to investigate acceptance and compliance of stimulant
medication and specifically the two preparations of MPΗ available in our country, one in
immediate and one in extended-release form (Ritalin and Concerta).
2. Patients and methods
Two independent samples of children fulfilling DSM-IV criteria for ADHD and their families
were recruited to test the study goals. Diagnosis was based on the clinical presentation of the
child and on specific standardized diagnostic tools and was established by a specialized group
of physicians (pediatrician, pediatric neurologist, pediatric psychiatrist), school and clinic
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psychologist and special educator. Relevant patient characteristics such as demographic
characteristics (age, sex), ADHD type, previous treatments, concomitant disorders, along with
information on the prescribed treatment were recorded.
Study group 1. Thirty three families with children who fulfilled DSM-IV criteria for ADHD,
5-16 years old, who consecutively visited our outpatient department for the first time received
an open ended questionnaire, consisting of 6 main questions and 12 sub-questions that investi‐
gated family impressions and experience in dealing with this disorder. More specifically, we
asked about a. reasons for seeking help, b. source of referral (self-referred, schools, special edu‐
cators, physicians, psychologists), c. obstacles they confronted in reaching diagnosis and treat‐
ment (difficulty in reaching specialized care, difficulty in dealing with education problems). A
DSM-IV derived inattention/hyperactivity scale was used in order for parents to rate their chil‐
dren for 18 DSM-IV category A symptoms, on a 4-point scale [20]. This form was used in the fol‐
low up visits of our patients in order to document response to treatment. Therapeutic options
were then offered including the use of short acting MPH, with a dosage schedule that called for 5
mg qam or bid at the onset and dosage titration to less than 2.0 mg/kg/day or 60 mg per day [21].
Patients were also offered a psychotherapeutic program focusing in social capabilities practice.
Their parents were involved in counseling sessions and were encouraged to participate in sup‐
port and advice groups, aiming at strengthening the net of care around the patients. Other treat‐
ment options were speech therapy, occupational therapy and special education as needed per
individual child. The therapy that was actually used as well as the efficacy of the medication
was subsequently explored by a different physician 6 months after the initial visit. The safety of
the prescribed medication was also explored at that time.
Study group 2. Eighty four patients ≤ 18 years old, who were also followed as outpatients in
the Pediatric Neurology Department, were included in the current study group. Inclusion
criteria were a. ADHD diagnosis and b. the decision to begin treatment with long acting MPH.
Doses were calculated according to body weight with the final dose less than 2.0 mg/kg/day
or 72 mg/day [21]. All patients had been also offered psychosocial and psychoeducational
intervention programs and their parents were involved in counseling sessions as well as
support and advice groups. Previous treatment with short acting MPH was not an exclusion
criterion in this study.
Six months after treatment initiation, a telephone interview was scheduled by a physician other
than the one who prescribed the treatment, in order to determine their satisfaction level from
the newly introduced treatment. A four level Likert scale was used for this purpose (0= no
satisfaction at all, 1=modest satisfaction, 2=moderate satisfaction, 4=great satisfaction) and free
comments on their impressions were encouraged and recorded. The safety of the treatment
was also explored.
3. Statistical analysis
Continuous variables were tested for normalcy with the Kolmogorov - Smirnov test. Normal
variables were then presented as mean values (± standard deviation). Categorical variables
were expressed either as percentages or as absolute numbers.
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Study group 1. Descriptive statistics based on the parents' answers are reported.
Study group 2. In order to determine the prognostic factors which could affect the satisfaction
level from the treatment with long standing methylphenidate a logarithmic regression model
was applied with the variable coding the level of satisfaction, used as dependent variable
modified to include only two categories (median to great satisfaction versus no to mild
satisfaction). As independent variables in the model we used variables coding patients'
characteristics (age, sex, ADHD type) and features of the treatment under study (previous
treatment with short acting MPH and the response rate to this previous therapy), that may
affect the level of satisfaction or that may be important confounding factors. Continuous
variables that were introduced in the model were previously centered.
4. Results
Table 1 displays a summary of the characteristics of the two study groups.
Study group 1. The parents of 33 children (20 boys and 13 girls), 6-16 years old (10 years 3
months ± 2 years 10 months) reported the following: a. The reasons reported for seeking help
were: 48.5 % increasing difficulties at home and poor school performance, 21.2 % school
recommendation, 18.2 % other developmental problem (such as speech delay) and 12.1%
parents' concern about child’s behavior. b. Only 3% of our patients were referred by their
peadiatrician, while 36.3% were self-referred, 27.3% were referred by a state mental health
clinic, 21.2% by a psychologist/speech-therapist or occupational therapist, and 12.2% by a
school teacher. c. Over half of the 33 families included in this study group had difficulties in
reaching specialized help; more specifically, 33.3% encountered ignorance about ADHD-
appropriate medical services, 27.3% reported no difficulty, 21.2% encountered lack of appro‐
priate medical services, 12.1%, large waiting lists in hospitals and mental health services and
6.1%, other problems. Almost 50% of them reported ignorance and unwillingness on the part
of school teachers to provide help with their children: 45.5 % of the school teachers were
ignorant and not helpful, 30.5 % were ignorant but helpful and supportive to the child in the
classroom and only 24 % were informed and helpful.
As for their impressions about the disorder, parents’ considerations about the cause of ADHD
were as follows: 30.3% reported ignorance, 24.3% believed that there was inheritance, 21.2%
attributed it to a complication in pregnancy-delivery, 15.2%, to problems in school / family
environment, 6%, to some psychological problem and 3%, to a complication due to a disease.
Treatment with short acting MPH (Ritalin) was proposed to 91% and 79% of this patient
population received Ritalin; of them 95% described benefit in attention and behavior (73%
reported major improvement in the ADHD core symptoms, 23% reported little but important
improvement). Continuation of treatment was accepted by 63%. Reasons for not accepting
continuation of methylphenidate were fear of addiction and unspecified side effects. The
medicine was well tolerated by the majority of them with only one having to interrupt the
treatment because of gastrointestinal symptoms (vomiting). Other side effects (reported by
38% of the parents) were decreased appetite, sleepiness, tics, nervousness and headache.
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Study group 2. Eighty four children, 66 boys and 18 girls, with a mean age of 13 years (± 3
years) were offered treatment with long standing methylphenidate (Table 1). Thirteen of them
stopped prematurely or never started treatment and as consequence they were excluded from
the statistics. In the subsequent analysis, 71 children who received treatment were finally
included (55 males / 16 girls). According to their initial symptoms patients were categorized
into three ADHD types: inattentive type 33,4% (ν=23), hyperkinetic/impulsive type 64,8%
(ν=46) and mixed type 2,8% (ν=2). The age at diagnosis was 8 years and 4 months (SD = ± 3
years 3 months). Mean age at treatment onset was 10 years 8 months (± 3 years). Fifty of our
patients (70.42%) had been previously treated with short acting MP. However, data about
response to that treatment were available for 47 patients; with 34 out of them having responded
well to that treatment (27 had a good response and 7 a very good response).
Study group1 Study group 2
Age 10 years 3 months ± 2 years 10 months 10 years 8 months ± 3 years
Male/female 20/13 55/16
ADHD type (inattention /
hyperactive/ combined)
13/5/15 23/46/2
Previous treatment (yes/no) 0/33 50/21
Table 1. Demographic and clinical characteristics of the two study groups
At the time of treatment initiation with the long acting MPH (Concerta), most of our patients
(ν=47) were given an initial dose of 18 mg, that was subsequently titled to higher doses. A
higher initial dose (36 mg) was given to 33 patients (46.48%) who had high body weight.
Lowering this initial dose became necessary in only one patient.
Concerning parent satisfaction level, the majority of them (80.28%) reported moderate to full
satisfaction, 36.6% moderate satisfaction and 43.7% full satisfaction. The most frequent effect
was observed in the attention domain (improvement in 97.18% of the children), followed by
the effect in hyperkinetic behaviour (improvement in 63.38% of the children). Impulsivity was
not controlled in the majority of the patients (improvement in 19.72% of them). Almost half of
the patients reported improvement in two of the ADHD domains (n=34, 47,89%), 12 patients
(19,9%) improved in all three domains and only one reported no improvement in any of the
domains of the disorder. Thirty eight of the patients previously treated with short acting MPH
(80.85%) reported moderate to full satisfaction with the long acting formulation. Only one of
the parents who were not satisfied with short acting MPH (n=13) continued to be dissatisfied
with the long acting one. Eight patients with good response (2-3) to the short acting MPH,
however, were not satisfied with the long-acting MPH.
The logistic regression analysis applied in order to reveal prognostic factors affecting parental
satisfaction level showed that only age at treatment initiation with long acting MP was an
independent prognostic factor (OR=1.38, 95%CI=1.04 –1.83, p=0.025). Treatment initiation at
an older age resulted in higher probability (by 38%) of moderate to full parental satisfaction
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from the treatment, with the type of ADHD, sex and the previous treatment with short acting
MP treated as confounding factors (p=0,423 p=0,963 and p=0.299, respectively). Similar results
were also reported when the analysis was restricted to the subset of patients who were
previously treated with the short acting regimen. In this analysis we also examined the
response rate to the previous medication as an important prognostic factor. Age at treatment
with long acting MPH onset was again the only significant determinant of parental satisfaction
(OR= 1.49, 95%CI= 1.05-2.11 p=0.026). ADHD type, sex and response to Ritalin (moderate to
full response vs no response to modest response) were not significant covariates (p=0.929, 0.543
and p=0.320, respectively).
5. Discussion
Families of children with ADHD frequently experience considerable emotional and financial
stressors [21-23]. These harmful effects of ADHD on patients and families affirm the need for
effective treatment and make it a public health concern [24]. Children with ADHD require
more than 1.5 times more primary care visits, 9 times more outpatient mental health visits, and
3 times more prescriptions per year, compared to children without ADHD [25]. It was
estimated that the total annual health care costs for children with ADHD is more than twice
that of children without the disorder, and these costs become significantly larger when a child
with ADHD is diagnosed with a comorbid condition [25-27]. It is also noted that the direct cost
of treatment for this disorder has increased considerably during the last years. The increase in
expenditure for the treatment of ADHD may be due to increasing demand for diagnostic and
therapeutic services and improved availability of such services. [28-30].
The first important finding of this study was that only one fourth of the families studied (Study
group 1) reported an easy accessibility to appropriate services for the diagnosis and therapy
of ADHD in their children. Several barriers to the diagnosis of the disorder have been previ‐
ously reported. It is interesting to note that, although parents usually realize that something
is wrong with their child, especially if symptoms are severe, they are not always seeking
medical advice. In 2003, Bussing et al demonstrated that whereas 88% of high risk for ADHD
elementary school students were recognized as having a problem, only 39% had been evalu‐
ated [31]. Few years later, in 2006, Sayal et al, in another study exploring barriers to the
identification of ADHD, found that the main barrier to care for ADHD is the limited presen‐
tation of these problems to primary care [32]. Although most of the parents contacted (80%)
recognized that their child had a problem, only few had consulted primary care physicians or
had sought help from specialist health services while some had been in contact with profes‐
sionals in educational services. On the other hand, Leslie and coworkers suggested the
existence of a pattern of delayed diagnosis, mostly associated with failure to recognize ADHD
by parents/ caregivers [33]. This pattern was more common among youths with complicated
clinical and/or environmental factors or primarily symptoms of inattention. Delayed diagnosis
was reported especially in girls with ADHD, due to the predominance of symptoms of
inattention rather than hyperactivity/impulsivity as compared to boys [34-35] and due to the
lower frequency of conduct disorder, aggression, or delinquency [35-38]. Parental recognition
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of problems and their perception of hyperactivity as a symptom of a disorder, rather than a
childhood feature, were reported as to the most significant factors influencing contact with
medical services [32, 39].
Recognition of the disorder by primary care physicians, though, was related to both child and
parent factors (especially the first). Non-recognition of ADHD in the primary care setting was
the main barrier to further accessing specialist services [39]; when the parent was unaware or
reticent about the possibility of requesting a referral, then the diagnosis could be missed.
Therefore, parental request for referral and thus parental recognition of hyperactive behaviour
as problematic plays a crucial role in accessing primary care as well as specialist services [39].
Race has been one of the factors contributing to barriers in diagnosis; Caucasian children had
twice the odds of being brought to attention than other racial groups, with boys having a 5-
fold increased possibility of being evaluated [32]. Ethnic minorities had a lower rate of
diagnosis and treatment for the disorder. Those racial/ethnic disparities in service use are the
result of a combination of access barriers and individual, cultural, and societal factors [40].
After the diagnosis of ADHD was established, Hispanic families used the fewest services,
single-mother families used the most of them and families with boys with ADHD used more
services as compared to families with girls with ADHD [38]. Surprisingly, economic status of
the family was not a stable prognostic factor of accessibility and usage of specialized services.
In the study of Kendall et al income was not a significant factor in any services used or services
requested, whereas in the study of Bussing et al poverty status was associated with lower
treatment rates and with the most pervasive barriers [31, 41].
Another striking finding of this study was that only 3% of patients were referred to specialized
care by a pediatrician; this points to the need for better education of paediatricians on ADHD
and dissemination of existing knowledge and guidelines on diagnosis and treatment. Accord‐
ing to clinicians' perceptions about ADHD, the diagnostic process is considered complicated,
time-consuming and experience requiring, while published guidelines were viewed as vague
[42]. Referral rate by school teachers was also quite low (approximately 12%); we believe that
lack of appropriate education of the teachers on ADHD seems to be the most important factor.
In a survey aiming at exploring perceptions of ADHD with a focus on gender differences, many
teachers reported that they have received little or no education in ADHD as part of their
curriculum (with only 10% of schools providing significant training for teachers on ADHD),
while few reported having received significant training [43]. Moreover, half of the interviewed
teachers revealed that even when they suspected that a child suffered of ADHD, they hesitated
to inform his/hers parent or guardian. The years of experience with hyperactive children, the
number of hyperactive pupils in their classrooms, and the level of perceived self-efficacy of
the teachers seems to have a positive correlation with their knowledge about ADHD, which
is focusing more on symptoms and diagnosis [44]. Lack of educational support and teachers'
understanding of ADHD were also identified as problems, in the study of Concannon and
Tang [6].
Concerning perceptions about the etiology of ADHD, one third of the parents we contacted
had complete ignorance about causes of ADHD, almost 20% believed that environmental and
psychological factors had a causal relationship and the remainder attributed the disorder to a
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from the treatment, with the type of ADHD, sex and the previous treatment with short acting
MP treated as confounding factors (p=0,423 p=0,963 and p=0.299, respectively). Similar results
were also reported when the analysis was restricted to the subset of patients who were
previously treated with the short acting regimen. In this analysis we also examined the
response rate to the previous medication as an important prognostic factor. Age at treatment
with long acting MPH onset was again the only significant determinant of parental satisfaction
(OR= 1.49, 95%CI= 1.05-2.11 p=0.026). ADHD type, sex and response to Ritalin (moderate to
full response vs no response to modest response) were not significant covariates (p=0.929, 0.543
and p=0.320, respectively).
5. Discussion
Families of children with ADHD frequently experience considerable emotional and financial
stressors [21-23]. These harmful effects of ADHD on patients and families affirm the need for
effective treatment and make it a public health concern [24]. Children with ADHD require
more than 1.5 times more primary care visits, 9 times more outpatient mental health visits, and
3 times more prescriptions per year, compared to children without ADHD [25]. It was
estimated that the total annual health care costs for children with ADHD is more than twice
that of children without the disorder, and these costs become significantly larger when a child
with ADHD is diagnosed with a comorbid condition [25-27]. It is also noted that the direct cost
of treatment for this disorder has increased considerably during the last years. The increase in
expenditure for the treatment of ADHD may be due to increasing demand for diagnostic and
therapeutic services and improved availability of such services. [28-30].
The first important finding of this study was that only one fourth of the families studied (Study
group 1) reported an easy accessibility to appropriate services for the diagnosis and therapy
of ADHD in their children. Several barriers to the diagnosis of the disorder have been previ‐
ously reported. It is interesting to note that, although parents usually realize that something
is wrong with their child, especially if symptoms are severe, they are not always seeking
medical advice. In 2003, Bussing et al demonstrated that whereas 88% of high risk for ADHD
elementary school students were recognized as having a problem, only 39% had been evalu‐
ated [31]. Few years later, in 2006, Sayal et al, in another study exploring barriers to the
identification of ADHD, found that the main barrier to care for ADHD is the limited presen‐
tation of these problems to primary care [32]. Although most of the parents contacted (80%)
recognized that their child had a problem, only few had consulted primary care physicians or
had sought help from specialist health services while some had been in contact with profes‐
sionals in educational services. On the other hand, Leslie and coworkers suggested the
existence of a pattern of delayed diagnosis, mostly associated with failure to recognize ADHD
by parents/ caregivers [33]. This pattern was more common among youths with complicated
clinical and/or environmental factors or primarily symptoms of inattention. Delayed diagnosis
was reported especially in girls with ADHD, due to the predominance of symptoms of
inattention rather than hyperactivity/impulsivity as compared to boys [34-35] and due to the
lower frequency of conduct disorder, aggression, or delinquency [35-38]. Parental recognition
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of problems and their perception of hyperactivity as a symptom of a disorder, rather than a
childhood feature, were reported as to the most significant factors influencing contact with
medical services [32, 39].
Recognition of the disorder by primary care physicians, though, was related to both child and
parent factors (especially the first). Non-recognition of ADHD in the primary care setting was
the main barrier to further accessing specialist services [39]; when the parent was unaware or
reticent about the possibility of requesting a referral, then the diagnosis could be missed.
Therefore, parental request for referral and thus parental recognition of hyperactive behaviour
as problematic plays a crucial role in accessing primary care as well as specialist services [39].
Race has been one of the factors contributing to barriers in diagnosis; Caucasian children had
twice the odds of being brought to attention than other racial groups, with boys having a 5-
fold increased possibility of being evaluated [32]. Ethnic minorities had a lower rate of
diagnosis and treatment for the disorder. Those racial/ethnic disparities in service use are the
result of a combination of access barriers and individual, cultural, and societal factors [40].
After the diagnosis of ADHD was established, Hispanic families used the fewest services,
single-mother families used the most of them and families with boys with ADHD used more
services as compared to families with girls with ADHD [38]. Surprisingly, economic status of
the family was not a stable prognostic factor of accessibility and usage of specialized services.
In the study of Kendall et al income was not a significant factor in any services used or services
requested, whereas in the study of Bussing et al poverty status was associated with lower
treatment rates and with the most pervasive barriers [31, 41].
Another striking finding of this study was that only 3% of patients were referred to specialized
care by a pediatrician; this points to the need for better education of paediatricians on ADHD
and dissemination of existing knowledge and guidelines on diagnosis and treatment. Accord‐
ing to clinicians' perceptions about ADHD, the diagnostic process is considered complicated,
time-consuming and experience requiring, while published guidelines were viewed as vague
[42]. Referral rate by school teachers was also quite low (approximately 12%); we believe that
lack of appropriate education of the teachers on ADHD seems to be the most important factor.
In a survey aiming at exploring perceptions of ADHD with a focus on gender differences, many
teachers reported that they have received little or no education in ADHD as part of their
curriculum (with only 10% of schools providing significant training for teachers on ADHD),
while few reported having received significant training [43]. Moreover, half of the interviewed
teachers revealed that even when they suspected that a child suffered of ADHD, they hesitated
to inform his/hers parent or guardian. The years of experience with hyperactive children, the
number of hyperactive pupils in their classrooms, and the level of perceived self-efficacy of
the teachers seems to have a positive correlation with their knowledge about ADHD, which
is focusing more on symptoms and diagnosis [44]. Lack of educational support and teachers'
understanding of ADHD were also identified as problems, in the study of Concannon and
Tang [6].
Concerning perceptions about the etiology of ADHD, one third of the parents we contacted
had complete ignorance about causes of ADHD, almost 20% believed that environmental and
psychological factors had a causal relationship and the remainder attributed the disorder to a
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medical condition/disease or to inheritance. Perceptions about ADHD causes have evolved
during the recent years in different communities. Almost two decades before, the disorder was
attributed to poor diet, antisocial conduct, lack of discipline, emotional problems at school and
in interpersonal relations [45]. Yet, even today an impressing reluctance to accept the biomed‐
ical explanation of ADHD exists, especially in developing countries. Psychological problems,
socio-environmental factors, learning and memory difficulties, inappropriate parenting and
disciplinary practices [46-49] continue to be seen as possible causes. Guilt and self-blame,
accusations towards the spouse and concerns about the volitional or non-volitional nature of
the problem, still, prevail in parents' beliefs. In a study conducted in Greece, parents were more
likely to report intentionality in boys with ADHD than in girls whereas biological dysfunction
was considered as a more likely etiology in girls than in boys [50].
In this study, we explored attitudes towards ADHD treatment among the families that
participated. In the first part of this study, 79% of the parents accepted MPH treatment
following medical advice but only 63% finally continued the therapy. The respective percent‐
age of the second study group for treatment initiation/6-month continuation was 84.5%, which
is considerably increased compared to the first one; this difference could be attributed to the
evolution of time, (study 1 preceded chronologically study 2). Yet, both rates are quite high.
Hoare et al, reported that 88.1% of their sample wanted their child to continue treatment more
than 21 days (the initial trial period) and 63 % completed the 1-year trial (extension phase) [51].
In contrast, Chen et al reported that approximately 30% of young people received MPH
treatment within one year after diagnosis, and virtually none remained in treatment beyond
12 months [52]. Sample study composition may be responsible for the discrepancy among our
results and those of Hoare et al in one hand and the results of Chen et al in the other hand. In
the study of Chen et al, only newly diagnosed, and thus treatment naive, children were
enrolled, whereas in our study more than half of the participants had previously used the short
acting MPH regimen and in the study of Hoare and coworkers, all participants had changed
from the short to the long acting MPH medication. It is reported that, despite high response
rates to the pharmacotherapy (approximately 70% or more when patients were strictly
complying with the treatment) [53-55], parents and teachers consider non-pharmacological
therapies or the combination of pharmacological and non-pharmacological therapies to be
more acceptable [54, 56-59]. Leslie et al suggested three types of parental reactions to medica‐
tion proposal: a pattern of preference towards non medication treatment as their initial choice;
a reluctant receipt of an ADHD diagnosis and/or treatment pattern, mainly seen among the
low-income, Spanish-speaking families; and a rapid engagement in medication use pattern,
characterized by directed movement to and maintenance of medication use [33].
Treatment decisions in ADHD are usually the result of a shared process between families,
children, and the clinician [42]. Parents and clinicians conceptualize ADHD differently and
they should negotiate a shared understanding of ADHD. Parents' terms reflected ADHD's
effects on the child and family, while clinicians often mentioned school. Treatment discussions
should be tailored to encompass families' varied emotional and educational needs [60].
Recognition of a medical etiology for the disorder was the most influential factor reported in
willingness to accept drugs and/or combination treatment [58-59]. On the other hand, the main
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reasons for hesitating to start medication were concerns about side effects, worries about the
stigma associated with ADHD or its treatment and concerns about medication (the belief that
the medication would lead to drug addiction in adulthood) [43, 46]. Factors associated with
earlier initiation of MPH treatment were older age, sex (with parents of girls being more willing
to start medication), lower socioeconomic status, diagnosis of the disorder while school was
in session, diagnosis from a physician specializing in pediatrics or psychiatry, and diagnosis
in a district hospital/clinic [43, 52]. Patients more severely ill and/or having co-morbidities had
also a greater possibility of receiving treatment [61] In a study aiming to evaluate predictors
of long-term adherence to treatment with methylphenidate the authors reported that the
presence of associated disorders, younger age, female gender, and single-parent families were
predictors for continuing medication for 36 months (study duration) [62]. On the contrary,
older age, medication concerns, the absence of associated disorders and serious side effects
appeared to increase the risk of discontinuation of the treatment or loss to follow up [52, 62,
63, 65]. Generally, ADHD medication adherence and persistence seems to be suboptimal, with
patients using non-stimulant medication being more compliant compared to stimulant users.
Since ADHD can be effectively treated with medications, health professionals should be
proactive in identifying patients with poor adherence and intervene to address barriers to
medication adherence and persistence [66]. In this study, the reasons for treatment discontin‐
uation were side effects and fears of addiction to treatment.
Side effects reported in this study included mostly gastrointestinal and central nervous system
symptoms. This finding is in accordance with a recent review in which, decrease in appetite,
gastrointestinal pain, and headache were considered as the most frequently reported adverse
reactions, with very few of them being rated as serious. However, since a large number of
children drop out of studies due to serious side effects, it is believed that their actual number
is probably higher. These side effects are reported in clinical studies of short duration, whereas
long term safety is still a matter of research [69, 71]. Concerns about possible harm, especially,
from the newly developed ADHD drugs have arisen, focusing on both minor adverse effects
and extremely serious issues such as sudden cardiac death and suicidality [72]. Another
important finding in this study was that a great percentage of the ADHD parents expressed
at least moderate satisfaction from the long acting MPH. This is not surprising since previous
studies had advocated overall medication satisfaction, as expressed by patients, parents/
caregivers and/or physicians. Generally, satisfaction with stimulant medication as the sole
therapy has been shown to be relatively high and 63–87% of patients, parents and teachers
made positive assessments [11, 64, 69 -70]. In most of these studies, the researchers explored
satisfaction rates for long acting MPH as compared to short acting MPH. In a study presented
at the 2004 Annual Meeting of the Canadian Academy of Child and Adolescent Psychiatry, on
the pharmacological evolutions concerning ADHD, Swanson and Hechtman reported
significantly higher remission rates and significantly higher Clinical Global Impression and
parent satisfaction scores with long acting MPH as compared to short acting MPH (results
from an 8-week open-label trial) [71]. Similar results were presented in 2006, in another 8 week,
multicentre, randomized, open-label study in which 147 ADHD patients (6-12 years old)
received either once-daily long acting MPH or usual care with the short acting regimen. The
first drug proved to be superior to the latter in terms of remission rate, severity of ADHD and
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medical condition/disease or to inheritance. Perceptions about ADHD causes have evolved
during the recent years in different communities. Almost two decades before, the disorder was
attributed to poor diet, antisocial conduct, lack of discipline, emotional problems at school and
in interpersonal relations [45]. Yet, even today an impressing reluctance to accept the biomed‐
ical explanation of ADHD exists, especially in developing countries. Psychological problems,
socio-environmental factors, learning and memory difficulties, inappropriate parenting and
disciplinary practices [46-49] continue to be seen as possible causes. Guilt and self-blame,
accusations towards the spouse and concerns about the volitional or non-volitional nature of
the problem, still, prevail in parents' beliefs. In a study conducted in Greece, parents were more
likely to report intentionality in boys with ADHD than in girls whereas biological dysfunction
was considered as a more likely etiology in girls than in boys [50].
In this study, we explored attitudes towards ADHD treatment among the families that
participated. In the first part of this study, 79% of the parents accepted MPH treatment
following medical advice but only 63% finally continued the therapy. The respective percent‐
age of the second study group for treatment initiation/6-month continuation was 84.5%, which
is considerably increased compared to the first one; this difference could be attributed to the
evolution of time, (study 1 preceded chronologically study 2). Yet, both rates are quite high.
Hoare et al, reported that 88.1% of their sample wanted their child to continue treatment more
than 21 days (the initial trial period) and 63 % completed the 1-year trial (extension phase) [51].
In contrast, Chen et al reported that approximately 30% of young people received MPH
treatment within one year after diagnosis, and virtually none remained in treatment beyond
12 months [52]. Sample study composition may be responsible for the discrepancy among our
results and those of Hoare et al in one hand and the results of Chen et al in the other hand. In
the study of Chen et al, only newly diagnosed, and thus treatment naive, children were
enrolled, whereas in our study more than half of the participants had previously used the short
acting MPH regimen and in the study of Hoare and coworkers, all participants had changed
from the short to the long acting MPH medication. It is reported that, despite high response
rates to the pharmacotherapy (approximately 70% or more when patients were strictly
complying with the treatment) [53-55], parents and teachers consider non-pharmacological
therapies or the combination of pharmacological and non-pharmacological therapies to be
more acceptable [54, 56-59]. Leslie et al suggested three types of parental reactions to medica‐
tion proposal: a pattern of preference towards non medication treatment as their initial choice;
a reluctant receipt of an ADHD diagnosis and/or treatment pattern, mainly seen among the
low-income, Spanish-speaking families; and a rapid engagement in medication use pattern,
characterized by directed movement to and maintenance of medication use [33].
Treatment decisions in ADHD are usually the result of a shared process between families,
children, and the clinician [42]. Parents and clinicians conceptualize ADHD differently and
they should negotiate a shared understanding of ADHD. Parents' terms reflected ADHD's
effects on the child and family, while clinicians often mentioned school. Treatment discussions
should be tailored to encompass families' varied emotional and educational needs [60].
Recognition of a medical etiology for the disorder was the most influential factor reported in
willingness to accept drugs and/or combination treatment [58-59]. On the other hand, the main
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reasons for hesitating to start medication were concerns about side effects, worries about the
stigma associated with ADHD or its treatment and concerns about medication (the belief that
the medication would lead to drug addiction in adulthood) [43, 46]. Factors associated with
earlier initiation of MPH treatment were older age, sex (with parents of girls being more willing
to start medication), lower socioeconomic status, diagnosis of the disorder while school was
in session, diagnosis from a physician specializing in pediatrics or psychiatry, and diagnosis
in a district hospital/clinic [43, 52]. Patients more severely ill and/or having co-morbidities had
also a greater possibility of receiving treatment [61] In a study aiming to evaluate predictors
of long-term adherence to treatment with methylphenidate the authors reported that the
presence of associated disorders, younger age, female gender, and single-parent families were
predictors for continuing medication for 36 months (study duration) [62]. On the contrary,
older age, medication concerns, the absence of associated disorders and serious side effects
appeared to increase the risk of discontinuation of the treatment or loss to follow up [52, 62,
63, 65]. Generally, ADHD medication adherence and persistence seems to be suboptimal, with
patients using non-stimulant medication being more compliant compared to stimulant users.
Since ADHD can be effectively treated with medications, health professionals should be
proactive in identifying patients with poor adherence and intervene to address barriers to
medication adherence and persistence [66]. In this study, the reasons for treatment discontin‐
uation were side effects and fears of addiction to treatment.
Side effects reported in this study included mostly gastrointestinal and central nervous system
symptoms. This finding is in accordance with a recent review in which, decrease in appetite,
gastrointestinal pain, and headache were considered as the most frequently reported adverse
reactions, with very few of them being rated as serious. However, since a large number of
children drop out of studies due to serious side effects, it is believed that their actual number
is probably higher. These side effects are reported in clinical studies of short duration, whereas
long term safety is still a matter of research [69, 71]. Concerns about possible harm, especially,
from the newly developed ADHD drugs have arisen, focusing on both minor adverse effects
and extremely serious issues such as sudden cardiac death and suicidality [72]. Another
important finding in this study was that a great percentage of the ADHD parents expressed
at least moderate satisfaction from the long acting MPH. This is not surprising since previous
studies had advocated overall medication satisfaction, as expressed by patients, parents/
caregivers and/or physicians. Generally, satisfaction with stimulant medication as the sole
therapy has been shown to be relatively high and 63–87% of patients, parents and teachers
made positive assessments [11, 64, 69 -70]. In most of these studies, the researchers explored
satisfaction rates for long acting MPH as compared to short acting MPH. In a study presented
at the 2004 Annual Meeting of the Canadian Academy of Child and Adolescent Psychiatry, on
the pharmacological evolutions concerning ADHD, Swanson and Hechtman reported
significantly higher remission rates and significantly higher Clinical Global Impression and
parent satisfaction scores with long acting MPH as compared to short acting MPH (results
from an 8-week open-label trial) [71]. Similar results were presented in 2006, in another 8 week,
multicentre, randomized, open-label study in which 147 ADHD patients (6-12 years old)
received either once-daily long acting MPH or usual care with the short acting regimen. The
first drug proved to be superior to the latter in terms of remission rate, severity of ADHD and
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ODD symptoms, Clinical Global Impression-Improvement, Parent Satisfaction with treatment
(50% of parents were ‘completely satisfied’ with long acting MPH given once daily, compared
with 21% with the short acting MPH given two or three times daily) and other secondary
outcome scores [10]. In 2005, Hoare at al, also, reported that in the case of children previously
treated with the short acting regimen and then switched to the long lasting one (n=105), the
parent/caregiver global assessment of satisfaction ranged from 49 to 69% after an initial 21-
day trial, and 49 to 71% of investigators rated the treatment as adequate [51]. Finally, in a
double-blind comparison of a long-acting MPH formulation (osmotic release oral system
[OROS] MPH [Concerta, Janssen-Cilag Ltd]) given once-daily versus three-times-daily MPH-
IR, 47% of parents preferred the long-acting formulation, 31% the IR formulation, and 15%
their previous MPH treatment [72].
In this study, the vast majority (~81%) of the patients' subgroup previously treated with the
short-acting regimen were at least moderately satisfied. From those parents who reported a
good response with the short acting MPH, 26/34 were satisfied with the long acting one and
only 8/34 were not. From those exhibiting an inadequate response with the short acting MPH,
12/13 subsequently report moderate to full satisfaction. This is consistent with previous results,
according to which, switching from one MPH preparation to another appears to be a valid
clinical approach that may contribute to treatment success. Four factors were postulated to be
responsible of the observed improvement in various treatment outcomes: first, the increase
(and thus optimization) of MPH dose; second, the shorter intervals between visits directly after
switching, leading to more intense education and guidance of those involved; third, a positive
expectation of improvement by all participants; and fourth, a possible increase in adherence
in the long-term [18, 73-74]. On the other hand, dissatisfaction rate does not necessarily reflect
low efficiency. In the study of Gortz-Dorten et al, approximately 30% of parents were dissat‐
isfied with the medication, while efficacy was highly rated, making treatment individualiza‐
tion a very important aspect of the pharmacological treatment [18].
In our study, most parents reported satisfaction with the MPH effect especially for inattention
symptoms, followed by the satisfaction rate on the hyperkinetic behavior. This high satisfac‐
tion rate on the grounds of improvement in attention had also been reported in a recent study,
in the school setting and in academic situations [18]. The overall parental satisfaction with the
medication exceeded the percentage of 70% (63-75.6%). The parents were also very satisfied
with the effects of the drug in the children’s social interactions with other children and within
the family. Finally, almost 56% of parents also reported high satisfaction with how the
medication helped their child feel good. These results are supported by other studies, per‐
formed in the UK and in Sweden [70, 75].
Finally, according to our results, age at treatment initiation was a significant determinant of
level of parent satisfaction. We were not able though to relate parent satisfaction with type of
ADHD, sex of the patient or the previous experience with short acting MPH. In 2005, Hoare
et al, exploring the efficacy of long acting MPH in the long term (12 months) reported that
efficacy and satisfaction were more common in patients of older age (10-16 years), those on a
higher dose (36 mg or 54 mg) and those with the predominantly inattentive ADHD subtype
[51], results only partly in aggreement with ours. In another study, parents expressed higher
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satisfaction rates if their children showed a greater reduction in ADHD symptoms and greater
improvements in all QoL domains [18]. They argued that symptom severity and/or functional
impairment at the end of the study, as well as QoL, were the most significant predictors for
parent and patient satisfaction. They also showed that satisfaction with medication slightly
but significantly increased during the treatment and as time passed (from visit 1 to visit 3).
The results of our study need to be viewed in light of several limitations.
Limitation 1: One major limitation of this study was that parents' satisfaction was assessed by
asking parents how satisfied they were, using a Likert scale. At the time of study conduction,
there were no standardized and validated rating scales for satisfaction in Greek, not to mention
that the whole concept of using such scales was new. The method we used is clearly not
consistent or uniform and prevents the conduction of immediately comparable studies [19].
In the literature on ADHD, measures of satisfaction with medication such as the medication
satisfaction questionnaire (MSS) [76] or the parent consumer satisfaction questionnaire (PCSQ)
[77] exist and these were not used by us. In a recent study, another measure, the satisfaction
with medication scale (SAMS) has been validated [18]. This new rating scale was designed to
assess the satisfaction with ADHD medication of parents and children on a per item basis. It
would be very informative if a new study using these measures is conducted in our setting.
Limitation 2: Satisfaction level in our study was reported only for parents/caregivers. Pa‐
tient satisfaction with medication though may be an important factor in the evaluation of
overall  treatment  outcome [64].  In  order  for  treatments  to  be  considered effective,  they
have to be viewed favorably by patients who also have to be willing to use them [19]. Al‐
though parental satisfaction is usually in accordance with the child's feeling on treatment
effect, this is not always the case. In a double-blind crossover study child and parent per‐
ceptions of treatment with stimulant medication in a sample of 102 children with ADHD
was  attempted;  disagreement  between  child  and  parental  perceptions  of  treatment  re‐
sponse existed in >25%. This involved mostly parental viewing of the child's response fa‐
vorably, while the child’s rating was unfavorable; side-effects were the main determinant
of children's perceptions of adverse outcome. Thus, parental report alone is not infallible
in providing reliable information regarding effects as experienced by the child [58]. In an‐
other study consisting of 79 child-parent peers, few differences between parents and chil‐
dren  for  positive  effects  existed,  although  parents  reported  higher  levels  of  negative
effects. This result suggested that parents' considerations clearly have an influence on the
way children perceive medication [69]. In the study of Gortz-Dorten et al, patients report‐
ed slightly but significantly higher satisfaction than parents. Overall satisfaction with the
medication was high for 79.0% of patients and 66.1% of children also reported high satis‐
faction with how the medication helped them feel good. In conclusion, it is important to
assess parental and child perspectives separately, with comparable questions, as their per‐
ceptions of medication are correlated, but only to a moderate degree [18].
Limitation 3: This was an observational study; assuch, selection of participants was based on
loose criteria and treatment conditions are less controlled and standardized. This study design
could be considered an advantage, from a different point of view, as it reflects routine care
conditions in a pragmatic setting. This could be especially true for studies evaluating satisfac‐
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ODD symptoms, Clinical Global Impression-Improvement, Parent Satisfaction with treatment
(50% of parents were ‘completely satisfied’ with long acting MPH given once daily, compared
with 21% with the short acting MPH given two or three times daily) and other secondary
outcome scores [10]. In 2005, Hoare at al, also, reported that in the case of children previously
treated with the short acting regimen and then switched to the long lasting one (n=105), the
parent/caregiver global assessment of satisfaction ranged from 49 to 69% after an initial 21-
day trial, and 49 to 71% of investigators rated the treatment as adequate [51]. Finally, in a
double-blind comparison of a long-acting MPH formulation (osmotic release oral system
[OROS] MPH [Concerta, Janssen-Cilag Ltd]) given once-daily versus three-times-daily MPH-
IR, 47% of parents preferred the long-acting formulation, 31% the IR formulation, and 15%
their previous MPH treatment [72].
In this study, the vast majority (~81%) of the patients' subgroup previously treated with the
short-acting regimen were at least moderately satisfied. From those parents who reported a
good response with the short acting MPH, 26/34 were satisfied with the long acting one and
only 8/34 were not. From those exhibiting an inadequate response with the short acting MPH,
12/13 subsequently report moderate to full satisfaction. This is consistent with previous results,
according to which, switching from one MPH preparation to another appears to be a valid
clinical approach that may contribute to treatment success. Four factors were postulated to be
responsible of the observed improvement in various treatment outcomes: first, the increase
(and thus optimization) of MPH dose; second, the shorter intervals between visits directly after
switching, leading to more intense education and guidance of those involved; third, a positive
expectation of improvement by all participants; and fourth, a possible increase in adherence
in the long-term [18, 73-74]. On the other hand, dissatisfaction rate does not necessarily reflect
low efficiency. In the study of Gortz-Dorten et al, approximately 30% of parents were dissat‐
isfied with the medication, while efficacy was highly rated, making treatment individualiza‐
tion a very important aspect of the pharmacological treatment [18].
In our study, most parents reported satisfaction with the MPH effect especially for inattention
symptoms, followed by the satisfaction rate on the hyperkinetic behavior. This high satisfac‐
tion rate on the grounds of improvement in attention had also been reported in a recent study,
in the school setting and in academic situations [18]. The overall parental satisfaction with the
medication exceeded the percentage of 70% (63-75.6%). The parents were also very satisfied
with the effects of the drug in the children’s social interactions with other children and within
the family. Finally, almost 56% of parents also reported high satisfaction with how the
medication helped their child feel good. These results are supported by other studies, per‐
formed in the UK and in Sweden [70, 75].
Finally, according to our results, age at treatment initiation was a significant determinant of
level of parent satisfaction. We were not able though to relate parent satisfaction with type of
ADHD, sex of the patient or the previous experience with short acting MPH. In 2005, Hoare
et al, exploring the efficacy of long acting MPH in the long term (12 months) reported that
efficacy and satisfaction were more common in patients of older age (10-16 years), those on a
higher dose (36 mg or 54 mg) and those with the predominantly inattentive ADHD subtype
[51], results only partly in aggreement with ours. In another study, parents expressed higher
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satisfaction rates if their children showed a greater reduction in ADHD symptoms and greater
improvements in all QoL domains [18]. They argued that symptom severity and/or functional
impairment at the end of the study, as well as QoL, were the most significant predictors for
parent and patient satisfaction. They also showed that satisfaction with medication slightly
but significantly increased during the treatment and as time passed (from visit 1 to visit 3).
The results of our study need to be viewed in light of several limitations.
Limitation 1: One major limitation of this study was that parents' satisfaction was assessed by
asking parents how satisfied they were, using a Likert scale. At the time of study conduction,
there were no standardized and validated rating scales for satisfaction in Greek, not to mention
that the whole concept of using such scales was new. The method we used is clearly not
consistent or uniform and prevents the conduction of immediately comparable studies [19].
In the literature on ADHD, measures of satisfaction with medication such as the medication
satisfaction questionnaire (MSS) [76] or the parent consumer satisfaction questionnaire (PCSQ)
[77] exist and these were not used by us. In a recent study, another measure, the satisfaction
with medication scale (SAMS) has been validated [18]. This new rating scale was designed to
assess the satisfaction with ADHD medication of parents and children on a per item basis. It
would be very informative if a new study using these measures is conducted in our setting.
Limitation 2: Satisfaction level in our study was reported only for parents/caregivers. Pa‐
tient satisfaction with medication though may be an important factor in the evaluation of
overall  treatment  outcome [64].  In  order  for  treatments  to  be  considered effective,  they
have to be viewed favorably by patients who also have to be willing to use them [19]. Al‐
though parental satisfaction is usually in accordance with the child's feeling on treatment
effect, this is not always the case. In a double-blind crossover study child and parent per‐
ceptions of treatment with stimulant medication in a sample of 102 children with ADHD
was  attempted;  disagreement  between  child  and  parental  perceptions  of  treatment  re‐
sponse existed in >25%. This involved mostly parental viewing of the child's response fa‐
vorably, while the child’s rating was unfavorable; side-effects were the main determinant
of children's perceptions of adverse outcome. Thus, parental report alone is not infallible
in providing reliable information regarding effects as experienced by the child [58]. In an‐
other study consisting of 79 child-parent peers, few differences between parents and chil‐
dren  for  positive  effects  existed,  although  parents  reported  higher  levels  of  negative
effects. This result suggested that parents' considerations clearly have an influence on the
way children perceive medication [69]. In the study of Gortz-Dorten et al, patients report‐
ed slightly but significantly higher satisfaction than parents. Overall satisfaction with the
medication was high for 79.0% of patients and 66.1% of children also reported high satis‐
faction with how the medication helped them feel good. In conclusion, it is important to
assess parental and child perspectives separately, with comparable questions, as their per‐
ceptions of medication are correlated, but only to a moderate degree [18].
Limitation 3: This was an observational study; assuch, selection of participants was based on
loose criteria and treatment conditions are less controlled and standardized. This study design
could be considered an advantage, from a different point of view, as it reflects routine care
conditions in a pragmatic setting. This could be especially true for studies evaluating satisfac‐
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tion with medication, in which ratings from clinical trials are less informative as they are
influenced by the fact that the sample is likely to be biased, given that those who agree to
participate in the studies tend to do so because they are not satisfied with their previous
medication [18-19].
Limitation 4: Both of our samples are comprised of parents who have already contacted
specialized help. They have accepted the diagnosis and they decided to be involved in a
therapeutic procedure, with some of them not treatment naive; parents who have not yet
sought health care for their child may have different impressions and experiences. This may
be considered as an important bias affecting perceptions, acceptance of the medication used
and satisfaction with it.
6. Conclusion
Despite medical advances, barriers for families with children with ADHD in accessing medical
services still exist. In this study, parents' perceptions, teachers' low educational status for the
disorder and low recognition rate from the pediatricians were important factors of low
accessibility of the medical services for diagnosis and treatment of the disorder. Most of the
families having a diagnosis of ADHD and a prescription of a stimulant medication, followed
medical advices. Stimulants, both short and long acting, were beneficial in improving ADHD
symptoms. Parents were satisfied with the use of long acting stimulants, with older age of their
child with ADHD being the only significant prognostic factor of their satisfaction level.
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tion with medication, in which ratings from clinical trials are less informative as they are
influenced by the fact that the sample is likely to be biased, given that those who agree to
participate in the studies tend to do so because they are not satisfied with their previous
medication [18-19].
Limitation 4: Both of our samples are comprised of parents who have already contacted
specialized help. They have accepted the diagnosis and they decided to be involved in a
therapeutic procedure, with some of them not treatment naive; parents who have not yet
sought health care for their child may have different impressions and experiences. This may
be considered as an important bias affecting perceptions, acceptance of the medication used
and satisfaction with it.
6. Conclusion
Despite medical advances, barriers for families with children with ADHD in accessing medical
services still exist. In this study, parents' perceptions, teachers' low educational status for the
disorder and low recognition rate from the pediatricians were important factors of low
accessibility of the medical services for diagnosis and treatment of the disorder. Most of the
families having a diagnosis of ADHD and a prescription of a stimulant medication, followed
medical advices. Stimulants, both short and long acting, were beneficial in improving ADHD
symptoms. Parents were satisfied with the use of long acting stimulants, with older age of their
child with ADHD being the only significant prognostic factor of their satisfaction level.
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1. Introduction
ADHD is the most common neurobehavioral disorder of childhood [1]. It is also one of the
most extensively studied childhood disorders. In spite of the thousands of research articles
written  about  ADHD,  a  cause  has  not  been  clearly  identified.  Theories  include  genetic
abnormalities, structural differences in the brain, food additives, and more. Although these
factors  may  be  physiological  correlates  to  the  symptoms  of  ADHD,  none  has  been
established as a cause.
Factors that have been identified to increase the risk of ADHD include premature birth, low
birth weight, poor maternal health, poverty, and maternal cigarette use. While at first glance
it may be difficult to find a unifying relationship among these risk factors, at a closer look all
of these situations place significant physiological, and potentially psychological, stress on the
developing fetus and growing child.
This chapter will consider the effects of stress on the brain, the relationship between stress and
ADHD, and the use of the Transcendental Meditation (TM) technique to reduce stress and
reduce the symptoms of ADHD. It will also explore the potential of the technique as a means
of lowering the risk, and possibly even preventing ADHD.
2. The developing brain
ADHD is a developmental disorder causing impaired executive function, or higher order
functioning of the brain. Therefore, it is important to consider how the brain develops.
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At birth, a baby has almost all the neurons, or brain cells, that individual will ever have.
However, there are few strong connections. It is somewhat like a pile of electrical wires with
a plug and a light bulb somewhere in the pile , but few of the wires are actually connected in
order to send a functioning signal from the wall socket to the light bulb. During the first two
years of life there is an explosion of brain connections, sometimes referred to as “neural
exuberance.” This is a critical period in brain development as the child learns from experience
and the environment. By age three, the brain has formed about 1,000 trillion connections —
twice as many as what is found in adulthood. A baby’s brain is very dense, and will stay that
way throughout the first decade of life.
Around age 7 the brain begins actively pruning unused or little used connections. Repeat‐
ed experiences create strong connections, while processes that are used only once or twice,
or are inhibited during this critical  period, are pruned. The connections that remain are
stronger and faster.
Though the brain reaches 90-95 percent of its adult size by age six, it continues to develop in
waves, with different parts of the brain developing at different times. The brain grows and
specializes, expanding from governing only the simple functions like appetite, sleep, and
motor activities, to developing more complex functions such as emotions, and finally, reason‐
ing and critical thinking – the “executive functions.” Executive function is controlled by the
cortex, particularly the frontal cortex, and is the last area of the brain to develop.
Roughly between the ages of 10 and 13, the frontal cortex experiences another growth spurt
(Figure  1).  This  growth  is  followed  by  another  period  of  pruning,  particularly  in  the
prefrontal cortex, beginning about age 12 and continuing into the early 20s. Consequently
the part  of  the brain responsible for higher executive functions such as planning,  work‐
ing memory, organization, reasoning, judgment, and impulse control is undergoing major
change during adolescence.
An important development during this period is the process called mylenation, development
of a fatty layer around the brain cell fibers which takes place during the brain’s growth spurts.
Mylenation increases the speed of information processing. Since the cortex is the last part of
the brain to mature, mylenation that connects the prefrontal cortex to the parts of the brain
responsible for lower order functioning such as sensory functions, movement, and emotion
does not begin to strengthen until the preteen and teen years. It is during this time that
preadolescents and adolescents begin exerting independence, thinking for themselves, making
their own decisions, and trying out independent reasoning.
As mentioned, this is also the time when the second period of pruning is taking place,
particularly in the frontal area of the brain. Executive function is improving as the prefrontal
cortex communicates more fully and effectively with other parts of the brain, including those
areas that are particularly associated with planning and problem-solving, emotion, and
impulses. As these connections strengthen over time, the teen may show mature, clear, lucid
thinking. But as a consequence of pruning, the teen may forget these lucid thoughts the next
day, and act in a more childish or impulsive way. Consequently, it is not surprising that it is
Attention Deficit Hyperactivity Disorder in Children and Adolescents72
during the middle school years that these actions are often interpreted as signs of a deeper
problem, and parents or teachers raise concern about ADHD.
Figure 1. Density of Neuronal Connections at Different Times During Brain Development
3. Factors that negatively affect the brain
Developmental psychologists often say the "first years last forever," because this is a time of
rapid development of the brain. It is a time when neurons are connecting in patterns and
pathways based on the experiences to which the infant is exposed. These early experiences
determine the strength and function of the brain's wiring.
Researchers have long known the importance of contact, touch and cuddling of a newborn for
the child to have healthy emotional development. The "prime time" for “emotional intelli‐
gence” to develop is from birth to age 18 months. This provides the foundation for other aspects
of emotional development as the child grows. The amygdala, which regulates emotion, is
shaped early by experience, and forms the brain's emotional wiring. Early nurturing is
important to learning empathy, happiness, hopefulness and resilience.
Traumatic events early in life, such as abuse, neglect,  severe deprivation, or exposure to
violence,  negatively  impact  psychosocial  development.  Children  who  are  exposed  to
violence and abuse at  an early age tend to have both mental  and physical  health prob‐
lems in childhood, with lasting effects in adulthood and throughout life. As they grow up,
these  children  are  more  prone  to  aggression,  conduct  disorder,  delinquency,  antisocial
behavior, anxiety, depression, and suicide [2], [3]. They are vulnerable to developing more
slowly in their social and behavioral skills than their peers, or to actually getting "stuck"
developmentally,  perpetually acting younger than their  age,  consequently increasing the
risk of being diagnosed with ADHD (Table 1).
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the child to have healthy emotional development. The "prime time" for “emotional intelli‐
gence” to develop is from birth to age 18 months. This provides the foundation for other aspects
of emotional development as the child grows. The amygdala, which regulates emotion, is
shaped early by experience, and forms the brain's emotional wiring. Early nurturing is
important to learning empathy, happiness, hopefulness and resilience.
Traumatic events early in life, such as abuse, neglect,  severe deprivation, or exposure to
violence,  negatively  impact  psychosocial  development.  Children  who  are  exposed  to
violence and abuse at  an early age tend to have both mental  and physical  health prob‐
lems in childhood, with lasting effects in adulthood and throughout life. As they grow up,
these  children  are  more  prone  to  aggression,  conduct  disorder,  delinquency,  antisocial
behavior, anxiety, depression, and suicide [2], [3]. They are vulnerable to developing more
slowly in their social and behavioral skills than their peers, or to actually getting "stuck"
developmentally,  perpetually acting younger than their  age,  consequently increasing the
risk of being diagnosed with ADHD (Table 1).
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Because early childhood is such a sensitive time in development, adverse influences during
this time significantly increases the risk of ADHD (Table 1). For example, children whose
parents divorce are almost twice as likely to be on ADHD medication after the split [2], [4].
Living with a single parent can increase the chances of a child being on ADHD medication by
more than 50 percent. If a child is from a family on welfare, the likelihood of the child being
on ADHD medication increases by a staggering 135 percent.
It is not only influences in the first few years that can permanently influence the growth and
development of a child, but also influences during prenatal development. Studies show that
when a mother drinks alcohol or takes drugs, especially early in pregnancy, it can alter the
baby’s brain development, reducing the number of neurons created, and affecting the way the
neurotransmitters function.
Alcohol is a leading cause of the destruction of myelination in the brain. As a result of maternal
alcohol abuse, the child comes into the world with neurobiological problems that include
difficulties with attention, memory, problem solving, and abstract thinking – problems that
will later become symptoms of ADHD.
Other aspects of  the mother’s  health similarly influence the health of  the child,  and the
likelihood  of  ADHD.  Children  born  to  mothers  who  have  physical  or  mental  health
problems  during  pregnancy,  including  depression,  anxiety,  and  musculoskeletal  symp‐
toms are more likely to later have ADHD [5] [6]. Similarly, if the mother experiences these
problems within two years after the baby is born, the child has a higher risk of ADHD [7].
If a mother suffers from depression in the first 5 years of the child’s life, the child is 2.5
times more likely to have ADHD.
Stress at birth is another factor raising the risk of ADHD. Danish researchers found that babies
born prematurely have up to 70% greater risk of ADHD. Similarly, babies born of low birth
weight have 50-90% greater risk of ADHD, depending on the weight at birth [8]. Babies born
prematurely who are exposed to prenatal smoking can have smaller frontal and cerebellar
areas of the brain, which are responsible for executive function and motor coordination,
respectively. Children of mothers who smoke more than a pack of cigarettes a day are two and
a half times more likely to later be taking medication for ADHD.
4. Effects of stress on the brain
Chronic physical or psychological stress can change the brain. The body's natural response to
stress is to activate the sympathetic nervous system and hypothalamic-pituitary-adrenal
(HPA) axis, leading to an increase in levels of catecholamines, corticotropin, and cortisol,
creating the fight-or-flight response. Adrenaline and then cortisol are secreted by the adrenal
glands, revving up the body, then sustaining energy flow to different systems. The lungs pump
faster, and the heart begins to race. Blood pressure rises, stimulating muscles and sharpening
the mind to a singular focus of attention. The release of endorphins numbs the body. Appetite,
libido, and the immune system shut down. Energy normally directed to these functions is
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redirected to the muscles. The response is intended to help the person react quickly and
effectively to a high-pressure situation (i.e., fight or flee).
In a normal stress response, the autonomic nervous system, the HPA axis, and the cardiovas‐
cular, metabolic, and immune systems protect the body by responding to internal and external
stress, then return to a balanced state.
However, chronic acute stress impairs the body's ability to return to alostasis, or baseline,
leading to an out of balance biochemistry, with elevated cortisol and suppressed serotonin.
Excessive levels of cortisol in the brain impair the function of the hippocampus, leading to
neuronal atrophy and destruction of neurons, decreased short term and contextual memory,
and poor regulation of the endocrine response to stress.
Prolonged stress hinders the body’s ability to tell the hypothalamus to stop calling for more
stress hormones.  As a result,  stress hormones flood the bloodstream, causing additional
damage to the hippocampus, and additional stress. The price can be allostatic load, which
is  the  wear  and tear  that  results  from chronic  overactivity  or  underactivity  of  allostatic
systems [9], [10].
The increase in cortisol inhibits utilization of blood sugar by the hippocampus, the brain's
primary memory center. Reduced glucose produces an energy shortage, and the brain has no
way to imprint memories. This results in the immediate short-term memory problems that are
associated with stress. Further, cortisol overproduction interferes with the brain's neurotrans‐
mitters, making it hard to retrieve stored memories. Too much cortisol disrupts normal brain
cell metabolism, eventually producing free radicals, which kill brain cells.
An increase in cortisol leads to a decrease in serotonin. Serotonin is a critical stress hormone,
influencing body temperature, blood pressure, pain, digestion, sleep, and circadian rhythms.
Deficiency in serotonin leads to behavioral concerns such as increases in irritability, aggression,
impulsivity, suicide, and alcohol and drug abuse.
Chronic stress damages or kills neuronal connections. As much as 34% reduction in cells in
the prefrontal cortex have been reported [11]. Significantly, chronic stress results in lower levels
Premature birth 70% increased risk
Low birth weight (3-5 lbs) 90% increased risk
Low birth weight (5-6 lbs) 50% increased risk
Mother's depression in child’s first 5
years
2.5 times higher risk
Living with single parent 50% increased risk
Maternal smoking 2.5 times more likely to be on ADHD
medication
Poverty 135% increased risk
Table 1. Factors that Increase the Risk of ADHD
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of expression of genes required for the function and structure of brain synapses [12]. Re‐
searchers found that a single transcription factor called GATA1, present with chronic stress,
represses the expression of several genes that are necessary to form synaptic connections
between brain cells in the prefrontal cortex (Figure 2).
Figure 2. Tissue sample on the left from the prefrontal cortex of a Control subject. Tissue on the right, from a subject
with depressive disorder shows dramatic reduction in prefrontal cortical synapses. (Figure courtesy of Kang, et al.)
5. Relationship between stress and ADHD
Disruptions of the neuronal connections in the prefrontal cortex caused by stress, interferes
with executive function and behavior regulation [9]. Stress-impaired executive function is
associated with impaired working memory, impaired impulse control, and lack of mental
flexibility and coping strategies. Stress also dramatically compromises selective attention and
the ability to sustain attention [10].
ADHD is associated with impaired executive function, specifically brain circuitry governing
behavior [13], [14], [15]. Dysfunction of these circuits leads to impulsivity and lack of normal
social inhibition, as well as impaired working memory, inability to focus attention, and
impaired temporal organization.
In light of these similarities, the connection between stress and the symptoms of ADHD begins
to emerge. Stress negatively affects brain function, resulting in the same symptoms associated
with ADHD. Table 2 compares symptoms of stress identified by the US Centers for Disease
Control and Prevention, and diagnostic factors for ADHD as defined by the Diagnostic and
Statistical Manual of Mental Disorders (DSM-lV). The symptoms are nearly parallel. In fact it
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can be said that the differences are simply the difference in the way the symptom might be
expressed in an adult compared to a child.
Symptoms of Stress Symptoms of ADHD
Inability to concentrate Difficulty sustaining attention
Not listening when spoken to
Difficulty organizing Difficulty organizing
Memory problems Forgetfulness
Poor judgment Speaks without thinking
Short temper Impulsivity
Table 2. Symptoms of stress closely match symptoms of ADHD
Recent research sheds further light on the relationship between stress and ADHD. Vance, et
al., demonstrated dysfunction of the right prefrontal regions of the brain in ADHD children
[16]. This region is responsible for developing coping strategies, influencing the ability to
handle stress. Early experiences of stress are believed to affect the level of responsiveness of
the HPA axis and autonomic nervous system.
Young children exposed to chronic stress, can become overly accustomed to dealing with fear
states, becoming conditioned to having or tolerating higher levels of adrenaline. Chronic acute
stress damages the body's ability to return to non-stress levels, leading to chronically elevated
levels of cortisol, a biochemical marker of stress. In children with ADHD high cortisol levels
impair executive function, self-regulation, and letter knowledge [17].
Dysregulation of the central noradrenergic pathways in the brain is believed to underlie the
pathophysiology of ADHD [18]. The noradrenergic system is associated with the modulation
of attention, alertness, vigilance and executive function. Specifically, dopamine is associated
with behavior and impulsive control, while norepinephrine is associated with focus, planning,
and concept thinking including sequence and time. Disruption of the noradrenergic function
seen in the presence of the “fight-or-flight” response involves the same neurochemistry
associated in ADHD. In fact, the majority of ADHD medication involves increasing the
presence of dopamine, norepinephrine, and serotonin.
6. The transcendental meditation technique
Given the role stress seems to play in the symptoms of ADHD, it is logical to explore stress
reduction techniques, such as meditation, as a means of minimizing the effects of stress and
reducing the related symptoms associated with ADHD.
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Is ADHD a Stress-Related Disorder? Why Meditation Can Help
http://dx.doi.org/10.5772/55127
77
There are many systems of meditation. Techniques differ widely from one another in their
procedures, content, beliefs, and goals. Each technique uses a different process and thus has
different effects [19], [20].
With advances in neuroscience, the study of meditation has become more specific and more
evidence based. Most recently, using EEG signatures and the corresponding cognitive
processes, meditation practices have been classified into three types: focused attention, open
monitoring, and automatic self-transcending [21].
Techniques  of  focused  attention  are  concentration  techniques,  and  are  associated  with
voluntary  sustained  control  of  attention  on  the  object  of  meditation,  such  as  an  event,
image, or sound. The brain activity during concentration meditations is characterized by
EEG in the beta-2 (20-30 Hz) and gamma (30-50 Hz) frequency bands. Open monitoring or
mindfulness-based techniques,  involve dispassionate non-evaluative monitoring of  ongo‐
ing  experience.  These  techniques  are  characterized  by  frontal  theta  (5-8  Hz)  EEG,  and
perhaps  occipital  gamma  (30-50  Hz)  EEG.  Automatic  self-transcending  meditation  is
defined as effortless transcending of the meditation process itself [22], [21]. EEG activity of
an automatic self-transcending technique is associated with alpha-1 (7-9 Hz), characteris‐
tic of reduced mental activity and relaxation.
The Transcendental Meditation technique falls into the category of automatic self-transcend‐
ing. Concentration and open monitoring meditations both require some mental effort (i.e.,
holding attention on its object or maintaining attention on an ongoing experience, respective‐
ly). The Transcendental Meditation technique automatically leads to the experience of
“consciousness itself,” awareness without any objects of awareness, a low-stress state called
transcendental or pure consciousness [23].
Practice of the technique is not based on concentrative effort, contemplation, prayer, or
deliberate attempts to make the awareness more mindful or alert. Rather, the technique allows
the conscious awareness, or active thinking, to spontaneously “transcend” to deeper, quieter
levels of the thinking process, eventually experiencing the most settled state of awareness,
where the mind is fully awake within itself, without experiencing objects of perception.
The Transcendental Meditation technique is a mental technique practiced for 10-20 minutes
twice each day, sitting in a chair with eyes closed. It is easy to learn and to practice. Because it
does not require concentration or controlling the mind, it is particularly well suited for children
or adults with ADHD.
The technique is taught by certified Transcendental Meditation teachers in a 7-Step course.
The 7-Step course of instruction involves two informational lectures (Steps 1 and 2), a brief
interview with the TM instructor (Step 3), individual personal instruction (Step 4), which is
followed by three days of verification of practice and additional information (Steps 5-7). The
interview is about 10 minutes, while the remaining steps are approximately 1-1.5 hr each day.
Each step can be conducted in a group except Steps 3 and 4, which are conducted individually,
one-on-one. Periodic meetings with the student assure correct practice and reinforce regularity
of the practice.
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During the course of instruction, the student learns how to let the mind move from active
focused levels of thinking to silent, expanded levels of wakefulness at the source of thought,
without concentration or effort [24] (Figure 3).
Figure 3. During the Transcendental Meditation technique the mind moves from the active, directed thinking level to
the more subtle levels of thinking, to eventually go beyond the boundaries of thought to experience ‘pure’ conscious‐
ness.
Regular practice of the technique creates a state referred to as "restful alertness." The term
reflects a combination of markedly decreased metabolism, heart rate, respiration rate, and
blood flow to the limbs, similar to deep rest or sleep; while at the same time mental alertness
is maintained, as demonstrated by EEG [25], [26], [27]. The TM technique produces a signifi‐
cantly greater degree of deep rest than sitting with eyes closed, measured by reduced respi‐
ration , reduced skin conductance (increased skin resistance), reduced plasma lactate [25],
more rapid recovery from stressful stimulus, and leads to a reversal of symptomatology
associated with severe and chronic stress [28].
Meta-analyses indicate that the Transcendental Meditation technique is two to four times more
effective in reducing stress and anxiety than other meditation or relaxation techniques [19]. A
2012 meta-analysis found Transcendental Meditation to be the most effective technique across
a broad spectrum of psychological and cognitive variables including negative emotions,
neuroticism, perception, trait anxiety, behavior, and memory and learning [29] (Figure 4).
Measurements of brain function show increases in brain coherence both during the practice of
the Transcendental Meditation technique, and afterwards in activity [21], [30], [31]. The
primary areas of the brain that are activated are the frontal and prefrontal executive areas
responsible for attention, executive function, emotional stability, and anxiety (Figure 5) [32],
[31], [33], [34]. Study of college students demonstrated increased frontal coherence and
reduced stress reactivity in the group practicing the Transcendental Meditation technique
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associated with severe and chronic stress [28].
Meta-analyses indicate that the Transcendental Meditation technique is two to four times more
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2012 meta-analysis found Transcendental Meditation to be the most effective technique across
a broad spectrum of psychological and cognitive variables including negative emotions,
neuroticism, perception, trait anxiety, behavior, and memory and learning [29] (Figure 4).
Measurements of brain function show increases in brain coherence both during the practice of
the Transcendental Meditation technique, and afterwards in activity [21], [30], [31]. The
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compared to controls [35], [36]. Further, students in the TM group showed that TM may lead
to a foundational or ‘ground’ state of cerebral functioning and more focused cognitive
processes [36].
Figure 5. fMRI showing increased activation in the frontal areas of the brain during the practice of the Transcendental
Meditation technique (Courtesy of M. Ludwig)
Figure 4. Meta-analysis of 163 studies of various meditation techniques, comparing the effects on psychological varia‐
bles [29].
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The effects of the Transcendental Meditation technique extend to the noradrenergic networks
[26], [37], [38], resulting in a decrease in the stress hormone cortisol, both during meditation
and continuing outside meditation, during activity. Practice of the technique increases
serotonin availability, improving mood and reducing the activation of the brain centers for
fear, anxiety, and anger.
The use of the TM technique for stress reduction in adolescents has resulted in improvement
in school behavior, decreases in absenteeism and rule infractions, and reduction in suspensions
due to behavior-related problems [39]. Students practicing the TM technique show higher
performance on scales of self-actualization [40], increased emotional regulation, and improved
well-being [41] as well as improved academic performance.
7. The Transcendental Meditation technique and ADHD
The Transcendental Meditation technique creates a neurobiological response opposite to that
induced by stress. It enlivens the executive areas of the brain, and is associated with improved
psychosocial behavior in normal populations.
Studies of the TM technique with students with ADHD demonstrate that the benefits of the
technique also extend to this population. A 3-month pilot study was conducted with children
ages 11 to 14 with the diagnosis of ADHD, and in some cases comorbidities, including general
anxiety disorder, dysthymia, obsessive compulsive disorder, pervasive developmental
disorder, sleep disorders, and tics [42]. These children also had language-based learning
disabilities. The study measured effects of the Transcendental Meditation technique on stress,
anxiety, and ADHD symptoms; and measured changes in executive function. Measures of
stress and ADHD symptoms included the Achenbach Child Behavior Checklist (CBCL)
completed by parents and teachers, the companion inventory the Achenbach Youth Self-
Report (YSR), and the Revised Children’s Manifest Anxiety Scale (RCMAS). Measures of
executive function included the Behavior Rating Inventory of Executive Function (BRIEF), the
Cognitive Assessment System (CAS) Expressive Attention, Delis-Kaplan Executive Function
System (D-KEFS) Verbal Fluency test, and Connor’s CPT II.
After three months, there were highly statistically significant reductions in anxiety and
anxiousness, depression symptoms, attention problems, and total problems (Table 3).
Statistically significant improvements in executive function as measured by the BRIEF showed
improved Behavioral Regulation (includes ability to Inhibit, Shift for one task to another, and
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Is ADHD a Stress-Related Disorder? Why Meditation Can Help
http://dx.doi.org/10.5772/55127
81
compared to controls [35], [36]. Further, students in the TM group showed that TM may lead
to a foundational or ‘ground’ state of cerebral functioning and more focused cognitive
processes [36].
Figure 5. fMRI showing increased activation in the frontal areas of the brain during the practice of the Transcendental
Meditation technique (Courtesy of M. Ludwig)
Figure 4. Meta-analysis of 163 studies of various meditation techniques, comparing the effects on psychological varia‐
bles [29].
Attention Deficit Hyperactivity Disorder in Children and Adolescents80
The effects of the Transcendental Meditation technique extend to the noradrenergic networks
[26], [37], [38], resulting in a decrease in the stress hormone cortisol, both during meditation
and continuing outside meditation, during activity. Practice of the technique increases
serotonin availability, improving mood and reducing the activation of the brain centers for
fear, anxiety, and anger.
The use of the TM technique for stress reduction in adolescents has resulted in improvement
in school behavior, decreases in absenteeism and rule infractions, and reduction in suspensions
due to behavior-related problems [39]. Students practicing the TM technique show higher
performance on scales of self-actualization [40], increased emotional regulation, and improved
well-being [41] as well as improved academic performance.
7. The Transcendental Meditation technique and ADHD
The Transcendental Meditation technique creates a neurobiological response opposite to that
induced by stress. It enlivens the executive areas of the brain, and is associated with improved
psychosocial behavior in normal populations.
Studies of the TM technique with students with ADHD demonstrate that the benefits of the
technique also extend to this population. A 3-month pilot study was conducted with children
ages 11 to 14 with the diagnosis of ADHD, and in some cases comorbidities, including general
anxiety disorder, dysthymia, obsessive compulsive disorder, pervasive developmental
disorder, sleep disorders, and tics [42]. These children also had language-based learning
disabilities. The study measured effects of the Transcendental Meditation technique on stress,
anxiety, and ADHD symptoms; and measured changes in executive function. Measures of
stress and ADHD symptoms included the Achenbach Child Behavior Checklist (CBCL)
completed by parents and teachers, the companion inventory the Achenbach Youth Self-
Report (YSR), and the Revised Children’s Manifest Anxiety Scale (RCMAS). Measures of
executive function included the Behavior Rating Inventory of Executive Function (BRIEF), the
Cognitive Assessment System (CAS) Expressive Attention, Delis-Kaplan Executive Function
System (D-KEFS) Verbal Fluency test, and Connor’s CPT II.
After three months, there were highly statistically significant reductions in anxiety and
anxiousness, depression symptoms, attention problems, and total problems (Table 3).
Statistically significant improvements in executive function as measured by the BRIEF showed
improved Behavioral Regulation (includes ability to Inhibit, Shift for one task to another, and
Emotional Control). Similar improvements were seen in the Metacognition Index (includes
ability to Initiate, Working Memory, Planning, Organize Material, and Monitoring).
A second study, a randomized control trial of a similar population as the previous study,
explored improvements in brain coherence and brain development [43]. The purpose was to
provide insight into the underlying mechanisms of observed changes. The study measured
EEG coherence, theta/beta ratio, and executive function.
Is ADHD a Stress-Related Disorder? Why Meditation Can Help
http://dx.doi.org/10.5772/55127
81
EEG of ADHD populations show decreased activation in parietal areas of the brain that weave
sensory input into concrete perception [44], higher density and amplitude of theta activity [45],
[46], and lower density and amplitude of alpha and beta activity [47]. Theta is thought to block
out irrelevant stimuli during memory processing. In ADHD subjects, greater theta activity
may block out relevant as well as irrelevant information. Theta/beta ratios are highly correlated
with severity of ADHD symptoms.
Another brain marker of ADHD is EEG coherence, a measure that reflects the number and
strength of connections between different brain areas. In children diagnosed with ADHD,
coherence in all frequencies is lower [48]. Alpha coherence is thought to play an important role
in attention.
In the TM study, EEG of ADHD students was taken during a computer-administered paired
choice reaction-time task to calculate theta/beta ratios and patterns of EEG coherence. The
study also applied employed several of the same measures of executive function used in the
previous study. At pretest, all students showed theta/beta ratios well above the normal range
(normal average=3). Subjects were randomly assigned to the TM group and delayed-start
group. The delayed-start group served as controls for the first three months, then also learned
the TM technique.
Coherence  maps ere  calculated at  pretest,  3  months,  and 6  months.  At  3  months,  from
pretest to posttests compared the TM group to the control group. At six months, changes
in coherence for the control group (delayed start, who had been meditating for 3 months)
were calculated from 3-month to 6-month posttests.  The resulting maps showed present
Student Teacher
Pretest Post Test Pretest Post Test
Symptom Mean SD Mean SD ES Mean SD Mean SD ES
Anxious/
Depressed
5.7 3.6 2.7* 3.7 .8 10.2 6.4 5.6* 3.6 .7
Withdrawn/
Depressed
4.8 2.7 3.9** 3.0 .3 4.3 3.8 3.6 4.0 .2
Affective Problems 5.8 3.4 4.1* 2.5 .5 5.0 3.7 3.6 3.6 .4
Anxiety Problems 3.2 2.0 1.6** 1.9 .8 3.7 3.5 2.1 2.4 .5
Attention
Problems
7.0 4.0 5.2* 3.5 .5 23.6 10.5 22 11.0 .2
ADHD Problems 5.4 2.9 4.3 2.7 .4 12.4 5.7 11.7 5.7 .3
Total Problems 52.5 25.6 40* 27.4 .5 63.1 24.8 56* 31.2 .3
* p ≤.05. **p<.005 ES=Effect Size
Table 3. Results of Achenbach Child Behavior Checklist and Youth Self Report after three months practice of the
Transcendental Meditation technique among children with ADHD.
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coherence  in  theta  (5.0-7.5  Hz),  alpha  (8.0-12  Hz),  beta1  (13-20  Hz),  and  gamma bands
(20.5-50 Hz).
Results (Figure 6) indicated few sensors with higher coherence in the delayed-start group at
the 3-month posttest compared to their pretest values. In contrast, in the TM group there were
many frontal and parietal areas at 3-month posttest compared to pretest values. At 6-month
posttest, the delayed start group (who learned TM at 3 months) also showed many frontal and
parietal areas with higher coherence compared to the 3-month posttest values.
Figure 6. Coherence maps of at baseline, 3-months, and 6-months among children with ADHD. Top row is coherence
during the 3-month posttest minus baseline coherence for the delayed-start subjects. Middle row is coherence during
the 3-month posttest minus baseline coherence for the TM subjects. Bottom row is coherence during the 6-month
posttest minus 3-month posttest for the delayed-start subjects, who had been meditating over this time.
At the 3-month posttest, theta/beta ratios increased in the delayed-start group, which is
opposite to the desired effect, while the TM subjects moved closer to normal values. At the 6-
month posttest, after both groups were practicing the TM technique, theta/beta ratios de‐
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creased in both groups. For the delayed start group, theta/beta ratios also significantly
decreased from the 3-month to 6-month posttest after three months practice of the TM
technique (Figure 7).
Figure 7. Theta/beta ratios compare results at pretest, 3-month and 6-month posttests. Transcendental Meditation
group showed reductions at 3-months compared to delayed start controls. TM group showed continued improve‐
ments at six months. Delayed start showed significant improvements from 3-months to 6-months, after meditating for
3 months.
8. Prevention
An initial literature search of research on preventing ADHD turns up no significant contribu‐
tion to the subject of effecting the underlying causes. In fact, it seems to be an area that is not
actively being addressed. Most research on prevention is focused on preventing of other social
problems that arise among children with ADHD, such as smoking or criminal behavior.
Without an understanding of the disorder’s etiology, prevention cannot be addressed. The
etiology currently gaining most attention is genetic causes. However, genetic alterations
associated with ADHD may be a correlate rather than a cause. As discussed earlier, chronic
stress can result in changing gene expression, resulting in structural impairment of the
prefrontal cortex.
Considering the factors discussed in this chapter, a unifying underlying cause emerges.
Chronic stress, whether physical or emotional, can result in structural impairment to brain,
and give rise to the symptoms identified as ADHD.
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Recognition of the role stress plays in ADHD offers an opportunity to intervene to alter the
course of the disorder. Some risk factors such as maternal smoking can addressed through
education and public health efforts, a child’s risk of developing ADHD. Other causes of stress,
however, may be more difficult to avoid or eliminate (e.g., premature birth, poverty). But many
of the stress factors that raise the risk of ADHD are known (Table 1), therefore, interventions
that immediately address reducing the effects of the stressors, have the potential of reducing
the damaging effects on the brain, and possibly avoid development of the symptoms of ADHD.
When a child, or even an adult, begins to show signs of difficulty with attention and focus,
disorganization, behavior issues, and difficulty controlling anger or impulses, a thorough
approach to diagnosis should include assessment of potential causative factors. In as many as
75- 85% of cases, ADHD is complicated by the presence of other emotional or behavioral
disorders [49]. Treating the underlying disorder can result in reduction of ADHD symptoms.
If the symptoms arise as a child enters school, an evaluation of learning can be useful.
Approximately 20-30% of children with ADHD also have a learning disability [50]. When a
child starts to show difficulty academically, he or she tends to lose interest in learning, can
become easily distracted, or may engage in disruptive behaviour. This can lead to a diagnosis
of ADHD since these are also clinical symptoms of the disorder. However, they may actually
be caused by a learning problem, whether it is a learning disorder or simply the consequence
of getting behind or confused in an academic subject and unable to catch up. An educational
assessment can help distinguish the underlying problem.
If symptoms arise when a child changes schools or environments, this can be an underlying
cause of stress, and consequently the appearance of ADHD related problems. Traumatic events
such as conflict at home, or lose or separation from parents or close caregivers can result in
ADHD symptoms.
Children  who  are  exposed  to  geopolitical  violence  or  natural  disasters  often  display
symptoms interpreted as ADHD, when they may actually be stress responses to the trauma
or the chronic stress of  living in fear.  Each year in the US,  more than five million chil‐
dren  are  exposed  to  some  form  of  extreme  traumatic  stressor.  These  traumatic  events
include natural disasters such as tornados, floods, hurricanes; motor vehicle accidents; life
threatening illness and associated painful experiences such as cancer or burns; or witness‐
ing violence in the home or  community.  Over  30 percent  of  these traumatized children
develop  a  clinical  syndrome  with  emotional,  behavioral,  cognitive,  social  and  physical
symptoms significant enough to be diagnosed with post traumatic disorder (PTSD). Some
of the symptoms of PTSD are very similar to those of ADHD. Without an exploration of
the underlying causes of ADHD symptoms, other problems may go undiagnosed.
Regardless of the underlying cause of the stress, the Transcendental Meditation technique can
provide an intervention that can reduce the effects of stress and related symptoms, including
symptoms that might be diagnosed as ADHD.
For children as young as four or five years old, the Transcendental Meditation technique has
been shown to effectively reduce stress and increase cognitive development. It can balance
neurochemistry, reversing the cycle of high cortisol leading to low serotonin; thus improving
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mood and impulse control. (Note: for children below the age of 10 years old, the technique is
slightly different, done with the eyes open, while engaged in non-focused activity.) The
technique also leads to balancing dopamine and norepinephrine, the same neurotransmitters
that are the target of common ADHD drugs.
For children younger than four years old, who may be too young to learn the TM technique,
the Maharishi Ayurveda Mother and Baby Program provides dietary and behavioral guide‐
lines that include foods cooked according to specific principles, and Ayurvedic massage that
reduces stress and improves the baby’s sleep and digestion [51]. When this approach is
incorporated for the mother and the baby, along with the mother’s practice of the Transcen‐
dental Meditation technique, it improves the mother’s mental and physical health, and leads
to a better start for the baby.
9. Case study
The following case study will illustrate how the concepts presented in this chapter can affect
an individual child. At the first introduction to Jessie (not his real name), he was 7 years old
and had just been diagnosed with ADHD. His mother explained, “He can’t control his
emotions - happy or sad emotions. He can be extreme in either direction.” She described that
sometimes he would be in such a rage, that he would hide under his bed or go out to his father’s
car to try to calm himself. “I’m afraid one day he’ll be standing over me with a knife. I don’t
know what to do,” she said. He was also having difficulty with attention and behaviour at
school.
Jessie seemed like a very sweet, though rambunctious, boy. He did not seem to display any
malice or meanness, but if he got frustrated or over-excited, he could not control his emotions.
He was from a warm and loving family with both parents and a younger brother. They had a
warm, healthy home life, and there did not seem to be cause for the level of stress that might
lead to the behavior Jessie would sometimes exhibit.
Discussion with Jessie’s mother, however, shed light on the situation. She had two miscarriages
before Jessie was born. As a result she was very anxious during her pregnancy with Jessie.
After he was born, she had another miscarriage, which led to depression and medication for
her depression. When she became pregnant again, she had complications requiring bedrest
for the last trimester, making it difficult to give full attention to Jessie.
During the time 2-year old Jessie’s mother was in the hospital giving birth to his brother, Jessie
stayed with his grandmother. While there, he got sick, requiring hospitalization, where he was
temporarily put on oxygen. One can imagine how scary this would be for a young child, and
though his father was with him, his mother was not.
Jessie’s situation was not serious, and he was not hospitalized long. However the newborn
had complications, which was finally diagnosed a year later as a digestive disease. This
resulted in much attention and worry around the newborn, which to young Jessie may have
seemed like a form of abandonment, creating greater stress for him. While any of these
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individual situations may not have caused emotional stress for Jessie, combined over an
extended period of time, likely caused a significant physiological response to chronic stress.
Consequently, the effect of the early adversity, several of which are known to increase the risk
of ADHD, may explain Jessie’s symptoms and lack of self-control, which were diagnosed as
ADHD.
Jessie’s parents did not want to put him on medication, so they sought another approach. At
age seven, Jessie and his whole family – parents and 5-year-old brother – learned the Tran‐
scendental Meditation technique. The boys learned the young child’s technique called the
Word of Wisdom.
Jessie found it effective in calming himself down. It also resulted in immediate improvements
in school. The next week after learning TM, he completed his weekly math test for the first
time all year. He was able to maintain his attention, focus, and easily get through the task.
When he turned 10 years old, Jessie learned the sitting, eyes closed technique. He does well in
school, is better able to control his emotions, and gets along well with his younger brother.
Jessie eventually added a low dose of ADHD medication to augment the benefits of the
meditation. He is a happy, well-adjusted child who does well in school. However, given the
extreme behaviors he displayed at a younger age, his life could have quickly taken a different
course. One could foresee significant behavior problems, the potential for strong life-long
medication, poor success in school, and a more troubled life for him and his family. Though
it is impossible to predict what would have happened over time, the value of early intervention
with an effective technique for reducing stress, balancing the neurochemistry, and improving
executive function can be appreciated.
10. Conclusion
A child or adult affected by trauma or severe stress looses the ability to return to a balanced
state, consequently creating a cycle of chronic stress. Chronic stress alters the biochemistry and
neuronal development particularly in the prefrontal cortex. The result is impaired executive
function, creating lack of control of attention, focus, memory, organization, and impulses,
displaying as symptoms of ADHD.
Early recognition of factors that cause severe or traumatic stress, and early intervention can
help mitigate the effects. The Transcendental Meditation technique has been shown to be
effective in reducing temporal and chronic stress, reducing ADHD symptoms, and improving
executive function. The technique is easy to learn and easy to practice, is appropriate for people
of all ages - children as young as four or five years old to adults of any age. In the presence of
ADHD risk factors, the Transcendental Meditation technique offers potential for preventing
full manifestation of symptoms, and provides a field for study of ADHD prevention.
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effective in reducing temporal and chronic stress, reducing ADHD symptoms, and improving
executive function. The technique is easy to learn and easy to practice, is appropriate for people
of all ages - children as young as four or five years old to adults of any age. In the presence of
ADHD risk factors, the Transcendental Meditation technique offers potential for preventing
full manifestation of symptoms, and provides a field for study of ADHD prevention.
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1. Introduction
Attention-Deficit/HyperactivityDisorder (ADHD) is one of the most prevalent neurodeve‐
lopmental disorders among children. It affects 3-10% of school-age children (Polanczyk et
al., 2007), and a prevalence rate of 7.5% was reported in a local Taiwan study (Gau et al.,
2005). The core symptoms of ADHD are inattention, hyperactivity, and impulsivity, and
ADHD patients are commonly comorbid with other neuropsychiatric disorders, such as Op‐
positional Defiant Disorder (ODD), Conduct Disorder (CD), and tic disorders (American
Psychiatric Association, 2000; Spencer et al., 2007). The most well-known neurobiological
hypotheses to account for the complexity in etiology of ADHD are the dysregulation of cate‐
cholaminergic neurotransmission (Biederman & Faraone, 2002). In recent years, many re‐
searchers have raised concerns with regards to the potential roles of the neuroendocrine
system in the pathogenesis of ADHD (Dubrovsky, 2005; Golubchik et al., 2007; Goodyer et
al., 2001; Martel et al., 2009; Strous et al., 2006), based on observations of the epidemiological
data of ADHD. ADHD is more prevalent in boys than in girls, with the ratio ranging from 4
to 1 to as much as 9 to 1, and boys generally exhibit more impaired cognitive control than
girls (American Psychiatric Association, 2000). In addition, longitudinal studies have shown
that there is a clear decline of symptoms with age, and a possible remission occurs after the
age of 12 (Polanczyk & Rohde, 2007). The neuroendocrine system, the activation of which is
closely associated with age and gender, may influence developing neural circuitry and be‐
havioral systems; thus it has reasonably been speculated that this system plays a role in the
pathogenesis of ADHD (Martel et al., 2009).
Methylphenidate (MPH), classified as a psychostimulant, is the most widely used drug for
the pharmacological management of children with ADHD (Swanson et al., 2002). The effects
of MPH on attention result from a combination of noradrenergic and dopaminergic mecha‐
© 2013 Wang and Chen; licensee InTech. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 2013 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
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nisms (Overtoom et al., 2003; Wilens, 2008). MPH exerts treatment effects by reducing im‐
pulsivity and disruptive behavior (Huang & Tsai, 2011), and it improves plenty of
dimensions of neurocognitive function in ADHD patients (Huang et al., 2007; Pollak et al.,
2010). Furthermore, some evidence has been revealed that MPH treatment possibly influen‐
ces the neuroendocrine system (Hibel et al., 2007; Lurie & O'Quinn, 1991), and these influen‐
ces possibly play a role as a mediator of the therapeutic effects for ADHD patients.
Therefore, we herein review the related literature which investigates the relationship be‐
tween ADHD, neuroendocrine, and MPH administration.
2. ADHD and neurosteroids
The term “neurosteroid” was first introduced by Baulieu (1981), which indicated steroid
hormones synthesized in brain cells from cholesterol, independent of peripheral endocrine
sources, acted at the central nervous system. Initially, neurosteroid referred to dehydroe‐
piandrosterone sulfate (DHEA-S) (Baulieu & Robel, 1996). DHEA-S concentration in the
brain was found to remain stable following adrenalectomy and gonadectomy. This implied
that DHEA-S levels in the central neural system appeared to be independent of peripheral
formation in the adrenals or gonads (Strous et al., 2006). Subsequently, progesterone, allo‐
pregnanolone, pregnenolone, dehydroepiandrosterone (DHEA) and their corresponding
sulfate esters were identified as neurosteroids (Baulieu & Robel, 1998). Neurosteroids are
important substrates that have been demonstrated to affect mood expression, energy level,
aggression, and general activity (Wolkowitz et al., 1999).
2.1. DHEA and DHEA-S
DHEA is one of the major circulating neurosteroids in human, and it is also an ACTH-regu‐
lated steroid and a substrate for the synthesis of androstenedione and testosterone (Gurnell
& Chatterjee, 2001). DHEA has been demonstrated to play several vital neurophysiological
roles and to be affected by various physiological processes, including those associated with
neurotrophic and neuronal excitability effects, circadian rhythms, sexual responses, immu‐
nological and stress reactions, memory, and sleep (Baulieu & Robel, 1996; Herbert, 1998).
DHEA-S is a sulfated form of DHEA that is believed to be the most abundant steroid in the
body (Wolf et al., 1997). DHEA-S is measured more frequently than DHEA because circulat‐
ing levels of DHEA-S are approximately 500 times higher due to its lower metabolic clear‐
ance rate and minimal diurnal variation (Longcope, 1996).
Strous et al. (2001) demonstrated that DHEA and DHEA-S levels in blood are inversely re‐
lated to the severity of hyperactivity/impulsivity symptoms in children with ADHD aged
between 7 and 12 years. Another study found that ADHD patients treated with methylphe‐
nidate for 3 months exhibited pre- to post-treatment increases in plasma levels of DHEA and
DHEA-S for 23% and 53.6%, respectively (Maayan et al., 2003). Subsequently, Lee et al.
(2008) were the first research group investigating the role of neurosteroids in Asian ADHD
population. They suggested that plasma DHEA-S levels in ADHD patients increased signifi‐
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cantly during a 12-week MPH treatment and under a 12-week bupropion treatment as well.
These studies revealed a substantial increase in DHEA levels among pre-pubertal ADHD
patients; however, there was no data with regards to age- and gender-matched healthy con‐
trols for comparison. Finally, our research team demonstrated that salivary DHEA levels
were significantly lower in ADHD patients than those in healthy controls (Wang et al.,
2011b). Salivary DHEA levels were not significantly correlated with ADHD clinical symp‐
tom severity, but positively correlated with performance in a neuropsychological test (Con‐
ner’s Continuous Performance Test, CPT). Thus the authors suggested that lower morning
DHEA levels might be a biological laboratory marker for ADHD, particularly for perform‐
ance during CPT. In the longitudinal analyses, we found that morning salivary DHEA levels
significantly increased under the 6-month MPH treatment course for ADHD patients. How‐
ever, the salivary DHEA levels in healthy age- and gender- matched controls remain un‐
changed during the 6-month natural observation. Similar with the findings in the cross-
sectional survey, DHEA levels exhibited a significant and independent association with
overall CPT performance during the course of MPH treatment (Wang et al., 2011a). We
could thus determine that the elevation of DHEA levels among ADHD patients is not de‐
rived from natural physiological change, but from MPH administration.
There is interesting coincidence in the similarity of the natural course of ADHD, brain devel‐
opment and age-related change in DHEA/DHEA-S levels. ADHD symptoms generally de‐
cline in severity between puberty and the early twenties (Biederman et al., 2000). Some brain
imaging studies have found there to be a dysfunction of the cerebellar-striatal-prefrontal cir‐
cuitry in ADHD (Gogtay et al., 2002), and that this may be the result of delayed maturation
of the cerebral cortex, especially the prefrontal region (Shaw et al., 2007; McAlonan et al.,
2009). Plasma DHEA/DHEA-S levels change with age, being low in the first years of life,
then rapidly increasing from about eight years of age through puberty to reach their highest
levels during early adulthood (de Peretti & Forest, 1978). DHEA-S has antiamnestic effects,
and also anxiolytic and anti-aggressive properties (Wolf & Kirschbaum, 1999). Both DHEA
and DHEA-S have been shown to regulate the motility and growth of neocortical neurons in
the rodent brain (Compagnone & Mellon, 1998). This implies that DHEA/DHEA-S exert bio‐
logical actions that may play crucial roles in guiding cortical projections to appropriate tar‐
gets, and thus may be important for the regulation of neurodevelopment (Golubchik et al.,
2007). It has been proposed that DHEA/DHEA-S exerts its positive effects in ADHD patients
through stimulatory or antagonist effects at the gammaaminobutyric acid A (GABAA) recep‐
tor and facilitation of the N-methyl-D-aspartate (NMDA) activity (Davies et al., 2009; Strous
et al., 2001; Tang et al., 1999). DHEA protects hippocampal neuronal activity from glutamate
toxicity. DHEA-S also protects hippocampal neuronal cells from excitatory amino acid in‐
duced neurotoxicity. Taken together, DHEA and DHEA-S may provide an important antiox‐
idant function and may thus play a role in neurodevelopment and have neuroprotective
effects (Strous et al., 2006).
Some molecular genetic studies demonstrated candidate genes contributing to ADHD. The
steroid sulfatase (STS) gene, which escapes X inactivation in humans, desulfates several sul‐
fatedsteroids, including DHEA-S to DHEA. In an animal study, it has been noticed that the
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nisms (Overtoom et al., 2003; Wilens, 2008). MPH exerts treatment effects by reducing im‐
pulsivity and disruptive behavior (Huang & Tsai, 2011), and it improves plenty of
dimensions of neurocognitive function in ADHD patients (Huang et al., 2007; Pollak et al.,
2010). Furthermore, some evidence has been revealed that MPH treatment possibly influen‐
ces the neuroendocrine system (Hibel et al., 2007; Lurie & O'Quinn, 1991), and these influen‐
ces possibly play a role as a mediator of the therapeutic effects for ADHD patients.
Therefore, we herein review the related literature which investigates the relationship be‐
tween ADHD, neuroendocrine, and MPH administration.
2. ADHD and neurosteroids
The term “neurosteroid” was first introduced by Baulieu (1981), which indicated steroid
hormones synthesized in brain cells from cholesterol, independent of peripheral endocrine
sources, acted at the central nervous system. Initially, neurosteroid referred to dehydroe‐
piandrosterone sulfate (DHEA-S) (Baulieu & Robel, 1996). DHEA-S concentration in the
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that DHEA-S levels in the central neural system appeared to be independent of peripheral
formation in the adrenals or gonads (Strous et al., 2006). Subsequently, progesterone, allo‐
pregnanolone, pregnenolone, dehydroepiandrosterone (DHEA) and their corresponding
sulfate esters were identified as neurosteroids (Baulieu & Robel, 1998). Neurosteroids are
important substrates that have been demonstrated to affect mood expression, energy level,
aggression, and general activity (Wolkowitz et al., 1999).
2.1. DHEA and DHEA-S
DHEA is one of the major circulating neurosteroids in human, and it is also an ACTH-regu‐
lated steroid and a substrate for the synthesis of androstenedione and testosterone (Gurnell
& Chatterjee, 2001). DHEA has been demonstrated to play several vital neurophysiological
roles and to be affected by various physiological processes, including those associated with
neurotrophic and neuronal excitability effects, circadian rhythms, sexual responses, immu‐
nological and stress reactions, memory, and sleep (Baulieu & Robel, 1996; Herbert, 1998).
DHEA-S is a sulfated form of DHEA that is believed to be the most abundant steroid in the
body (Wolf et al., 1997). DHEA-S is measured more frequently than DHEA because circulat‐
ing levels of DHEA-S are approximately 500 times higher due to its lower metabolic clear‐
ance rate and minimal diurnal variation (Longcope, 1996).
Strous et al. (2001) demonstrated that DHEA and DHEA-S levels in blood are inversely re‐
lated to the severity of hyperactivity/impulsivity symptoms in children with ADHD aged
between 7 and 12 years. Another study found that ADHD patients treated with methylphe‐
nidate for 3 months exhibited pre- to post-treatment increases in plasma levels of DHEA and
DHEA-S for 23% and 53.6%, respectively (Maayan et al., 2003). Subsequently, Lee et al.
(2008) were the first research group investigating the role of neurosteroids in Asian ADHD
population. They suggested that plasma DHEA-S levels in ADHD patients increased signifi‐
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cantly during a 12-week MPH treatment and under a 12-week bupropion treatment as well.
These studies revealed a substantial increase in DHEA levels among pre-pubertal ADHD
patients; however, there was no data with regards to age- and gender-matched healthy con‐
trols for comparison. Finally, our research team demonstrated that salivary DHEA levels
were significantly lower in ADHD patients than those in healthy controls (Wang et al.,
2011b). Salivary DHEA levels were not significantly correlated with ADHD clinical symp‐
tom severity, but positively correlated with performance in a neuropsychological test (Con‐
ner’s Continuous Performance Test, CPT). Thus the authors suggested that lower morning
DHEA levels might be a biological laboratory marker for ADHD, particularly for perform‐
ance during CPT. In the longitudinal analyses, we found that morning salivary DHEA levels
significantly increased under the 6-month MPH treatment course for ADHD patients. How‐
ever, the salivary DHEA levels in healthy age- and gender- matched controls remain un‐
changed during the 6-month natural observation. Similar with the findings in the cross-
sectional survey, DHEA levels exhibited a significant and independent association with
overall CPT performance during the course of MPH treatment (Wang et al., 2011a). We
could thus determine that the elevation of DHEA levels among ADHD patients is not de‐
rived from natural physiological change, but from MPH administration.
There is interesting coincidence in the similarity of the natural course of ADHD, brain devel‐
opment and age-related change in DHEA/DHEA-S levels. ADHD symptoms generally de‐
cline in severity between puberty and the early twenties (Biederman et al., 2000). Some brain
imaging studies have found there to be a dysfunction of the cerebellar-striatal-prefrontal cir‐
cuitry in ADHD (Gogtay et al., 2002), and that this may be the result of delayed maturation
of the cerebral cortex, especially the prefrontal region (Shaw et al., 2007; McAlonan et al.,
2009). Plasma DHEA/DHEA-S levels change with age, being low in the first years of life,
then rapidly increasing from about eight years of age through puberty to reach their highest
levels during early adulthood (de Peretti & Forest, 1978). DHEA-S has antiamnestic effects,
and also anxiolytic and anti-aggressive properties (Wolf & Kirschbaum, 1999). Both DHEA
and DHEA-S have been shown to regulate the motility and growth of neocortical neurons in
the rodent brain (Compagnone & Mellon, 1998). This implies that DHEA/DHEA-S exert bio‐
logical actions that may play crucial roles in guiding cortical projections to appropriate tar‐
gets, and thus may be important for the regulation of neurodevelopment (Golubchik et al.,
2007). It has been proposed that DHEA/DHEA-S exerts its positive effects in ADHD patients
through stimulatory or antagonist effects at the gammaaminobutyric acid A (GABAA) recep‐
tor and facilitation of the N-methyl-D-aspartate (NMDA) activity (Davies et al., 2009; Strous
et al., 2001; Tang et al., 1999). DHEA protects hippocampal neuronal activity from glutamate
toxicity. DHEA-S also protects hippocampal neuronal cells from excitatory amino acid in‐
duced neurotoxicity. Taken together, DHEA and DHEA-S may provide an important antiox‐
idant function and may thus play a role in neurodevelopment and have neuroprotective
effects (Strous et al., 2006).
Some molecular genetic studies demonstrated candidate genes contributing to ADHD. The
steroid sulfatase (STS) gene, which escapes X inactivation in humans, desulfates several sul‐
fatedsteroids, including DHEA-S to DHEA. In an animal study, it has been noticed that the
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STS may modify the attentional function and motor impulsivity through administration of
the substrate DHEA and DHEA-S (Davies et al., 2009). The same research team showed that
the 39,X(Y*)O mice (which lack the STS gene but no other known genes as a consequence of
end-to-end fusion of the X and Y chromosomes) exhibited significantly lower DHEA serum
levels than 40,XY mice. They concluded that STS-deficient mice exhibit endophenotypes rel‐
evant to ADHD (Trent et al., 2012). In human studies, Kent et al. (2008) have demonstrated
that boys with X-linked ichthyosis who have a deletion or point mutation of STS are at an
increased risk of ADHD. In addition, Brookes et al. (2008) indicated that common variants
within the STS gene may increase susceptibility to ADHD. The over transmitted risk allele of
rs12861247 was also associated with reduced STS mRNA expression, and hence deficit in
STS protein production is at a significantly increased risk of developing ADHD (Brookes et
al., 2010). However, ethnic differences in epidemiology and genetic polymorphism of
ADHD patients have been demonstrated in some studies (Nikolaidis & Gray, 2009; Pastor &
Reuben, 2005). It remains unclear whether the relationships between the STS gene, ADHD
and neurosteroids also exist among non-Caucasian populations.
Neurochemical findings showing MPH exerts its effects on catecholamines in areas such as
the prefrontal cortex, nucleus accumbens, and striatum are consistent with the neurobiologi‐
cal and clinical effects of MPH on memory, attention, and movement (Wilens, 2008). The
neuroendocrine effects of MPH administration might be related to its dopaminergic and
adrenergic agonistic activity (Hibel et al., 2007; Lurie & O'Quinn, 1991; Weizman et al.,
1987). Hibel et al. (2007) demonstrated that children taking concerta (methylphenidate ex‐
tended-release tablets) had higher average levels of DHEA than those who were non-medi‐
cated. Several studies suggested that MPH increased DHEA or DHEA-S levels of ADHD
patients during a 3-month treatment (Lee et al., 2008; Maayan et al., 2003; Wang et al.,
2011a). One possible neurochemical explanation for this phenomenon is that MPH-induced
increases in DHEA or DHEA-S may act either by decreasing levels of the GABAA antago‐
nist-like pregnenolone sulfate, or by increasing levels of the GABAA agonist-like progester‐
one metabolites (Robel & Baulieu, 1995). In addition, the direct influence of medications on
salivary hormones may act on the secretion and feedback control of the HPA and hypothala‐
mic-pituitary-gonadal (HPG) axes. MPH may also indirectly influence DHEA or DHEA-S by
attenuating or potentiating the impact of environmental events and subjective experience on
HPA axis and HPG activity (Hibel et al., 2007). However, it is not clear whether DHEA or
DHEA-S exerts effects in conjunction with or independently of MPH on neurocognitive
function in ADHD. It remains to be clarified whether DHEA or DHEA-S plays a role as a
mediator of the therapeutic effects of MPH, or if these associations are epiphenomena of the
benefits of MPH treatment. Moreover, it would also be interesting to investigate whether
DHEA or DHEA-S could directly benefit the treatment of ADHD patients.
2.2. Other neurosteroids and gonadal hormones
Neurosteroids, other than DHEA and DHEA-S, mainly contain pregnenolone (PREG) and
progesterone, which is metabolized to 5a-dihydroprogesterone (5α-DH PROG) and 3α,5α-
tetrahydroprogesterone (3α,5α-TH PROG), also named allopregnanolone (Vallee et al.,
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2001). PREG is the principal precursor of DHEA. The sulfated form of pregnenolone (PREG-
S) exerts its neurochemical action as a negative modulator of the GABAA and also as a posi‐
tive modulator of the NMDA subtype of glutamate receptor (Mayo et al., 2001). PREG-S is
also capable of modulating acetylcholine neurotransmission associated with paradoxical
sleep modifications (Mayo et al., 2003). In animal studies, PREG-S in the hippocampus re‐
gion plays a physiological role in preserving and enhancing cognitive abilities, possibly via
an interaction with central cholinergic systems (Vallee et al., 1997; Vallee et al., 2001).
Among humans, PREG appears to improve clinical symptoms in patients with mood disor‐
ders (Osuji et al., 2010), and in patients with schizophrenia as well (Marx et al., 2011). To
date, there has been only one study investigating the relationship of PREG and ADHD
(Strous et al., 2001), and this study revealed that PREG levels in the blood are inversely relat‐
ed to the severity of hyperactivity/impulsivity symptoms in children with ADHD.
Gonadal hormones may act on the prenatal development of dopaminergic neural circuitry
and dopamine function in the nucleus accumbens, striatum, and prefrontal cortex via its
masculinizing effects (Martel et al., 2009). Therefore, gonadal hormones may modulate cor‐
responding deficits in cognitive control and reward processes in ADHD. In animal studies,
estradiol and progesterone both appear capable of inducing increases in dendritic spine
density during development. Estradiol and progesterone have been also proposed to play a
role in ADHD, because they are synthesized de novo in the cerebellum during critical devel‐
opmental periods (Dean & McCarthy, 2008). In addition, estrogen has been identified to
have neuroprotective effects through protection against oxidative stress, and neurotrophic
cross-talk through the signal cascade shared with neurotrophic factors (Sawada & Shimoha‐
ma, 2000). However, the relationship of estradiol, progesterone and ADHD in humans has
not yet been well-established in clinical studies.
Prenatal testosterone exposure has been implied in the etiology of ADHD. High levels of
prenatal testosterone may moderate the relationship between prenatal risk factors, and fur‐
ther affect dopaminergic neural circuitry by slowing down neural development globally
(Morris et al., 2004). Several studies have examined the association between the presence of
ADHD phenotype and the ratio of the length of the second and fourth digits (2D:4D ratio),
which is a marker of fetal testosterone exposure (de Bruin et al., 2006; Lemiere et al., 2010;
Stevenson et al., 2007). However, the findings are inconsistent between these studies. Fur‐
thermore, Yu & Shi (2009) found that salivary testosterone levels are higher in children with
aggressive tendencies than those without aggressive tendencies. Whereas Dorn et al., (2009)
suggested that no significant difference in salivary testosterone levels between children with
and without disruptive behavior disorders. Regarding the effects of MPH on testosterone,
Avital et al., (2011) indicated that long-term exposure to MPH led to elevated testosterone
levels in rodents. However, Mattison et al., (2011) reported that MPH administration in rhe‐
sus macaques, beginning before puberty, led to delay in pubertal testicular development un‐
til 5 years of age. Among humans, Hibel et al. (2007) investigated the relationship of salivary
biomarker levels, diurnal variation and the effects of medications among maltreated or low-
income disadvantaged children. They found that testosterone in non-medicated children de‐
creased along with time in a day, but those in children taking psychostimulants remained
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STS may modify the attentional function and motor impulsivity through administration of
the substrate DHEA and DHEA-S (Davies et al., 2009). The same research team showed that
the 39,X(Y*)O mice (which lack the STS gene but no other known genes as a consequence of
end-to-end fusion of the X and Y chromosomes) exhibited significantly lower DHEA serum
levels than 40,XY mice. They concluded that STS-deficient mice exhibit endophenotypes rel‐
evant to ADHD (Trent et al., 2012). In human studies, Kent et al. (2008) have demonstrated
that boys with X-linked ichthyosis who have a deletion or point mutation of STS are at an
increased risk of ADHD. In addition, Brookes et al. (2008) indicated that common variants
within the STS gene may increase susceptibility to ADHD. The over transmitted risk allele of
rs12861247 was also associated with reduced STS mRNA expression, and hence deficit in
STS protein production is at a significantly increased risk of developing ADHD (Brookes et
al., 2010). However, ethnic differences in epidemiology and genetic polymorphism of
ADHD patients have been demonstrated in some studies (Nikolaidis & Gray, 2009; Pastor &
Reuben, 2005). It remains unclear whether the relationships between the STS gene, ADHD
and neurosteroids also exist among non-Caucasian populations.
Neurochemical findings showing MPH exerts its effects on catecholamines in areas such as
the prefrontal cortex, nucleus accumbens, and striatum are consistent with the neurobiologi‐
cal and clinical effects of MPH on memory, attention, and movement (Wilens, 2008). The
neuroendocrine effects of MPH administration might be related to its dopaminergic and
adrenergic agonistic activity (Hibel et al., 2007; Lurie & O'Quinn, 1991; Weizman et al.,
1987). Hibel et al. (2007) demonstrated that children taking concerta (methylphenidate ex‐
tended-release tablets) had higher average levels of DHEA than those who were non-medi‐
cated. Several studies suggested that MPH increased DHEA or DHEA-S levels of ADHD
patients during a 3-month treatment (Lee et al., 2008; Maayan et al., 2003; Wang et al.,
2011a). One possible neurochemical explanation for this phenomenon is that MPH-induced
increases in DHEA or DHEA-S may act either by decreasing levels of the GABAA antago‐
nist-like pregnenolone sulfate, or by increasing levels of the GABAA agonist-like progester‐
one metabolites (Robel & Baulieu, 1995). In addition, the direct influence of medications on
salivary hormones may act on the secretion and feedback control of the HPA and hypothala‐
mic-pituitary-gonadal (HPG) axes. MPH may also indirectly influence DHEA or DHEA-S by
attenuating or potentiating the impact of environmental events and subjective experience on
HPA axis and HPG activity (Hibel et al., 2007). However, it is not clear whether DHEA or
DHEA-S exerts effects in conjunction with or independently of MPH on neurocognitive
function in ADHD. It remains to be clarified whether DHEA or DHEA-S plays a role as a
mediator of the therapeutic effects of MPH, or if these associations are epiphenomena of the
benefits of MPH treatment. Moreover, it would also be interesting to investigate whether
DHEA or DHEA-S could directly benefit the treatment of ADHD patients.
2.2. Other neurosteroids and gonadal hormones
Neurosteroids, other than DHEA and DHEA-S, mainly contain pregnenolone (PREG) and
progesterone, which is metabolized to 5a-dihydroprogesterone (5α-DH PROG) and 3α,5α-
tetrahydroprogesterone (3α,5α-TH PROG), also named allopregnanolone (Vallee et al.,
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2001). PREG is the principal precursor of DHEA. The sulfated form of pregnenolone (PREG-
S) exerts its neurochemical action as a negative modulator of the GABAA and also as a posi‐
tive modulator of the NMDA subtype of glutamate receptor (Mayo et al., 2001). PREG-S is
also capable of modulating acetylcholine neurotransmission associated with paradoxical
sleep modifications (Mayo et al., 2003). In animal studies, PREG-S in the hippocampus re‐
gion plays a physiological role in preserving and enhancing cognitive abilities, possibly via
an interaction with central cholinergic systems (Vallee et al., 1997; Vallee et al., 2001).
Among humans, PREG appears to improve clinical symptoms in patients with mood disor‐
ders (Osuji et al., 2010), and in patients with schizophrenia as well (Marx et al., 2011). To
date, there has been only one study investigating the relationship of PREG and ADHD
(Strous et al., 2001), and this study revealed that PREG levels in the blood are inversely relat‐
ed to the severity of hyperactivity/impulsivity symptoms in children with ADHD.
Gonadal hormones may act on the prenatal development of dopaminergic neural circuitry
and dopamine function in the nucleus accumbens, striatum, and prefrontal cortex via its
masculinizing effects (Martel et al., 2009). Therefore, gonadal hormones may modulate cor‐
responding deficits in cognitive control and reward processes in ADHD. In animal studies,
estradiol and progesterone both appear capable of inducing increases in dendritic spine
density during development. Estradiol and progesterone have been also proposed to play a
role in ADHD, because they are synthesized de novo in the cerebellum during critical devel‐
opmental periods (Dean & McCarthy, 2008). In addition, estrogen has been identified to
have neuroprotective effects through protection against oxidative stress, and neurotrophic
cross-talk through the signal cascade shared with neurotrophic factors (Sawada & Shimoha‐
ma, 2000). However, the relationship of estradiol, progesterone and ADHD in humans has
not yet been well-established in clinical studies.
Prenatal testosterone exposure has been implied in the etiology of ADHD. High levels of
prenatal testosterone may moderate the relationship between prenatal risk factors, and fur‐
ther affect dopaminergic neural circuitry by slowing down neural development globally
(Morris et al., 2004). Several studies have examined the association between the presence of
ADHD phenotype and the ratio of the length of the second and fourth digits (2D:4D ratio),
which is a marker of fetal testosterone exposure (de Bruin et al., 2006; Lemiere et al., 2010;
Stevenson et al., 2007). However, the findings are inconsistent between these studies. Fur‐
thermore, Yu & Shi (2009) found that salivary testosterone levels are higher in children with
aggressive tendencies than those without aggressive tendencies. Whereas Dorn et al., (2009)
suggested that no significant difference in salivary testosterone levels between children with
and without disruptive behavior disorders. Regarding the effects of MPH on testosterone,
Avital et al., (2011) indicated that long-term exposure to MPH led to elevated testosterone
levels in rodents. However, Mattison et al., (2011) reported that MPH administration in rhe‐
sus macaques, beginning before puberty, led to delay in pubertal testicular development un‐
til 5 years of age. Among humans, Hibel et al. (2007) investigated the relationship of salivary
biomarker levels, diurnal variation and the effects of medications among maltreated or low-
income disadvantaged children. They found that testosterone in non-medicated children de‐
creased along with time in a day, but those in children taking psychostimulants remained
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unchanged. In summary, evidence about the role of gonadal hormones in the aetiology of
ADHD in humans is remains scarce, thus future clinical studies are warranted to eluci‐
date this issue.
3. Cortisol
Dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis in ADHD children was pro‐
posed to address the complexity in the pathophysiology of ADHD (Kaneko et al., 1993; Ma
et al., 2011). The HPA axis plays an important role in regulating central nervous system neu‐
rotransmitters and behavior, such as attention, emotion, memory, and learning (Talge et al.,
2007). The function of the HPA axis has typically been assessed by cortisol levels, which can
be measured from a number of sources (saliva, urine, and blood plasma) (Hellhammer et al.,
2009). Low cortisol levels generally reflect under arousal or an elevated threshold for the de‐
tection of stressors (Freitag et al., 2009; Kaneko et al., 1993). Many clinical studies investigat‐
ed cortisol levels in either a stress response or an awakening response (Freitag et al., 2009;
Popma et al., 2006; Stadler et al., 2011; Yang et al., 2007). For example, Popma et al. (2006)
reported that patients with disruptive behavior disorders showed a significantly decreased
cortisol response after a standard public speaking task as compared with the normal con‐
trols. Yang et al. (2007) demonstrated that the magnitude of the increase in cortisol reactivity
to stress was inversely correlated with aggression tendency in patients with ADHD. Freitag
et al. (2009) indicated that ADHD children comorbid with ODD showed a weaker cortisol
awakening response compared to ADHD children without comorbidity and control chil‐
dren. Stadler et al. (2011) reported that ADHD patients scoring high on callous unemotional
traits showed a blunted HPA axis reactivity to the experimentally induced stress. Moreover,
it has also been suggested that the cortisol reactivity to stress at baseline in ADHD patients
could predict treatment effects (van de Wiel et al., 2004), and was associated with the one-
year outcome (King et al., 1998).
On the other hand, some studies aimed to determine the basal level of morning cortisol in
ADHD patients, and to determine the relationship between cortisol levels and ADHD re‐
lated social/behavioral  symptoms or cognition deficit.  Among these,  Schulz et  al.,  (1997)
showed that there was no significant difference in basal cortisol levels between aggressive
and nonaggressive boys with ADHD. In addition, the basal level of morning cortisol was
not  significantly  correlated  with  the  severity  of  ADHD hyperactivity/impulsivity  symp‐
toms (Strous  et  al.,  2001)  and the  performance  in  neuropsychological  test  (Wang et  al.,
2011b). However, there is one study which demonstrated gender differences in the corti‐
sol levels among a community sample of adolescents, which showed that females carry a
positive and males a negative association between cortisol and conduct symptoms (Young
et al., 2012). For ADHD subtypes, Ma et al. (2011) reported that the level of cortisol in the
ADHD group was significantly lower than that of the control group. There was a signifi‐
cant  difference  in  cortisol  levels  between  ADHD  subtypes:  The  level  of  cortisol  of  the
ADHD-predominantly  hyperactive  impulsive  type  was  significantly  lower  than  that  of
ADHD-predominantly inattention type and ADHD-combined type (Ma et al.,  2011). Fur‐
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thermore, a recent meta-analysis revealed that the age of the children significantly moder‐
ated the relation between basal cortisol and externalizing behavior. Externalizing behavior
was associated with higher basal cortisol in preschoolers, and with lower basal cortisol in
elementary school-aged children (Alink et al., 2008).
Regarding with the effects of MPH on cortisol, Weizman et al. (1987) reported that plasma
cortisol levels of ADHD patients increased under acute challenge of MPH; nevertheless, the
effects disappeared when subjects were re-challenged after 4 weeks. Similar effect of acute
challenge MPH for increasing cortisol levels was also observed among normal adults (Joyce
et al., 1986). However, Lee et al. (2008) showed that during a 12-week period, there was no
significant change in cortisol levels in ADHD patients under MPH treatment. In contrast,
Chen et al. (2012) reported that basal plasma cortisol levels were significant increased after
treatment either with MPH or with atomoxetine. Furthermore, our research team showed
that the morning levels of salivary cortisol in the patients with ADHD were significantly in‐
creased from baseline at 1 month after the MPH treatment was started (Wang et al., 2012).
Subsequently, the cortisol levels dropped to an intermediary level that differed from the
baseline and 1-month values. The effects of MPH on the neuroendocrine system were pro‐
posed to result from a combination of noradrenergic and dopaminergic mechanisms (Lurie
& O'Quinn, 1991). The higher concentrations of dopamine and norepinephrine could pro‐
mote the release of corticotropin releasing hormone (CRH) and the adrenocorticotropic hor‐
mone (ACTH) (Biondi & Picardi, 1999). It might be a possible explanation of MPH-induced
cortisol elevation; however, the effect of MPH on cortisol secretion seems to be temporary.
Acute tolerance to MPH has long been reported in the treatment of ADHD in children
(Swanson et al., 1999). It warrants further investigation to clarify whether the transient effect
on cortisol increment shares similar neurobiological mechanisms with the tolerance of MPH.
4. Conclusion
Awareness of the prominent position that the neuroendocrine system has to play in patho‐
physiology of ADHD is increasing. DHEA and DHEA-S are important neurosteroids sub‐
strates which demonstrate a potential correlation to symptoms severity and neurocognitive
function in ADHD patients. MPH, the most therapeutically efficient drugs in
ADHD, exerts its pharmacological effects via increasing the level of the dopamine and nore‐
pinephrine. Extant studies almost identically indicate that MPH administration would lead
to increases in the levels of DHEA or DHEA-S. With regards to other neurosteroids or gona‐
dal hormones, their influence on developing neural circuitry and behavioral systems has al‐
ready been established in animal models. However, many findings noted in animal studies
have yet to be replicated in humans, in particular patients with ADHD. The HPA-axis dys‐
function, which was measured by cortisol levels, has also been indicated to address the com‐
plexity in the pathogenesis of ADHD. Current studies revealed that ADHD patients,
especially for those with higher aggression tendencies or comorbidities, might have lower
levels of cortisol than healthy controls. MPH administration is able to elevate cortisol levels,
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unchanged. In summary, evidence about the role of gonadal hormones in the aetiology of
ADHD in humans is remains scarce, thus future clinical studies are warranted to eluci‐
date this issue.
3. Cortisol
Dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis in ADHD children was pro‐
posed to address the complexity in the pathophysiology of ADHD (Kaneko et al., 1993; Ma
et al., 2011). The HPA axis plays an important role in regulating central nervous system neu‐
rotransmitters and behavior, such as attention, emotion, memory, and learning (Talge et al.,
2007). The function of the HPA axis has typically been assessed by cortisol levels, which can
be measured from a number of sources (saliva, urine, and blood plasma) (Hellhammer et al.,
2009). Low cortisol levels generally reflect under arousal or an elevated threshold for the de‐
tection of stressors (Freitag et al., 2009; Kaneko et al., 1993). Many clinical studies investigat‐
ed cortisol levels in either a stress response or an awakening response (Freitag et al., 2009;
Popma et al., 2006; Stadler et al., 2011; Yang et al., 2007). For example, Popma et al. (2006)
reported that patients with disruptive behavior disorders showed a significantly decreased
cortisol response after a standard public speaking task as compared with the normal con‐
trols. Yang et al. (2007) demonstrated that the magnitude of the increase in cortisol reactivity
to stress was inversely correlated with aggression tendency in patients with ADHD. Freitag
et al. (2009) indicated that ADHD children comorbid with ODD showed a weaker cortisol
awakening response compared to ADHD children without comorbidity and control chil‐
dren. Stadler et al. (2011) reported that ADHD patients scoring high on callous unemotional
traits showed a blunted HPA axis reactivity to the experimentally induced stress. Moreover,
it has also been suggested that the cortisol reactivity to stress at baseline in ADHD patients
could predict treatment effects (van de Wiel et al., 2004), and was associated with the one-
year outcome (King et al., 1998).
On the other hand, some studies aimed to determine the basal level of morning cortisol in
ADHD patients, and to determine the relationship between cortisol levels and ADHD re‐
lated social/behavioral  symptoms or cognition deficit.  Among these,  Schulz et  al.,  (1997)
showed that there was no significant difference in basal cortisol levels between aggressive
and nonaggressive boys with ADHD. In addition, the basal level of morning cortisol was
not  significantly  correlated  with  the  severity  of  ADHD hyperactivity/impulsivity  symp‐
toms (Strous  et  al.,  2001)  and the  performance  in  neuropsychological  test  (Wang et  al.,
2011b). However, there is one study which demonstrated gender differences in the corti‐
sol levels among a community sample of adolescents, which showed that females carry a
positive and males a negative association between cortisol and conduct symptoms (Young
et al., 2012). For ADHD subtypes, Ma et al. (2011) reported that the level of cortisol in the
ADHD group was significantly lower than that of the control group. There was a signifi‐
cant  difference  in  cortisol  levels  between  ADHD  subtypes:  The  level  of  cortisol  of  the
ADHD-predominantly  hyperactive  impulsive  type  was  significantly  lower  than  that  of
ADHD-predominantly inattention type and ADHD-combined type (Ma et al.,  2011). Fur‐
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thermore, a recent meta-analysis revealed that the age of the children significantly moder‐
ated the relation between basal cortisol and externalizing behavior. Externalizing behavior
was associated with higher basal cortisol in preschoolers, and with lower basal cortisol in
elementary school-aged children (Alink et al., 2008).
Regarding with the effects of MPH on cortisol, Weizman et al. (1987) reported that plasma
cortisol levels of ADHD patients increased under acute challenge of MPH; nevertheless, the
effects disappeared when subjects were re-challenged after 4 weeks. Similar effect of acute
challenge MPH for increasing cortisol levels was also observed among normal adults (Joyce
et al., 1986). However, Lee et al. (2008) showed that during a 12-week period, there was no
significant change in cortisol levels in ADHD patients under MPH treatment. In contrast,
Chen et al. (2012) reported that basal plasma cortisol levels were significant increased after
treatment either with MPH or with atomoxetine. Furthermore, our research team showed
that the morning levels of salivary cortisol in the patients with ADHD were significantly in‐
creased from baseline at 1 month after the MPH treatment was started (Wang et al., 2012).
Subsequently, the cortisol levels dropped to an intermediary level that differed from the
baseline and 1-month values. The effects of MPH on the neuroendocrine system were pro‐
posed to result from a combination of noradrenergic and dopaminergic mechanisms (Lurie
& O'Quinn, 1991). The higher concentrations of dopamine and norepinephrine could pro‐
mote the release of corticotropin releasing hormone (CRH) and the adrenocorticotropic hor‐
mone (ACTH) (Biondi & Picardi, 1999). It might be a possible explanation of MPH-induced
cortisol elevation; however, the effect of MPH on cortisol secretion seems to be temporary.
Acute tolerance to MPH has long been reported in the treatment of ADHD in children
(Swanson et al., 1999). It warrants further investigation to clarify whether the transient effect
on cortisol increment shares similar neurobiological mechanisms with the tolerance of MPH.
4. Conclusion
Awareness of the prominent position that the neuroendocrine system has to play in patho‐
physiology of ADHD is increasing. DHEA and DHEA-S are important neurosteroids sub‐
strates which demonstrate a potential correlation to symptoms severity and neurocognitive
function in ADHD patients. MPH, the most therapeutically efficient drugs in
ADHD, exerts its pharmacological effects via increasing the level of the dopamine and nore‐
pinephrine. Extant studies almost identically indicate that MPH administration would lead
to increases in the levels of DHEA or DHEA-S. With regards to other neurosteroids or gona‐
dal hormones, their influence on developing neural circuitry and behavioral systems has al‐
ready been established in animal models. However, many findings noted in animal studies
have yet to be replicated in humans, in particular patients with ADHD. The HPA-axis dys‐
function, which was measured by cortisol levels, has also been indicated to address the com‐
plexity in the pathogenesis of ADHD. Current studies revealed that ADHD patients,
especially for those with higher aggression tendencies or comorbidities, might have lower
levels of cortisol than healthy controls. MPH administration is able to elevate cortisol levels,
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but the effects seem to be temporary. To date, much remains unclear about the complex in‐
teraction between neuroendocrine system, pathophysiology of ADHD and effects of MPH.
Further research at the basic scientific level as well as in the context of double-blinded place‐
bo controlled investigation is mandated to better elucidate the role of neuroendocrine in the
understanding and management of ADHD patients.
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1. Introduction
In this chapter, we will discuss the interactions between a neurotransmitter that has been
heavily implicated in ADHD, dopamine, and a neurotransmitter just beginning to be inves‐
tigated, glutamate. We will examine the literature to reveal how current treatments for
ADHD affect these neurotransmitter levels in specific areas of the brain that are thought to
be dysfunctional in ADHD. Additionally, we will detail new data on dopamine and gluta‐
mate dysfunction utilizing approaches that are capable of accurately measuring levels of
these neurotransmitters in two separate rodent models of ADHD. Finally, we will speculate
on the role that the dopamine-glutamate interaction will play in the future neuropharmacol‐
ogy of ADHD and how measuring these neurotransmitter levels in rodent models of ADHD
may aid in furthering the future pharmacotherapy of ADHD.
Throughout the text, we will use ADHD (Attention-Deficit/Hyperactivity Disorder) without
reference to the DSM-IV type, unless a specific reference pertains to combined, inattentive or
hyperactive subtypes.
2. ADHD and the link to neurochemistry
When the Diagnostic and Statistical Manual of Mental Disorders (DSM-1) was first publish‐
ed in 1952, childhood psychiatric disorders were thought to be caused by environment and
referred to as ‘reactions’ [1]. It wasn’t until the DSM-2 was published in 1968 that ADHD
© 2013 Miller et al.; licensee InTech. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
 2013 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, 
and reproduction in any medium, provided the original work is properly cited.
with attention deficit hyperactivity disorder during six months of treatment with
methylphenidate. Psychoneuroendocrinology, 36, 1209-1216.
[73] Wang, L.J., Huang, Y.S., Hsiao, C.C., Chiang, Y.L., Wu, C.C., Shang, Z.Y., et al.
(2011b). Salivary dehydroepiandrosterone, but not cortisol, is associated with atten‐
tion deficit hyperactivity disorder. World J Biol Psychiatry, 12, 99-109.
[74] Wang, L.J., Huang, Y.S., Hsiao, C.C., Chen, C.K. (2012). The Trend in Morning Levels
of Salivary Cortisol in Children with ADHD during 6 Months of Methylphenidate
Treatment. J Attention Disorders, (In press)
[75] Weizman, R., Dick, J., Gil-Ad, I., Weitz, R., Tyano, S. & Laron, Z. (1987). Effects of
acute and chronic methylphenidate administration on beta-endorphin, growth hor‐
mone, prolactin and cortisol in children with attention deficit disorder and hyperac‐
tivity. Life Sci, 40, 2247-2252.
[76] Wilens, T.E. (2008). Effects of methylphenidate on the catecholaminergic system in
attention-deficit/hyperactivity disorder. J Clin Psychopharmacol, 28, S46-53.
[77] Wolf, O.T. & Kirschbaum, C. (1999). Actions of dehydroepiandrosterone and its sul‐
fate in the central nervous system: effects on cognition and emotion in animals and
humans. Brain Res Brain Res Rev, 30, 264-288.
[78] Wolf, O.T., Neumann, O., Hellhammer, D.H., Geiben, A.C., Strasburger, C.J., Dres‐
sendorfer, R.A., et al. (1997). Effects of a two-week physiological dehydroepiandros‐
terone substitution on cognitive performance and well-being in healthy elderly
women and men. J Clin Endocrinol Metab, 82, 2363-2367.
[79] Wolkowitz, O.M., Reus, V.I., Keebler, A., Nelson, N., Friedland, M., Brizendine, L., et
al. (1999). Double-blind treatment of major depression with dehydroepiandrosterone.
Am J Psychiatry, 156, 646-649.
[80] Yang, S.J., Shin, D.W., Noh, K.S. & Stein, M.A. (2007). Cortisol is inversely correlated
with aggression for those boys with attention deficit hyperactivity disorder who re‐
tain their reactivity to stress. Psychiatry Res, 153, 55-60.
[81] Young, R., Sweeting, H. & West, P. (2012). Associations between DSM-IV diagnosis,
psychiatric symptoms and morning cortisol levels in a community sample of adoles‐
cents. Soc Psychiatry Psychiatr Epidemiol, 47, 723-733.
[82] Yu, Y.Z. & Shi, J.X. (2009). Relationship between levels of testosterone and cortisol in
saliva and aggressive behaviors of adolescents. Biomed Environ Sci, 22, 44-49.
Attention Deficit Hyperactivity Disorder in Children and Adolescents108
Chapter 6
Dopamine and Glutamate Interactions in ADHD:
Implications for the Future Neuropharmacology of
ADHD
Erin M. Miller, Theresa C. Thomas,
Greg A. Gerhardt and Paul E. A. Glaser
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/54207
1. Introduction
In this chapter, we will discuss the interactions between a neurotransmitter that has been
heavily implicated in ADHD, dopamine, and a neurotransmitter just beginning to be inves‐
tigated, glutamate. We will examine the literature to reveal how current treatments for
ADHD affect these neurotransmitter levels in specific areas of the brain that are thought to
be dysfunctional in ADHD. Additionally, we will detail new data on dopamine and gluta‐
mate dysfunction utilizing approaches that are capable of accurately measuring levels of
these neurotransmitters in two separate rodent models of ADHD. Finally, we will speculate
on the role that the dopamine-glutamate interaction will play in the future neuropharmacol‐
ogy of ADHD and how measuring these neurotransmitter levels in rodent models of ADHD
may aid in furthering the future pharmacotherapy of ADHD.
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began to be separated from general reactions and become its own diagnosis, referred to as
the ‘hyperkinetic reaction of childhood.’ This reaction was characterized by a short attention
span, hyperactivity, and restlessness [2], and in 1980, with the publication of the DSM-3, the
ADHD diagnosis became more specific and was described as ADD (attention-deficit disor‐
der) [3]; however, by this time, this disorder was already being treated with stimulant medi‐
cations, a treatment still used to this day.
Stimulant medications were initially discovered to treat hyperactivity in the early 1900s
when the psychiatrist Charles Bradley used amphetamines to treat children with headaches
caused by pneumoencephalography and found it improved their school performance, social
interactions and emotional responses. However, amphetamine as a treatment for ADHD
was ignored until years later due to a variety of reasons [4]. In the 1950s, researchers were
beginning to look for the underlying mechanisms causing behavioral problems and it was at
this time that Bradley’s discovery of amphetamine as a treatment for hyperactivity was un‐
covered and investigations into the mechanism of action of amphetamine began. The am‐
phetamine formulation Bradley used in his patients was called Benzedrine, a racemic
mixture of 50/50 d- and l-amphetamine, produced by the company Smith, Kline and French
[4]. Treatment with this medication in a variety of experimental paradigms reduced hyper‐
activity [5]; however, of particular note is a study published in 1976 showing decreased hy‐
peractivity when treated with amphetamine in rodents with dopamine depletion [6]. This
was the first time that hyperactivity was linked to dopamine, but far from the last.
2.1. Dopamine
Dopamine, classified as a catecholamine neurotransmitter, is produced in the cells of the
substantia nigra (SN, A9) and ventral tegmental area (VTA, A10) of the midbrain and project
to numerous brain regions, including the prefrontal cortex (PFC), striatum and nucleus ac‐
cumbens (NA, see Figure 1). Projections from the VTA to the NA are identified as the meso‐
limbic pathway, or the “reward pathway,” because these dopamine projections are involved
in rewarding behaviors, [7] firing when a reward is greater than expected or when a reward
is anticipated [8-10]. Projections from the SN to the striatum are referred to as the nigrostria‐
tal pathway and play a role in many aspects of motor control [11]. The mesocortical system
consists of dopaminergic projections from the VTA to the PFC, and it is implicated in many
cognitive functions including, but most certainly not limited to, attention and memory [11].
The mesocortical system will be the main focus in this chapter.
Dopamine is produced from tyrosine into 3,4-dihydroxyphenylalanine (DOPA) by the en‐
zyme tyrosine hydroxylase. DOPA is then made into dopamine via DOPA-decarboxylase.
Conversely, dopamine is broken down or converted by a number of mechanisms: 1) dopa‐
mine-β-hydroxylase converts dopamine into norepinephrine, 2) monoamine oxidase (MAO)
converts dopamine into 3,4-dihydroxyphenylacetic acid (DOPAC), and 3) catechol-o-methyl‐
transferase (COMT) catalyzes the formation of homovanillic acid (HVA). Dopamine-β -hy‐
droxylase only exists in norepinephrine neurons and thus will not be a focus here; however,
MAO exists on the outer mitochondrial membrane and is also thought to be in abundance
extracellularly, and COMT is mostly present extracellularly and plays a major role in regu‐
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lating dopamine neurotransmission, especially in the PFC [11]. The final and most impor‐
tant method in which dopamine is cleared from the synapse is via the dopamine transporter
(DAT). The DAT primarily exists on the presynaptic neuron and can transport dopamine ei‐
ther into or out of the neuron, dependent upon the concentration gradient. It has been dis‐
covered that the removal of dopamine from the synapse is predominantly performed by the
DAT and not metabolism or diffusion [12].
Figure 1. Modulatory dopaminergic neurons (blue) project to the dorsal striatum via the substantia nigra (SN, A9) and
the ventral striatum and prefrontal cortex (PFC) via the ventral tegmental area (VTA, A10) in the rodent brain. From
the striatum, inhibitory GABA neurons (green) extend to multiple regions including the thalamus, which has reciprocal
excitatory glutamate connections (red) to the striatum, as well as connections to the PFC. Prefrontal cortical efferent
excitatory glutamate neurons extend to the striatum, nucleus accumbens (NA), SN, as well as the VTA.
Intracellularly, dopamine is packaged into vesicles via the vesicular monoamine transporter
(VMAT-2). The release of dopamine from the vesicle is Ca2+ and Na+ dependent and occurs
when an action potential raises the Ca2+ levels in the presynaptic neuron, causing vesicles
stored with dopamine to bind to the cellular membrane and release their contents. The re‐
sulting synaptic dopamine is then able to bind to dopamine receptors on both the pre- and
postsynaptic neurons. These receptors are classified into two major categories: 1) D1-type re‐
ceptors, consisting of D1 and D5 and expressed postsynaptically, and 2) D2-type receptors ex‐
pressed both pre- and postsynaptically, consisting of D2 (short), D2 (long), D3 and D4.
Stimulation of D1-type receptors causes increased cAMP production (activating), whereas
stimulation of D2-type receptors causes inhibition of cAMP production (inhibiting). The ef‐
fects of these receptors give dopamine the classification of a modulatory neurotransmitter.
For a simplified PFC dopamine synapse diagram, see Figure 2.
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ther into or out of the neuron, dependent upon the concentration gradient. It has been dis‐
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Figure 2. Dopaminergic and glutamatergic synapses in the PFC, simplified. Left: pre-synaptically, dopamine is trans‐
ported into vesicles, which release their contents upon increase of the Ca2+ concentration. Synaptic dopamine is then
able to stimulate dopamine receptors on both the pre- and postsynaptic neurons before it is cleared by the DAT or
metabolism. Right: presynaptically, glutamate is stored in vesicles and then released into the extracellular space. Syn‐
aptic glutamate is then able to stimulate glutamate receptors (here represented as the NMDA and mGluR) on both
the pre- and postsynaptic neurons before it is cleared by the EAAT located on nearby glial cells.
2.2. Glutamate
Recent clinical evidence has implicated glutamate in ADHD. Much of the initial evidence
stems from proton magnetic resonance spectroscopy studies of children and adults with
ADHD.  These  studies  have  shown  increased  levels  of  a  marker  for  glutamate  in  the
striatum and anterior cingulate cortex of the PFC [13-15]. Based on this evidence, new in‐
vestigations  into  glutamatergic  function  in  ADHD are  ongoing.  Glutamate  is  the  major
excitatory neurotransmitter  in the central  nervous system and must be tightly regulated
for proper neuronal signaling to occur [16]. Unlike dopamine, glutamate is in abundance
in  most  areas  of  the  brain.  Glutamate  projections  originating  in  the  PFC extend  to  the
striatum, NA, VTA and SN of the midbrain (see Figure 1). Glutamate is produced in the
nerve  terminals  of  these  projections  from two sources:  1)  the  Krebs  cycle  and 2)  gluta‐
mine produced and excreted into  the  extracellular  space  via  glial  cells.  Once produced,
glutamate  is  transported  into  vesicles  via  the  vesicular  glutamate  transporter  (VGLUT)
and when Ca2+ levels increase to cause an action potential, vesicles stored with glutamate
bind  to  the  cellular  membrane  and  release  their  contents.  Clearance  of  glutamate  after
this calcium-dependent release into the extracellular space is primarily performed by the
membrane-bound  glutamate  transporter,  called  the  excitatory  amino  acid  transporter
(EAAT),  located  on  the  presynaptic  neuron  and  to  the  greatest  extent  by  surrounding
glial  cells.  The glutamate is  primarily taken up by the EAATs located on the glial  cells
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and is converted by glutamine synthetase into glutamine and transported out of the glial
cell by system N transporter. The glutamine is then taken up by the system A transport‐
er on the presynaptic neuron to help replenish glutamate levels through the mitochondri‐
al bound glutaminase [11].  Glutamate acts on synaptic glutamate receptors in the target
brain region, which are classified into two major types:  1) ionotropic,  which include the
NMDA,  AMPA  and  kainate  receptors  and  2)  metabotropic,  including  the  excitatory
mGluRs 1 and 5 (postsynaptic) and the inhibitory mGluRs 2, 3, 4, 6, 7, and 8 (presynap‐
tic). For a simplified PFC glutamate synapse diagram, see Figure 2.
2.3. Dopamine and glutamate interactions
A dysfunctional interaction between the dopamine and glutamate systems has been impli‐
cated in numerous neuropsychiatric disorders such as drug addiction, Alzheimer's disease,
schizophrenia, and ADHD. The brain regions most often linked to these disorders and the
dopamine-glutamate dysfunction are the PFC and striatum, as these regions both receive
heavy innervation from the dopaminergic SN/VTA and glutamate innervation from thala‐
mic relays and other glutamate rich regions, as described in the previous section.
Studies of signaling interactions between the dopaminergic and glutamatergic systems dem‐
onstrate that the NMDA receptor is crucial in activating dopamine neurons in the VTA/SN
[17, 18]. Also, it has been found that stimulation of the D2-class dopamine receptor is in‐
volved in the downstream inhibition of the NMDA receptor, weakening the excitatory re‐
sponse to those neurons [19]. Likewise, it was found that activation of D4 receptors
depressed AMPA receptor-mediated excitatory synaptic transmission in PFC pyramidal
neurons, which was accompanied by a D4-induced decrease of AMPA receptors at the syn‐
apse [20]. These results provide substantial evidence that the dopamine and glutamate neu‐
ronal systems work in tandem to create a balance of neurotransmission in these regions.
The hypodopaminergic theory of ADHD asserts that the hyperactive and inattentive behav‐
iors are caused by low levels of either tonic or phasic dopamine. If true, decreased dopamine
released in the striatum and PFC would then be expected to lead to more active NMDA and
AMPA receptors based on the studies mentioned above resulting in increased glutamatergic
output to the striatum and SN/VTA, as well as an increased glutamate signal to the PFC.
Glutamate coming into the SN/VTA would normally go on to release more dopamine [17];
however, in the ADHD brain, this feedback does not seem to occur.
2.4. Translational neuropharmacology of ADHD treatments
Investigations into the effects of stimulant action on the dopaminergic system have revealed
that these medications increase extracellular dopamine levels via numerous mechanisms.
First, amphetamine has been found to increase dopamine through calcium-independent
mechanisms such as increased release of dopamine and blocking the reuptake of dopamine
through the DAT [21, 22]. Methylphenidate (MPH), another stimulant medication common‐
ly used to treat ADHD, increases dopamine levels by inhibiting dopamine reuptake via the
DAT [23-29].
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the pre- and postsynaptic neurons before it is cleared by the EAAT located on nearby glial cells.
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ronal systems work in tandem to create a balance of neurotransmission in these regions.
The hypodopaminergic theory of ADHD asserts that the hyperactive and inattentive behav‐
iors are caused by low levels of either tonic or phasic dopamine. If true, decreased dopamine
released in the striatum and PFC would then be expected to lead to more active NMDA and
AMPA receptors based on the studies mentioned above resulting in increased glutamatergic
output to the striatum and SN/VTA, as well as an increased glutamate signal to the PFC.
Glutamate coming into the SN/VTA would normally go on to release more dopamine [17];
however, in the ADHD brain, this feedback does not seem to occur.
2.4. Translational neuropharmacology of ADHD treatments
Investigations into the effects of stimulant action on the dopaminergic system have revealed
that these medications increase extracellular dopamine levels via numerous mechanisms.
First, amphetamine has been found to increase dopamine through calcium-independent
mechanisms such as increased release of dopamine and blocking the reuptake of dopamine
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The non-stimulant medication atomoxetine (ATX) is becoming increasingly popular as a
treatment for ADHD compared to the stimulant medications because it has lower abuse lia‐
bility. ATX has been found to increase levels of the catecholamines by selectively blocking
the norepinephrine transporter (NET), which is also able to clear dopamine [30-32] and, like
stimulants, is effective at lessoning the intensity of ADHD symptoms [33-36]. In vitro work
has shown that ATX acts as an NMDA receptor antagonist [37], providing preliminary evi‐
dence that current treatments for ADHD may have a direct effect on the glutamatergic sys‐
tem.
Using magnetic resonance spectroscopy, it was found that children treated with ATX, but
not MPH, had decreased levels of a marker for glutamate/glutamine in the PFC, though
MPH was able to decrease glutamate in the anterior cingulate cortex [38]. In the striatum,
both ATX and MPH decreased the glutamate/glutamine marker levels compared to controls
[13]. These results suggest that ATX may be regulating and activating prefrontal cortex neu‐
rons. However, another clinical study using a similar technique found that chronic long-act‐
ing MPH decreased glutamate levels in the PFC of children with ADHD [39]. Wiguna et al.
(2012) also discovered that MPH treatment resulted in an increase in the amount of and
functional state of the neurons in the PFC, supporting that the current ADHD stimulant
treatment MPH can activate PFC neurons as well. Further evidence of PFC activation comes
from a study of brain-derived neurotropic factor (BDNF), a marker for neuronal plasticity.
ATX was found to increase BDNF expression in the PFC; however, MPH had the opposite
effect and reduced BDNF expression in the PFC [40], though it must be noted that this study
was completed in naïve rodents and may explain why these results do not match those seen
in ADHD patients.
Many  second-line  and  experimental  treatments  for  ADHD  are  now  targeting  both  the
dopamine  and glutamate  systems.  Memantine  is  an  uncompetitive  NMDA receptor  an‐
tagonist [41] and has also been found to act as a D2 receptor agonist [42]. It has been ap‐
proved and used as  a  treatment  for  Alzheimer’s  disease;  however,  in  an 8  week open-
label  pilot  study  in  children  with  ADHD,  memantine  was  found  to  improve  ADHD
symptoms (Findling et  al,  2007).  Surman et  al.  (2011)  extended these  findings  to  adults
with  ADHD in a  separate  open-label  study lasting 12  weeks  and found similar  results,
with memantine improving ADHD symptoms and neuropsychological performance [43].
The MAO-B inhibitor (deprenyl),  which stops the degradation of dopamine and is  used
as a treatment in Parkinson’s disease,  was found to alleviate ADHD symptoms [44,  45].
These clinical data using glutamate and dopamine altering drugs provide strong links for
dysfunctional dopamine-glutamate interactions in ADHD, though the importance of this
dysfunction is still unknown. Based on these data, we believe it’s important to not over‐
look  the  possible  role  of  dysfunctional  dopamine-glutamate  interactions,  but  to  instead
focus on this relationship. Animal models of ADHD provide a unique opportunity to in‐
vestigate neurotransmitter system dysfunction as well  as to develop novel ways to treat
ADHD targeting  these  systems.  We will  next  highlight  two separate  models  of  ADHD
and how they are implicating both dopamine and glutamate dysfunction in ADHD.
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2.5. Animal models of ADHD: Hypotheses
The spontaneously hypertensive rat
The spontaneously hypertensive rat (SHR) has been used as an animal model for ADHD
combined type since the 1970’s because of its sustained attention deficits [46], motor im‐
pulsiveness  [47-49],  and hyperactivity  [46]  with  the  hyperactivity  absent  in  novel  situa‐
tions [50]. Currently, there exists conflicting data on dopamine release and uptake levels
in  the  brain  areas  thought  to  be  involved  in  the  pathophysiology  of  ADHD,  including
the PFC [51]. Our lab has previously reported enhanced dopamine uptake in the ventral
striatum and nucleus accumbens core of the SHR [52];  however,  investigations into PFC
dopamine regulation are still  not  clear.  The PFC of  the SHR has been reported to have
decreased dopamine uptake [53],  yet a study found no differences in the levels of DAT,
tyrosine hydroxylase, D1, D2, D3, D5  receptors, and dopamine-β-hydroxylase between the
SHR and its progenitor strain, the Wistar Kyoto (WKY), in the PFC. Regional differences
in the D4 receptors in the PFC were found, providing evidence that the SHR’s D4 levels
are  lower  than those  of  the  WKY [54].  Further,  it  was  found that  PFC AMPA receptor
activity was increased in the SHR [55] and inhibitory dopaminergic activity was found to
be  decreased while  noradrenergic  activity  increased in  the  SHR [56].  These  findings  all
convey a message that dopamine regulation is dysfunctional in the PFC of the SHR mod‐
el of ADHD; however, direct observation of in vivo dopamine dynamics in the separate
PFC sub-regions (cingulate, prelimbic, and infralimbic) of the SHR have not yet been ac‐
curately defined.
The dopamine receptor D4 knockout mouse
The correlation between ADHD and the 7-repeat polymorphism in the dopamine D4 recep‐
tor (DRD4.7) is supported by neuroanatomical, neurochemical, molecular genetics and phar‐
macological studies [57-60]. Recently, the DRD4.7 was identified as having the most
significant genetic relationship to ADHD in pooled family and case-controlled studies [61].
Clinical studies in adolescents report that ADHD patients with the DRD4.7 have thinner
frontal cortical structures in comparison to age matched controls [62]. The highest concen‐
tration of DRD4s is in the frontal cortex, an area implicated in the pathophysiology of
ADHD using neuroimaging and neuropsychological evaluation of ADHD patients [63-66].
There is evidence that changes in DRD4 expression can affect glutamate levels in the stria‐
tum of DRD4-/- mice [67]. Previous studies show that DRD4-/- mice are supersensitive to etha‐
nol, cocaine and methamphetamine [68]; have enhanced reactivity to unconditioned fear
[69]; reduced exploration of novel stimuli [70]; and hypersensitivity to amphetamine [71]. In
the cortex, hyperexcitability has been demonstrated in DRD4-/- mice using immunohisto‐
chemical, electrophysiological, pharmacological and ultrastructural methods, indicating that
DRD4 activation has an inhibitory influence on glutamate neurons in the frontal cortex [72].
At this time, no direct studies of in vivo glutamate have been investigated in the intact PFC
of the DRD4-/- mouse. Therefore, in vivo measures of glutamatergic modulation in the PFC
may correlate changes in glutamate neurotransmission to the expression levels of the DRD4
and understanding the physiological role of the DRD4 may elucidate the importance of dop‐
amine and glutamate interactions in the PFC.
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rons. However, another clinical study using a similar technique found that chronic long-act‐
ing MPH decreased glutamate levels in the PFC of children with ADHD [39]. Wiguna et al.
(2012) also discovered that MPH treatment resulted in an increase in the amount of and
functional state of the neurons in the PFC, supporting that the current ADHD stimulant
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tyrosine hydroxylase, D1, D2, D3, D5  receptors, and dopamine-β-hydroxylase between the
SHR and its progenitor strain, the Wistar Kyoto (WKY), in the PFC. Regional differences
in the D4 receptors in the PFC were found, providing evidence that the SHR’s D4 levels
are  lower  than those  of  the  WKY [54].  Further,  it  was  found that  PFC AMPA receptor
activity was increased in the SHR [55] and inhibitory dopaminergic activity was found to
be  decreased while  noradrenergic  activity  increased in  the  SHR [56].  These  findings  all
convey a message that dopamine regulation is dysfunctional in the PFC of the SHR mod‐
el of ADHD; however, direct observation of in vivo dopamine dynamics in the separate
PFC sub-regions (cingulate, prelimbic, and infralimbic) of the SHR have not yet been ac‐
curately defined.
The dopamine receptor D4 knockout mouse
The correlation between ADHD and the 7-repeat polymorphism in the dopamine D4 recep‐
tor (DRD4.7) is supported by neuroanatomical, neurochemical, molecular genetics and phar‐
macological studies [57-60]. Recently, the DRD4.7 was identified as having the most
significant genetic relationship to ADHD in pooled family and case-controlled studies [61].
Clinical studies in adolescents report that ADHD patients with the DRD4.7 have thinner
frontal cortical structures in comparison to age matched controls [62]. The highest concen‐
tration of DRD4s is in the frontal cortex, an area implicated in the pathophysiology of
ADHD using neuroimaging and neuropsychological evaluation of ADHD patients [63-66].
There is evidence that changes in DRD4 expression can affect glutamate levels in the stria‐
tum of DRD4-/- mice [67]. Previous studies show that DRD4-/- mice are supersensitive to etha‐
nol, cocaine and methamphetamine [68]; have enhanced reactivity to unconditioned fear
[69]; reduced exploration of novel stimuli [70]; and hypersensitivity to amphetamine [71]. In
the cortex, hyperexcitability has been demonstrated in DRD4-/- mice using immunohisto‐
chemical, electrophysiological, pharmacological and ultrastructural methods, indicating that
DRD4 activation has an inhibitory influence on glutamate neurons in the frontal cortex [72].
At this time, no direct studies of in vivo glutamate have been investigated in the intact PFC
of the DRD4-/- mouse. Therefore, in vivo measures of glutamatergic modulation in the PFC
may correlate changes in glutamate neurotransmission to the expression levels of the DRD4
and understanding the physiological role of the DRD4 may elucidate the importance of dop‐
amine and glutamate interactions in the PFC.
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Measuring neurotransmitters in these rodent models of ADHD
Recent studies point to the importance of a dysfunctional relationship between dopaminer‐
gic and glutamatergic neurotransmission in ADHD, therefore new investigations into this
relationship are necessary to improve our understanding and may lead to improved thera‐
peutics for ADHD. Based on our development of novel and revolutionary methods of meas‐
uring dopamine and glutamate in vivo, we realize we are in a unique position to test our
hypotheses that dopamine and glutamate regulation play a major role in the pathophysiolo‐
gy of ADHD. The development of carbon fiber microelectrodes and glutamate oxidase-coat‐
ed microelectrode arrays (MEAs) provide improved spatial resolution, sub-second temporal
resolution, and low limits of detection (<10 nM for dopamine [52], <0.2 µM for glutamate
[73]) over conventional techniques used in the past, such as microdialysis. The smaller size
of these probes and decreased damage to tissue compared to microdialysis probes allows for
the in vivo characterization of dopamine and glutamate signaling closer to the synapse. Us‐
ing these technologies, we were able to explore if dysfunction in dopamine and glutamate
neurotransmission occur in the PFC of the SHR and DRD4 models of ADHD. The studies
described here could potentially lead to the development of novel therapies for ADHD,
which will be discussed in detail later.
2.6. Neurotransmitter recording techniques: Methods
High-speed chronoamperometric recordings of dopamine release and uptake in the PFC
of the SHR
Male, 8-10 weeks old, inbred spontaneously hypertensive rats (SHR, average 225 g, average
PND 60), inbred Wistar Kyoto rats (WKY, average 210 g, average PND 61), and outbred
Sprague Dawley rats (SD, average 289 g, average PND 69) were obtained from Charles River
Laboratories (NCrl), Wilmington, Massachusetts. Animals were given access to food and
water ad libitum and housed in a 12 hour light/dark cycle. Protocols for animal use were
approved by the Institutional Animal Care and Use Committee, which is Association for As‐
sessment and Accreditation of Laboratory Animal Care International approved. All proce‐
dures were carried out in accordance with the National Institutes of Health Guide for Care
and Use of Laboratory Animals and all efforts were made to minimize animal suffering and
to reduce the number of animals used.
High-speed chronoamperometric measurements (1 Hz sampling rate, 200 ms total) were
performed using the FAST16mkII recording system (Fast Analytical Sensing Technology,
Quanteon, LLC, Nicholasville, Kentucky) as previously described [52, 74]. Single carbon fi‐
ber electrodes (SF1A; 30 µm outer diameter × 150 µm length; Quanteon, LLC, Nicholasville,
Kentucky) were coated with Nafion® (5% solution, 1–3 coats at 180oC, Aldrich Chemical Co.,
Milwaukee, Wisconsin) prior to an in vitro calibration used to determine selectivity, limit of
detection, and sensitivity before use in vivo: average selectivity for all microelectrodes used
in these experiments was 1877 ± 664 µM for dopamine vs. ascorbic acid; average limit of de‐
tection for the measurement of dopamine was 0.028 ± 0.008 µM (S/N of 3); average slope for
the electrodes was -0.492 ± 0.111 nA/µM dopamine. After calibration, miniature Ag/AgCl
reference electrodes were prepared as previously described [74]. The carbon fiber microelec‐
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trode was affixed to a micropipette (10 µm inner diameter) which was positioned approxi‐
mately 200 µm from the carbon fiber electrode tip using sticky wax (Kerr USA, Romulus,
Michigan).
Rats were anesthetized intraperitonealy (i.p.) using a 25% urethane solution (1.25 g/kg) and
placed in a stereotaxic frame (David Kopf Instruments, Tujunga, California). A circulating
heating pad (Gaymar Industries, Inc., Orchard Park, New York) was used to maintain body
temperature. The skull was removed bilaterally for recordings in the PFC (AP +3.2, ML ±1.0,
DV -2 to -6 in 0.5 mm increments) [75]. A small hole remote from the site of surgery was
drilled for placement of the miniature Ag/AgCl reference electrode. Prior to experimenta‐
tion, the micropipette was filled with filtered isotonic KCl (120 mM KCl, 29 mM NaCl, 2.5
mM CaCl2•2H2O) solution (pH 7.2-7.4) using a 4 inch filling needle (Cadence Inc., Staunton,
Virginia) and a 5 ml syringe. Experiments were then initiated with the insertion of the mi‐
cropipette/microelectrode assembly into a stereotactically selected region of the left or right
hemisphere’s PFC. After a 30-45 minute baseline, the effect of a single local application of
KCl on dopamine release was determined [52]. The KCl solution was locally applied by
pressure ejection (5–25 psi for 0.5 seconds) and the single application of a set volume of KCl
(75–125 nl) was delivered to each sub-region, measured by determining the amount of fluid
ejected from the micropipette using a dissection microscope fitted with an eyepiece reticule
that was calibrated so that 1 mm of movement was equivalent to 25 nl of fluid ejected [76,
77]. If the volume was determined to be greater or less than 75-100 nl, then that data point
was excluded. After the KCl studies, the micropipette/microelectrode assembly was filled
with filtered isotonic 200 µM dopamine solution containing 100 µM ascorbic acid (an anti-
oxidant) in 0.9% saline (pH 7.2-7.4). The micropipette/microelectrode assembly was inserted
stereotactically into the animal’s contralateral PFC. Again, a stable baseline was achieved be‐
fore the dopamine solution was locally applied by pressure ejection (10-30 psi for 0.5-10 s) to
achieve a maximum amplitude between the range of 0.5 to 1 µM dopamine. The maximum
concentration of the dopamine in the extracellular space was measured by subtracting the
apex of the recorded peak from the baseline recorded prior to the ejection. If the peak ampli‐
tude was greater or less than 0.5 to 1 µM dopamine, then that data point was excluded.
Brains were removed and processed (frozen) for histological evaluation of microelectrode
recording tracks. Only data from histologically confirmed placements of microelectrodes in‐
to the PFC were used for final data analysis. Based on histological analyses, no animals were
excluded due to microelectrode placement errors.
Collected data were processed using a custom Matlab®-based analysis package. For KCl-
evoked DA release, maximum amplitude of the evoked dopamine peak was used. The vol‐
ume of KCl applied was kept constant across depths and strains (75–125 nl). For dopamine
uptake the time to 80% decay of the dopamine signal (T80) was examined. dopamine signals
were amplitude matched (ranging from 0.5 to 1 µM dopamine) to ensure accurate measure‐
ment of dopamine uptake kinetics [52, 74]. Outliers were excluded via the Grubb’s test be‐
fore averaging if the conditions for homogeneity of variance were met. To compare
dopamine dynamics in the separate PFC subregions, one-way ANOVAs followed by Bonfer‐
roni post-hoc comparisons were used. Significance was set at p<0.05 (GraphPad Prism 5.0).
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Measuring neurotransmitters in these rodent models of ADHD
Recent studies point to the importance of a dysfunctional relationship between dopaminer‐
gic and glutamatergic neurotransmission in ADHD, therefore new investigations into this
relationship are necessary to improve our understanding and may lead to improved thera‐
peutics for ADHD. Based on our development of novel and revolutionary methods of meas‐
uring dopamine and glutamate in vivo, we realize we are in a unique position to test our
hypotheses that dopamine and glutamate regulation play a major role in the pathophysiolo‐
gy of ADHD. The development of carbon fiber microelectrodes and glutamate oxidase-coat‐
ed microelectrode arrays (MEAs) provide improved spatial resolution, sub-second temporal
resolution, and low limits of detection (<10 nM for dopamine [52], <0.2 µM for glutamate
[73]) over conventional techniques used in the past, such as microdialysis. The smaller size
of these probes and decreased damage to tissue compared to microdialysis probes allows for
the in vivo characterization of dopamine and glutamate signaling closer to the synapse. Us‐
ing these technologies, we were able to explore if dysfunction in dopamine and glutamate
neurotransmission occur in the PFC of the SHR and DRD4 models of ADHD. The studies
described here could potentially lead to the development of novel therapies for ADHD,
which will be discussed in detail later.
2.6. Neurotransmitter recording techniques: Methods
High-speed chronoamperometric recordings of dopamine release and uptake in the PFC
of the SHR
Male, 8-10 weeks old, inbred spontaneously hypertensive rats (SHR, average 225 g, average
PND 60), inbred Wistar Kyoto rats (WKY, average 210 g, average PND 61), and outbred
Sprague Dawley rats (SD, average 289 g, average PND 69) were obtained from Charles River
Laboratories (NCrl), Wilmington, Massachusetts. Animals were given access to food and
water ad libitum and housed in a 12 hour light/dark cycle. Protocols for animal use were
approved by the Institutional Animal Care and Use Committee, which is Association for As‐
sessment and Accreditation of Laboratory Animal Care International approved. All proce‐
dures were carried out in accordance with the National Institutes of Health Guide for Care
and Use of Laboratory Animals and all efforts were made to minimize animal suffering and
to reduce the number of animals used.
High-speed chronoamperometric measurements (1 Hz sampling rate, 200 ms total) were
performed using the FAST16mkII recording system (Fast Analytical Sensing Technology,
Quanteon, LLC, Nicholasville, Kentucky) as previously described [52, 74]. Single carbon fi‐
ber electrodes (SF1A; 30 µm outer diameter × 150 µm length; Quanteon, LLC, Nicholasville,
Kentucky) were coated with Nafion® (5% solution, 1–3 coats at 180oC, Aldrich Chemical Co.,
Milwaukee, Wisconsin) prior to an in vitro calibration used to determine selectivity, limit of
detection, and sensitivity before use in vivo: average selectivity for all microelectrodes used
in these experiments was 1877 ± 664 µM for dopamine vs. ascorbic acid; average limit of de‐
tection for the measurement of dopamine was 0.028 ± 0.008 µM (S/N of 3); average slope for
the electrodes was -0.492 ± 0.111 nA/µM dopamine. After calibration, miniature Ag/AgCl
reference electrodes were prepared as previously described [74]. The carbon fiber microelec‐
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trode was affixed to a micropipette (10 µm inner diameter) which was positioned approxi‐
mately 200 µm from the carbon fiber electrode tip using sticky wax (Kerr USA, Romulus,
Michigan).
Rats were anesthetized intraperitonealy (i.p.) using a 25% urethane solution (1.25 g/kg) and
placed in a stereotaxic frame (David Kopf Instruments, Tujunga, California). A circulating
heating pad (Gaymar Industries, Inc., Orchard Park, New York) was used to maintain body
temperature. The skull was removed bilaterally for recordings in the PFC (AP +3.2, ML ±1.0,
DV -2 to -6 in 0.5 mm increments) [75]. A small hole remote from the site of surgery was
drilled for placement of the miniature Ag/AgCl reference electrode. Prior to experimenta‐
tion, the micropipette was filled with filtered isotonic KCl (120 mM KCl, 29 mM NaCl, 2.5
mM CaCl2•2H2O) solution (pH 7.2-7.4) using a 4 inch filling needle (Cadence Inc., Staunton,
Virginia) and a 5 ml syringe. Experiments were then initiated with the insertion of the mi‐
cropipette/microelectrode assembly into a stereotactically selected region of the left or right
hemisphere’s PFC. After a 30-45 minute baseline, the effect of a single local application of
KCl on dopamine release was determined [52]. The KCl solution was locally applied by
pressure ejection (5–25 psi for 0.5 seconds) and the single application of a set volume of KCl
(75–125 nl) was delivered to each sub-region, measured by determining the amount of fluid
ejected from the micropipette using a dissection microscope fitted with an eyepiece reticule
that was calibrated so that 1 mm of movement was equivalent to 25 nl of fluid ejected [76,
77]. If the volume was determined to be greater or less than 75-100 nl, then that data point
was excluded. After the KCl studies, the micropipette/microelectrode assembly was filled
with filtered isotonic 200 µM dopamine solution containing 100 µM ascorbic acid (an anti-
oxidant) in 0.9% saline (pH 7.2-7.4). The micropipette/microelectrode assembly was inserted
stereotactically into the animal’s contralateral PFC. Again, a stable baseline was achieved be‐
fore the dopamine solution was locally applied by pressure ejection (10-30 psi for 0.5-10 s) to
achieve a maximum amplitude between the range of 0.5 to 1 µM dopamine. The maximum
concentration of the dopamine in the extracellular space was measured by subtracting the
apex of the recorded peak from the baseline recorded prior to the ejection. If the peak ampli‐
tude was greater or less than 0.5 to 1 µM dopamine, then that data point was excluded.
Brains were removed and processed (frozen) for histological evaluation of microelectrode
recording tracks. Only data from histologically confirmed placements of microelectrodes in‐
to the PFC were used for final data analysis. Based on histological analyses, no animals were
excluded due to microelectrode placement errors.
Collected data were processed using a custom Matlab®-based analysis package. For KCl-
evoked DA release, maximum amplitude of the evoked dopamine peak was used. The vol‐
ume of KCl applied was kept constant across depths and strains (75–125 nl). For dopamine
uptake the time to 80% decay of the dopamine signal (T80) was examined. dopamine signals
were amplitude matched (ranging from 0.5 to 1 µM dopamine) to ensure accurate measure‐
ment of dopamine uptake kinetics [52, 74]. Outliers were excluded via the Grubb’s test be‐
fore averaging if the conditions for homogeneity of variance were met. To compare
dopamine dynamics in the separate PFC subregions, one-way ANOVAs followed by Bonfer‐
roni post-hoc comparisons were used. Significance was set at p<0.05 (GraphPad Prism 5.0).
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Urethane, dopamine, ascorbic acid, sodium chloride, potassium chloride, calcium chloride
and Nafion® were obtained from Sigma (St. Louis, MO). Carbon fiber microelectrodes
(SF1A’s) were fabricated by the Center for Microelectrode Technology.
High-speed amperometric recordings of glutamate levels in the PFC of the DRD4 knock‐
out mouse
Male mice (5-7 months; ~32 g) descended from the original F2 hybrid of mice with a truncat‐
ed and non-expressing DRD4 gene (DRD4-/-; 129/SvEv × C57BL/6J) were derived by back‐
crossing the DRD4+/- mouse line for 20 generations [68]. In all experiments, the DRD4-/- mice
(n=5-8) and DRD4+/- (n=5-9) were compared to litter-matched DRD4+/+ (n=5-8) animals. Mice
were group-housed (2-4 per cage) with unlimited access to food and water. Mice were main‐
tained on a twelve hour light/dark cycle. Protocols for animal use were approved by the In‐
stitutional Animal Care and Use Committee (IACUC), which is Association for Assessment
and Accreditation of Laboratory Animal Care International approved, and all procedures
were carried out in accordance with the National Institutes of Health Guide for Care and
Use of Laboratory Animals.
Ceramic-based microelectrode arrays (MEA) that contained 4 platinum (Pt) recording surfa‐
ces (sites 1-4) in an S2 configuration (two sets of side-by-side recording sites) were prepared
to selectively measure glutamate. The electrodes were fabricated for in vivo recordings us‐
ing published methods [73, 78, 79]. All 4 sites were electroplated with meta-phenylene dia‐
mine (mPD) by applying a potential of +0.5 V to the Pt sites vs. a silver/silver chloride (Ag/
AgCl) reference electrode (Bioanalytical Systems, RE-5) in a deoxygenated 0.05 M phosphate
buffered saline (PBS; pH 7.1-7.4) with 5 mM mPD. The mPD forms a size-exclusion layer
over the sites, blocking dopamine, ascorbic acid (AA), DOPAC, and other electroactive com‐
pounds. Pt sites 1 and 2 were coated with glutamate oxidase (Glu-Ox) within an inert pro‐
tein matrix of bovine serum albumin (BSA) and gluteraldehyde, enabling these sites to
detect glutamate levels on a sub-second timescale with low levels of detection (0.2 µM). Sites
3 and 4 were coated with only BSA and gluteraldehyde [80, 81]. In the presence of Glu-Ox,
glutamate is broken down into α-ketoglutarate and peroxide (H2O2). The H2O2 is small
enough to traverse the mPD layer and is readily oxidized and recorded as current using the
FAST-16 equipment (Fast Analytical Sensor Technology (FAST); Quanteon L.L.C., Nicholas‐
ville, KY). For calibration details, see [73, 78]. From the calibration, average values for slope
were -7.7 ± 4.8 pA/µM, selectivity 214 ± 64 to 1 and LOD 0.59 ± 0.06 µM (n=26 electrodes; 51
glutamate recording sites). After the MEA was calibrated; a single barrel glass capillary with
filament (1.0 x 0.58 mm2, 6”, A-M Systems, Inc., Everett, WA) was pulled using a Kopf Pip‐
ette Puller (David Kopf Instruments, Tujunga, CA) and bumped against a glass rod so that
the inner diameter of the micropipette was 10-12 µm. The tip of the micropipette was placed
between the 4 Pt recording sites, approximately 50-80 µm away from the electrode surface
and secured using Sticky Wax (Kerr Manufacturing Co, Detroit, Michigan).
Mice were anesthetized using i.p. injections of 10% urethane solution (1.25 g/kg) and placed
in a stereotaxic frame (David Kopf Instruments, Tujunga, CA) fitted with a Cunningham™
Mouse and Neonatal Rat Adaptor (Stoelting Co., Wood Dale, IL). A circulating heating pad
(Gaymar Industries, Inc., Orchard Park, NY) was used to maintain body temperature. The
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skull overlying the PFC was removed bilaterally. The MEA–micropipette assembly was
positioned in the brain according to the following stereotaxic coordinates where all anterior-
posterior (AP) measures were from bregma, medial-lateral (ML) measures were from mid‐
line and dorsal-ventral (DV) measures were from dura: AP: +2 mm, ML: ±1 mm, DV: -1.8 to
2.6 mm at an angle of 8 degrees according to the atlas of The Mouse Brain in Stereotaxic Co‐
ordinates [82]. An additional hole, remote from the surgery site, was opened for a Ag/AgCl
reference electrode. Prior to placement of the MEA-pipette assembly, the micropipette was
filled with isotonic 125 µM glutamate (125 µM L-glutamate in 0.9% physiological saline;
pH= 7.2-7.4) using a combination of a 1 ml syringe filled with glutamate solution, a 0.22 µm
sterile syringe filter (Costar Corporation), and a 4” stainless steel pulled needle (30 gauge,
beveled tip; Popper and Son, Inc., NY). A potential of +0.7 V was applied versus a miniature
Ag/AgCl reference electrode and the data were displayed at a frequency of 2 Hz. Upon ster‐
eotaxic placement of the MEA-micropipette assembly, 10-20 minutes of baseline data were
acquired. Extracellular levels of glutamate were measured by averaging 30 seconds of base‐
line recordings prior to application of glutamate or KCl. Then, a 125 µM glutamate solution
was locally applied via pressure ejection using a Picospritzer II connected to the open end of
the micropipette by plastic tubing (Parker Hannifin Corp., General Valve Corporation).
Pressure was applied at 5-25 psi for 1 second in all of the experiments. Glutamate was ap‐
plied every 30-60 seconds for a total of 10 recordings. The MEA was then lowered in 350 µm
increments. Baseline recordings were acquired for 5-10 minutes and the recordings were re‐
peated. Parameters from three of the ten signals ranging from 10-30 µM in amplitude were
averaged for each Pt electrode site at each depth. Signals were analyzed for time required to
rise to maximum amplitude (rise time), time for 80% of the signal to decay from maximum
amplitude (T80), and the rate of uptake. The uptake rate was calculated by multiplying the
first order rate constant (k-1, seconds-1) by the maximum amplitude (uptake rate = µM/s) [81].
All data from local applications of glutamate from a given site were pooled into a single
point. Amplitude-matched signals were compared to assess genotypic differences in the
rates of clearance of exogenous glutamate [83]. Brains were removed and processed for his‐
tological evaluation of microelectrode recording tracts. Only data from histologically con‐
firmed placements of microelectrodes within the PFC were used for final data analysis.
Data from the side-by-side recordings were averaged and used as a single data point. If only
one microelectrode site provided usable data, then the recordings were reported as from
that site. Very few data points were omitted in this study due to outlier status, with excep‐
tion for constraints on amplitude-matching. To determine statistical significance (p<0.05),
processed data were analyzed using a one-way ANOVA with Tukey’s post-hoc compari‐
sons across all genotypes (Graphpad Prism 4.0). Urethane, L-glutamate, dopamine, ascorbic
acid, and 1,3-phenylenediamine dihydrochloride were obtained from Sigma-Alderich, St.
Louis MO). Microelectrode arrays were provided by Quanteon L.L.C. (Nicholasville, KY).
2.7. Dopamine dysfunction in the PFC of the SHR model of ADHD: Results
High-speed chronoamperometry coupled with carbon fiber microelectrodes was used to
evaluate KCl-evoked dopamine release because of its capability to record dopamine release
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Urethane, dopamine, ascorbic acid, sodium chloride, potassium chloride, calcium chloride
and Nafion® were obtained from Sigma (St. Louis, MO). Carbon fiber microelectrodes
(SF1A’s) were fabricated by the Center for Microelectrode Technology.
High-speed amperometric recordings of glutamate levels in the PFC of the DRD4 knock‐
out mouse
Male mice (5-7 months; ~32 g) descended from the original F2 hybrid of mice with a truncat‐
ed and non-expressing DRD4 gene (DRD4-/-; 129/SvEv × C57BL/6J) were derived by back‐
crossing the DRD4+/- mouse line for 20 generations [68]. In all experiments, the DRD4-/- mice
(n=5-8) and DRD4+/- (n=5-9) were compared to litter-matched DRD4+/+ (n=5-8) animals. Mice
were group-housed (2-4 per cage) with unlimited access to food and water. Mice were main‐
tained on a twelve hour light/dark cycle. Protocols for animal use were approved by the In‐
stitutional Animal Care and Use Committee (IACUC), which is Association for Assessment
and Accreditation of Laboratory Animal Care International approved, and all procedures
were carried out in accordance with the National Institutes of Health Guide for Care and
Use of Laboratory Animals.
Ceramic-based microelectrode arrays (MEA) that contained 4 platinum (Pt) recording surfa‐
ces (sites 1-4) in an S2 configuration (two sets of side-by-side recording sites) were prepared
to selectively measure glutamate. The electrodes were fabricated for in vivo recordings us‐
ing published methods [73, 78, 79]. All 4 sites were electroplated with meta-phenylene dia‐
mine (mPD) by applying a potential of +0.5 V to the Pt sites vs. a silver/silver chloride (Ag/
AgCl) reference electrode (Bioanalytical Systems, RE-5) in a deoxygenated 0.05 M phosphate
buffered saline (PBS; pH 7.1-7.4) with 5 mM mPD. The mPD forms a size-exclusion layer
over the sites, blocking dopamine, ascorbic acid (AA), DOPAC, and other electroactive com‐
pounds. Pt sites 1 and 2 were coated with glutamate oxidase (Glu-Ox) within an inert pro‐
tein matrix of bovine serum albumin (BSA) and gluteraldehyde, enabling these sites to
detect glutamate levels on a sub-second timescale with low levels of detection (0.2 µM). Sites
3 and 4 were coated with only BSA and gluteraldehyde [80, 81]. In the presence of Glu-Ox,
glutamate is broken down into α-ketoglutarate and peroxide (H2O2). The H2O2 is small
enough to traverse the mPD layer and is readily oxidized and recorded as current using the
FAST-16 equipment (Fast Analytical Sensor Technology (FAST); Quanteon L.L.C., Nicholas‐
ville, KY). For calibration details, see [73, 78]. From the calibration, average values for slope
were -7.7 ± 4.8 pA/µM, selectivity 214 ± 64 to 1 and LOD 0.59 ± 0.06 µM (n=26 electrodes; 51
glutamate recording sites). After the MEA was calibrated; a single barrel glass capillary with
filament (1.0 x 0.58 mm2, 6”, A-M Systems, Inc., Everett, WA) was pulled using a Kopf Pip‐
ette Puller (David Kopf Instruments, Tujunga, CA) and bumped against a glass rod so that
the inner diameter of the micropipette was 10-12 µm. The tip of the micropipette was placed
between the 4 Pt recording sites, approximately 50-80 µm away from the electrode surface
and secured using Sticky Wax (Kerr Manufacturing Co, Detroit, Michigan).
Mice were anesthetized using i.p. injections of 10% urethane solution (1.25 g/kg) and placed
in a stereotaxic frame (David Kopf Instruments, Tujunga, CA) fitted with a Cunningham™
Mouse and Neonatal Rat Adaptor (Stoelting Co., Wood Dale, IL). A circulating heating pad
(Gaymar Industries, Inc., Orchard Park, NY) was used to maintain body temperature. The
Attention Deficit Hyperactivity Disorder in Children and Adolescents118
skull overlying the PFC was removed bilaterally. The MEA–micropipette assembly was
positioned in the brain according to the following stereotaxic coordinates where all anterior-
posterior (AP) measures were from bregma, medial-lateral (ML) measures were from mid‐
line and dorsal-ventral (DV) measures were from dura: AP: +2 mm, ML: ±1 mm, DV: -1.8 to
2.6 mm at an angle of 8 degrees according to the atlas of The Mouse Brain in Stereotaxic Co‐
ordinates [82]. An additional hole, remote from the surgery site, was opened for a Ag/AgCl
reference electrode. Prior to placement of the MEA-pipette assembly, the micropipette was
filled with isotonic 125 µM glutamate (125 µM L-glutamate in 0.9% physiological saline;
pH= 7.2-7.4) using a combination of a 1 ml syringe filled with glutamate solution, a 0.22 µm
sterile syringe filter (Costar Corporation), and a 4” stainless steel pulled needle (30 gauge,
beveled tip; Popper and Son, Inc., NY). A potential of +0.7 V was applied versus a miniature
Ag/AgCl reference electrode and the data were displayed at a frequency of 2 Hz. Upon ster‐
eotaxic placement of the MEA-micropipette assembly, 10-20 minutes of baseline data were
acquired. Extracellular levels of glutamate were measured by averaging 30 seconds of base‐
line recordings prior to application of glutamate or KCl. Then, a 125 µM glutamate solution
was locally applied via pressure ejection using a Picospritzer II connected to the open end of
the micropipette by plastic tubing (Parker Hannifin Corp., General Valve Corporation).
Pressure was applied at 5-25 psi for 1 second in all of the experiments. Glutamate was ap‐
plied every 30-60 seconds for a total of 10 recordings. The MEA was then lowered in 350 µm
increments. Baseline recordings were acquired for 5-10 minutes and the recordings were re‐
peated. Parameters from three of the ten signals ranging from 10-30 µM in amplitude were
averaged for each Pt electrode site at each depth. Signals were analyzed for time required to
rise to maximum amplitude (rise time), time for 80% of the signal to decay from maximum
amplitude (T80), and the rate of uptake. The uptake rate was calculated by multiplying the
first order rate constant (k-1, seconds-1) by the maximum amplitude (uptake rate = µM/s) [81].
All data from local applications of glutamate from a given site were pooled into a single
point. Amplitude-matched signals were compared to assess genotypic differences in the
rates of clearance of exogenous glutamate [83]. Brains were removed and processed for his‐
tological evaluation of microelectrode recording tracts. Only data from histologically con‐
firmed placements of microelectrodes within the PFC were used for final data analysis.
Data from the side-by-side recordings were averaged and used as a single data point. If only
one microelectrode site provided usable data, then the recordings were reported as from
that site. Very few data points were omitted in this study due to outlier status, with excep‐
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processed data were analyzed using a one-way ANOVA with Tukey’s post-hoc compari‐
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acid, and 1,3-phenylenediamine dihydrochloride were obtained from Sigma-Alderich, St.
Louis MO). Microelectrode arrays were provided by Quanteon L.L.C. (Nicholasville, KY).
2.7. Dopamine dysfunction in the PFC of the SHR model of ADHD: Results
High-speed chronoamperometry coupled with carbon fiber microelectrodes was used to
evaluate KCl-evoked dopamine release because of its capability to record dopamine release
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within sub-regions of the striatum and the NA [52, 74] using a local application of 75-125 nl
KCl in 500 µm increments. To examine potential differences in evoked dopamine release in
the separate sub-regions of the PFC between the outbred SD, the WKY progenitor, and the
SHR model of ADHD, one-way ANOVAs were used. No significant differences were found
between strains (cingulate cortex, p=0.1295; prelimbic cortex, p=0.1998; infralimbic cortex,
p=0.1050). These data suggests that the cingulate, prelimbic and infralimbic regions in all
three strains have a similar capacity to release dopamine during an action potential event.
It’s important to note that in both the SD and SHR strains, dopamine peak amplitudes in‐
creased as the microelectrode was moved ventrally; however, the WKY strain displayed the
opposite effect. See Figure 3. Note that all dopamine signals were indicative of the detection
of dopamine and/or norepinephrine based on the reduction/oxidation rations of the signals























































Figure 3. No differences were observed between the outbred SD control strain, the WKY progenitor strain, and the
SHR model of ADHD in the KCl-evoked dopamine peak amplitudes following a local application of KCl in any of the
prefrontal cortical sub-regions. Values represent the mean ± SEM.














































Figure 4. The SHR model of ADHD and the outbred SD control strain exhibited significantly faster dopamine uptake
than the WKY strain in the cingulate cortex (*p<0.05, ***p<0.001). No dopamine uptake differences were observed in
the prelimbic cortex; however, the SHR exhibited significantly faster dopamine uptake in the infralimbic cortex com‐
pared to both the SD control and WKY strain (*p<0.05, **p<0.01). Values represent the mean ± SEM.
To examine differences in dopamine uptake in the separate prefrontal cortical sub-regions,
we used local applications of dopamine to directly observe the functional properties of the
dopamine and norepinephrine transporters. One-way ANOVAs followed by Bonferroni
post-hoc comparisons were used in each sub-region. It was discovered that the SHR model
of ADHD (p<0.05) and the outbred SD control strain (p<0.001) displayed significantly faster
dopamine uptake compared to the WKY strain in the cingulate cortex (F(2,23)=11.11). The
average dopamine uptake times in the cingulate cortex were: SD, 30.8 ± 2 seconds; WKY,
79.1 ± 10 seconds; and SHR, 44.8 ± 3 seconds. No dopamine uptake differences were ob‐
served in the prelimbic cortex (p=0.9605); however, the SHR exhibited significantly faster
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It’s important to note that in both the SD and SHR strains, dopamine peak amplitudes in‐
creased as the microelectrode was moved ventrally; however, the WKY strain displayed the
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SHR model of ADHD in the KCl-evoked dopamine peak amplitudes following a local application of KCl in any of the
prefrontal cortical sub-regions. Values represent the mean ± SEM.
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than the WKY strain in the cingulate cortex (*p<0.05, ***p<0.001). No dopamine uptake differences were observed in
the prelimbic cortex; however, the SHR exhibited significantly faster dopamine uptake in the infralimbic cortex com‐
pared to both the SD control and WKY strain (*p<0.05, **p<0.01). Values represent the mean ± SEM.
To examine differences in dopamine uptake in the separate prefrontal cortical sub-regions,
we used local applications of dopamine to directly observe the functional properties of the
dopamine and norepinephrine transporters. One-way ANOVAs followed by Bonferroni
post-hoc comparisons were used in each sub-region. It was discovered that the SHR model
of ADHD (p<0.05) and the outbred SD control strain (p<0.001) displayed significantly faster
dopamine uptake compared to the WKY strain in the cingulate cortex (F(2,23)=11.11). The
average dopamine uptake times in the cingulate cortex were: SD, 30.8 ± 2 seconds; WKY,
79.1 ± 10 seconds; and SHR, 44.8 ± 3 seconds. No dopamine uptake differences were ob‐
served in the prelimbic cortex (p=0.9605); however, the SHR exhibited significantly faster
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dopamine uptake compared to both the SD control (p<0.01) and the WKY strain (p<0.05) in
the infralimbic cortex (F(2,28)=6.53). The average dopamine uptake times in the infralimbic
cortex were: SD, 61.6 ± 8 seconds; WKY, 49.8 ± 11 seconds; and SHR, 18 ± 4 seconds. These
data reveal that the dopamine and norepinephrine transporters clear dopamine faster in the
SHR in the cingulate and infralimbic cortices compared to control, but not the prelimbic cor‐
tex. It’s important to note that as the microelectrode was moved ventrally in the control SD
strain, the dopamine uptake became slower; however, in the WKY and SHR strains, dopa‐
mine uptake became faster as the electrode moved ventrally.
2.8. Glutamate dysfunction in the PFC of the DRD4-/-
mouse model of ADHD: Results
In  order  to  evaluate  the  effect  of  DRD4s  on  extracellular  levels  of  glutamate,  we  com‐
pared  extracellular  glutamate  levels  across  genotypes  in  the  PFC.  Extracellular  resting
levels  of  glutamate  were  higher  by  approximately  73%  in  the  PFC  of  DRD4-/-  mice  in
comparison to their  DRD4+/+  littermates (DRD4+/+:  1.4 ± 0.2 µM, n=8,  signals=22;  DRD4+/-:
1.9 ± 0.3 µM, n=8, signals=23; DRD4-/-: 2.5 ± 0.3 µM, n=8, signals=24; p<0.05, see Figure 5).
A depth analysis showed that DRD4+/+  mice maintained similar extracellular resting glu‐
tamate levels across depths (1.4 ± 0.3 µM), while DRD4-/- mice tended to have higher lev‐
els  throughout  all  areas.  The  most  profound  difference  was  the  stepwise  increase  in
extracellular  glutamate  levels  in  the  cingulate  cortex  with  a  significant  difference  ob‐
served between the DRD4+/+ and DRD4-/-  mice (DRD4+/+: 1.4 ± 0.3 µM, n=8; DRD4+/-:  2.0 ±
0.6 µM, n=7 ; DRD4-/-: 3.0 ± 0.7 µM, n=8; Student’s t-test: p<0.05; see Figure 5) These data
indicate that the loss of DRD4s results in increased extracellular resting glutamate levels
in the PFC, most dramatically in the cingulate cortex.
The in vivo activity of glutamate uptake was examined with a high degree of temporal and
spatial resolution by locally applying exogenous glutamate to the extracellular space of the
brain and measuring the presence and successive clearance kinetics. Resulting data provid‐
ed kinetic measures that allowed us to evaluate the efficiency of exogenous glutamate re‐
moval from the extracellular space within the 3 different brain areas of the medial PFC.
Statistical comparisons were made on amplitude-matched data in order to make sure that
variations in maximum amplitude would not contribute to changes in rise time, uptake rate
and T80. Average maximum amplitudes were 15.39 ± 1.30 µM (n=8; signals= 21), 13.62 ± 0.78
µM (n=9; signals =25) and 13.93 ± 0.91 µM (n=8; signals = 21) in the DRD4+/+, DRD4+/- and
DRD4-/-, respectively. Uptake rates within the PFC were similar across genotypes (DRD4+/+:
4.85 ± 0.69 µM, n=8; DRD4+/-: 4.82 ± 0.46 µM, n=9; DRD4-/-: 5.28 ± 0.74 µM, n=8; see Figure 6).
The time it took for 80% of the signal to decay (T80) was significantly longer in DRD4-/- mice
than wildtype (DRD4+/+: 2.50 ± 0.16 µM, n=8; DRD4+/-: 2.84 ± 0.12 µM, n=9; DRD4-/-: 3.00 ± 0.14
µM, n=8; p<0.05) with the most profound changes occurring in the prelimbic area (p<0.05).
These kinetic measures of glutamate clearance in the PFC indicate that the DRD4 may play
an important role in glutamate clearance.
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Figure 5. Extracellular resting levels of glutamate in the PFC. The top bar graph shows increased extracellular levels of
glutamate in the PFC of DRD4-/- in comparison to DRD4+/+ mice (*p<0.05). The bottom graph depicts extracellular rest‐
ing glutamate levels broken down by depth in the PFC. The numbers on the x-axis represent the depth of the micro‐
electrode (1.8, 2.15 and 2.5 mm) and indicate the cingulate cortex, the prelimbic area and the infralimbic area;
respectively. Values represent the mean ± SEM.
2.9. Implications of dysfunctional neurotransmitter systems
The SHR and dopaminergic PFC dysfunction
Based on current stimulant treatments for ADHD that target the dopaminergic system, such
as MPH, the hypofunctional catecholamine theory has evolved and states that behaviors
seen with ADHD are caused by decreased levels of catecholamines in the brain regions asso‐
ciated with attention and reward processing [84] including the striatum and PFC. In the
spontaneously hypertensive rat (SHR) model of ADHD, there have been conflicting reports
of dopamine levels in the striatum and PFC; however, the techniques used varied with each
study. Some studies revealed a hypodopaminergic tone [85, 86], while others found no dif‐
ference in dopamine levels [87, 88]. Microdialysis measures of dopamine levels in the SHR
are at most unreliable and poorly reflect concentrations of dopamine near the synapse due
to the limited spatial resolution (>1 mm), slow sampling rates (1-20 min), and significant
damage to the surrounding tissue [89-91]. Based on this premise, it is necessary that a tech‐
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levels  of  glutamate  were  higher  by  approximately  73%  in  the  PFC  of  DRD4-/-  mice  in
comparison to their  DRD4+/+  littermates (DRD4+/+:  1.4 ± 0.2 µM, n=8,  signals=22;  DRD4+/-:
1.9 ± 0.3 µM, n=8, signals=23; DRD4-/-: 2.5 ± 0.3 µM, n=8, signals=24; p<0.05, see Figure 5).
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els  throughout  all  areas.  The  most  profound  difference  was  the  stepwise  increase  in
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indicate that the loss of DRD4s results in increased extracellular resting glutamate levels
in the PFC, most dramatically in the cingulate cortex.
The in vivo activity of glutamate uptake was examined with a high degree of temporal and
spatial resolution by locally applying exogenous glutamate to the extracellular space of the
brain and measuring the presence and successive clearance kinetics. Resulting data provid‐
ed kinetic measures that allowed us to evaluate the efficiency of exogenous glutamate re‐
moval from the extracellular space within the 3 different brain areas of the medial PFC.
Statistical comparisons were made on amplitude-matched data in order to make sure that
variations in maximum amplitude would not contribute to changes in rise time, uptake rate
and T80. Average maximum amplitudes were 15.39 ± 1.30 µM (n=8; signals= 21), 13.62 ± 0.78
µM (n=9; signals =25) and 13.93 ± 0.91 µM (n=8; signals = 21) in the DRD4+/+, DRD4+/- and
DRD4-/-, respectively. Uptake rates within the PFC were similar across genotypes (DRD4+/+:
4.85 ± 0.69 µM, n=8; DRD4+/-: 4.82 ± 0.46 µM, n=9; DRD4-/-: 5.28 ± 0.74 µM, n=8; see Figure 6).
The time it took for 80% of the signal to decay (T80) was significantly longer in DRD4-/- mice
than wildtype (DRD4+/+: 2.50 ± 0.16 µM, n=8; DRD4+/-: 2.84 ± 0.12 µM, n=9; DRD4-/-: 3.00 ± 0.14
µM, n=8; p<0.05) with the most profound changes occurring in the prelimbic area (p<0.05).
These kinetic measures of glutamate clearance in the PFC indicate that the DRD4 may play
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2.9. Implications of dysfunctional neurotransmitter systems
The SHR and dopaminergic PFC dysfunction
Based on current stimulant treatments for ADHD that target the dopaminergic system, such
as MPH, the hypofunctional catecholamine theory has evolved and states that behaviors
seen with ADHD are caused by decreased levels of catecholamines in the brain regions asso‐
ciated with attention and reward processing [84] including the striatum and PFC. In the
spontaneously hypertensive rat (SHR) model of ADHD, there have been conflicting reports
of dopamine levels in the striatum and PFC; however, the techniques used varied with each
study. Some studies revealed a hypodopaminergic tone [85, 86], while others found no dif‐
ference in dopamine levels [87, 88]. Microdialysis measures of dopamine levels in the SHR
are at most unreliable and poorly reflect concentrations of dopamine near the synapse due
to the limited spatial resolution (>1 mm), slow sampling rates (1-20 min), and significant
damage to the surrounding tissue [89-91]. Based on this premise, it is necessary that a tech‐
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nique with increased spatial and temporal resolution over microdialysis, such as carbon fi‐
ber microelectrodes coupled to high-speed chronoamperometric recordings, be used to
measure dopamine dynamics in this popular animal model [92].
Figure 6. Glutamate clearance in the PFC. The top bar graphs represent changes in glutamate clearance in the PFC as
a function of DRD4 expression for amplitude-matched signals. The T80 is significantly longer in DRD4-/- mice in com‐
parison to DRD4+/+ (*p<0.05). A depth profile of the T80 values (bottom) indicate that the most significant difference
was in the prelimbic area of the PFC (2.15 mm) in the DRD4-/-. Values represent the mean ± SEM.
Recent data from our lab using carbon fiber microelectrodes with high-speed chronoamper‐
ometry have shown decreased potassium-evoked dopamine signals in the dorsal striatum of
the SHR model of ADHD compared to the WKY, as well as faster dopamine uptake in the
ventral striatum and NA core in the SHR compared to both the SD and WKY controls [52].
Previous investigations have implicated the dopamine transporter (DAT) in the dopamine
dysfunction of the SHR model of ADHD [93-98] and our data revealing differences in dopa‐
mine regulation in the striatum can be attributed to increased activity of the DAT in the
striatum of the SHR. It is reasonable to assume that if the striatum has increased DAT activi‐
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ty, it’s likely that similar dopamine dysfunction exists in the PFC of the SHR. It’s important
to clarify that the norepinephrine transporter (NET) is present in certain regions of the PFC
in much greater concentrations than the DAT and dopamine uptake in the PFC is thought to
be preferentially due to the NET instead of the DAT [99], so investigations into the mecha‐
nism of dopamine clearance in the PFC of the SHR should be examined in the future.
Using similar volumes of a potassium solution, evoked overflow of catecholamine nerve ter‐
minals surrounding the tip of the carbon fiber microeletrode was used to attempt to locate
differences in vesicular dopamine storage in the different PFC sub-regions. Upon stimula‐
tion, no differences were observed between the inbred SHR model of ADHD, the inbred
progenitor WKY and the outbred SD control strains. The lack of differences signifies to us
that the separate PFC sub-regions all have the same capacity to store and release dopamine
and/or norepinephrine in these strains. MAO and VMAT, both implicated in ADHD, can
then be considered to be functional in the PFC of the SHR model of ADHD and drugs tar‐
geting these proteins, such as deprenyl, may not be useful in this model.
Though no differences were observed in the KCl-evoked dopamine signals, there were sig‐
nificant differences in the length of time required to clear exogenous dopamine applications
between the SHR and control strains. Similar maximum dopamine amplitudes were ach‐
ieved by applying various volumes of an exogenous dopamine solution in order to evaluate
the uptake kinetics of the signals. The DAT is electrogenic and depolarization causes the
DAT to change from the basal state [100-104] and in order to test the full uptake capabilities
of the transporters, including both the DAT and NET, it was necessary to study the trans‐
porters in their more natural state using local applications of dopamine. Utilizing this ap‐
proach, it was discovered that the SHR displayed faster uptake in the cingulate and
infralimbic cortices compared to the WKY strain, but not the prelimbic cortex. The SHR
model of ADHD was also discovered to have faster dopamine uptake compared to the SD
strain in the infralimbic cortex. These results are significant because the cingulate cortex is
involved with learning and memory, playing a vital role in the Papez circuit and the cortical
control of emotions in humans [105]. These data further demonstrate that there exists a neu‐
rochemical dysfunction in a region important for linking behavioral outcomes to motivation
[106, 107] in the SHR. Also, the infralimbic cortex in rodents is known to be involved with
attention to stimulus features, task contingencies, and attentional set-shifting [108] – all be‐
haviors known to be affected in individuals with ADHD [109-111].
The SHR has previously been found to have dysfunctional dopamine dynamics in the stria‐
tum and NA core [52], but here we also show evidence for faster dopamine uptake in the
cingulate and infralimbic cortices of the medial PFC. These regions are heavily implicated in
ADHD [66, 112, 113] and these data give further evidence for use of the SHR as a model of
ADHD. Therapeutics targeting this dysfunction may prove to be useful in the SHR. Howev‐
er, MPH, a DAT blocker, has been investigated and found to not be useful in this model be‐
cause instead of calming these animals as it does in humans, it increased locomotion in
clinically relevant doses [46, 47, 114]. This signifies to us that targeting the NET instead of
the DAT, such as with the use of ATX, may provide a more useful option of targeting PFC
dopamine dysfunction in the SHR model of ADHD.
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nique with increased spatial and temporal resolution over microdialysis, such as carbon fi‐
ber microelectrodes coupled to high-speed chronoamperometric recordings, be used to
measure dopamine dynamics in this popular animal model [92].
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a function of DRD4 expression for amplitude-matched signals. The T80 is significantly longer in DRD4-/- mice in com‐
parison to DRD4+/+ (*p<0.05). A depth profile of the T80 values (bottom) indicate that the most significant difference
was in the prelimbic area of the PFC (2.15 mm) in the DRD4-/-. Values represent the mean ± SEM.
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ometry have shown decreased potassium-evoked dopamine signals in the dorsal striatum of
the SHR model of ADHD compared to the WKY, as well as faster dopamine uptake in the
ventral striatum and NA core in the SHR compared to both the SD and WKY controls [52].
Previous investigations have implicated the dopamine transporter (DAT) in the dopamine
dysfunction of the SHR model of ADHD [93-98] and our data revealing differences in dopa‐
mine regulation in the striatum can be attributed to increased activity of the DAT in the
striatum of the SHR. It is reasonable to assume that if the striatum has increased DAT activi‐
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The DRD4 and glutamatergic PFC dysfunction
The 7-repeat polymorphism of the DRD4 has been implicated in ADHD. Little is known
about the neurochemical effects of the DRD4 and thus the DRD4.7. While the DRD4-/- mouse
is not an exact model for ADHD, it does provide insight to the neurochemistry of DRD4 sig‐
naling. In these studies we used in vivo amperometry coupled to a glutamate-selective MEA
to measure extracellular levels of glutamate and glutamate clearance in the PFC of DRD4+/+,
DRD4+/- and DRD4-/- mice. We measured a significant increase in extracellular resting levels
of glutamate, most prevalent in the cingulate cortex of the medial PFC. We also discovered
increased glutamate uptake times that were seen primarily in the prelimbic area. These data
support the hypothesis that DRD4 signaling is actively involved in regulating glutamate
neurotransmission in the PFC.
We found that lack of DRD4 expression resulted in increased extracellular resting levels
of glutamate in the PFC. We are unaware of any extracellular glutamate levels reported
from  the  PFC  of  anesthetized  C57BL\6  mice.  Using  similar  technology,  Hascup  et  al.
(2007) found extracellular levels of glutamate in the PFC of awake, freely-moving C57Bl
\6 mice to be 3.3 ± 0.1 µM [81]. In this study, we reported approximately 60% of the ex‐
tracellular  levels  recorded from these  prior  studies  in  awake  animals  (1.42  ±  0.19  µM).
Urethane  anesthesia  has  been  documented  to  reduce  extracellular  glutamate  levels  by
58-80% in rats and may be contributing to the lower levels of glutamate measured here
[81, 115].  The relative contributions of metabolic and neuronal pools of glutamate to ex‐
tracellular levels of glutamate and the role of D4 receptors in astrocytic regulation of glu‐
tamate  still  requires  investigation.  Consequences  of  increased  extracellular  levels  of
glutamate in  the PFC would cause alterations in  signaling due to  increased stimulation
of  glutamate receptors  on astrocytes  and presynaptic  and postsynaptic  neurons.  Further
studies  are  required  to  test  these  potential  changes.  There  is  also  indication  that  the
DRD4 is localized to GABA containing interneurons in the PFC [116, 117]. Lack of inhibi‐
tion resulting from loss  of  expression of  the  DRD4 could result  in  decreased release  of
GABA. This loss of inhibition could also contribute to increased tonic levels of glutamate
in the PFC.
Loss of DRD4 resulted in approximately a 20% increase in clearance times in DRD4-/- mice.
The mechanism of the increased clearance time is unknown, but the capacity of this tissue to
clear similar amounts of exogenous glutamate was not significantly altered in the DRD4-/-
mice, suggesting that transporter expression was unchanged. It is not known whether the
measured effects on uptake rate were a direct or indirect effect of DRD4 signaling loss. In all
areas of the brain, 80-90% of glutamate transporters are located on astrocytes [16]. Increased
activation of metabotropic glutamate receptors (mGluRs) on astrocytes could potentially af‐
fect glutamate clearance in this case, depending on the affinity for glutamate by the mGluRs
on astrocytes [118]. Interestingly, there have been reports of the presence of dopamine D2-
receptors on the astrocytes in the PFC [119]. Prior microdialysis data suggests that extracel‐
lular dopamine content and KCl-evoked release of dopamine are lower in the striatum and
NAc of DRD4-/- mice [120]. Alterations in dopamine neurotransmission in the PFC of these
mice may elucidate a special role for the D2 receptor on astrocytes in regulation of dopa‐
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mine and glutamate interactions in DRD4-/- mice in PFC neurotransmission. Dopamine neu‐
rotransmission studies have not been done in these mice, but changes in whole tissue levels
of dopamine and dopamine metabolites do not indicate any changes [72].
In multiple publications, the DRD4 has been indicated as having an important role in the
cortico-striatal-thalamic loop. Previously, we measured increased extracellular glutamate
and slower clearance of glutamate in the striatum, indicating DRD4 regulation in the corti‐
costriatal projections [67]. In these experiments, we measured increased extracellular gluta‐
mate levels and slower glutamate clearance in the PFC, representing alterations in
glutamatergic projections that primarily originate in the thalamus. Mrzljak et al. (1996) al‐
luded that the DRD4s role in pallido-thalamic pathways may be as a regulator of GABA re‐
lease [117]. By blocking these receptors, GABA release would be weakened and result in
enhanced excitatory pathways beginning in the thalamus. This presents a feed forward sit‐
uation in which lack of inhibitory modulation of the excitatory pathways of the cortico-stria‐
tal-thalamic loop results in increased levels of glutamate in the PFC and the striatum.
Although measures of GABA in the pallido-thalamic and striatopallidal projections are nec‐
essary, our data continues to support the importance of the DRD4 in the cortico-striatal-tha‐
lamic loop, specifically in the regulation of tonic glutamate.
Region specific changes may be due to the concentration of DRD4s and cell types to which
they are localized. In a study where bacterial artificial chromosomes expressed enhanced
green florescent protein under the transcriptional control of the DRD4, DRD4 localization
was found to be high in the orbital, prelimbic, cingulate and rostral agranular potions of the
prefrontal cortex [116]. Our study found changes in the cingulate and prelimbic areas, but
not the infralimbic area. Localization of DRD4s to interneurons vs. pyramidal neurons may
be helpful in elucidating a relationship between altered extracellular glutamate levels in the
cingulate cortex in comparison to altered clearance times in the prelimbic area. One caveat
of transgenic mice is that compensatory effects may be contributing to the neurochemical ef‐
fects that we measured. While compensatory effects in the PFC have not been evaluated, al‐
terations in dopamine D1 receptor and NMDA receptor expression were reported in the
striatum, nucleus accumbens and hippocampus [67, 120, 121]. Assessment of dopamine, glu‐
tamate, and GABA related receptors in the PFC would provide important information nec‐
essary for proper evaluation of receptors that could be contributing to the findings reported
in this paper and need to be further investigated. Compensatory mechanisms can be indica‐
tive of developmental functions that are influenced by the absence of the DRD4 and are im‐
portant to consider when evaluating glutamate function in the PFC of these knockouts.
2.10. Future directions in the neuropharmacology of ADHD
The data presented above in the SHR and DRD4-/- rodent models of ADHD provide evi‐
dence for dopaminergic and glutamatergic system dysfunction in the PFC. Likewise, it has
previously been demonstrated that in the striatum of both models, similar neurotransmitter
system dysfunction exists [52, 67]. The DRD4 knockout mouse has also been found to exhibit
decreased dopamine levels in the striatum [120]. These data in the DRD4-/- reveal that the D4
receptor is vital in the regulation of dopamine-glutamate interactions in the striatum and
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The DRD4 and glutamatergic PFC dysfunction
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mice, suggesting that transporter expression was unchanged. It is not known whether the
measured effects on uptake rate were a direct or indirect effect of DRD4 signaling loss. In all
areas of the brain, 80-90% of glutamate transporters are located on astrocytes [16]. Increased
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mice may elucidate a special role for the D2 receptor on astrocytes in regulation of dopa‐
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The data presented above in the SHR and DRD4-/- rodent models of ADHD provide evi‐
dence for dopaminergic and glutamatergic system dysfunction in the PFC. Likewise, it has
previously been demonstrated that in the striatum of both models, similar neurotransmitter
system dysfunction exists [52, 67]. The DRD4 knockout mouse has also been found to exhibit
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PFC. Recent pilot data from our lab (unpublished) reveal that in the SHR model of ADHD,
there exists increased resting glutamate levels in the striatum and PFC; however, further ex‐
perimentation is necessary to verify these results. Glutamate dysfunction in the SHR would
then create the possibility that targeting the dopamine-glutamate interaction in this model of
ADHD may prove useful as well.
These animal models grant us the ability to investigate neurotransmitter system regulation
in vivo, creating a more accurate depiction of the dysfunction in multiple subregions within
the PFC. Using these animals, we plan to use common ADHD treatments, such as MPH and
ATX, as well as unconventional treatments, such as memantine and deprenyl, to examine
the effects of these drugs on the dopamine and glutamate neuronal systems. Our ultimate
goal is to discover novel ways to treat ADHD with minimal side-effects and clear long-term
safety and efficacy. Avoiding the confounding side effect of abuse potential will be especial‐
ly advantageous given the difficulties this presents to prescribing stimulants. We believe
that targeting the interaction between the dopamine and glutamate systems will provide a
new avenue to achieve our goal.
As more and more research is beginning to implicate a dysfunctional glutamate system in
ADHD, it’s hard to ignore that glutamate may be playing some role in the pathophysiology
of ADHD. Although it is too early to know if pharmaceuticals that modulate glutamate will
be able to benefit ADHD without their own set of side-effects, it is still our hope that
through modification of these interactions, we will be able to better treat individuals with
ADHD and greatly improve their quality of life.
3. Conclusion
In this chapter, we have reviewed dopamine and glutamate neurotransmission, as well as
dopamine-glutamate interactions, specifically relating to ADHD. We have reviewed current
literature and have shown the effects of ADHD treatments on these neurotransmitters. We
have discussed and detailed two rodent models of ADHD as well as the techniques used to
highlight novel data revealing dopamine and glutamate dysfunction in these models of
ADHD. Finally, we’ve examined ways these data will enable the future neuropharmacology
of ADHD to move forward. Ultimately, our goal is to find novel therapies targeting dopa‐
mine-glutamate interactions to better treat ADHD in individuals of all ages.
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1. Introduction
ADHD is the most common behavior diagnosis given in a approximately 5.4 million chil‐
dren between 4 and 17 years of age [1]. ADHD can profoundly affect the academic achieve‐
ment, well being and social interactions of children. Clinically, ADHD may be confused
with other medical conditions, including seizures and anxiety but not limited to behavior or
paying attention only. If a child is not hyperactive, it may take a long time before it is
brought to the attention of others for treatment. The American Academy of Pediatrics (AAP)
recently issued new guidelines for the diagnosis and treatment of ADHD, expanding recom‐
mendations for age ranges including both early pre-school children and adolescence.
Three types of ADHD have been identified:
1. ADHD combined type; the individual displays both inattentive and hyperactive/ im‐
pulsive symptoms.
2. ADHD, predominately inattentive type; the individual has symptoms primarily related
to inattention. Individuals do not display significant hyperactivity/impulsive behaviors.
3. ADHD, predominately hyperactivity/impulsive type; symptoms are primarily related
to hyperactivity and impulsivity. The individual does not display significant attention
problems [2]. Symptoms are typically seen early in the child’s life, often when he or she
enters the school setting. In order to meet the criteria for ADD/ADHD symptoms must
be more excessive than would be appropriate for individual’s age and developmental
level. Problematic behaviors may continue through adolescence and into adulthood.
The diagnosis of ADD/ADHD is a clinical diagnosis.
The individual must meet criteria requirements listed in the Diagnostic and Statistical Man‐
ual of Mental Disorders (DSM).
© 2013 Patel; licensee InTech. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
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Six or more of the following symptoms of inattention have been present for at least 6 months
to the point that it is disruptive and inappropriate for the developmental level.
Often does not give close attention to details or makes careless mistakes in school work,
work or other activities.
Often has trouble keeping attention on task or play activities.
Often does not seem to listen when spoken to directly.
Often does not follow instructions and fails to finish school work, chores or duties in the
workplace. Often has trouble organizing activities.
Often avoids dislikes or doesn’t want to do things that take a lot of mental effort for a long
period of time.
Often loses things needed for tasks and activities.
Is often easily distracted.
Is often forgetful in daily activities.
Six or more of following symptoms of hyperactivity/ impulsivity have been present for at least
6 months to an extent that it is disruptive and inappropriate for the developmental level.
2. Hyperactivity
Often fidgets with hands or feet or squirms in seat.
Often gets up from seat when remaining is seat is expected.
Often runs about or climbs where it is not appropriate.
Adolescence and adults may feel very restless.
Often has trouble playing or enjoying leisure activities quietly.
Is often “On the go” or acts as if “Driven by a motor”.
Often talks excessively.
3. Impulsivity
Often blurts out answers before questions have been finished.
Often has trouble waiting when it’s his turn.
Often interrupts or intrudes on others [3].
There must be clear evidence of clear impairment in social, school or work function; these
symptoms do not occur only during the course of a pervasive developmental disorder,
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schizophrenia or other psychotic disorder; and the symptoms are not better accounted for
by other mental disorder, sensory disorder (hearing or visual impairment) and those who
have experienced child abuse and sexual abuse [4].
The American Academy of Pediatrics (AAP) recently stated, “a primary care provider
should initiate an evaluation for ADHD for any child, 4-18 years of age who presents with
academic or behavior problems and symptoms of inattention, hyperactivity or impulsivity.
The AAP went further in stating that the clinician should determine that the diagnostic crite‐
ria of DSM-IV have been met including documentation from parents, teachers or others
school personnel and mental health clinician involved in the child’s care.
There are many different rating scales available to be completed by parent, other care givers
and school personnel.
The Vanderbilt ADHD diagnostic rating scale includes DSM-IV based skills with teacher
and parent report forms. It screens for co-morbid conditions. It is normed for age and sex.
The Vanderbilt separates inattention and hyperactivity/impulsive behaviors. It can be used
free of charge [6].
The Connors rating scale has been the most utilized method of trying to diagnose ADHD
and other problem childhood behavior. It follows the DSM-IV guidelines. There are forms
for teachers and parents to fill that are gender specific. There is a form for the child to fill out
called “a self report” [7].
Child attention profile. This is based on inattention and over reactive items from the Achen‐
bach Child Behavior Checklist. It is normed by sex. It separates inattention and over reactive
factors. This can be used free of charge [8].
The Weschsler Individual Achievement Test, 2nd edition, this provides standardized nor‐
mative value academic achievement scores across a variety of subjects for individuals be‐
tween the ages of 4 and 85. The reading, numerical, and spelling subtest provide brief
estimates of academic achievements [9].
Changes in the definition of the diagnosis of ADHD are being considered with the next
edition of the DSM that is expected to be published in May 2013. One problem with using
the current DSM-IV subtypes is they are often unstable and changing over time. For exam‐
ple, a child may meet the criteria for one subtype at the initial evaluation and meet the
criteria  for  another at  the follow up appointment.  In order for  more accuracy,  one pro‐
posed revision is  to specify diagnosis based on current presentation of  symptoms: com‐
bined presentation predominately inattentive presentation or predominately hyperactive/
impulsive presentation. In addition a fourth presentation: inattentive presentation (restric‐
tive) may be added to be more precise in identifying individuals who display impairment
only in attention not hyperactivity.
Symptoms of impulsivity are also under represented in the current DSM-IV criteria. Possible
updates to the DSM-V include adding additional criteria to impulsivity.
Examples are:
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tends to act without thinking, starts a task without adequate preparation or avoids listening
or reading instructions.
Is often impatient, restless when waiting for others, wanting others to get to the point,
speeding when driving.
Is uncomfortable doing things slowly and systematically.
Often rushes through activities or tasks.
Finds it difficult to resist temptations or opportunities, even if it means taking risks. Exam‐
ple: a child may play with dangerous objects; or adults may commit to a relationship after a
brief acquaintance [10].
There is mounting evidence that many conditions exist with ADHD and modify the overall
clinical presentation and treatment response. Co-morbid conditions should be considered si‐
multaneously and in order to better understand and maximize therapy. These conditions
may be emotional, behavioral, developmental or physical conditions. Co-morbid conditions
include Oppositional Defiance Disorder (ODD), substance abuse, conduct disorder, anxiety,
depression, tic disorder, Tourette’s syndrome, and learning disability. Co-morbidities have
their own symptoms, which may or may not overlap the symptoms of ADHD.
Oppositional Defiance Disorder (ODD). Does the person defy you or the teacher by simply saying
no or ignoring you? Does the person appear to be annoyed easily and bothered by trivial things? Does
the person appear to annoy other people on purpose? Does the person appear angry, hot tempered,
resentful or full of spite?
Oppositional defiant disorder is a pattern of disobedient, hostile and defiant behavior to‐
ward authority figures. This disorder is more common in boys than girls. Children with
ODD are overly stubborn, rebellious, often argue with adults and refuse to obey rules [11].
These children often blame others for their mistakes. Are in constant trouble in school. Are
touchy or easily annoyed. Are spiteful and seek revenge. To fit this diagnosis, the pattern
must last for at least 6 months and must be more than normal childhood misbehaviors.
ODD is a less severe condition than Conduct Disorder. Frequently those who have persis‐
tent ODD later develop symptoms that qualify for diagnosis of conduct disorder [13]. Chil‐
dren with a diagnosis of ODD often require treatment for the ADHD as well as individual
and possibly family therapy. The parents should learn how to manage the child’s behavior.
Conduct Disorder. Does the person lie a lot? Does the person get into physical fights? Does the per‐
son try of hurt people? Has the person ever stolen or damaged people’s property?
Conduct disorder is a disorder of childhood and adolescence that involves long-term
(chronic) behavior problems. Conduct disorder has been associated with child abuse, drug
addiction or alcoholism in the parents, genetic defects and poverty. This condition includes
behaviors in which the child may lie, steal, fight, or bully others. He or she may destroy
property, break into homes or play with fire. They may carry or use weapons. These chil‐
dren are at greater risk of using illegal substances. Children with conduct disorder are at
risk of getting in trouble at school or with police [11]. The presence of negativistic, hostile
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and defiant behaviors that include losing their temper, arguing with adults, refusing to com‐
ply with the rules of society, deliberately annoying people, consistent anger/resentment to‐
wards others. There is a history of physical aggression towards people or animals [16].
These children make no effort to hide their aggressive behaviors. They may have a hard
time making friends. Children with conduct disorder require treatment for their ADHD as
well as for their conduct disorder. The child’s family needs to be closely involved. Parents
can learn techniques to help manage their child’s problem behavior. Many “behavior modi‐
fication” school, “wilderness programs” or “boot camps” are sold to parents as solutions for
conduct disorder. These programs use a form of “confrontation” which can actually be
harmful. Treating the child at home with their family is more effective [18].
Anxiety. Does the person appear to be nervous and anxious? Are there times when the person ap‐
pears panicked, stricken, or frozen by anxiety? Does the person appear very shy compared to others
his same age? Does the person repeat certain actions over and over like a ritual?
The most common anxiety disorder with ADHD is social phobia. This condition is present
in nearly 1/3 of patients with ADHD. Social phobia describes a chronic and persistent fear of
being scrutinized in social situations. Many people with ADHD experience repetitive nega‐
tive social encounters related to inattention which results in their misreading social cues.
Disorganization causes them to be chronically tardy for social events. Impulsivity explains
why they blurt out unedited and embarrassing comments. This causes them to be over
whelmed and uncomfortable in social situations [12]. The treatment for this is to stabilize the
ADHD [11]. Some children with anxiety did require the addition of an SSRI.
Depression. Does the person appear sad, blue or down and how can you tell? Is the person irritable,
cranky, and moody? Has the person been doing the activity once enjoyed? Does the person talk about
suicide or about uselessness of life, has the person attempted suicide?
Depression frequently occurs independently of ADHD. If depression is not identified and
treated concurrently with the ADHD it can become treatment resistant depression. (12) De‐
pression is the most common co-morbid condition in adolescents with ADHD [4]. Prelimi‐
nary studies suggest that depression co-exists with the predominately inattentive and
combined sub-types of ADHD [14, 15]. In many cases, ADHD related problems at school
and with family and friends trigger depression by undermining a child’s self esteem. This is
called “secondary” depression, because it arises as the aftermath of another problem, includ‐
ing ADHD, it is important to taylor the treatment for the depression to the cause. If it is
ADHD, treat the ADHD [19].
Bipolar disorders: are there times where the person thinks he or she is able to do anything he or she
wants? Does the person appear unusually energetic at times or almost high without drugs? Does the
person miss a lot of sleep at night but still acts energetic the next day? Does the person appear to have
thought that appear so fast that it is impossible to keep up with them?
Bipolar disorder may occur with ADHD or may mimic its symptoms. Half of the boys and
one-fourth of the girls with bipolar disorder also meet the criteria for ADHD. Children and
adolescents with bipolar disorder often show strong emotional feelings, hyperactive behav‐
ior, overbearing manner, and difficulty waking up in the morning. Children and adolescents
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Oppositional defiant disorder is a pattern of disobedient, hostile and defiant behavior to‐
ward authority figures. This disorder is more common in boys than girls. Children with
ODD are overly stubborn, rebellious, often argue with adults and refuse to obey rules [11].
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and defiant behaviors that include losing their temper, arguing with adults, refusing to com‐
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fication” school, “wilderness programs” or “boot camps” are sold to parents as solutions for
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pears panicked, stricken, or frozen by anxiety? Does the person appear very shy compared to others
his same age? Does the person repeat certain actions over and over like a ritual?
The most common anxiety disorder with ADHD is social phobia. This condition is present
in nearly 1/3 of patients with ADHD. Social phobia describes a chronic and persistent fear of
being scrutinized in social situations. Many people with ADHD experience repetitive nega‐
tive social encounters related to inattention which results in their misreading social cues.
Disorganization causes them to be chronically tardy for social events. Impulsivity explains
why they blurt out unedited and embarrassing comments. This causes them to be over
whelmed and uncomfortable in social situations [12]. The treatment for this is to stabilize the
ADHD [11]. Some children with anxiety did require the addition of an SSRI.
Depression. Does the person appear sad, blue or down and how can you tell? Is the person irritable,
cranky, and moody? Has the person been doing the activity once enjoyed? Does the person talk about
suicide or about uselessness of life, has the person attempted suicide?
Depression frequently occurs independently of ADHD. If depression is not identified and
treated concurrently with the ADHD it can become treatment resistant depression. (12) De‐
pression is the most common co-morbid condition in adolescents with ADHD [4]. Prelimi‐
nary studies suggest that depression co-exists with the predominately inattentive and
combined sub-types of ADHD [14, 15]. In many cases, ADHD related problems at school
and with family and friends trigger depression by undermining a child’s self esteem. This is
called “secondary” depression, because it arises as the aftermath of another problem, includ‐
ing ADHD, it is important to taylor the treatment for the depression to the cause. If it is
ADHD, treat the ADHD [19].
Bipolar disorders: are there times where the person thinks he or she is able to do anything he or she
wants? Does the person appear unusually energetic at times or almost high without drugs? Does the
person miss a lot of sleep at night but still acts energetic the next day? Does the person appear to have
thought that appear so fast that it is impossible to keep up with them?
Bipolar disorder may occur with ADHD or may mimic its symptoms. Half of the boys and
one-fourth of the girls with bipolar disorder also meet the criteria for ADHD. Children and
adolescents with bipolar disorder often show strong emotional feelings, hyperactive behav‐
ior, overbearing manner, and difficulty waking up in the morning. Children and adolescents
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with sever bipolar symptoms may have excessive and lengthy temper tantrums that are de‐
structive and often based on gross distortion of objective events. For example, when a friend
wants to play a different game, bipolar children may think the friend is trying to purposeful‐
ly be mean. The child gets angry at such mistreatment. This may result in a temper tantrum.
Other symptoms include excessive talking, increased activity, inappropriate actions and ver‐
bal responses in social situations, lack of inhibition, chronic irritability and distractibility.
The prevalence is up to 20% [21, 22]. According to an Italian study, 24% of 7-18 year old clin‐
ic attendees with bipolar disease had existing ADHD [23].
The child behavior check list score better discriminates between children with ADHD, co-
mania in context to pediatric bipolar disorders and control subjects.
The pharmacological treatment, mood stabilizers are the first line treatment for periodic bi‐
polar disorders. However, when ADHD symptoms are present, subjects may benefit from
short-term co-concomitant treatment with a stimulant or a co-medication of a non-stimulant.
The etiology of comorbid pediatric bipolar and ADHD have distinct characteristics. Neuro
imaging studies suggest general changes in prefrontal areas in both disorders. However,
there are a few primary differences between the two patient groups in the areas in indiffer‐
ence control, working memory, planning cognitive flexibility and fluency. Several authors
reported that ADHD with comorbid pediatric bipolar disorder is its own distinct form of
ADHD [24]
Fifty percent of the prepubescent depressed children in one sample manifest bipolar disor‐
der within ten year of the onset of depression [25]. Another study found 20%of depressed
adolescents in another sample had revealed a bipolar disorder within 1-4 years [26]. When
comparing to the children with ADHD without mania, the manic children have significantly
higher rates of major depression, psychosis, multiple anxiety, conduct disorder, or opposition‐
al defiant disorder, as well as significantly greater impairment of psychosocial functioning.
As with depression, bipolar must be treated effectively with symptoms of ADHD to resolve
comorbidity affecting the individual. An atypical anti-psychotic agent appears to be effec‐
tive in the elimination of juvenile mania. In an open study, Risperdal was found to be effec‐
tive anti-manic but did not help ADHD symptoms, among bipolar adults comorbid for
ADHD, Bupropion is effective for ADHD and depression but may lower the threshold for
inducing mania.
Tic disorder and Tourette’s syndrome. Does the person have movement such as eye blinking, mak‐
ing an odd face, shrugging or moving an arm a lot that is not intentional? Does the person make
noise without meaning to such as grunting, sniffing, or saying certain words? Do these symptoms
get worse when the person is under stress or anxiety and/or are these symptoms present while the
person sleeping?
Tics are complex, stereotyped movements (motor tics) or utterances (verbal tics) that are
sudden, brief and purposeless. Tics are suppressible for short periods of time, with some
discomfort and never incorporated into a voluntary movement. Stress exacerbates tics and
they disappear during sleep.
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Tourette syndrome is any combination of verbal and motor tics. There is a strong genetic ba‐
sis for Tourette syndrome and environmental factors play a role. Stimulants provoke tics in
pre disposed children.
Onset is anytime from 2 to 15 years of age. The period of greatest severity is between 8 and
12 years of age and half of the children are tic free by 18 years of age. Common tics include
eye blinking, grimacing, lip smacking, and shoulder shrugging. The initial verbal tics are
usually throat clearing, shorting or sniffing. Symptoms wax and wane in response to stress
and excitement. The decision to prescribe medication depends on whether the tics bother
the child. Drug therapy is not required if the tics bother the parents but do not disturb the
child’s life [20].
Obsessive compulsive disorders: Obsessive –compulsive disorders are characterized by re‐
current intrusive thoughts and images and repetitive behaviors that aim to reduce anxiety.
Up to 30% [27] of children and adolescents with obsessive-compulsive disorders are present
with ADHD symptoms. The rate of OCD among children with ADHD is 8-11% [28], but that
rate is higher among children with Tourrette’s disorder. Patient with comorbid ADHD and
OCD were characterized by early onset of OCD symptoms. Patients with cormorbid OCD
and ADHD symptoms seem to require special care and treatment because the longer those
symptoms persist, the more they increase in severity. OCH can be treated with and SSRI,
like Prozac, and behavior modification.
Learning disability. Even when the person is paying attention, is learning difficult? Are there cer‐
tain subjects that the person has extreme difficulty with? How does this person do in reading, writ‐
ing, and mathematic? Hs the person ever been tested for a learning disability?
Preschool children with a learning disability may have difficulty understanding certain
sounds or words, or have problems expressing himself or herself in words. School age child
may struggle with reading, spelling, writing, or math [11]. Poor school performance may in‐
dicate a disability in learning. Testing may be required to determine whether a discrepancy
exists between the child’s learning potential (intelligence quotient) and his actual academic
progress (achievement test scores), indicating the presence of a learning disability [13]. If a
child with ADHD also has a learning disability, neuropsychological testing can be done to
help determine the best ways to help the child learn. The school can provide an Individual‐
ized education program to assist the child in learning.
Substance abuse. Do you suspect this person smokes, uses drugs and drinks alcohol? Why do you
suspect this?
Substance abuse disorder is common in adult ADHD patients [12]. It can be seen in adoles‐
cent patients as well. These patients will demonstrate behaviors of increasing isolation from
family and friends. May see the presence of drug paraphernalia. They may use alcohol or
drugs to alter their mood state or to escape. There are consequences at school, in the home
or authorities related to their use of alcohol or drugs [16]. Drugs may provide temporary re‐
lief from the distress caused by the anxiety, social dysfunction, stress and conflict that can
result from ADHD. Parents should stay aware in child’s social relationships, unexpected
changes in mood, and notable declines in academic performances.
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It is important to have an accurate diagnosis which involves a combination of physical ex‐
amination to rule out organic causes (ear infections, elevated lead levels, seizure), behavioral
observation and standard tests. Public interest in ADHD has increased along with medical
debate in diagnosis and treatment. Some concerns have been emphasized over diagnosis.
There is a wide variation of diagnostic criteria and treatment seen among primary care doc‐
tors. Primary care physicians should recognize ADHD as a chronic condition, therefore con‐
sider children, adolescence, and children with special health care needs. No instrument can
replace clinical judgment regarding initial diagnosis and follow up of treatment assessment
in children with ADHD. For treatment purposes this varies by age. The specific behavior
modification in psychological counseling must be considered in addition to pharmacological
treatment titrated to achieve maximum benefit with minimum side effects.
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dren and adolescents. It is a severe disorder that can cause grave problems for sufferers
and those around them. The interest in the study of ADHD in the scientific community
is undeniable, as proved by the multitude of articles and books on the subject published
annually. As indicated by Lavigne and Romero [1], interest in this condition is such that
it has breached the boundaries of academic research and study and has become a social
phenomenon in  itself,  to  such  an  extent  that  any  child  who shows a  certain  degree  of
activity,  who  does  not  remain  seated  and  quiet  for  hours  and  does  not  instantly  obey
each  and  every  instruction  he  or  she  receives  is  immediately  suspected  of  having
ADHD. The readiness  with which children are  labeled as  having ADHD is  surely  due,
in  part,  to  the  lack  of  information  about  the  various  factors  apart  from  ADHD,  that
cause lack of attention, hyperactivity and/or impulsiveness.
Neither are teachers free from the tendency to attribute ADHD to too many children in spite
of having greater possibilities of obtaining more reliable information about ADHD either
through professional articles and books, training courses or other professionals at their
schools that work with pupils with ADHD, etc. Despite this greater ease of access to infor‐
mation, various studies have shown that teachers’ knowledge of ADHD could be improved
[2-7]. Furthermore the knowledge teachers have about ADHD is also the source of ever
greater interest among scientists as they are actors with a key role in the development of the
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and their families. For this reason, in order to find out exactly what level of knowledge
teachers have about this problem it is crucial to have assessment tools with appropriate psy‐
chometric properties, that are reliable and valid and that provide accurate data about teach‐
ers’ knowledge of ADHD.
In this chapter, the fundamental reasons for which teachers have to have a basic level of
knowledge of ADHD are examined, an exhaustive analysis is carried out of the main instru‐
ments which have been developed to assess teachers’ knowledge of ADHD, and the chapter
ends with the main conclusions drawn from this study.
2. ADHD and teachers
ADHD is currently one of the disorders that has generated the largest number of research
studies among the scientific community but despite this, in the words of Barkley [8], a lot
remains unknown or misunderstood about it. Teachers, along with the family, are one of the
most important agents of socialization during infancy, so they are one of the most suitable
groups to receive information and training with regard to ADHD. A significant percentage
of teachers have false ideas or gaps in their knowledge of ADHD, which causes them to be‐
have inappropriately in the classroom. In this regard, it has been observed that specific
training of teachers in the field and positive attitudes on their part have positive consequen‐
ces for children with ADHD.
Soroa, Balluerka and Gorostiaga [9] hold that infant and primary school teachers should
have general and specific knowledge about ADHD for six fundamental reasons. Firstly, be‐
cause ADHD is one of the most common psychological disorders among children. The
American Psychiatric Association [10] indicates that between 3% and 5% of school children
suffer from ADHD, that is to say that on average there is one pupil with ADHD in every
classroom of 25 [11-13].
Secondly, teachers are in a uniquely advantageous position for detecting possible cases of
ADHD. They can pretty accurately distinguish normal development from what is not.
Therefore, increasing teachers’ knowledge about ADHD can facilitate, among other factors,
early detection of the disorder and the application of the appropriate treatment [4, 14].
Thirdly, it should be noted that the role of the teacher is also essential in establishing the
diagnosis. The assessments made of the behavior of the students, along with those of the pa‐
rents and the results of other tests to which children are subjected, are part of the data that
allow the diagnosis to be established [4-6].
Fourthly, it should be noted that teachers play a very important role in the implementation,
evaluation and support of the treatment received by children with ADHD [14]. Their coop‐
eration is necessary for the results of the treatment received by the child to be successful,
and their evaluation of and opinions about the treatment of ADHD have a profound effect
on its efficacy [15].
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A fifth reason for teachers to be trained about ADHD lies in direct contact they have with
the parents of the children. Several authors have argued that teachers make recommenda‐
tions, appropriate or inappropriate, about ADHD to the parents, who tend to follow such
recommendations [14, 16].
The sixth and final reason is that the knowledge that teachers have about ADHD affects
their behavior and attitudes towards children with this condition [17]. Teachers with more
knowledge about ADHD have a more favorable conduct and attitudes towards students
with this disorder [3, 16, 18].
In  spite  of  the  existence  of  many  reasons  why  teachers  should  have  knowledge  on
ADHD,  various  studies  have  shown  that,  in  general,  teachers  show  only  moderate
knowledge  of  ADHD and that  it  is  necessary  to  improve  this  level  of  knowledge  [3-6,
19,  20].  Also  it  must  be  noted that  many teachers  present  a  general  lack  of  knowledge
and/or  false  ideas  on the  nature,  course,  consequences,  causes  and treatment  of  ADHD
[21].  In some research programmes the average percentage of  correct  answers by teach‐
ers  to  questionnaires  prepared  in  order  to  measure  their  knowledge  on  ADHD  was
around 80% [14,  18,  22-24],  while in other studies the average percentage of  correct  an‐
swers  did not  exceed 53% [4-6,  20,  25].  At  world level  there  is  much research in  prog‐
ress  on  the  knowledge  that  teachers  have  on  ADHD;  however,  there  is  a  scarcity  of
instruments to measure this knowledge precisely [9].
It has been found that teachers who consider that their level of knowledge about ADHD is
optimum do not seek additional information; in contrast, those who consider that they do
not understand many aspects referring to this topic, do look for it. For this reason, it is im‐
portant that the teachers should be aware of their actual knowledge about ADHD and the
possible repercussions of a lack of knowledge or erroneous knowledge. For this purpose, it
is essential to use evaluation instruments which have appropriate psychometric properties
for measuring such knowledge.
3. Instruments for assessing the level of knowledge of teachers regarding
ADHD
Over recent decades, many instruments have been developed in order to assess the level of
knowledge of teachers regarding ADHD. Given that the school setting is probably the place
where children and young people spend most of the day, it is important to have a range of
instruments to measure teacher knowledge about ADHD throughout the different stages of
child development. These instruments, in addition to identifying gaps that teachers may
have in their knowledge of the disorder, can be useful to educate the teachers about the
need for more training in this area.
In this section a review is carried out of each of the main instruments developed for the eval‐
uation of teachers’ knowledge about ADHD. In the course of the description of each instru‐
ment their general characteristics are set out (the construct evaluated, items, response




and their families. For this reason, in order to find out exactly what level of knowledge
teachers have about this problem it is crucial to have assessment tools with appropriate psy‐
chometric properties, that are reliable and valid and that provide accurate data about teach‐
ers’ knowledge of ADHD.
In this chapter, the fundamental reasons for which teachers have to have a basic level of
knowledge of ADHD are examined, an exhaustive analysis is carried out of the main instru‐
ments which have been developed to assess teachers’ knowledge of ADHD, and the chapter
ends with the main conclusions drawn from this study.
2. ADHD and teachers
ADHD is currently one of the disorders that has generated the largest number of research
studies among the scientific community but despite this, in the words of Barkley [8], a lot
remains unknown or misunderstood about it. Teachers, along with the family, are one of the
most important agents of socialization during infancy, so they are one of the most suitable
groups to receive information and training with regard to ADHD. A significant percentage
of teachers have false ideas or gaps in their knowledge of ADHD, which causes them to be‐
have inappropriately in the classroom. In this regard, it has been observed that specific
training of teachers in the field and positive attitudes on their part have positive consequen‐
ces for children with ADHD.
Soroa, Balluerka and Gorostiaga [9] hold that infant and primary school teachers should
have general and specific knowledge about ADHD for six fundamental reasons. Firstly, be‐
cause ADHD is one of the most common psychological disorders among children. The
American Psychiatric Association [10] indicates that between 3% and 5% of school children
suffer from ADHD, that is to say that on average there is one pupil with ADHD in every
classroom of 25 [11-13].
Secondly, teachers are in a uniquely advantageous position for detecting possible cases of
ADHD. They can pretty accurately distinguish normal development from what is not.
Therefore, increasing teachers’ knowledge about ADHD can facilitate, among other factors,
early detection of the disorder and the application of the appropriate treatment [4, 14].
Thirdly, it should be noted that the role of the teacher is also essential in establishing the
diagnosis. The assessments made of the behavior of the students, along with those of the pa‐
rents and the results of other tests to which children are subjected, are part of the data that
allow the diagnosis to be established [4-6].
Fourthly, it should be noted that teachers play a very important role in the implementation,
evaluation and support of the treatment received by children with ADHD [14]. Their coop‐
eration is necessary for the results of the treatment received by the child to be successful,
and their evaluation of and opinions about the treatment of ADHD have a profound effect
on its efficacy [15].
Attention Deficit Hyperactivity Disorder in Children and Adolescents152
A fifth reason for teachers to be trained about ADHD lies in direct contact they have with
the parents of the children. Several authors have argued that teachers make recommenda‐
tions, appropriate or inappropriate, about ADHD to the parents, who tend to follow such
recommendations [14, 16].
The sixth and final reason is that the knowledge that teachers have about ADHD affects
their behavior and attitudes towards children with this condition [17]. Teachers with more
knowledge about ADHD have a more favorable conduct and attitudes towards students
with this disorder [3, 16, 18].
In  spite  of  the  existence  of  many  reasons  why  teachers  should  have  knowledge  on
ADHD,  various  studies  have  shown  that,  in  general,  teachers  show  only  moderate
knowledge  of  ADHD and that  it  is  necessary  to  improve  this  level  of  knowledge  [3-6,
19,  20].  Also  it  must  be  noted that  many teachers  present  a  general  lack  of  knowledge
and/or  false  ideas  on the  nature,  course,  consequences,  causes  and treatment  of  ADHD
[21].  In some research programmes the average percentage of  correct  answers by teach‐
ers  to  questionnaires  prepared  in  order  to  measure  their  knowledge  on  ADHD  was
around 80% [14,  18,  22-24],  while in other studies the average percentage of  correct  an‐
swers  did not  exceed 53% [4-6,  20,  25].  At  world level  there  is  much research in  prog‐
ress  on  the  knowledge  that  teachers  have  on  ADHD;  however,  there  is  a  scarcity  of
instruments to measure this knowledge precisely [9].
It has been found that teachers who consider that their level of knowledge about ADHD is
optimum do not seek additional information; in contrast, those who consider that they do
not understand many aspects referring to this topic, do look for it. For this reason, it is im‐
portant that the teachers should be aware of their actual knowledge about ADHD and the
possible repercussions of a lack of knowledge or erroneous knowledge. For this purpose, it
is essential to use evaluation instruments which have appropriate psychometric properties
for measuring such knowledge.
3. Instruments for assessing the level of knowledge of teachers regarding
ADHD
Over recent decades, many instruments have been developed in order to assess the level of
knowledge of teachers regarding ADHD. Given that the school setting is probably the place
where children and young people spend most of the day, it is important to have a range of
instruments to measure teacher knowledge about ADHD throughout the different stages of
child development. These instruments, in addition to identifying gaps that teachers may
have in their knowledge of the disorder, can be useful to educate the teachers about the
need for more training in this area.
In this section a review is carried out of each of the main instruments developed for the eval‐
uation of teachers’ knowledge about ADHD. In the course of the description of each instru‐
ment their general characteristics are set out (the construct evaluated, items, response




format, dimensionality, etc.), as well as their scoring rules and psychometric properties.
Their strengths and weaknesses are also evaluated. The instruments are presented in chro‐
nological order.
3.1. ADHD Knowledge Scale (Jerome, Gordon & Hustler, 1994) [23]
3.1.1. Description and development
This instrument was developed by American and Canadian researchers, in the English lan‐
guage, in order to assess the general knowledge of teachers regarding ADHD. It consists of
two sections, the first includes 20 items that are socio-demographic in nature (age, sex, train‐
ing about ADHD, etc.) in a multiple choice format, and a second section with 20 items, 13
positive and 7 negative, with a dichotomous (True/False) response format.
In the preparation of the questionnaire, the authors contacted several teachers and directors
of special education to review the instrument. The authors do not provide more information
about the process.
The instrument was applied to a sample of 1289 elementary school teachers, 439 in the Unit‐
ed States and 850 in Canada. No information is given about the sampling procedure. 46% of
the sample in the United States was made up of teachers from the state of New York school
district, and 54% by teachers from Broward County in Florida. The majority were women
(86%), aged between 31 and 50 (67%) and had been teachers for 9 or more years. 79% taught
the general school population in ordinary classes while 21% were special education teachers.
The Canadian sample consisted of teachers from a wide area of south west Ontario and no
further information is given by the authors about it.
3.1.2. Scoring rules
Correct answers receive 1 point and incorrect ones 0 points. So the range of possible scores
goes from 0, the lowest level of knowledge, to 20, for the highest.
3.1.3. Psychometric properties
No publications have been found which provide validity evidences or reliability indices.
3.1.4. Strengths and weaknesses
This is believed to be the first study designed to test the knowledge of elementary school
teachers about ADHD. A great number of subsequent studies have used this questionnaire
or been inspired by it due to its simplicity and that the fact that it was a pioneer in the field
that concerns us here. Furthermore, the sample used is very broad and heterogeneous. How‐
ever, the response format is dichotomous, so does not provide detailed information about
the real knowledge the teachers have about ADHD. Furthermore, the psychometric proper‐
ties of the questionnaire are not provided.
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3.2. Knowledge of Attention Deficit Disorder Questionnaire (Riley, 1994) [26]
3.2.1. Description and development
This is an instrument drawn up in the United States and in the English language to investi‐
gate teachers’, counselors’ and principals’ knowledge of ADHD in school age children. The
instrument has two sections. The first is made up of six items that gather information of a
socio-demographic character (sex, training, education experience, etc.) and a second made
up of 35 items which evaluates participants’ knowledge of ADHD. The 35 items were taken
from the DSM-III: 15 related to Attention Deficit Disorder (ADD), 11 related to diagnostic
criteria for Conduct Disorder (CD) and 9 that deal with Oppositional Defiant Disorder
(ODD). Participants are asked to identify the 15 statements that best characterize children
with ADHD with an X marking the space before each statement.
The instrument was applied to a stratified sample of 303 participants in the Kansas School
district: 160 teachers, 61 principals and 82 counselors. 91 were male and 212 female. Hardly
any other information is given about the sample.
3.2.2. Scoring standards
Correct answers to the items received 1 point, while the rest of the answers received 0
points. Thus, the possible scores ranged from 0, for the lowest level of knowledge, to 15, for
the highest.
3.2.3. Psychometric properties
No publications have been found which provide validity evidences or reliability indices.
3.2.4. Strengths and weaknesses
This is a simple and easy instrument to apply. The problem is that the response format is
similar to the dichotomous one and respondents can try to guess the right answer. Further‐
more, the psychometric properties of the instrument are not known.
3.3. ADHD Knowledge Questionnaire (Barbaresi & Olsen, 1998) [21]
3.3.1. Description and development
This is an instrument developed in the United States and in the English language in order to
examine the effectiveness of a training program on ADHD given to infant and primary
school teachers. The questionnaire is based on the items produced by Jerome et al. [23] and
consists of two sections: A first socio-demographic section and a second section consisting of
27 items that assess teachers’ knowledge regarding ADHD. The response format of the in‐
strument is dichotomous (True, False), and includes positive and negative items (the au‐
thors do not specify the number of positive and negative items).
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The questionnaire was administered to 44 teachers, of whom 33 were women and 11 men.
The mean age of participants was 42 years, and they had an average of 15 years of teaching
experience. 66% were ordinary classroom teachers while the remaining 34% were specialists
(art, music, physical education, etc.). They had an average of 24 students per teacher. 77%
had not received any training on ADHD while being trained as teachers and 27% had re‐
ceived no training in the subject after completion of their studies.
3.3.2. Scoring standards
Correct answers received a score of 1 and incorrect ones 0. Thus, the possible scores ranged
from 0, for the lowest level of knowledge, to 27, for the highest.
3.3.3. Psychometric properties
No publications have been found which provide validity evidences or reliability indices.
3.3.4. Strengths and weaknesses
This is a simple and easy instrument to apply. However, the sample is very small and the
dichotomous response format (True/False) places limits on the possibility of assessing the
real level of knowledge of the teachers as the absence of a third (Don’t Know) option invites
respondents to guess the right answer. Furthermore, the psychometric properties of the in‐
strument are not known.
3.4. The Knowledge of Attention Deficit Disorders Scale (KADDS)
3.4.1. Original version of The Knowledge of Attention Deficit Disorders Scale (KADDS) (Sciutto,
Terjesen & Bender, 2000) [5]
3.4.1.1. Description and development
It was developed in the United States and in the English language. This is one of the most
widely used instruments to assess the level of knowledge of teachers regarding ADHD, and
is the first instrument whose indices of reliability and validity were published in this field. It
consists of 36 items, 18 positive and 18 negative, and measures three areas of knowledge re‐
lated to ADHD: 1) Symptoms/Diagnosis of ADHD (9 items), 2) General information on the
nature, causes and impact of ADHD (15 items), and 3) Treatment of ADHD (12 items). It has
a three option response format (True, False, Don’t Know), which allows it to overcome the
limits of previously used dichotomous formats (True, False) and collect more detailed infor‐
mation about the knowledge of teachers with respect to ADHD. The use of the three option
response format allows the authors to discern those areas in which teachers have more
knowledge, areas where they have the least knowledge and the areas in which they commit
the greatest number of errors.
In the drawing up of the items the authors strove to include only those with the support of
the scientific literature, citing references for each item in the manual accompanying the in‐
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strument. They also sought to include positive and negative aspects relating to ADHD, and
positive and negative statements in nature.
Once they had drawn up the items the authors contacted a group of 40 students working for
doctorates in clinical and child psychology. The participants, based on the three sub-scales
provided by the authors, had to assign each item to one of the sub-scales provided. An item
was considered as belonging to a particular sub-scale if at least 75% of the group was in
agreement with the decision.
The authors then conducted a series of preliminary investigations to explore the reliabili‐
ty coefficients of the instrument. They administered an instrument of 27 items with a di‐
chotomous response format (True, False) to 73 teachers of kindergartens and elementary
schools  [27]  and obtained a  Cronbach’s  alpha  of  0.38  for  the  total  scale.  In  a  subsequent
study they modified the items that had an inadequate item-total correlation and incorpo‐
rated the three option (True, False, Don’t Know) response format. The resulting scale was
administered to 46 undergraduate and graduate education students and the overall alpha
coefficient obtained for this version was 0.71 [27]. Several items were reformulated and 9
new items were included in the final version of the instrument which now had 36 items
and which Bender  [28]  administered to  63  prospective  elementary  teachers,  obtaining a
coefficient alpha of 0.81.
Finally, Sciutto et al. [5] administered the resulting 36 item scale along with a socio-demo‐
graphic questionnaire (age, sex, teaching experience, teaching speciality, etc.) and a scale of
seven points dealing with respondents’ self-perception of their effectiveness as teachers of
children with ADHD to a broader sample. 149 primary school teachers from six public
schools participated in the validation of the instrument. The sampling procedure is not ex‐
plained. There were 134 female and 9 male participants; the sex of six participants was not
given. Their average age was 41 years (SD=11.43) and they had an average of 12.57 years of
experience as teachers (SD=8.06). 19% of the sample were special needs teachers and 37%
said they had done special needs teaching at some point. 79% of participants had a Master’s
degree, whereas the other 21% reported having a Bachelor’s degree. With regard to ADHD,
52% of the teachers said that had taught at least one pupil who had been diagnosed with
this condition.
It is worth pointing out that Sciutto and Terjesen [29] carried out an additional study on
primary school teachers and university students in the state of Ohio to expand the relia‐
bility and the evidence of validity of KADDS. This study has not been published and no
more data is available about the sample. However, the authors refer to this study along
with the study Sciutto,  Nolfi  & Bluhm [30] carried out on primary school teachers with
the KADDS manual.
3.4.1.2. Scoring standards
1 point was given for correct answers and 0 for incorrect ones and gaps in knowledge. Thus,
the possible scores ranged from 0, for the lowest level of knowledge, to 36, for the highest.
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For reliability analysis, internal consistency was first calculated, producing a Cronbach’s al‐
pha of 0.71 for each sub-scale and 0.86 for the scale as a whole. Furthermore, it was also seen
that each KADDS sub-scale had a high correlation with the total KADDS score (range r=0.85
to r=0.91) and that there was a correlation between the three sub-scales (range r=0.63 to
r=0.69). In order to analyze the stability of the scale, Sciutto and Terjesen [29] administered
the KADDS in two occasions to a group of 185 university students (what they were students
of is not stated) leaving an interval of two weeks between one application and the other. The
test-retest correlations for the KADDS scores range between r=0.59 and r=0.70 for the three
sub-scales and were r=0.76 for the scale as a whole.
No test was carried out on the factorial structure of the instrument. In order to find evidence
of validity, the correlations between the scale scores and a series of variable related to the
construct to be measured were examined. With regard to the previous exposure of teachers
in their classrooms to pupils diagnosed with ADHD, statistically significant differences were
found in the KADDS scores obtained (p<0.01), as well as in various sub-scales (p<0.01 for the
General information and Symptoms/Diagnosis sub-scales). The same occurred with the uni‐
versity students who knew a person with ADHD. In the KADDS and the Treatment sub-
scale they achieved significantly higher scores (p<0.01) than those that had no contact
whatever with people with ADHD [29]. Furthermore the authors of the KADDS have point‐
ed out that the scores obtained by the teachers on the scale correlated in a statistically signif‐
icant and positive way with the number of ADHD students that had in their classes (r=0.23,
p<0.01 for the New York sample and r=0.31, p<0.01 for the Ohio sample in the KADDS total)
[5, 30]. In this case, the same phenomenon also occurred with the university students that
had some kind of contact with people with ADHD (r=0.18, p<0.01 for the KADDS total) [29].
Finally, they found that people with more information about ADHD had higher KADDS
scores, both in the case of teachers (r=0.40, p<0.001 for the KADDS total) [30] and in the case
of university students (r=0.36, p<0.001 for the total KADDS score) [29].
3.4.1.4. Strengths and weaknesses
Considering that the validation of the KADDS was carried out mainly based on the study of
Sciutto et al. [5], it should be emphasized that the sample used is fairly small in size and geo‐
graphically homogenous. Furthermore, the specific data from the Ohio sample are not
known [29].
The reliability of the KADDS was analyzed satisfactorily. As to evidence of validity, we be‐
lieve that it could be improved but this is understandable considering it was the first instru‐
ment constructed to assess knowledge of teachers regarding ADHD whose psychometric
properties have been published. The authors provide information on content validity,
thanks to which it is known that they tried to be careful in their selection of test items but
they do not provide detailed information about the construction of the instrument (number
of items initially created, etc.), and the panel of experts consulted in the process for getting
content validity was fairly homogeneous (students in the same doctoral program). Further‐
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more, there is no factorial analysis which would justify the sub-scales defended by the au‐
thors of the KADDS.
In any case we regard the instrument developed by Sciutto et al. [5] to be a significant refer‐
ence point for any researcher trying to create one with a similar purpose because it was a
pioneering effort in the field with good reliability and sufficient external validity. As well as
that, it is an instrument that is easy to answer due to its brief and precise instructions, its
small size and its three option response format. It is also worth mentioning that it has a sim‐
ple scoring system and thanks to the aforementioned response format, it provides informa‐
tion regarding the knowledge, false beliefs and areas of lack of knowledge of the teachers,
information which the previous instruments, with their dichotomous response format, could
not provide.
3.4.2. The Spanish version of The Knowledge of Attention Deficit Disorders Scale (KADDS) (Jarque,
Tárraga & Miranda, 2007) [4]
3.4.2.1. Description and development
This is the Spanish adaptation of the KADDS [5]. Like the original instrument it has 36
items, 18 positive and 18 negative, and it measures three areas of knowledge related to
ADHD: 1) Symptoms/Diagnosis of ADHD (9 items), 2) General information on the nature,
causes and impact of ADHD (15 items), and 3) Treatment of ADHD (12 items). The three
option response format (True, False, Don’t Know) is the same as that of the original instru‐
ment and it has a more extensive socio-demographic section than the original instrument
(age, sex, years of experience as a teacher, teaching speciality, etc.).
In the first phase of the adaptation process of the instrument, two doctoral students in devel‐
opmental and educational psychology translated KADDS into Spanish making the adjust‐
ments required for the new socio-cultural context. After that, native speakers of English
translated the text back into English to test the validity of the original translation. In this sec‐
ond phase the authors found 18 words different from the original version and agreed on a
final version of the translation of those words and drew up initial version of the instrument.
The initial version was sent to 15 experts in ADHD (ADHD researchers and educational
psychologists) who were asked to place each of the items on one of the three sub-scales that
make up the instrument. The level of agreement on the assignment of items to the sub-scales
was 94%. Finally, a pilot study was conducted on a sample of 35 primary school teachers
who were asked to reply to the scale and indicate errata, difficulties to understand expres‐
sions or doubts that may have arisen during completion of the questionnaire. Corrections
were made and the final version was thus produced.
For the analysis of reliability and validity of the final version of the instrument, the authors
contacted various public and subsidized schools in the province of Valencia. The sampling
was not random. The Spanish version of the KADDS was administered to 193 teachers, 68
from infant education and 125 from primary education, of whom 130 were women and 43
men (20 teachers did not specify their sex). They had a mean age of 42 years (SD=11.40), and
an average of 17 years of teaching experience (SD=12.03). 13.8% were special education
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teachers. 51.6% had received specific training on ADHD, with an average of 7.80 hours
(SD=17) training. In addition, 59.1% of the teachers had had some experience teaching chil‐
dren with ADHD, and the average number of children with ADHD that they had in their
classrooms during the previous two school years was 1.39 (SD=1.89).
3.4.2.2. Scoring standards
Identical to KADDS [5].
3.4.2.3. Psychometric properties
The reliability of the scale, measured by the Cronbach’s alpha coefficient showed adequate in‐
ternal consistency. The alpha coefficient ranged between 0.74 and 0.77 for the three sub-
scales and was 0.89 for the total scale. These rates were higher than those obtained by
Sciutto et al. [5] in the original instrument. In addition, each of the sub-scales showed a high
correlation with the total scale score (range r=0.85 to r=0.90), and there also was correlation
between the three sub-scales (range r=0.62 to r=0.69). These data are also consistent with
those provided by Sciutto et al. [5]. There was no test-retest reliability check conducted.
The validity of the scale was studied using a series of Pearson correlations between teacher
knowledge of ADHD and various socio-demographic variables, specifically, teachers’
knowledge of ADHD correlated in a statistically significant way with the number of hours
of training they had received, r(152)=0.17, p=0.036; with the number of children with ADHD
they had taught, r(180)=0.29, p=0.001; with the number of courses during which they had
children with ADHD in their classes, r(172)=0.23, p=0.002; and their self-perceived level of
effectiveness as teachers of children with ADHD, r(179)=0.50, p=0.001.
3.4.2.4. Strengths and weaknesses
The sample used for the KADDS adaptation was quite small and geographically homogene‐
ous. Also, test-retest reliability was not checked and the factorial structure of the scale was
not analyzed. Apart from these weaknesses and those mentioned in the original version of
KADDS, it should be noted that the instrument has adequate internal consistency and some
evidence of external validity.
3.5. Attention-Deficit Hyperactivity Disorder Knowledge and Opinion Survey (AKOS-
IV) – Knowledge Scale (Power & Rostain, 2003) [31]
3.5.1. Description and development
This instrument was developed in the United States in the English language and consists of
21 items, 8 positive and 13 negative with a dichotomous response format (True, False). The
lead author of AKOS-IV participated in the development of different versions of the instru‐
ment. The first version was designed to analyze the level of knowledge among parents re‐
garding ADHD [see 32]. There is a lack of published information about the second version.
The third version was used to assess the level of knowledge that teachers of primary and
Attention Deficit Hyperactivity Disorder in Children and Adolescents160
secondary education have regarding ADHD [33], and the fourth and final version [31] has
not been published, so its target population is unknown.
3.5.2. Scoring standards
1 point was given for correct answers and 0 for incorrect ones and gaps in knowledge. Thus,
the possible scores ranged from 0, for the lowest level of knowledge, to 21, for the highest.
3.5.3. Psychometric properties
No publications have been found which provide validity evidences or reliability indices.
3.5.4. Strengths and weaknesses
On the positive side, it should be noted that the questionnaire is short and simple to com‐
plete, but it uses a response format with two options (True, False) which can lead to a bias in
the collection of information as those subjects who did not know what to answer are re‐
quired to choose one of the two alternatives provided. In addition, there is a lack of publish‐
ed information relating to the development of the instrument and its psychometric
properties.
3.6. Attention Deficit Hyperactivity Disorder and Stimulant Medication Survey (Snider,
Busch & Arrowood, 2003) [34].
3.6.1. Description and development
This is an instrument developed in the United States in the English language and it is aimed
at primary school and special education teachers. Its aim is to test their knowledge of the
nature of ADHD and its treatment through stimulant medication. The questionnaire is div‐
ided into six sections. The first consists of 8 socio-demographic items: The number of stu‐
dents the teacher has, the number of students diagnosed with ADHD, years of teaching
experience, etc. The second section is made up of 47 Likert scale items with 5 options
(1=Strongly Disagree, 2=Disagree; 3=Neutral/Don’t know, 4=Agree, 5=Strongly Agree) divid‐
ed into three blocks: A first block of 13 items to assess factual knowledge about ADHD and
the use of stimulant medication, a second block of 23 items that asked participants to indi‐
cate their views about the effects of stimulant medication on classroom behavior, and a third
block of 11 items assessing teachers’ experience and involvement with students who have
ADHD. In the third section the subjects have to state which sources they regard as most reli‐
able for obtaining information about ADHD. In the fourth section they had to state which
people usually recommend that children suspected of having ADHD be evaluated by. In the
fifth section the teachers are asked about what teaching techniques they have most frequent‐
ly used for dealing with children with ADHD. In the sixth and final section, there is an open
question which enquires about teachers’ opinions regarding the use of stimulant medication
for the treatment of students with ADHD.
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The pilot version was administered to 15 teachers participating in a graduate clinical experi‐
ence at the University of Wisconsin. Small changes were made in the wording of the items
and it was confirmed that the time required to respond to the questionnaire was about 10 to
15 minutes.
The definitive version of the questionnaire was administered to 145 teachers in Wisconsin,
29 women and 116 men. The subjects were randomly chosen from the Department of Public
Instruction. Among the participants 43% were special education teachers and 30% general





No publications have been found which provide validity evidences or reliability indices.
3.6.4. Strengths and weaknesses
On the positive side, it should be noted that this is a questionnaire with clear instructions
and is easy to fill out. However, the response format used by the authors (Likert 5 options)
may complicate the interpretation of the results, since it offers the option to partially agree
or disagree with the questionnaire items. Moreover, the sample used for the application of
the instrument was small and geographically homogeneous, and the psychometric proper‐
ties of the instrument are not known. Finally, it should be noted that one of the main objec‐
tives of the questionnaire was to analyze teachers' knowledge of stimulant medication, a
very specific purpose and one distinct from the object of study of the other questionnaires
that have been examined in this chapter.
3.7. Attention Deficit Hyperactivity Disorder (ADHD) Questionnaire (Kos, Richdale &
Jackson, 2004) [20]
3.7.1. Description and development
This instrument was drawn up in Australia in the English language to test the perceived and
real knowledge of primary teachers and trainee teachers of ADHD. Section b) of the ques‐
tionnaire was drawn up to examine this main point and contains some items from Jerome et
al. [23], Sciutto et al. [5] and another series of items taken from the scientific literature relat‐
ed to ADHD. The instrument was made up of 131 items divided into six sections. Section a)
collects information on socio-demographic aspects of the sample and included an analog
scale of 10 cm on which respondents had to indicate what they thought they knew about
ADHD. The bottom end of this scale indicates the minimum level of knowledge (Very Lit‐
tle), while the upper level indicates the maximum level (A Lot). Section b) includes 27 items,
11 positive and 16 negative, with a three option response format (True, False, Don’t know)
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drawn up to assess respondents real knowledge of ADHD. Section c) has a focus on identi‐
fying the teaching strategies which subjects might use with pupils with ADHD. For this pur‐
pose they were given a brief description of a practical case and a series of multiple choice
and open questions. Section d) collects information about participants’ beliefs about ADHD
and the possibility of having pupils with it in their classes. For this purpose it had 31 items
which required a response on an analog scale of 10 cm the bottom of which indicated com‐
plete agreement with the statement (Strongly Agree) and the top of which indicated com‐
plete disagreement (Strongly Disagree). Section e) was designed to evaluate beliefs
regarding the different strategies for action possible in classes with pupils with ADHD. It
has 56 items divided into various sub-sections to which respondents had to respond on 10
cm analogical scales the bottom ends of which indicated complete agreement (Strongly
Agree) and the upper ends of which indicated complete disagreement (Strongly Disagree).
Finally, section f) includes two multiple choice items to which subjects have to respond re‐
garding whether or not they want more training on ADHD and to specify the way they be‐
lieve most appropriate to find out more about ADHD.
The questionnaire was revised by two educational and developmental psychologists not as‐
sociated with the study. It was later piloted on a sample of 9 primary school teachers from
Victoria (Australia), arising from which no change was made. The questionnaire was finally
administered to 120 primary school teachers in Victoria, 91 women and 29 men with an
average age of 39.2 years (SD=10.2), and 45 students in the last year of their education de‐
gree, all women and with an average age of 23.6 years (SD=5.6). The sampling procedure
was not explained.
3.7.2. Scoring standards
Section b) of the questionnaire had 27 items. Correct responses received a score of 1 and incor‐
rect ones, 0. Thus, the possible scores ranged from 0, for the minimum level of knowledge, to
27, for the maximum level. The scoring standards for the other sections were not given.
3.7.3. Psychometric properties
No publications have been found which provide validity evidences or reliability indices.
3.7.4. Strengths and weaknesses
On the positive side, it should be noted that the authors have attempted to develop an in‐
strument that collects a variety of information relating to ADHD. However, the instrument
has many weaknesses: The sample used is quite small and geographically homogeneous, the
information given relating to the development of the instrument is scant, the presentation of
the items and response formats vary from one section to another, and there are questions
with 34 possible answers and analog scales of 10 cm which make it difficult to interpret the
response provided by the subject. In short, it is a long and complex questionnaire for the
subject. Additionally, the psychometric properties are not known.
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3.8. Knowledge of ADHD Rating Evaluation (KARE) (Vereb & DiPerna, 2004) [35]
3.8.1. Description and development
This instrument was developed in the United States and in the English language. Its pur‐
pose is to analyze the knowledge that elementary school teachers have about ADHD and
assess their level of acceptance with respect to the medication and behaviorist treatments
that  are  used with children with ADHD. The instrument  is  divided into three  sections.
The first section collects socio-demographic data. The second section consists of 43 items,
positive and negative in nature (the authors do not specify the number of each),  and is
divided into two sub-scales:  A first  sub-scale assesses knowledge of the etiology,  symp‐
toms  and  prognosis  of  ADHD  (31  items),  and  a  second  sub-scale  assesses  knowledge
about treatments that are used most frequently in ADHD cases (12 items). The third and
final section consists of 10 items divided into two sub-scales: The first sub-scale assesses
the level of acceptance that subjects presented with respect to medication (5 items),  and
the second sub-scale assesses the level of acceptance of the behavioral intervention guide‐
lines used with children with ADHD (5 items). The second section of the instrument has
a response format of three options (True, False, Don’t Know) and the third section, being
an opinion section,  has  a  Likert-type response format  of  4  options (1=Not  at  all  Likely,
2=Somewhat Likely, 3=Moderately Likely, 4=Very Likely).
The preliminary version of the instrument was made up of 59 items. 20 experts, members
of  the  International  Society  for  Research  in  Child  and  Adolescent  Psychopatology  who
had conducted research in the area of ADHD and/or treatment acceptability were called
upon to revise it.  The items that received a negative evaluation from these experts were
modified or removed.
Finally, the study was carried out on 47 elementary school teachers in five different districts
of Pennsylvania and New Jersey. The sampling procedure was not specified. 94% of the
sample was female and had an average of 13 years of teaching experience (SD=8.76). 85% of
the teachers were general teachers, while 4.35% worked in special education and 10.6%
worked in both areas.
3.8.2. Scoring standards
In the second section of the instrument 1 point was given for correct answers and 0 for in‐
correct ones and gaps in knowledge. Thus, the possible scores ranged from 0, for the lowest
level of knowledge, to 43, for the highest. The scoring standards for the third section of the
questionnaire are unknown.
3.8.3. Psychometric properties
For the reliability analysis, the internal consistency was first calculated, obtaining a Cron‐
bach’s alpha coefficient that ranged from 0.58 (Knowledge of treatments sub-scale) to 0.81
(Behavioral management acceptability sub-scale) for the four sub-scales in the questionnaire.
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In order to analyze the stability of the instrument, the authors administered the KARE a sec‐
ond time to a sample of 24 subjects (without further details being given of the sample) with
a time interval of four weeks between the first and the second administration. The test-retest
reliability ranged from 0.76 (Behavioral management acceptability sub-scale) to 0.80 (Medi‐
cation acceptability and Knowledge of treatment sub-scales).
No publications have been found which provide validity evidences.
3.8.4. Strengths and weaknesses
On the positive side, it should be noted that this is a not too long instrument with response
formats that are easy to fill out. It also has an acceptable internal consistency for three of the
four subs-scales that compose it, and has good test-retest stability. However, the sample
used for obtaining the reliability indices is small, and no published validity evidences of the
instrument have been found.
3.9. Educator ADHD knowledge (Niznik, 2004) [36]
3.9.1. Description and development
This instrument was drawn up in the United States in the English language. The main pur‐
pose of it is to assess the level of knowledge of elementary school teachers regarding ADHD
before and after they received a specific training program on the subject. The instrument
consists of 23 items and has a multiple choice format: Each item is followed by five possible
answers, one correct and four distractors.
In the course of its development process, the instrument was administered to 10 doctors
working as psychologists in the Cypress-Fairbanks school district (Texas) to receive their
feedback. Adjustments have been made for a better understanding of the items and re‐
sponse options (the authors did not provide further details). The test authors also conducted
a pilot study with 133 participants (no further description were given of the sample), as a
result of which a number of items were removed.
The resulting instrument was administered to 47 elementary school teachers in the Cypress-
Fairbanks school district. 91.5% of the participants were female and 8.5% male. 55.3% of
them were general teachers while 44.7% were special education teachers. The age of the
teachers ranged from 18 upwards, and they had an average of 11 years teaching experience.
30% of the sample had never received training about ADHD, and 95.7% had a child in their
classroom with the disorder diagnosed in recent years.
3.9.2. Scoring standards
1 point was given for each correct answer so the possible scores ranged from 0, for the low‐
est level of knowledge, to 23, for the highest level.
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The reliability of the instrument was calculated using the Kuder-Richardson formula 20, and a
reliability of 0.65 was obtained. No publications have been found that provide validity evi‐
dences.
3.9.4. Strengths and weaknesses
On the positive side, it should be noted that this is a not too long instrument with a novel
response format in the field that concerns us. However, the authors provide few details
about the construction process of the test, the sample that has been used with the final in‐
strument is quite small and homogeneous, and has a low reliability index. Furthermore, the
validity evidences of the instrument were not provided.
3.10. The knowledge about Attention Deficit Disorder Questionnaire (KADD-Q) (West,
Taylor, Houghton & Hudyma, 2005) [6]
3.10.1. Description and development
This is an instrument that was drawn up in Australia in the English language in order to
assess the knowledge about ADHD of primary and secondary teachers and parents of chil‐
dren with the same condition. It consists of a scale of 67 items, constructed on the basis of 20
items from the KADDS [5]. It has a three option response format (True, False, Don’t Know)
and measures three areas of knowledge connected to ADHD: 1) Causes of ADHD, 2) Char‐
acteristics of ADHD, and 3) Treatment of ADHD. Like the KADDS scale it has positive and
negative items, and for the drawing up of which the authors made efforts to use only those
items with support in the scientific literature.
The KADD-Q authors obtained the sample needed for the analysis of reliability and validity
of the scale by making a random selection of schools in metropolitan Perth (Western Aus‐
tralia) and by way of the Centre for Attention and Related Disorders of The University of
Western Australia. The sample consisted of 348 participants: 256 teachers (51% primary and
43% secondary) and 92 parents. Of the teachers involved in the sample, 22% were male and
78% female. 180 teachers were recruited in their workplaces and had an average of 20.2
years (SD=10.3) of teaching experience, the remaining 76 teachers were recruited through
the Centre for Attention and Related Disorders, and had an average amount of teaching ex‐
perience of 15.8 years (SD=10). 96% of teachers said they had a student with ADHD in the
classroom at some point and 20% were qualified in special education. As for the group of 92
parents participating in the study, it should be noted that 8% were male and 92% female. In
addition, the average age at which their child had been diagnosed with ADHD was 10.3
years (SD=3.1). 23% of the parents were attending a support group for parents of children
with ADHD and 31% had attended informational seminars about ADHD in the preceding
12 months.
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3.10.2. Scoring standards
In the SPSS statistical package correct answers were coded with a 1, incorrect ones with a 0,
and the gaps as a missing value. Possible answers ranged from 0, for the minimum level of
knowledge, to 67, for the maximum level.
3.10.3. Psychometric properties
The reliability of the KADD-Q and its sub-scales was estimated using Cronbach’s alpha coeffi‐
cient. The results suggest that the internal consistency of the KADD-Q is high for the sample
of teachers (alpha=0.91) and parents (alpha=0.93). For the sub-scales Causes, Characteristics
and Treatment, alphas obtained were of 0.86, 0.80 and 0.79 for teachers and 0.85, 0.84 and
0.84 for the parents, respectively. In addition, each of the sub-scales of the KADD-Q had a
high correlation with the total scale score (range r=0.73 to 0.92) in both the sample of teach‐
ers and parents. There were moderate correlations between the three sub-scales of teachers
in the sample (range r=0.34 to 0.56), and somewhat ones higher in the sample of parents
(range r=0.56 to 0.77). There was no test test-retest reliability conducted.
Convergent validity was not evaluated, nor was any test of the factorial structure of the in‐
strument made. The scale authors present data on a series of relationships that exist between
the scale scores and several variables related to the construct they purport to measure,
which provide certain information concerning the external validity. The level of teachers’
knowledge about ADHD was significantly higher depending on the stage of their profession
they were at. Primary school teachers obtained higher scores than their secondary education
colleagues (p=0.001). Teachers who had attended to professional development sessions
about ADHD in the previous 12 months and those who had specific training in special edu‐
cation had higher scores on the scale (p<0.001 and p=0.024, respectively).
3.10.4. Strengths and weaknesses
On the positive side, it is noteworthy that the authors of KADD-Q have tried to create a sin‐
gle instrument to assess the knowledge of teachers in primary and secondary education and
the parents of children with ADHD. This instrument has an easily completed response for‐
mat and has good internal consistency. However, the teachers and parents samples used for
the study were small and geographically homogeneous, the information relating to the de‐
velopment of the instrument is scant, the instrument lacks test-retest reliability indices, evi‐
dence of convergent validity is not provided, and nor is there any factorial analysis to
confirm the presence of the three sub-scales of the instrument. To all this must be added the
fact that data concerning the external validity of the instrument are scarce.
3.11. Teacher knowledge about ADHD (Jones & Chronis-Tuscano, 2008) [24]
3.11.1. Description and development
This instrument was drawn up in the United States and in the English language for the pur‐
pose of assessing teachers’ knowledge of ADHD after they have receiving training related to
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it. It consists of 25 items with a dichotomous response format (True, False). The items were
designed to cover six areas of content: 1) Causes of ADHD, 2) Assessment of ADHD, 3)
ADHD sub-types, 4) Associated problems of ADHD, 5) Treatment of ADHD, and 6) Specific
school-based behavioral strategies for children with ADHD.
The questionnaire was administered to a non-random sample of 142 elementary school
teachers in the Washington DC metropolitan area, of whom 74 belonged to the experimental
group receiving training in ADHD and the remaining 68 to a control group that did not re‐
ceive such training. The average age of all participants in the sample was about 37 years
(SD=12.45) and they had an average amount of teaching experience of 11.34 years
(SD=10.40). 92% were women and only 17% were special education teachers. Approximately
34% of the sample had had experience of a child with ADHD in their classroom.
3.11.2. Scoring standards
1 point was given for correct answers and 0 for incorrect ones, so the range of possible
scores went from 0, for the lowest possible level, to 25, for the highest possible level.
3.11.3. Psychometric properties
Internal consistency scores were 0.68 and 0.97 before and after training, respectively. No
publications have been found which provide validity evidences of the instrument.
3.11.4. Strengths and weaknesses
On the positive side, it should be noted that the questionnaire is short and easy to fill out.
However, it uses a dichotomous response format which prevents information being collect‐
ed about the areas where the teachers’ lack of knowledge is concentrated. Furthermore, in‐
formation about the validity of the instrument is not available.
3.12. Questionnaire to Assess Teachers' Knowledge about ADHD
3.12.1. Basque language version of the Questionnaire to Assess Teachers’ Knowledge about ADHD
(Irakasleek AGHNari buruz duten ezagutza ebaluatzeko galdera-sorta – IRA-AGHN) (Soroa,
Balluerka & Gorostiaga, unpublished)
3.12.1.1. Description and development
This is a newly developed questionnaire produced in Spain in the Basque language and
which has yet to be published. Its purpose is to assess the knowledge of infant and primary
school teachers about ADHD. It is divided into two sections. The first collects socio-demo‐
graphic data (age, sex, teaching speciality, teaching experience, etc.) as well as data on the
perceived knowledge of teachers of ADHD and their perceived capacity to teach children
suffering from this condition. The second section assesses their real knowledge of these mat‐
ters with 26 items that use a three option response format (True, False, Don’t Know). The
questionnaire items, 21 positive and 5 negative, assessed four areas of knowledge related to
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ADHD: 1) General information about ADHD (4 items), 2) Symptoms/Diagnosis of ADHD
(11 items), 3) Etiology of ADHD (4 items), and 4) Treatment of ADHD (7 items). The ques‐
tionnaire items were developed from an extensive review of the literature on ADHD.
To obtain data on content validity, the authors of the instrument sought the cooperation of 8
experts in ADHD (university lecturers from different fields of knowledge and clinical or ed‐
ucational psychologists). Thanks to their participation the initial questionnaire of 105 items
was reduced to 76 which were distributed into their corresponding sub-scales of the ques‐
tionnaire when there was an agreement level of 70% among the experts. Subsequently, a pi‐
lot study was conducted on 98 infant and primary school teachers in the Autonomous
Community of the Basque Country and Navarre. 83 participants were women and 15 men,
with a mean age of 40 years (SD=9.8). They had an average of 15 years (SD=10) in the teach‐
ing profession, 50.5% had never received training about ADHD, and 47% said they had ex‐
perience of having a child with ADHD in their classroom. 86% were infant education
specialists or primary teachers and 8% were special education teachers. Thanks to the partic‐
ipation of these teachers, the authors of the questionnaire selected those items with high dis‐
crimination power and revised the wording of 6 statements, obtaining a preliminary
instrument of 51 items.
The draft instrument was finally applied to a sample of 752 infant and primary education
teachers in 84 schools in the Autonomous Community of the Basque Country and Navarre.
The schools were randomly selected. 86% of participants were female and 14% male, with a
mean age of 42 years (SD=9.68). They had an average of 17 years (SD=10.55) experience as
teachers, 80% were infant and primary teachers and 12% special education teachers. 59%
said they never received training about ADHD, and 54% stated that they had had experi‐
ence of children with ADHD during their careers. The final instrument of 26 items as descri‐
bed earlier in this section was thus obtained.
3.12.1.2. Scoring standards
1 point was given for each correct answer and 0 for incorrect ones and gaps in knowledge.
Thus, the possible scores ranged from 0, for the minimum level of knowledge, to 26, for the
highest level.
3.12.1.3. Psychometric properties
With the purpose of selecting the final items for the IRA-AGHN, a factor analysis with obli‐
que rotation was carried out. Items with a factor loading equal to or greater than .35, and
which adequately reflected the underlying construct, were selected. Using the 26 selected
items, the dimensionality of the instrument was examined by means of an exploratory factor
analysis based on polychoric correlations. The Unweighted Least Squares (ULS) estimation
method was used. Kaiser procedure was used to decide the number of factors, and the Di‐
rect Oblimin rotation method was selected in order to simplify the factor structure. The re‐
sulting structure confirmed the multi-dimensional character of the construct. Four factors
were obtained which explained 53.2% of the variance: The first factor, Etiology of ADHD,
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explained 29.15% of the variance; the second factor, Symptoms/Diagnosis of ADHD, ex‐
plained 9.8% of the variance; the third factor, General information about ADHD, explained
7.8% of the variance; and the fourth and final factor, Treatment of ADHD, explained 6.4% of
the variance.
For the reliability analysis, the internal consistency was first calculated, with an Omega coef‐
ficient which ranged from 0.76 to 0.90 being obtained for the four sub-scales. For the pur‐
pose of analyzing the stability of the instrument the authors administered the IRA-AGHN a
second time to a sample of 123 teachers with a period of four weeks between the first and
second administration. The Spearman’s Rho test-retest correlations for the IRA-AGHN scores
ranged from r=0.49 to r=0.77 (p<0.01) for the four sub-scales.
Convergent validity was tested by comparing the results obtained by the subjects in the
IRA-AGHN with the results obtained in the Spanish version of the KADDS [4]. The correla‐
tion between the scores obtained by the subjects in the dimensions shared by both question‐
naires was r=0.54 for the General information sub-scale, r=0.45 for the Symptoms/Diagnosis
sub-scale and r=0.33 for the Treatment sub-scale (p<0.01 in all cases).
Finally, to obtain evidence of external validity, the relationships between the scores obtained
by the participants in the IRA-AGHN sub-scales and a series of variables related to the con‐
struct that it was sought to measure were examined. The data showed that the scores ob‐
tained by the teachers in the Symptoms/Diagnosis sub-scale had a moderate correlation with
variables such as the number of children diagnosed with ADHD the teachers had taught in
the course of their careers (r = .29, p = .001), the teachers’ perceived knowledge of ADHD (r
= .37, p = .001), and the teachers’ perceived capacity to teach effectively children with ADHD
(r = 0.30, p = 0.001). Meanwhile, it was observed that the scores obtained by the teachers in
the General information sub-scale showed a moderate correlation with the teachers’ per‐
ceived knowledge of ADHD variable (r = .30, p = .001). In addition, using the Mann-Whitney
U test a comparison was drawn between the average score ranges obtained by teachers who
had taught children diagnosed with ADHD in the course of their careers and those who
hadn’t. Results showed that there were statistically significant differences between the
groups’ mean score ranges in the Symptoms/Diagnosis sub-scale (Mann-Whitney U test =
44503; p = .0001; r = .29).
3.12.1.4. Strengths and weaknesses
On the positive side, it should be noted that this is a short questionnaire and easy to com‐
plete with a three option response format (True, False, Don’t Know), and that it success‐
fully  evaluates  teachers’  knowledge,  false  beliefs  and  areas  of  lack  of  knowledge
regarding ADHD. The sample used for the validation of the instrument is geographically
diverse and extensive, being representative of the target population for the questionnaire.
The  instrument  development  process  was  thorough  and  rigorous,  and  has  appropriate
psychometric properties, although evidence of external validity is not supported by high
levels of correlation.
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3.12.2. Spanish version of the Questionnaire to Assess Teachers’ Knowledge about ADHD
(Cuestionario para evaluar el conocimiento de los maestros acerca del TDAH – MAE-TDAH) (Soroa,
Balluerka & Gorostiaga, unpublished)
3.12.2.1. Description and development
This is a questionnaire recently produced in Spain in the Spanish language and which has
yet to be published. The description is the same as that for the above mentioned version of
the instrument in the Basque language.
To obtain evidence of content validity, the authors of the instrument sought the cooperation
of 8 experts in ADHD (university lecturers from different fields of knowledge, child and
youth psychiatrists, pediatricians, one educational psychologist and one education expert
who are members of various associations of families of children with ADHD). Thanks to
their participation, the initial questionnaire of 105 items was reduced to 76 items that were
distributed in the corresponding sub-scales of the questionnaire with the agreement of at
least 70% of the judges. Subsequently, a pilot study was conducted on 68 infant and primary
school teachers in the Autonomous Community of the Basque Country and Navarre. 53 par‐
ticipants were women and 15 men, with a mean age of 43 years (SD=10.87). They had an
average of 18 years (SD=11.67) in the teaching profession, 47% had never received training
regarding ADHD, and 73% said they had a child diagnosed with ADHD in their classroom
at some point in their career. 73% were infant or primary school teachers, and 15% were spe‐
cial education teachers. Thanks to the participation of these teachers, the authors of the
questionnaire selected those items with high discrimination power and revised the wording
of two of the statements, obtaining a preliminary instrument of 51 items.
Finally, the draft instrument was applied to a sample of 526 infant and primary school
teachers in 57 schools in the Autonomous Community of the Basque Country and Navarre.
The schools were randomly selected. 85% of participants were female and 15% male, with a
mean age of 43 years (SD=10.89). They had an average of 17 years (SD=11.31) experience as
teachers, 77% were infant or primary teachers and 11% were special education teachers. 56%
said they had never received training regarding ADHD, and 67% stated that they had a
child diagnosed with ADHD in their classroom at some point in their career. From this
study the final 26 items instrument was obtained.
3.12.2.2. Scoring standards
Identical to those in the Basque language version of the questionnaire.
3.12.2.3. Psychometric properties
With the aim of selecting the final items for the MAE-TDAH, a factor analysis with oblique
rotation was carried out. Items with a factor loading equal to or greater than .35, and which
adequately reflected the underlying construct, were selected. Using the 26 selected items,
the dimensionality of the instrument was examined by means of an exploratory factor analy‐
sis based on polychoric correlations. The Unweighted Least Squares (ULS) estimation meth‐
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od was used. Kaiser procedure was used to decide the number of factors, and the Direct
Oblimin rotation method was selected in order to simplify the factor structure. The resulting
structure confirmed the multi-dimensional character of the construct. Four factors were ob‐
tained which explained 60.73% of the variance: Etiology of ADHD explained 34.04% of the
variance, General information about ADHD explained 12.14% of the variance, Treatment of
ADHD explained 8.92% of the variance, and the fourth and final factor, Symptoms/Diagno‐
sis of ADHD, explained 5.6% of the variance.
For reliability analysis, the internal consistency was first calculated and an Omega coefficient
which ranged from 0.83 to 0.91 for four sub-scales was obtained. In order to analyze the sta‐
bility of the instrument, the authors administered the MAE-TDAH a second time to a group
of 112 teachers four weeks after the first application. The Spearman’s Rho test-retest correla‐
tions for the MAE-TDAH scores ranged from r=0.62 to r=0.79 (p<0.01) for the four sub-scales.
Convergent validity was tested by comparing the results obtained by the subjects in the
MAE-TDAH with the results obtained in the Spanish version of KADDS [4]. The correla‐
tions observed between the scores obtained by the subjects in the dimensions shared by both
questionnaires were r=0.58 for the General information sub-scale, r=0.43 for the Symptoms/
Diagnosis sub-scale, r=0.30 for the Etiology and r=0.39 for the Treatment sub-scale (p<0.01 in
all cases).
In order to find evidence of external validity the authors of the MAE-TDAH examined the
correlations between the questionnaire scores and a series of variables related to the con‐
struct it was sought to measure. Significant statistical differences were found between the
teachers’ perceived knowledge of ADHD and the scores they obtained for all the sub-scales
of the questionnaire (r=0.38 for General information, r=0.37 for Symptoms/Diagnosis, r=0.30
for Etiology and r=0.31 for Treatment; p=0.001 for all cases), as well between the teachers
perceived capacity to effectively teach children with ADHD and the scores obtained in the
sub-scales General information and Symptoms/Diagnosis of ADHD (r=0.29, p=0.001 and
r=0.30, p=0.001, respectively).
3.12.2.4. Strengths and weaknesses
These are similar to those set out regarding the Basque language version of the question‐
naire. The main difference is that in this case the sample used for the validation of the ques‐
tionnaire was quite homogenous as it was confined to two autonomous communities of the
Spanish state.
4. Conclusions
In the review that has been carried out in this chapter, it has been observed that there exist a
great number of tools that have been developed to assess the level of knowledge of teachers
regarding ADHD. However, most of them do not have good psychometric properties. The
authors of this chapter consider necessary to develop and validate instruments with psycho‐
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metric properties to measure teachers’ knowledge of ADHD with rigor. These instruments,
in addition to identifying gaps in teachers’ knowledge of the disorder, can be useful in rais‐
ing the awareness of teachers about the need for more training in this area, help in the de‐
sign of training tailored to the needs of teachers, and ultimately, promote the welfare of
children and young people with ADHD.
This lack of methodological rigor in these measurement instruments may cause the obtain‐
ing of erratic and false results. With regard to the measurement instruments used to assess
teachers’ knowledge of ADHD it can be seen that this knowledge varies among the studies
examined here. This variability may, in part, be due to an increase in teachers’ knowledge of
ADHD over recent decades but it might also be due to methodological reasons such as the
following: The number and content of the items in the various instruments varies; the re‐
sponse formats also differ and this affects the results; the size of the samples also varies con‐
siderably, in some cases being very big and in others quite small; different studies have
collected different socio-demographic data from their sample, which affects the description
made of it and the interpretations which might be made of the reasons for the knowledge
teachers have about ADHD. All these aspects should be taken into account when it comes to
interpreting, comparing and generalizing the results obtained from these instruments.
Regarding the dimensionality of the instruments analyzed here, it should be noted that five
of the twelve (KADDS [4, 5], KARE [35], KADD-Q [6], Teacher Knowledge About ADHD
[24], and IRA-AGHN/MAE-TDAH) used a number of dimensions ranging from 2 to 6 for
the assessment of teachers knowledge of ADHD. It can be seen that Treatment is the only
common to all the instruments. In general, the various dimensions proposed by the authors
deal with the symptoms, sub-types, associated problems, evaluation, prognosis and etiology
of ADHD. However, it should be noted that only one of the instruments reviewed, the IRA-
AGHN/MAE-TDAH conducted a factor analysis to confirm the multidimensional nature of
the construct.
Furthermore, the external validity of the instruments analyzed provides information about
the variables that can influence the knowledge that teachers have regarding ADHD. Three
of the twelve instruments reviewed (KADDS [4, 5], KADD-Q [6], and IRA-AGHN/MAE-
TDAH) provide evidence of external validity. If we focus on those variables that have rela‐
tionships with knowledge about ADHD with effect size equal to or greater than 0.30 in any
of the instruments, it can be concluded that the variables that correlated with teachers’
knowledge about ADHD are: Prior exposure of teachers to children diagnosed with ADHD
in the classroom, the number of children with ADHD teachers have had in their classrooms,
having had specific training about ADHD, the degree of teachers’ self-perceived efficacy in
teaching children with ADHD and teachers’ self-perceived knowledge of ADHD.
Finally, it should be pointed out that we consider the present chapter to be of interest be‐
cause it provides an exhaustive review of the main instruments identified in the scientific
literature to assess teachers’ knowledge of ADHD. The identification of instruments with
optimal psychometric properties is fundamental because it allows for the obtaining of valid
and reliable data about the construct being studied. With regard to teachers’ knowledge of
ADHD it has been shown that there exist a significant percentage of teachers with gaps in
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interpreting, comparing and generalizing the results obtained from these instruments.
Regarding the dimensionality of the instruments analyzed here, it should be noted that five
of the twelve (KADDS [4, 5], KARE [35], KADD-Q [6], Teacher Knowledge About ADHD
[24], and IRA-AGHN/MAE-TDAH) used a number of dimensions ranging from 2 to 6 for
the assessment of teachers knowledge of ADHD. It can be seen that Treatment is the only
common to all the instruments. In general, the various dimensions proposed by the authors
deal with the symptoms, sub-types, associated problems, evaluation, prognosis and etiology
of ADHD. However, it should be noted that only one of the instruments reviewed, the IRA-
AGHN/MAE-TDAH conducted a factor analysis to confirm the multidimensional nature of
the construct.
Furthermore, the external validity of the instruments analyzed provides information about
the variables that can influence the knowledge that teachers have regarding ADHD. Three
of the twelve instruments reviewed (KADDS [4, 5], KADD-Q [6], and IRA-AGHN/MAE-
TDAH) provide evidence of external validity. If we focus on those variables that have rela‐
tionships with knowledge about ADHD with effect size equal to or greater than 0.30 in any
of the instruments, it can be concluded that the variables that correlated with teachers’
knowledge about ADHD are: Prior exposure of teachers to children diagnosed with ADHD
in the classroom, the number of children with ADHD teachers have had in their classrooms,
having had specific training about ADHD, the degree of teachers’ self-perceived efficacy in
teaching children with ADHD and teachers’ self-perceived knowledge of ADHD.
Finally, it should be pointed out that we consider the present chapter to be of interest be‐
cause it provides an exhaustive review of the main instruments identified in the scientific
literature to assess teachers’ knowledge of ADHD. The identification of instruments with
optimal psychometric properties is fundamental because it allows for the obtaining of valid
and reliable data about the construct being studied. With regard to teachers’ knowledge of
ADHD it has been shown that there exist a significant percentage of teachers with gaps in




this area [3-7, 19, 20]. For this reason, we believe that the use of instruments which measure
this knowledge with rigor could contribute to devising of training materials and courses ap‐
propriate for the needs of teachers. And this would, of course, result in benefits for the chil‐
dren who suffer from this condition.
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1. Introduction
Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common mental disorders
in children and adolescents, with an estimated 3–5% of children diagnosed with this disorder
[1,2]. ADHD is characterized by symptoms of inattention, impulsivity and hyperactivity. It
has been suggested that a core deficiency in inhibitory control accounts for many deficits in
executive function observed in ADHD that underlie most of the dysfunctional behaviors
associated with this syndrome [3]. The apparent importance of executive dysfunction in
children with ADHD has thus led to an increasing number of investigations in this area.
Executive control is engaged in situations requiring decision making, conflict resolution, error
correction, and response inhibition. An important aspect of executive function is the inhibition
of a prepared response, where inhibition refers to the ability to actively suppress, interrupt or
delay an action [4]. Without inhibition, there is no capacity to avoid the execution of inappro‐
priate responses, or ensure attainment of appropriate responses, thereby preventing realiza‐
tion of an intended result.
One commonly used paradigm in the investigation of executive function is  the continu‐
ous performance test (CPT), which is a classical GO/NOGO paradigm. CPT was firstly used
as a measure of sustained attention [5], and has since been widely applied in the investiga‐
tion  of  cognitive  response  control  and  response  inhibition,  in  both  clinical  groups  and
healthy subjects [6].
Event-related potentials (ERPs) are electroencephalogram (EEG) recorded changes that are
time locked to sensory, motor, or cognitive events. Event-related potentials provide a safe,
noninvasive approach to study of the psychophysiological correlates of mental processing.
© 2013 Yan-ling and Xuan; licensee InTech. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
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GO/NOGO tasks are a particularly suitable paradigm for investigating response inhibition
with ERPs. In this task, subjects are usually required to respond either overtly or covertly to a
given target stimulus (a tone or a letter) (GO condition). In a second condition, however,
subjects are required to withhold a response to a given stimulus (NOGO condition). The ERPs
of CPT tasks are investigated by comparing ERP differences induced by the GO condition (“9”
after “1”) and NOGO condition (no “9” after “1”). The NOGO condition has a more significant
N2 component between 200 and 300 ms over the frontocentral scalp than the Go condition,
and the subsequent frontal-central region a larger P3 component; the GO stimulus has a larger
P3 component in the parietal region. The NOGO-N2 and the NOGO-P3 components are related
to response inhibition [7]. The GO-P3 component is related to the attention of the GO stimulus
[8]. An increasing body of recent evidence suggests that the NOGO-N2 is related to conflict
monitoring, while the NOGO-P3 is related to response inhibition [9, 10]. The source of response
inhibition has been localized in the anterior cingulate cortex (ACC).
Stimulant  medication [11,21],  particularly  methylphenidate  (MPH),  is  the  most  common
treatment for children with ADHD, and has been shown to improve attention and behavior;
low doses of MPH are highly effective and widely prescribed for the treatment of ADHD
[12].  ERP  analysis  has  been  employed  in  efforts  to  gain  knowledge  about  stimulant
mechanisms and their relationship to appropriate effect, and studies have suggested that
ERPs may predict  the clinical  response of children with ADHD to MPH [13].  Low dose
MPH has been associated with reduced impulsivity (fewer false alarms) and decreased P3
latencies, whereas the higher doses have been associated with reduced impulsivity and less
inattention  (more  hits),  in  addition  to  increased  P2  and N2 latencies  and  decreased  P3
latencies  [14].  The Continuous Performance Test  (CPT) is  an appropriate  instrument for
assessment of the correlates between attention-related electrical activity levels in the brain
and responses to stimulant medication [15].
This study investigates the effect of Methylphenidate on the relationship between the ERP
waveform and behavioral results of children with ADHD. Therefore, based on their behavioral
results pre- and post-administration of MPH, the ADHD children were divided into two
groups: an ADHD good performance group and an ADHD poor performance group. We are
interested in whether the changes in the ERP waveform correlate with the behavioral results,
and the ERP waveform differences from the control group waveforms.
2. Materials and methods
2.1. Subjects
2.1.1. ADHD group
Twenty-eight children aged from 6 to 13 years (24 males and 4 females, mean age =9.25±1.86
years) with a primary diagnosis of ADHD participated. Children with ADHD were recruited
from the ADHD clinic at the Third Affiliated Hospital of Soochow University. All of the
children were identified as meeting DSM-IV criteria for ADHD based on a structured clinical
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interview and parent rating scales. Excluded from the study were subjects with a conduct
disorder, internalizing disorder (e.g. anxiety), low intelligence (IQ<85), and gross neurological
and other organic disorders. All subjects had not taken any stimulant medication. ADHD
children were given a low dose of 0.3mg/kg of methylphenidate (MPH). Verbal assent was
provided by the subjects and written informed consent obtained from their parents.
2.1.2. The control group
The control group consisted of 28 age- and gender-matched healthy children, 6.8-13.2 years
old (mean age = 9.15 ± 1.94 years),  were right-handed, with Screened IQ ≥ 85,  visual or
corrected visual acuity greater than 1.0,  without diseases of the nervous system, and no
special learning difficulties or language barriers. They were tested only one time. Verbal
assent was obtained from the children and their teachers, with written informed consent
obtained from their parents.
2.1.3. Behavioral results–basis for group division
Children with ADHD were tested twice. They were tested once following diagnosis (pre-
administration of M PH); and a second time two hours post-administration of MPH
(0.3mg/kg body weight).
The ADHD good performance group: after taking MPH, behavioral results were improved,
with the number of omission errors and/or commission errors reduced by a factor of five in a
total of 12 patients (1 female), mean age 9.17 ± 2.19 years old. Prior to administration of MPH,
the number of omission errors and commission errors (respectively 8.37 ± 3.92, 7.78 ± 5.10)
were significantly higher than the results obtained of 2 hours post-administration of MPH
(respectively 2.92 ± 3.61, 3.91 ± 2.62) (P< 0.05).
The ADHD poor performance group: post-administration of MPH, behavioral results were
not significantly improved, with behavioral changes not meeting behavioral improvement
standards in  a  total  of  16  patients  (3  females),  mean age 9.31 ±  1.66 years  old.  Prior  to
administration of MPH, the number of omission errors and commission errors (respective‐
ly 7.95 ± 4.61, 7.46 ± 5.81) were higher than the results obtained 2 hours post-administra‐
tion MPH (respectively 5.79 ± 2.71, 5.83 ± 2.91),  but the differences were not statistically
significant (P> 0.05).
2.2. Electrophysiological paradigm
The participants were investigated electrophysiologically in an electrically shielded, dimly lit
room, sitting on a comfortable chair in front of a computer screen to perform the CPT tasks,
with a viewing distance of 80 cm, horizontal visual angle of 0.7°, and a vertical visual angle of
1.4°. During the task, digits were presented in a random order, and subjects instructed to press
a response button whenever the digit “9”appeared immediately after the digit“1”. The whole
stimulus set consisted of 400 digits, with 80 prime conditions (digit“1”), 40 GO (“9” after “1”)
and NOGO (no “9” after “1”) conditions and 240 distracters (other digits, including the digit
“9”, without a preceding “1”) (see fig.1). The digits were presented for 200 ms each, followed
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GO/NOGO tasks are a particularly suitable paradigm for investigating response inhibition
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by an inter-stimulus interval of 1400 ms, resulting in a total duration of approximately 11
minutes. After a short training session, subjects performed this version of the CPT while an
ongoing EEG was recorded.
Figure 1. The sequence of stimulus presentation
2.3. EEG recording
Scalp voltages were collected with a StellateTM System 32 channel Digital Video EEG (Stellate
System Inc., CA) connected to a 32-Channel Digital Amplifier (LA MONT MEDICAL Inc.,
Montreal, CA). The EEG was recorded from 23 scalp electrodes which were placed according
to the International 10-20 system at FP1, FP2, Fz, F3, F4, F7, F8, CZ, C3, C4, T3, T4, PZ, P3, P4, T5, T6,
OZ, O1, O2, M1, M2 and a common reference. Vertical electro-oculogram (VEOG) electrodes,
located at 2 cm above and below the left eye, were used to subtract the eye movement artifact.
Impedances was <5 KΩ, bandpass filtered from 0.1 to 35 Hz and digitized at 500 Hz. A midline
electrode was used as the common reference for recording.
Trials were discarded from analysis if they contained eye movements (vertical EOG channel
differences greater than 100µV) or more than five bad channels.
2.4. Data analysis
Grand average ERP waveforms were used to determine the individual NOGO-N2 and NOGO-
P3 time window. NOGO-N2 at Fz and Cz electrodes were maximal from 250-300 ms, 280-350
ms at Pz electrode; NOGO-P3 at Fz and Cz electrodes were maximal from 400-500 ms, 420-520
ms at Pz electrode. In each time window, the amplitudes of NOGO-N2 and NOGO-P3 at Fz,
Cz, Pz electrodes were measured. Latency represented the time from the stimulus onset to the
wave peak; amplitude represented the vertical distance from the baseline to the wave peak.
2.5. Statistical analysis
SPSS12.0 statistical software was used for data processing, using t-test for the difference
between two groups and ANOV for the differences among multiple groups. All data were
expressed as Mean ± SD (x̄± s), with the difference was considered significant if the P value
was smaller than 0.05.
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3. Results
3.1. ERP results of the ADHD good performance group
Comparing the results of this group, both pre- and post-administration of MPH, with the
control group, the amplitude of the NOGO-N2 displayed no significant difference (P> 0.05).
Pre-administration of MPH, the amplitude of the NOGO-P3 was significantly lower than the
results obtained 2 hours post-administration of MPH and by the control group; at the Fz and
Cz electrodes the differences were statistically significant (P <0.05). Comparied to the control
group, the amplitude of the NOGO-P3 2 hours post-administration of MPH showed no
significantly difference (P> 0.05).








the control group F value P value
Fz N2(250-300ms) -7.17±5.81 -5.84±4.71 -7.67±4.32 0.62 0.54
P3(400-500ms) 20.34±11.42 30.24±10.78(1) 33.26±9.83 (2) 6.49 0.003
Cz N2(250-300ms) -3.01±4.68 -2.08±3.37 -4.76±6.60 1.09 0.34
P3(400-500ms) 16.28±6.36 22.20±5.07 (1) 23.67±8.14(1) 4.52 0.02
Pz N2(280-330ms) -1.73±3.63 -0.28±2.71 -1.25±3.94 0.51 0.60
P3(420-520ms) 14.34±5.72 18.20±4.41 18.88±7.69 2.00 0.15
(1) Comparing to pre- administration of MPH, P <0.05;
(2) Comparing to pre- administration of MPH, P<0.01.
Table 1. The ADHD good performance group pre- and post-administration of MPH and the control group at Fz, Cz, Pz
electrodes amplitudes of the NOGO-N2 and NOGO-P3 comparison (x̄± s) (μ v)
3.2. ERP results of the ADHD poor performance group
As with the ADHD good performance group, in comparing the results pre- and post-admin‐
istration of MPH with the control group, the amplitude of the NOGO-N2 also displayed no
significant difference (P> 0.05). However, in this case both pre- and 2 hours post-administration
of MPH, no statistically significant difference in the amplitude of the NOGP-P3 (P> 0.05) was
found. Pre- and post-administration of MPH, the amplitude of the NOGO-P3 at the Fz
electrode was significantly lower than that of control group (P <0.05). At the Cz electrode, the
amplitude of the NOGO-P3 pre-administration of MPH was also significantly lower than that
of the control group (P <0.05). However, compared to the control group, the amplitude of the
NOGO-P3 post-administration of MPH showed no significant difference (P> 0.05).
See Table 2 for details.
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Trials were discarded from analysis if they contained eye movements (vertical EOG channel
differences greater than 100µV) or more than five bad channels.
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ms at Pz electrode; NOGO-P3 at Fz and Cz electrodes were maximal from 400-500 ms, 420-520
ms at Pz electrode. In each time window, the amplitudes of NOGO-N2 and NOGO-P3 at Fz,
Cz, Pz electrodes were measured. Latency represented the time from the stimulus onset to the
wave peak; amplitude represented the vertical distance from the baseline to the wave peak.
2.5. Statistical analysis
SPSS12.0 statistical software was used for data processing, using t-test for the difference
between two groups and ANOV for the differences among multiple groups. All data were
expressed as Mean ± SD (x̄± s), with the difference was considered significant if the P value
was smaller than 0.05.
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3. Results
3.1. ERP results of the ADHD good performance group
Comparing the results of this group, both pre- and post-administration of MPH, with the
control group, the amplitude of the NOGO-N2 displayed no significant difference (P> 0.05).
Pre-administration of MPH, the amplitude of the NOGO-P3 was significantly lower than the
results obtained 2 hours post-administration of MPH and by the control group; at the Fz and
Cz electrodes the differences were statistically significant (P <0.05). Comparied to the control
group, the amplitude of the NOGO-P3 2 hours post-administration of MPH showed no
significantly difference (P> 0.05).
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Table 1. The ADHD good performance group pre- and post-administration of MPH and the control group at Fz, Cz, Pz
electrodes amplitudes of the NOGO-N2 and NOGO-P3 comparison (x̄± s) (μ v)
3.2. ERP results of the ADHD poor performance group
As with the ADHD good performance group, in comparing the results pre- and post-admin‐
istration of MPH with the control group, the amplitude of the NOGO-N2 also displayed no
significant difference (P> 0.05). However, in this case both pre- and 2 hours post-administration
of MPH, no statistically significant difference in the amplitude of the NOGP-P3 (P> 0.05) was
found. Pre- and post-administration of MPH, the amplitude of the NOGO-P3 at the Fz
electrode was significantly lower than that of control group (P <0.05). At the Cz electrode, the
amplitude of the NOGO-P3 pre-administration of MPH was also significantly lower than that
of the control group (P <0.05). However, compared to the control group, the amplitude of the
NOGO-P3 post-administration of MPH showed no significant difference (P> 0.05).
See Table 2 for details.










the control group F value P value
Fz N2(250-300ms) -6.88±6.59 -7.08±8.18 -7.67±4.32 0.10 0.91
P3(400-500ms) 23.51±11.97 25.88±13.96 33.26±9.83 (1) (2) 4.23 0.02
Cz N2(250-300ms) -2.79±6.61 -2.22±6.33 -4.76±6.60 0.92 0.40
P3(400-500ms) 17.28±7.56 19.94±7.09 23.67±8.14 (1) 3.68 0.03
Pz N2(280-330ms) 0.48±6.33 -0.36±4.68 -1.25±3.94 0.66 0.52
P3(420-520ms) 15.21±6.17 16.34±5.90 18.88±7.69 1.63 0.20
(1) Comparing to pre- administration of MPH, P <0.05;
(2) Comparing to 2 hours post-administration of MPH, P<0.05.
Table 2. The ADHD poor performance group pre- and post-administration of MPH and the control group at Fz, Cz, Pz
electrodes amplitudes of the NOGO-N2 and the NOGO-P3 comparison (x̄± s) (μ v)
3.3. ERP results of the two ADHD group pre-administration of MPH
The amplitudes of the NOGO-N2 and the NOGO-P3 showed no significant differences (P>
0.05).
3.4. Grand average ERP waves
As can be seen in Figure 2, the ERP components of the ADHD good performance group, the
ADHD poor performance group and the control group were consistent; all showed N1, P2, N2
and P3 components. In the ADHD good performance group, the amplitudes of the NOGO-N2
pre- and post-administration of MPH showed no significant changes; At the Fz and Cz
electrodes, the amplitude of the NOGO-P3 2 hours post-administration of MPH was signifi‐
cantly higher than pre-administration of MPH, while the amplitude of the NOGO-P3 at the Pz
electrode showed no significant changes. In the ADHD poor performance group, the ampli‐
tudes of the NOGO-N2 and NOGO-P3 at the Fz, Cz, Pz electrodes showed no significant
changes both pre- and post-administration of MPH; the amplitude of the NOGO-P3 was
significantly lower than that of the control group.
4. Discussion
Central stimulants are the first choice for the treatment children with ADHD, and the most
widely used is Methylphenidate. MPH can improve attention deficit and interpersonal
relations, lower activity levels and impulsivity, and improve academic achievement, and have
a positive effect on children with ADHD. While there is a previously reported efficiency of
approximately 75% [11], our clinical work indicates an efficiency rate was below this number.
This study uses the continuous performance test (CPT) to s investigate the relationship
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between behavioral results and ERP changes pre- and post-administration of MPH in children
with ADHD, and compares these results to a control group.
This study found that in the ADHD group pre-administration of MPH the amplitude of the
NOGO-P3 was significantly lower than that of the control group, while the amplitude of the
NOGO-N2 showed no difference between the control group and the ADHD group pre-
administration of MPH. This suggests the existence of frontal inhibition functional deficiencies
rather than the conflict monitoring deficiencies, consistent with Fallgatter’s study [16],
confirming the existence of cingulate cortex dysfunction in children with ADHD.
In the ADHD good performance group, 2 hours post-administration of MPH, behavioral
results  were  significantly  improved;  that  is,  omission  errors  and  commission  errors
significantly reduced and the amplitude of the NOGO-P3 was significantly higher, although
the  amplitude  of  the  NOGO-N2  showed  no  significant  changes.  Methylphenidate  can
improve  attention  deficit  and the  ability  to  inhibit  impulsive  reactions  in  children  with
ADHD. However,  no significant  changes  in  conflict  monitoring ability  were  observed 2
hours  post-administration  of  MPH.  The  amplitude  of  the  NOGO-P3  was  significantly
increased,  with no significant  difference in comparison to the control  group,  suggesting
MPH  can  normalize  both  the  amplitude  of  the  NOGO-P3  and  the  ability  to  inhibit
impulsive reactions in children with ADHD.
In the ADHD poor performance group, 2 hours post-administration of MPH, behavioral results
showed no significant improvement; that is, omission errors and commission errors were
reduced, but the difference did not reach statistical significance. The amplitudes of the NOGO-
N2 and NOGO- P3 showed no significant changes either pre- or post-administration of MPH;
changes in ERP and behavioral results were consistent. This suggested that MPH had no
significant impact on behavioral performance and ERP results, that it does not improve
attention deficit and the ability to inhibit response, and there is no effect on the conflict
monitoring and response inhibition. 2 hours post-administration of MPH, the amplitude of
the NOGO-P3 was still lower than that of the control group, in which the frontal electrode had
Figure 2. The grand average EPR waveforms
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statistically significance. The result suggests that MPH failed to improve the ability of response
inhibition of children with ADHD to normal levels.
Methylphenidate can be effective in improving the symptoms of children with ADHD,
primarily through the promotion of dopamine (DA) and norepinephrine (NE) release to reduce
reuptake. The pre-frontal region is rich with DA and NE receptors, and it is assumed that MPH
acts through these receptors. ADHD is associated with a irregularity in a variety of cognitive
and behavioral processes [11]. Recent studies have found that low-dose MPH in the treatment
of ADHD may activate the locus coeruleus - norepinephrine (LC -NE) system, by influencing
the locus coeruleus neurons in different discharge modes (phase- and tension-type) to alter
behavioral and cognitive processes [17]. Neuroimaging, neuropsychological and neurochem‐
ical studies have also implicated dysfunction of fronto-striatal structures [18]. An fMRI study
found that fronto-striatal activation, significantly lower in an ADHD group compared to a
control group, increased post-administration of MPH [19]. The frontal lobe plays an important
role in attention, executive function, working memory, regulating activities and decision-
making. Most of the studies of children with ADHD consider that the frontal lobe dysfunction
causes attention deficit and presents obstacles to response regulation. MPH treatment may be
either effective or ineffective in children with ADHD, dependent on their age and emotional
state, with treatment least effective in older age groups [20]. While this present study did not
find such factors, children are nevertheless primary candidates for MPH treatment, though it
should be observed that individuals respond differently
Young ES, et al [13] used an auditory oddball P300 paradigm to compare the ERP changes pre-
administration and 2 hours post-administration of MPH. A prediction of the long-term benefit
of medication was then made, based on the magnitude of the acute changes in P3b amplitude.
The MPH challenge classification accurately predicted the outcome in 81% of cases. This
present study used CPT tasks to test children with ADHD pre-administration and 2 hours
post-administration of MPH. According to their behavioral results, the ADHD group was
divided into an ADHD good performance group and an ADHD poor performance group. In
the good performance group, the amplitude of the NOGO-P3 was significantly higher; the
poor performance group, however, showed no obvious changes. The results suggested the
amplitudes of the NOGO-P3 pre-administration and 2 hours post-administration of MPH were
consistent with the behavioral results. Therefore, it can be posited that the amplitude of the
NOGO-P3 can predict the long-term clinical efficacy of MPH treatment for ADHD. Where the
amplitude of the NOGO-P3 is significantly increased post-administration of MPH, MPH may
be an effective treatment; where the amplitude of the NOGO-P3 shows no significant increase
post-administration of MPH, MPH is less likely to be an effective treatment. This can be
primarily used to predict the efficacy of Methylphenidate for the treatment of ADHD, and
assist in the selection of suitable treatment for children with ADHD. Further clinical tests will
determine the accuracy of the prediction of Methylphenidate efficacy in children with ADHD.
The present study can not avoid confounding medication effects with retest effects; this
variable should be eliminated in future studies.
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1. Introduction
ADHD constitutes a serious issue in the African-American community. The Center for Dis‐
ease Control and Prevention lists the African American males as leading other racial groups
and gender in the diagnosis of learning and behavioral disorders, incarceration rates, new
HIV infections, homicide and poverty. Although the reason for these observations are quite
complex and multidimensional, some of the comorbidities found in untreated African
Americans patients with ADHD include conduct disorder, oppositional defiant disorder, de‐
pression, anxiety disorders, learning disabilities, and alcohol or drug addiction. In addition,
even though African American males living in poverty are most likely to be referred to men‐
tal health agencies for mental health services, they are the least likely to receive mental
health services. In 2006, the number of children in the United States aged between 5 and 7
who were diagnosed with ADHD was 4.5 million. In the last decades the number of chil‐
dren diagnosed with ADHD who are on psychotropic medication continues to rise steadily.
However, the impact of this steady rise has been skewed and not evenly distributed by eth‐
nicity, socioeconomic status and gender as minorities (African Americans and Hispanics)
are most often diagnosed or misdiagnosed. The incidence of ADHD appears to be similar in
African-Americans and White populations. ADHD is diagnosed in 4.1% of all children with
the greatest prevalence among Caucasian children (5.1%). However, when the prevalence of
ADHD among male children are considered by race, African American children and adoles‐
cents are disproportionately diagnosed with ADHD, with an estimated prevalence rate of
5.65%, 4.3% for Hispanics, 3% for Whites; and 1.77% for females of all races. The prevalence
of ADHD in African-Americans is most likely similar to that in the general population
(3-5%); nevertheless, minority children have lower likelihood of receiving a diagnosis of
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ADHD and of receiving any treatment. Reasons for this disparity are multifaceted and di‐
verse and have not been fully elucidated. Among some of the identifiable barriers that at‐
tempt to explain these disparities are family-driven (parent, patient, and family) and Policy-
driven (healthcare system and physician bias) obstacles.
The primary goals of treatment of ADHD are to decrease disruptive behaviors, enhance aca‐
demic performance, improve interpersonal relationships with peers, family and friends, im‐
prove self-esteem, and promote independence. There are difficulties inherent in the
diagnosis of ADHD. These include absence of specific diagnostic tests, the lack of specificity
of symptoms, inability to observe symptoms that may not be present in an office setting, low
rate of concordance in symptom-reporting among various informants (i.e. parents, teachers
and parents) and a lack of a standard evaluative process. Although medical professionals
may use different diagnostic routes to diagnose ADHD, most agree that the Diagnostic and
Statistical Manual of Mental Disorders (DSM-IV) is the basis for an appropriate diagnostic
process. Others have suggested the use of multiple methods of assessment which are cultur‐
ally-sensitive and, which involves several people with varying degrees of relationship to the
child to be the most effective way to reduce the bias associated with diagnosis. Whaley &
Geller observed that the use of informal interviews and methods of assessment seem to in‐
crease the bias towards more diagnosis of ADHD towards African Americans. In recent
years, following extensive research in this subject by major medical organizations such as
the American Academy of Pediatrics (AAP) and the American Academy of Child and Ado‐
lescent Psychiatry (AACAP), guidelines have been published to assist physicians in making
the diagnosis of ADHD. Efforts must be made to identify these barriers of the diagnosis and
treatment of ADHD, awareness among healthcare providers, and the African-American and
other Minority communities. The objective of this chapter is to examine the disparities in the
diagnosis and treatment of ADHD in the minority groups in America, especially the Afri‐
can-American community, the factors associated with disparities and the impacts of these
disparities. The strategies and interventions to address the issue will also be outlined.
2. Challenges in diagnosis and treatment of ADHD in African-Americans
2.1. Parent-driven barriers to care
2.1.1. Lack of knowledge/awareness about ADHD
Perceptions of ADHD-related symptoms among parents of African American children ap‐
pear to differ in important ways from those of parents of White children. African American
families from low to middle class incomes, compared with Whites, tend to view behavioral
and emotional difficulties as problems of and for families, institutions and communities
rather than as constituting individual psychopathology. It is not uncommon for African-
American parents to perceive many of the symptoms and behaviors associated with ADHD
to be variants of normal behavior and not in need of professional intervention. When com‐
pared with parents from other ethnic backgrounds, many African-American parents are not
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well-informed about the symptoms and treatment of ADHD. Indeed, studies suggest that
African-American parents may be even more uninformed about ADHD, its causes, diagno‐
sis and treatment than are parents form other ethnic and racial backgrounds. Bussing and
colleagues (1998) conducted a study that sought to identify the differences in ADHD knowl‐
edge between 224 African-American parents and 262 White parents. They reported that only
69% of African-American parents compared with 95% of White parents had ever heard
about ADHD (p<0.01), and that 36% of African-Americans knew “a lot”, “some” or “a little”
about ADHD, compared with 70% of White parents (p<0.01). In addition, as reported by Af‐
rican-American parents, only 18% of them received information about ADHD from their
physician, compared with 29% of White parents (p<0.01). Equally important, the study
found the effects of ethnicity on ADHD familiarity were independent of other covariates,
such as socioeconomic status. Furthermore, the lack of knowledge about ADHD among the
African-American community has been described as a “vicious cycle” that may be caused
when members of this community seek medical advice from other individuals within their
own ethnic background who are equally uninformed about ADHD.
2.1.2. Fear of over-, under-, and misdiagnosis
ADHD in African-American children is associated with comorbid disruptive behavior;
mood and anxiety disorders. However, African-American families may not attribute the
symptoms of ADHD to the disorder itself and are less aware than White families about the
etiology of ADHD. For example, sugar intake has been reported as a common explanation
for the symptoms of ADHD among members of the African-America community. ADHD
symptoms in African-Americans are frequently missed or incorrectly diagnosed and comor‐
bid disorders go unattended. African-American parents feel more uneasy than White pa‐
rents about treating their children with pharmacologic interventions. Dos and other
investigators evaluated parental perceptions of stimulant medication for the treatment of
ADHD; they demonstrated that significant numbers of non-whites parents (63%) than white
parents (29%) thought that counseling was the best choice of treatment, whereas 59% of
white parents of white parents preferred medication over counseling compared with 36% of
non-white parents. In addition, 16% of non-whites compared with 5% of white parents be‐
lieved that the use of stimulants would lead to drug abuse. School officials are more likely to
assign African-American children to special education classes (which is the only educational
resource employed to address many black children with ADHD), although many of the
symptoms they display may be resolved with proper treatment that would allow them to
remain in their regular classes. Between 1980 and 1990, black children were placed in special
education at more than twice the rate of whites.
2.1.3. Fear of social stigma
African-American parents (57%) are more likely to believe that their children’s race or eth‐
nicity and fears of being “labeled” remain one of the important factors preventing accept‐
ance of the diagnosis and treatment of children with ADHD. Many parents fear the
perceived social stigma of ADHD diagnosis, and some fear overdiagnosis and misdiagnosis.
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African-American parents (57%) are more likely to believe that their children’s race or eth‐
nicity and fears of being “labeled” remain one of the important factors preventing accept‐
ance of the diagnosis and treatment of children with ADHD. Many parents fear the
perceived social stigma of ADHD diagnosis, and some fear overdiagnosis and misdiagnosis.
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The stigma of ADHD and lack of information about ADHD were found to be significant bar‐
riers to treatment of ADHD among African Americans [Table 1]. In their survey study,
Omolara and colleagues (2007) found evidence of racial concerns about the stigma of ADHD
diagnosis among African American participants. While some believe that a diagnosis of
ADHD “gives children a label for the rest of their lives’, others viewed that medicalization
as a form of social control with historical roots.
In addition, pressures from family and friends to refrain from seeking treatment, fear of
jeopardizing future employment or ability to serve in the military, concerns that parental
skills will be questioned, and fear of the unknown are other factors that have been described
by patient and families and these are thought to impact the diagnosis and treatment of
ADHD. The African-American population fear of the unknown may be related in part to the
consequences of the Tuskegee Experiment, which caused many in the community to lose
trust in the field of medical research. However, African American health professionals were
even found to be less likely to diagnose ADHD or prescribe stimulant medication treatment
due to their social and culturally constructed views of the disorder.
It has also been demonstrated from studies that a substantial proportion of children from all
races who are at a high risk for ADHD drop out of care, and that adolescent perceived stig‐
ma about ADHD is influential, above and beyond the perspectives of parents.
Table 1. Most prominent difference between African-American and white respondents in perceptions and attitudes
about ADHD
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2.2. Health system/clinician-driven barriers
A substantial number of obstacles to the successful diagnosis and successful treatment of
ADHD overall are related to limitations in the diagnosis and treatment of ADHD in African-
American patients. While some of these barriers are easier to remove, others may prove
more difficult. Some of these barriers are race or ethnicity-related, while others may be at‐
tributable to limited access to healthcare or insurance coverage, low socioeconomic status of
African-American patients and a dearth of culturally-competent mental healthcare provid‐
ers. Bussing et al. (2003) found that African American children were less than half as likely
to be assessed, diagnosed, and treated for ADHD as Caucasians. Their research survey
among African American parents to determine common barriers to help seeking for their
children with symptoms of ADHD found that across race, the most commonly cited barriers
are system barriers, no perceived need and negative expectations of treatment outcomes.
2.2.1. Lack of culturally competent healthcare providers
It  has  been  reported  that  during  clinician-patient  encounter,  negative  social  stereotypes
are  known  to  shape  behaviors  and  influence  decisions  made  by  healthcare  providers.
Race and ethnicity is  known to adversely influence the medical  care provided for other
medical conditions.  Minority patients with ADHD are likely to be affected by this prac‐
tice  as  well.  Historically,  there  has  been a  disproportionate  pattern  of  diagnosis  among
minority populations in the category of disability. While some of this pattern of diagno‐
sis  may  be  related  to  minorities  being  disproportionately  exposed  to  risk  factors  and
psychosocial  stressors  and  are  more  likely  to  be  economically  disadvantaged,  the  com‐
monly  used  instruments  of  assessment  which  could  provide  misleading  or  invalid  re‐
sults when used alone to assess patients from various cultural backgrounds may explain
the  this  phenomenon.  Frequently,  the  quality  of  healthcare  delivered  is  compromised
when healthcare providers are culturally insensitive to patients. There are important cul‐
tural differences among individuals of diverse ethnic backgrounds pertaining to their at‐
titudes  and beliefs  of  illness,  choice  of  care,  access  to  care,  and degree  of  trust  toward
authority  figures  or  institutions  and  tolerances  for  certain  behaviors.  Investigators  may
have to  use  culturally  sensitive  diagnostic  tools  to  assist  them in  uncovering important
aspects about ADHD that may be unique to the African-American population.
2.2.2. Healthcare provider/teacher bias or prejudice
Humans have the inclination to perceive or  label  other  people or  things based on their
initial  impressions  or  due  to  harboring  elements  of  discrimination  and  stigma.  Health‐
care  workers  and  physicians  who  care  for  mental  health  patients  are  not  exonerated
from  this  attribute.  Eack  and  colleagues  (2008)  reported  that  African-Americans  were
three  times  more  likely  as  whites  to  receive  a  diagnosis  of  schizophrenia  based on the
physician  perception  of  the  truthfulness,  suspicion  of  symptom  denial,  poor  insight  or
“uncooperativeness”  of  their  African-American  patients.  Without  a  good understanding
of cultural  nuances that may provide clues about other possible diagnoses and the stig‐
ma  associated  with  a  diagnosis  of  mental  illness  among  the  Black  community,  white
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physicians may view black patients with suspicion which may color or affect their clini‐
cal  judgment.  Interestingly,  the  same study reported  that  this  disparity  did  not  appear
to affect other US minority groups, such as Hispanics.
Conscious (Explicit)  or  unconscious (Implicit)  bias  or  prejudices held by healthcare pro‐
viders  and  sometimes  racially-motivated  discrimination  by  mental  healthcare  personnel
can cause the cross-cultural diagnosis of ADHD to be challenging. In addition, biases ex‐
pressed by the evaluators,  interviewers or the researcher may influence the outcomes of
scoring the behavioral expressions of African-American children. Depending on this held
biases  or  cultural  expectations  of  what  constitutes  “normal  behaviors”,  non-African
American evaluators may rate American-American children with higher levels of hyper‐
active  or  disruptive  behaviors  even when the  behavior  is  normal  within  the  context  of
cultural expectations. It is not uncommon for parents and patients of ethnic minorities to
report  discrimination in receiving health care.  Gingerich and colleagues (1998) reviewed
several  comparative  studies  in  the  1970  which  used  teachers’  ratings  to  compare  the
prevalence of  hyperactivity,  a  component  of  ADHD among ethnic  minorities  and white
children.  They  reported  one  large  study  conducted  using  1700  elementary  school  chil‐
dren  from  rural  and  urban  Texan  locations  in  which  African-American  children  were
rated as more hyperactive than expected based on their representative population when
compared with schools  located in  white,  middle-class  neighborhoods where  they found
that  the  frequency  of  hyperactivity  was  consistent  across  all  ethnic  groups.  The  biases
held by health care  workers  or  mental  health  service  providers  can result  in  either  un‐
der or over-diagnosis of ADHD in African-American children.
2.2.3. Dearth of African-America healthcare providers
This factor may prevent the optimal care of Africa-American children with ADHD. More
minority clinicians are needed to alleviate the intercultural issues of trust and communica‐
tions that often arise. In 1985, out of the 30,000 Psychiatrists registered to practice in Ameri‐
can, only about 600 were Black (Bell, Fayen & Mattox, 1998). In spite of the efforts and
progress made in promoting diversity of healthcare professionals among the physician
workforce, the concern about a lack of diversity continues to be an impediment to access
and care, especially in the minority populations. Thus, despite some initial progress, African
Americans, Latinos/Hispanics, and Native Americans continue to be underrepresented in
the U.S. physician workforce. The American Medical Association Council on Medical Edu‐
cation Report 7 (2007) put the total number of US physicians involved in patient care in 2006
as 723,118. When categorized into Race/Ethnicity, 71.4% of these physicians were white,
15.8% were Asian, 6.4% were Hispanic, and 4.5% were Black/African-Americans. The Amer‐
ican Medical Association report in 2012 puts the total number of Black physicians in the
workforce at 3.5%, indicating a decline (Table 2). Complicating access to care, most of these
physicians set up their practices in urban areas to the detriment of rural communities.
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2.2.4. Limited access to mental health care
African-American families are less likely than their white counterparts to have access to the
healthcare system. This may partly be due to the lower socioeconomic class and higher pov‐
erty levels among African-Americans. African-Americans tend to lack insurance coverage
for psychiatric or psychological evaluations, behavior modification programs, school consul‐
tations, parent management training, and other specialized program. Substantial costs barri‐
ers exist resulting in out-of-pocket costs. Pastor and Reuben reported a significantly wide
and long-standing gap in the rate of the diagnosis of ADHD based on the type of health in‐
surance coverage. They reported that those with Medicaid insurance are most likely to be
diagnosed with ADHD, followed by those with private insurance coverage, while those
without insurance ended at a distant third. Even when they have insurance, the capitation
imposed by the State Mental Health Services further makes access to care very difficult or
inadequate, especially, for African Americans and other minority populations. Low income
African American caregivers are often frustrated and feel helpless while trying to navigate
the maze of the care system. There is no funded special education category specifically for






American Native/Alaska Native 1,594 .16
Other 13,019 1.3
Unknown 223,071 23.4
Total physicians by race/ethnicity – 2008
(Total physicians = 954,224)
Table 2. Source: Physician Characteristics and Distribution in the US, 2010 Edition. American Medical Association.
3. Impact of ADHD in African-Americans
Comorbidities associated with ADHD include Conduct Disorders, Opposition Defiant Dis‐
orders (ODD), Depressive Disorders, Anxiety disorders, Learning disabilities and Alcohol
and Drug addiction. Samuel and colleagues (1999) stated that African-American children
with ADHD have higher levels of comorbid psychopathology (Opposition Defiant Disorder,
Severe Major Depression, Bipolar Depression, and Separation Anxiety) than in African-
American controls. They also reported that when compared to their Caucasian counterparts,
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African-American youths have a tendency to be more resistant or unable to seek treatment,
only doing so when their symptoms are more severe. This may be responsible for a broader
spectrum of the severity of ADHD symptoms in African-American youths. Epstein (2005) at‐
tributed the exhibition of more ADHD symptoms in African-American youths to fact that
they are exposed to more ADHD-related risk factors. This concept was supported by Stein
and colleagues (2002) who reported that African-American youth may be exposed to these
risk factors at higher rates other than other youth, which may account for the higher preva‐
lence of ADHD in African-Americans. In the general population, some of the risk factors as‐
sociated with the development of ADHD and related pathology include low socioeconomic
status (SES), juvenile detainee status, prenatal marijuana exposure and exposure to environ‐
mental toxins. Lead, one of the most thoroughly studied environmental toxins, is linked to
impaired attention, hyperactivity, and aggression even at low levels of exposure. Bazargan
and colleagues (2005) found that African-Americans living in Public Housing reportedly
have higher incidence of ADHD than in the general population as a whole (19%) as com‐
pared to the pooled rate of 5%. The increased exposure resulted from paints used in housing
before 1950s which contained a high percentage of lead. Other risk factors attributable to
higher incidence of ADHD in African-Americans include low socioeconomic status, lack of
access to healthcare (Kendall & Hatton, 2002) and high incidence of low birth weight (Bre‐
slau & Chilcoat, 2000). The higher incidence and symptomatology of ADHD in African-
Americans has its consequences some of which will be further elucidated.
3.1. ADHD among African-American youth and the criminal justice system
There appears to be an epidemic of incarceration, especially of African-American males in
the United States of America. Compared to the rest of the industrialized world, America has
the highest rate of incarceration, currently at about 738 per 100,000. The Justice Department
reports that there are about 2.3 million inmates incarcerated in America. In 2010, Dick and
Sharon Kyle, a pair of citizen journalists and information activists reported (www.LAProg‐
ressive.com) in an article titled “More Black Men in Prison than Were Enslaved II” that by
race, Black males continued to be incarcerated at an extraordinary rate. They pointed out
that Black males make up 35.4 percent of the jail and prison population, even though they
make up less than 10 percent of the overall U.S population. They also observed that four
percent of U.S. black males were in jail or prison in 2009, compared to 1.7 percent of Hispan‐
ic males and 0.7 percent of white males. This translated to black males being locked up at
almost six times the rate of their white counterparts.
Black and colleagues (2010) reported that although Attention Deficit/Hyperactivity Disorder
(ADHD) is associated with comorbid psychiatric diagnoses and antisocial behavior that con‐
tribute to criminality, yet studies of ADHD in offenders are few. Out of the 319 offenders
they evaluated using the Mini International Neuropsychiatric Interview and Medical Out‐
come Health Survey; ADHD was present in 68 (21.3%) subjects. Offenders with ADHD were
more likely to report problems with emotional and social functioning and to have a higher
suicide risk scores. Other psychopathologies identified in offenders with ADHD include
higher rates of mood, anxiety, psychotic and somatoform disorders. They are also more like‐
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ly to have antisocial and borderline personality disorders. To reduce the impact of ADHD
on the rate of incarceration of African-American youth, they recommended that Prison Ad‐
ministrators be trained to recognize the symptoms of ADHD and recommend offenders for
further intensive screening rather than commitment to prisons first.
Figure 1. Source: www.prisonerhealth.org
Figure 2. Source: Justice Policy Institute Report: The Punishing Decade, & U.S. bureau of Justice Statistics Bulletin.
NCJ219416. Prisoners in 2006.
The Impact of Attention Deficit/Hyperactivity Disorder in African-Americans…
http://dx.doi.org/10.5772/54276
201
African-American youths have a tendency to be more resistant or unable to seek treatment,
only doing so when their symptoms are more severe. This may be responsible for a broader
spectrum of the severity of ADHD symptoms in African-American youths. Epstein (2005) at‐
tributed the exhibition of more ADHD symptoms in African-American youths to fact that
they are exposed to more ADHD-related risk factors. This concept was supported by Stein
and colleagues (2002) who reported that African-American youth may be exposed to these
risk factors at higher rates other than other youth, which may account for the higher preva‐
lence of ADHD in African-Americans. In the general population, some of the risk factors as‐
sociated with the development of ADHD and related pathology include low socioeconomic
status (SES), juvenile detainee status, prenatal marijuana exposure and exposure to environ‐
mental toxins. Lead, one of the most thoroughly studied environmental toxins, is linked to
impaired attention, hyperactivity, and aggression even at low levels of exposure. Bazargan
and colleagues (2005) found that African-Americans living in Public Housing reportedly
have higher incidence of ADHD than in the general population as a whole (19%) as com‐
pared to the pooled rate of 5%. The increased exposure resulted from paints used in housing
before 1950s which contained a high percentage of lead. Other risk factors attributable to
higher incidence of ADHD in African-Americans include low socioeconomic status, lack of
access to healthcare (Kendall & Hatton, 2002) and high incidence of low birth weight (Bre‐
slau & Chilcoat, 2000). The higher incidence and symptomatology of ADHD in African-
Americans has its consequences some of which will be further elucidated.
3.1. ADHD among African-American youth and the criminal justice system
There appears to be an epidemic of incarceration, especially of African-American males in
the United States of America. Compared to the rest of the industrialized world, America has
the highest rate of incarceration, currently at about 738 per 100,000. The Justice Department
reports that there are about 2.3 million inmates incarcerated in America. In 2010, Dick and
Sharon Kyle, a pair of citizen journalists and information activists reported (www.LAProg‐
ressive.com) in an article titled “More Black Men in Prison than Were Enslaved II” that by
race, Black males continued to be incarcerated at an extraordinary rate. They pointed out
that Black males make up 35.4 percent of the jail and prison population, even though they
make up less than 10 percent of the overall U.S population. They also observed that four
percent of U.S. black males were in jail or prison in 2009, compared to 1.7 percent of Hispan‐
ic males and 0.7 percent of white males. This translated to black males being locked up at
almost six times the rate of their white counterparts.
Black and colleagues (2010) reported that although Attention Deficit/Hyperactivity Disorder
(ADHD) is associated with comorbid psychiatric diagnoses and antisocial behavior that con‐
tribute to criminality, yet studies of ADHD in offenders are few. Out of the 319 offenders
they evaluated using the Mini International Neuropsychiatric Interview and Medical Out‐
come Health Survey; ADHD was present in 68 (21.3%) subjects. Offenders with ADHD were
more likely to report problems with emotional and social functioning and to have a higher
suicide risk scores. Other psychopathologies identified in offenders with ADHD include
higher rates of mood, anxiety, psychotic and somatoform disorders. They are also more like‐
Attention Deficit Hyperactivity Disorder in Children and Adolescents200
ly to have antisocial and borderline personality disorders. To reduce the impact of ADHD
on the rate of incarceration of African-American youth, they recommended that Prison Ad‐
ministrators be trained to recognize the symptoms of ADHD and recommend offenders for
further intensive screening rather than commitment to prisons first.
Figure 1. Source: www.prisonerhealth.org
Figure 2. Source: Justice Policy Institute Report: The Punishing Decade, & U.S. bureau of Justice Statistics Bulletin.
NCJ219416. Prisoners in 2006.
The Impact of Attention Deficit/Hyperactivity Disorder in African-Americans…
http://dx.doi.org/10.5772/54276
201
3.2. ADHD and substance abuse disorder in African-Americans
Records show that many American youth are caught up in our juvenile justice system. Sig‐
nificant proportions of the arrests are due to either possession of or use of substances, partic‐
ularly marijuana and crack cocaine. The United States Department of Justice puts the
estimate of yearly arrest of juveniles at 2.5 million with approximately over a 100,000 youth
under the age of 18 years incarcerated daily. Minority youth in the African-America and
Hispanic population are overrepresented, accounting for more than 60% of juvenile offend‐
ers in the juvenile justice system. Interestingly, many of these detained youth have psychiat‐
ric disorders and are housed in detention facilities that lack mental health services, thereby
compounding the problem.
Individuals with substance abuse disorders exhibit hyperactivity, inattention and impulsivi‐
ty which are core symptoms of ADHD. These symptoms may promote antisocial behaviors
which may contribute or exacerbate substance use or abuse. Conversely, substance use
could worsen the symptoms of ADHD.
Studies of substance abusers and delinquents revealed a higher prevalence of ADHD co‐
morbidity.  ADHD is  associated with an earlier  onset  of  psychoactive substance use dis‐
orders,  independent  of  psychiatric  comorbidities.  Retz  et  al.  (2007)  stated  that  children
with  ADHD  show  higher  levels  of  substance  use  disorder  comorbidity,  particularly
when it  is  associated with social  maladaptation and antisocial  behavior.  Addicted delin‐
quents with ADHD showed worse social environment and a higher degree of psychopa‐
thology, including internalizing and externalizing behaviors, when compared to addicted
delinquents  without  ADHD.  Retz  and  coworkers  (2007)  systematically  examined  129
young  male  prison  inmates  for  ADHD  and  substance  use  disorder.  They  found  that
64.3% showed harmful alcohol consumption and 67.4% fulfilled DSM-IV criteria for any
drug abuse or dependence. Further analysis showed that 28.8% of the participants had a
diagnosis  of  ADHD  combined  type  and  52.1%  showed  ADHD  residual  type.  The  out‐
come  of  these  results  should  suggest  adequate  therapeutic  interventions  for  addicted
young prison inmates, considering the ADHD comorbidity, which is associated with ad‐
ditional psychopathology and social problems.
3.3. ADHD, African-American children/youth, and the school system
The core symptoms of ADHD, hyperactivity, inattention and impulsivity, are associated
with poor developments in several areas of normal functioning. This may be reflected in Af‐
rican-American children with ADHD as poor academic achievements and comportment at
school. Biederman and other investigators found that while hyperactivity declines over the
course of the disorder, inattention symptoms persist into adulthood. Currie and Stabile,
(2006) stated that this persistence of the inattention component of ADHD may be associated
with numerous functional deficits, including educational failure. ADHD symptoms affect
social functioning, interactions with teachers, peers, siblings and overall quality of life. Non-
African-American teachers are more likely to rate African-American children as more hy‐
peractive and disruptive in class than children from other ethnic backgrounds. The Office of
Special Education Report (2005) revealed that although African-American children represent
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only 15% of the US population in 2001, they were overrepresented in specific learning disa‐
bilities (18%), mental retardation (34%) and are more likely to be emotionally disturbed
(28%). The National Center for Education Statistics (2001) documented that African-Ameri‐
can males make up the majority of students described as “emotionally disturbed” and are
more likely to be suspended, expelled from school or subjected to corporal punishment than
their white or female peers. In addition to living in extreme poverty and other social dys‐
functions, it has been suggested that ADHD may be contributory to the high rates of school
drop-out among African-American youth
3.4. The economic impacts of ADHD on African-American families
There is evidence that ADHD places a substantial economic burden on patients, their fami‐
lies and third-party payers. Pelham and his colleagues (2007) projected that the economic
impact of education and medical services for children diagnosed with ADHD as at 2005 was
conservatively estimated at $36-$52 billion per year, which makes ADHD an important eco‐
nomic and social issue. It is also true that most African-American families live in poverty
and are less likely to be insured or have access to mental health services. ADHD leads to
increased costs in healthcare and other domains, which is likely to have economic implica‐
tions for African-American families, their children with ADHD diagnosis and the society in
general. Das and colleagues documented a correlation between ADHD, employment status
and financial stress in middle-age individuals with ADHD. They also reported significant
impairment in health, personal and social domains in their study group.
The economic implications of ADHD on African-America families may include the costs re‐
lated to common psychiatric and medical comorbidities of ADHD, the indirect costs associ‐
ated with work loss among adults with ADHD, the costs of managing accidents among
individuals with ADHD and the costs associated with the legal issues engendered by the
criminality and deviant behaviors among individuals with ADHD. Chow and colleagues
(2003) reported that the economic difficulties imposed on African-Americans due to poverty
and lack of health insurance makes it more likely that African-Americans resort to the use of
emergency services when they receive mental health care.
3.5. ADHD and the risk of sexually transmitted diseases among African-Americans
A comparative study on self-reported risky sexual behaviors was conducted by Flory and
colleagues (2006) in young adults (ages 18 to 26) with and without childhood attention defi‐
cit/hyperactivity disorder diagnosis. Among the participants were 175 males with a Pitts‐
burg Longitudinal Study (PALS) diagnosis of childhood ADHD. The controls were 111
demographically similar males without childhood ADHD diagnosis. The conclusion drawn
from this study is that childhood ADHD predicted earlier initiation of sexual activity and
intercourse, more sexual partners, more casual sex, and more partner pregnancies. Although
they pointed out that childhood conduct problems did contribute significantly to risky sexu‐
al behaviors among participants with ADHD, they also observed an independent contribu‐
tion of ADHD, which suggested that the characteristic deficits of the disorder or other
associated features may be useful childhood markers of later vulnerability. White and col‐
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3.2. ADHD and substance abuse disorder in African-Americans
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with  ADHD  show  higher  levels  of  substance  use  disorder  comorbidity,  particularly
when it  is  associated with social  maladaptation and antisocial  behavior.  Addicted delin‐
quents with ADHD showed worse social environment and a higher degree of psychopa‐
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ditional psychopathology and social problems.
3.3. ADHD, African-American children/youth, and the school system
The core symptoms of ADHD, hyperactivity, inattention and impulsivity, are associated
with poor developments in several areas of normal functioning. This may be reflected in Af‐
rican-American children with ADHD as poor academic achievements and comportment at
school. Biederman and other investigators found that while hyperactivity declines over the
course of the disorder, inattention symptoms persist into adulthood. Currie and Stabile,
(2006) stated that this persistence of the inattention component of ADHD may be associated
with numerous functional deficits, including educational failure. ADHD symptoms affect
social functioning, interactions with teachers, peers, siblings and overall quality of life. Non-
African-American teachers are more likely to rate African-American children as more hy‐
peractive and disruptive in class than children from other ethnic backgrounds. The Office of
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conservatively estimated at $36-$52 billion per year, which makes ADHD an important eco‐
nomic and social issue. It is also true that most African-American families live in poverty
and are less likely to be insured or have access to mental health services. ADHD leads to
increased costs in healthcare and other domains, which is likely to have economic implica‐
tions for African-American families, their children with ADHD diagnosis and the society in
general. Das and colleagues documented a correlation between ADHD, employment status
and financial stress in middle-age individuals with ADHD. They also reported significant
impairment in health, personal and social domains in their study group.
The economic implications of ADHD on African-America families may include the costs re‐
lated to common psychiatric and medical comorbidities of ADHD, the indirect costs associ‐
ated with work loss among adults with ADHD, the costs of managing accidents among
individuals with ADHD and the costs associated with the legal issues engendered by the
criminality and deviant behaviors among individuals with ADHD. Chow and colleagues
(2003) reported that the economic difficulties imposed on African-Americans due to poverty
and lack of health insurance makes it more likely that African-Americans resort to the use of
emergency services when they receive mental health care.
3.5. ADHD and the risk of sexually transmitted diseases among African-Americans
A comparative study on self-reported risky sexual behaviors was conducted by Flory and
colleagues (2006) in young adults (ages 18 to 26) with and without childhood attention defi‐
cit/hyperactivity disorder diagnosis. Among the participants were 175 males with a Pitts‐
burg Longitudinal Study (PALS) diagnosis of childhood ADHD. The controls were 111
demographically similar males without childhood ADHD diagnosis. The conclusion drawn
from this study is that childhood ADHD predicted earlier initiation of sexual activity and
intercourse, more sexual partners, more casual sex, and more partner pregnancies. Although
they pointed out that childhood conduct problems did contribute significantly to risky sexu‐
al behaviors among participants with ADHD, they also observed an independent contribu‐
tion of ADHD, which suggested that the characteristic deficits of the disorder or other
associated features may be useful childhood markers of later vulnerability. White and col‐
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leagues (2012) reported that ADHD symptoms were associated with greater sexual victimi‐
zation during adolescence and engagement in risky sexual behaviors. The same study also
found a strong association between ADHD symptoms, sexual victimization as well as risky
sexual behaviors which is stronger for black women than their white counterparts. Risky
sexual behaviors result in increased incidence of Sexually Transmitted Diseases (STDs),
HIV/AIDS and unplanned teen pregnancies among African-American youth. Currently, The
Center for Disease Control and Prevention (CDC) ranks African-American males as leading
other races and gender groups in incarceration rates, new HIV infections, homicide deaths,
poverty rates, and diagnosed learning disorders. In addition, the 2011 CDC Report on “Afri‐
can Americans and sexually Transmitted Diseases” showed that STDs take an especially
heavy toll on African Americans, particularly young African American women and men. Al‐
though African Americans represent just 14 percent of the U.S. population, yet they account
for approximately half of all reported chlamydia and syphilis cases and almost three-quar‐
ters of all reported gonorrhea cases.
3.6. Impact of ADHD on family structure and cohesion among African-Americans
Das and colleagues reported that inattention symptoms associated with ADHD significantly
affects multiple life domains in mid-life. Marriages, spousal relationships, social interactions
and health-related quality of life are all negatively impacted by ADHD symptoms. The fami‐
lies of children with ADHD have to contend with a greater number of behavioral, develop‐
mental and educational disturbances which often requires that more time, commitment,
logistics and energy be spent. ADHD can put a strain on family relationships, especially for
partners that have different views on discipline and parenting styles. The stress may be ele‐
vated if either parent feels they are bearing the burden of dealing with the child with
ADHD, like taking time off to deal with behavioral problems, school attendance, medical
consultations or meeting as part of ADHD management. Parents can feel overwhelmed or
find it challenging to cope with their child’s disruptive behaviors. Parents may feel socially
isolated if they start avoiding social events or family gatherings in hope of avoiding behav‐
ioral problems associated with their child’s diagnosis. The child with ADHD may uninten‐
tionally hurt other kids or their siblings during plays or damage property, thereby causing
strained relationships. Spousal relationships may be strained. There is the danger of both or
either parents spending so much time on the child with ADHD that they do not spend
enough time cementing their relationship as couples. This may lead to domestic conflicts, vi‐
olence and sometimes divorce. The level of attention paid by parents to the child with
ADHD may engender sibling jealousy and rival with the family
4. Conclusion
Strategies and interventions
A number of strategies and interventions have been suggested to improve outcomes and re‐
duce the impact of ADHD in African-Americans. These should be targeted at early diagno‐
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sis and treatment of ADHD, increasing awareness about ADHD, removing the stigma of
mental illness, elimination of healthcare disparities, enabling access to healthcare and teach‐
ing the benefits of ADHD treatment. The importance of early diagnosis and prompt treat‐
ment cannot be overemphasized. Instead of using one-size-fits-all or the traditional
diagnostic parameters, clinicians should incorporate ethnically-sensitive structured parent
questionnaires or rating scales to aid in the diagnosis of ADHD in African American chil‐
dren. It is also suggested that care be tailored to suit the needs of African-American children
with ADHD and their care-givers. This may engender more corporation and acceptance of a
diagnosis of ADHD in their children and compliance with treatment programs. It is impor‐
tant to have an integrated health care system where patients and their families can have
greater access to culturally sensitive materials or programs that will educate them about the
symptoms of ADHD and the benefits of proper treatment that will improve behaviors. Pa‐
rents, caregivers and mental health counselors should be involved in all the stages of diag‐
nosis and treatment planning of African-American children with ADHD. This strategy will
enable them to become partners in their own care and secure their cooperation as much as
possible. This will also decrease the rate of discontinuity of care since management of
ADHD of ADHD requires adherence to treatment regimens and medical appointments.
Odom  and  colleagues  evaluated  and  demonstrated  the  usefulness  of  increasing  aware‐
ness  of  ADHD  through  educational  intervention  in  mothers,  predominantly  African
Americans  and  reported  increase  in  parental  confidence  and  satisfaction  among  those
who  were  taught  about  ADHD;  since  these  qualities  are  needed  in  coping  with  this
chronic  illness.  Same education and training should be  provided to  teachers  who serve
the African American populations.
As earlier stated, clinicians may consider using ethnically sensitive, structured question‐
naires or rating scales to aid in the diagnosis of ADHD in African Americans. Obtaining a
thorough medical history, conducting a thorough physical examination and utilization of
guidelines on the diagnosis and evaluation of ADHD is imperative rather than relying too
heavily on questionnaires for the diagnosis of ADHD.
Substantial strides at improving outcomes can be made by clinicians and healthcare provid‐
ers by initiating pilot programs that will track the efficacy of a longitudinal care model
whereby primary care physicians will collaborate with mental healthcare professionals. Fur‐
thermore, schools, primary care providers and service agents should be incorporated into
this collaborative effort to monitor symptoms of ADHD and the response to treatment since
a successful management of ADHD is contingent on cooperation and open communication
among these caretakers. It is very important that adequate numbers of minority healthcare
providers be accessible in schools, clinics and hospitals to address the potential issues of
cross-cultural bias and mistrust. Thus, healthcare organizations must recruit and retain a di‐
verse staff whose demographic characteristics are representative of the service area
Healthcare institutions must consider ways of offering improved access to medical services
and raising the level of awareness in the community. For example, community events,
churches and day care centers could be used to disseminate information and teach about
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lies of children with ADHD have to contend with a greater number of behavioral, develop‐
mental and educational disturbances which often requires that more time, commitment,
logistics and energy be spent. ADHD can put a strain on family relationships, especially for
partners that have different views on discipline and parenting styles. The stress may be ele‐
vated if either parent feels they are bearing the burden of dealing with the child with
ADHD, like taking time off to deal with behavioral problems, school attendance, medical
consultations or meeting as part of ADHD management. Parents can feel overwhelmed or
find it challenging to cope with their child’s disruptive behaviors. Parents may feel socially
isolated if they start avoiding social events or family gatherings in hope of avoiding behav‐
ioral problems associated with their child’s diagnosis. The child with ADHD may uninten‐
tionally hurt other kids or their siblings during plays or damage property, thereby causing
strained relationships. Spousal relationships may be strained. There is the danger of both or
either parents spending so much time on the child with ADHD that they do not spend
enough time cementing their relationship as couples. This may lead to domestic conflicts, vi‐
olence and sometimes divorce. The level of attention paid by parents to the child with
ADHD may engender sibling jealousy and rival with the family
4. Conclusion
Strategies and interventions
A number of strategies and interventions have been suggested to improve outcomes and re‐
duce the impact of ADHD in African-Americans. These should be targeted at early diagno‐
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sis and treatment of ADHD, increasing awareness about ADHD, removing the stigma of
mental illness, elimination of healthcare disparities, enabling access to healthcare and teach‐
ing the benefits of ADHD treatment. The importance of early diagnosis and prompt treat‐
ment cannot be overemphasized. Instead of using one-size-fits-all or the traditional
diagnostic parameters, clinicians should incorporate ethnically-sensitive structured parent
questionnaires or rating scales to aid in the diagnosis of ADHD in African American chil‐
dren. It is also suggested that care be tailored to suit the needs of African-American children
with ADHD and their care-givers. This may engender more corporation and acceptance of a
diagnosis of ADHD in their children and compliance with treatment programs. It is impor‐
tant to have an integrated health care system where patients and their families can have
greater access to culturally sensitive materials or programs that will educate them about the
symptoms of ADHD and the benefits of proper treatment that will improve behaviors. Pa‐
rents, caregivers and mental health counselors should be involved in all the stages of diag‐
nosis and treatment planning of African-American children with ADHD. This strategy will
enable them to become partners in their own care and secure their cooperation as much as
possible. This will also decrease the rate of discontinuity of care since management of
ADHD of ADHD requires adherence to treatment regimens and medical appointments.
Odom  and  colleagues  evaluated  and  demonstrated  the  usefulness  of  increasing  aware‐
ness  of  ADHD  through  educational  intervention  in  mothers,  predominantly  African
Americans  and  reported  increase  in  parental  confidence  and  satisfaction  among  those
who  were  taught  about  ADHD;  since  these  qualities  are  needed  in  coping  with  this
chronic  illness.  Same education and training should be  provided to  teachers  who serve
the African American populations.
As earlier stated, clinicians may consider using ethnically sensitive, structured question‐
naires or rating scales to aid in the diagnosis of ADHD in African Americans. Obtaining a
thorough medical history, conducting a thorough physical examination and utilization of
guidelines on the diagnosis and evaluation of ADHD is imperative rather than relying too
heavily on questionnaires for the diagnosis of ADHD.
Substantial strides at improving outcomes can be made by clinicians and healthcare provid‐
ers by initiating pilot programs that will track the efficacy of a longitudinal care model
whereby primary care physicians will collaborate with mental healthcare professionals. Fur‐
thermore, schools, primary care providers and service agents should be incorporated into
this collaborative effort to monitor symptoms of ADHD and the response to treatment since
a successful management of ADHD is contingent on cooperation and open communication
among these caretakers. It is very important that adequate numbers of minority healthcare
providers be accessible in schools, clinics and hospitals to address the potential issues of
cross-cultural bias and mistrust. Thus, healthcare organizations must recruit and retain a di‐
verse staff whose demographic characteristics are representative of the service area
Healthcare institutions must consider ways of offering improved access to medical services
and raising the level of awareness in the community. For example, community events,
churches and day care centers could be used to disseminate information and teach about
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ADHD in order to raise awareness regarding the importance of treatment and to lessen fears
of stigmatization in the community.
It is important that care be tailored to suit the needs of various ethnic groups, such the Afri‐
can American community. Culturally competent medical care ensures that all patients will
receive care that is compatible with their cultural beliefs and practices. The need to increase
cultural competence in healthcare is described in detail in “Healthy People 2010”, which is a
statement of national health objectives that are designed to identify the most significant pre‐
ventable threats to health and to establish national goals to reduce these threats. The crimi‐
nal code of sentencing and guidelines for African-Americans with a diagnosis of ADHD
needs to be reviewed with a view to the elimination of the zero tolerance policy. Instead of
confining African American youths to the prison In conclusion, healthcare providers must
be diligent in their commitment to reduce or remove barriers to the proper diagnosis and
treatment of ADHD in African Americans. There is the need to increase awareness in the
African American community regarding the symptoms of ADHD and its treatment, and to
improve cultural awareness and sensitivity towards African-American patients among clini‐
cians to reduce the challenges involved in the cross-cultural diagnosis.
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1. Introduction
Attention-Deficit/Hyperactivity Disorder (ADHD) is a universal condition transcending
cultural, socio-economic and racial barriers. It is considered to be the most common psychiatric
disorder amongst children in the United States and Europe, with an estimated 3-10% of
children being affected [1]. The situation in Africa does not appear to be much different and
although there is a lack of knowledge with regards to ADHD on the African continent, it is
believed that the disorder is as prevalent as it is in Western countries [1]. In South Africa
specifically it is considered to be the most prevalent psychiatric disorder amongst children
with a prevalence rate of approximately 10% [2]. As this has not been confirmed officially, it
raises issues relating to possible over-identification of the disorder in South Africa. However,
it is feasible that children present with comorbid attention difficulties, when taking into
consideration the huge backlog in the education system and the high incidence of learning
disorders and language difficulties as additional barriers to learning.
The South African education system is still struggling with the aftermath of Apartheid, which
promoted exclusion in schools, not only based on race, gender, class, and ethnic background,
but also on disability. This lead to the creation of a dual education system and learners, who
did not meet the requirements of mainstream education, were placed in special education
when educationalists considered it to be in the best interest of the learner [3]. With the abolition
of Apartheid and the advent of the Constitution of the Republic of South Africa, Act No. 108
of 1996 [4], respect for the rights of all children regardless of variables such as race, gender,
ethniticity, religion and ability was emphasised. This lead to the adaption of a new South
African Education Policy, embedded in the philosophy of inclusive education and with its
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primary focus on “meeting the needs of all learners and actualising the full potential of all
learners” [5, p.344].
Inclusive education is not uniquely South African and emerged as a key international policy
when UNESCO’s Salamanca Statement was adopted in 1994, at the World Conference on
Special Needs Education in Salamanca, Spain [6]. The emphasis at the Salamanca Conference
was on the development of an inclusive education system that would
...accommodate all children, regardless of their physical, intellectual, social, emotional,
linguistic or other conditions. This should include disabled and gifted children, street and
working children, children from remote or nomadic populations, children from linguistic,
ethnic, or cultural minorities and children from other disadvantaged or marginalised areas or
groups. [7]
It was further noted that inclusive education systems, must not only recognise and respond to
the diverse needs of learners, but also make room for different learning styles and rates. In
addition, it is important that education systems ensure the quality of education through the
design of appropriate curricula and teaching strategies, whilst also using and involving
appropriate community and other resources. [7]
Although inclusive education therefore has a universal philosophy and universal practices, in
the South African context it needed to be indigenised to meet the needs of the South African
education system. This was done partially through the adoption of an eco-systemic framework
in viewing barriers to learning and development.
2. Eco-systemic framework
Seen in different contexts, human nature, which I had previously thought of as a singular noun,
became plural and pluralistic; for the different environments were producing discernible
differences, not only across, but also within societies, in talent, temperament, human relations,
and particularly in the ways in which the culture, or subculture, brought up its next generation.
(Bronfenbrenner, 1979:p.xiii as cited in [8])
Urie Bronfenbrenner is widely known for his development of the eco-systemic theory which
looks at the manner in which different environments and social contexts, including political,
socio-economical, and cultural patterns, produce distinct differences in the way in which
children develop. He argues that to truly understand a child, as well as his/her developmental
difficulties, one must view the child holistically within his/her context [9]. The eco-systemic
theory, which forms part of the broader social ecological model to understanding learning
barriers and more recently titled the bio-ecological perspective [10], amalgamates ecological
and systems theories to exemplify how a person’s physical environment and the different
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levels of the person’s social context are linked in dynamic, interacting, and interdependent
relationships.
Therefore, on the one hand the eco-systemic perspective emphasises the importance of the
impact that a person’s physical environment can have on the development of the person. On
the other hand, systems theory examines the multiple levels and groupings of a person’s social
context that function interdependently so that the whole is reliant upon the interaction of the
parts and can only be understood if the different parts are examined. Furthermore, as the
different levels of a person’s social context is linked in every-changing, interacting and
interdependent relationships; a shift in one system will impact the whole in a cyclical fashion.
Applied to ADHD within the South African context, the eco-systemic theory assists us in
understanding how environmental factors such as lead poisoning [11], which are prevalent in
the South African context [12-13], can have on the development of the disorder. Other
environmental factors that are of particular importance in the development of ADHD [11] and
prevalent in the South African context [14], include poverty and insufficient living conditions.
In addition, the eco-systemic theory also assists us in understanding how the child’s micro-,
meso-, exo-, macro-, and chronosystems [10] can have on the developmental course of ADHD.
Here factors such as family discord, a maternal history of psychiatric disorders and a particular
parenting style, are of importance [11]. Therefore, applied to ADHD, the eco-systemic
perspective helps us to understand that children cannot be viewed in isolation, but as part of
the bigger whole and in a reciprocal relationship with it. Taking this into consideration, one
of the major challenges in effectively addressing ADHD within the South African context is to
understand the complexity of the disorder as seen in a particular context and environment [9].
3. Barriers to learning and development
Although the predominant paradigm in understanding learning barriers such as ADHD, used
to be the medical-deficit model, a more social-ecological approach is applicable when intro‐
ducing inclusive education into an education system as it shifts attention from viewing
psychiatric disorders as caused by or located within the individual, to viewing the child as
being part of a broader system that contains many risk and protective factors that either
contribute to the development and maintenance of a particular difficulty, or the prevention
thereof. The World Health Organisation [15] defines environmental factors such as poor socio-
economic status and high crime rates that can increase the risk of the developmental of
externalising difficulties such as ADHD, as risk factors. In contrast, factors such as supportive
parenting styles and educational support that moderate the effects of ADHD and assist in the
appropriate adaptation of children with this to the school environment, are seen as protective
factors.
In adopting a more socio-ecological paradigm, there will therefore be a shift from using labels
such as special needs to applying terminology such as risk and protective factors, or as it is
noted in the South African policy documentation; barriers to learning and development [16].
Barriers to learning and development are defined as all factors that can impact upon learning
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primary focus on “meeting the needs of all learners and actualising the full potential of all
learners” [5, p.344].
Inclusive education is not uniquely South African and emerged as a key international policy
when UNESCO’s Salamanca Statement was adopted in 1994, at the World Conference on
Special Needs Education in Salamanca, Spain [6]. The emphasis at the Salamanca Conference
was on the development of an inclusive education system that would
...accommodate all children, regardless of their physical, intellectual, social, emotional,
linguistic or other conditions. This should include disabled and gifted children, street and
working children, children from remote or nomadic populations, children from linguistic,
ethnic, or cultural minorities and children from other disadvantaged or marginalised areas or
groups. [7]
It was further noted that inclusive education systems, must not only recognise and respond to
the diverse needs of learners, but also make room for different learning styles and rates. In
addition, it is important that education systems ensure the quality of education through the
design of appropriate curricula and teaching strategies, whilst also using and involving
appropriate community and other resources. [7]
Although inclusive education therefore has a universal philosophy and universal practices, in
the South African context it needed to be indigenised to meet the needs of the South African
education system. This was done partially through the adoption of an eco-systemic framework
in viewing barriers to learning and development.
2. Eco-systemic framework
Seen in different contexts, human nature, which I had previously thought of as a singular noun,
became plural and pluralistic; for the different environments were producing discernible
differences, not only across, but also within societies, in talent, temperament, human relations,
and particularly in the ways in which the culture, or subculture, brought up its next generation.
(Bronfenbrenner, 1979:p.xiii as cited in [8])
Urie Bronfenbrenner is widely known for his development of the eco-systemic theory which
looks at the manner in which different environments and social contexts, including political,
socio-economical, and cultural patterns, produce distinct differences in the way in which
children develop. He argues that to truly understand a child, as well as his/her developmental
difficulties, one must view the child holistically within his/her context [9]. The eco-systemic
theory, which forms part of the broader social ecological model to understanding learning
barriers and more recently titled the bio-ecological perspective [10], amalgamates ecological
and systems theories to exemplify how a person’s physical environment and the different
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levels of the person’s social context are linked in dynamic, interacting, and interdependent
relationships.
Therefore, on the one hand the eco-systemic perspective emphasises the importance of the
impact that a person’s physical environment can have on the development of the person. On
the other hand, systems theory examines the multiple levels and groupings of a person’s social
context that function interdependently so that the whole is reliant upon the interaction of the
parts and can only be understood if the different parts are examined. Furthermore, as the
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environmental factors that are of particular importance in the development of ADHD [11] and
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psychiatric disorders as caused by or located within the individual, to viewing the child as
being part of a broader system that contains many risk and protective factors that either
contribute to the development and maintenance of a particular difficulty, or the prevention
thereof. The World Health Organisation [15] defines environmental factors such as poor socio-
economic status and high crime rates that can increase the risk of the developmental of
externalising difficulties such as ADHD, as risk factors. In contrast, factors such as supportive
parenting styles and educational support that moderate the effects of ADHD and assist in the
appropriate adaptation of children with this to the school environment, are seen as protective
factors.
In adopting a more socio-ecological paradigm, there will therefore be a shift from using labels
such as special needs to applying terminology such as risk and protective factors, or as it is
noted in the South African policy documentation; barriers to learning and development [16].
Barriers to learning and development are defined as all factors that can impact upon learning
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[17]. These barriers can occur within all levels of the eco-system and can be placed on a
continuum; from intrinsic barriers that can be found within the individual, to extrinsic barriers
which refer to factors outside the individual [17]. Some of the most prominent extrinsic barriers
within the South African context include socio-economic barriers, negative attitudes towards
difference and psychiatric disorders, inflexible curricula, inaccessible and unsafe building
environments and schools, inappropriate and inadequate provision of support services, lack
of enabling and protective legislation and policy, lack of parental recognition and involvement,
and lack of human resource development strategies [16]. Some of the most prominent intrinsic
barriers include language and communication difficulties, health difficulties such as HIV and
tuberculosis, sensory impairments, intellectual and learning difficulties, and pervasive
developmental disorders [17].
ADHD would be considered an intrinsic barrier as research has shown that genetic and
biological factors such as an imbalance in the neurotransmitters noradrenalin and dopamine
play an important role in the development of the disorder. It is however important to also take
cognisance of the role that extrinsic barriers such as those noted above, as well as poor socio-
economic circumstances, high crime rates, repeated trauma, parenting styles and parent-child
interactions play in the maintenance and further developmental course of the disorder [15].
4. Teachers: A pivotal part of the eco-system
From an eco-systemic perspective, teachers can act as extrinsic barriers to learning and
development when they act as risk factors in the developmental course of ADHD in particular
learners in their classrooms. Likewise, teachers can also act as protective factors when their
understanding of ADHD and support offered to the learners in their classrooms, positively
impact on the developmental course of the disorder.
Teachers are often the primary source of identification and play a pivotal role in the diagnosis,
management and intervention of ADHD. They have firsthand experience of the learner in the
classroom situation; a setting which requires the learner to sit still, pay attention, adhere to
instructions and interact with peers and adults in an appropriate manner. Teachers’ knowledge
and understanding will determine how they engage with and manage learners experiencing
ADHD. Furthermore, their attitudes towards different forms of ADHD intervention would
affect their support of these treatment methods and the learners in their classrooms. Early
identification and intervention by teachers is vital, especially as a large percentage of individ‐
uals continue to have symptoms in adolescence and adulthood [18], which can impede their
future wellbeing. It is important to take cognisance of the manner in which teachers’ percep‐
tions, knowledge and attitudes are influenced by contextual and socio-cultural factors, as
shown in previous studies [1, 19-20].
It has however been found that teachers’ understanding of ADHD is often based on myths
and false beliefs. It has been reported that some teachers believe that ADHD is a direct cause
of the intake of certain food additives and eating too many sweets [21]. Others are of the idea
that ADHD is mainly as a result of biological abnormalities [11], or as a direct result of bad
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parenting and a lack of parental supervision [22]. It is essential to understand that if teachers
have an incorrect understanding of ADHD and its causes and symptoms, it may lead them to
actually support the presence of behaviours associated with ADHD, which can lead to
inaccurate diagnosis [23].
Over the past decade, many research studies have been done on teachers’ perceptions and
knowledge of ADHD. In the United States, a sample of primary school teachers watched a
video of a student displaying ADHD-like behaviours as well as those behaviours that are
characteristic and unique to Oppositional Defiant Disorder (ODD). When examined, teachers
were accurate in their evaluations of ADHD-like symptoms such as inattention and hyperac‐
tivity. However, when students displayed behaviours that belong solely to the domain of
ODD, such as opposition and non-compliance, teachers automatically assumed that these
behaviours were indicative of ADHD. Thus, teachers mistakenly assumed that children who
displayed only ODD-like behaviours also exhibited ADHD-like behaviours [23]. A study
conducted in Australia likewise revealed that teachers often provide parents and professionals
with incorrect and inappropriate advice and information regarding the child who is displaying
ADHD-like symptoms [21]. A study conducted in South Africa by [24] revealed that teachers
are actually over identifying children with ADHD, as in the study 11.9% of the learners actually
had ADHD, whilst teachers identified 15.4% of the learners to have ADHD. Thus, misunder‐
standings and misperceptions held by teachers may lead to inaccurate information being
passed onto professionals, who carry out the task of making an actual ADHD diagnosis.
In support of these findings, further evidence reveals that teacher knowledge of ADHD tends
to be very narrow and limited and even incorrect [21]. Three studies, as discussed in [21] were
conducted in Australia over the last decade, which explored this area. One of the studies
revealed that the teachers in the selected sample group were able to answer 60.7% of items in
a questionnaire on ADHD. In a different study, the researchers administered the Knowledge
of Attention Deficit Disorders Scale (KADDS) to a group of teachers. The findings of this study
reflected that teachers knew more about the causes of ADHD, but possessed less information
regarding treatment interventions for ADHD [21].
In South Africa, a study conducted in the peripheral areas of the Cape Town Metropole in the
Western Cape, also employed the KADDS to assess 552 teachers’ knowledge of ADHD [2].
Their study revealed that the participants did not have an adequate understanding of ADHD.
An overall score of correct responses of 42,6% was obtained. An overall percentage of 35.4%
was gathered for “don’t know” responses, and 22% for incorrect responses [2].
These above results are consistent with a study conducted by [25]. In this South African study
teachers’ perceptions of their ability to identify and manage learners diagnosed with ADHD
were investigated. Four out of five teachers did not consider themselves able to adequately
manage ADHD symptoms, and some of the teachers misidentified and misunderstood certain
symptoms of this condition. In a further study, [26] revealed that teachers do not have a sound
understanding of the symptoms of ADHD, and the majority of teachers in the sample were
unable to distinguish between inattention and ADHD. According to Venter (2011, as cited in
[27]), teachers from poor black communities that teach at rural South African schools are the
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[17]. These barriers can occur within all levels of the eco-system and can be placed on a
continuum; from intrinsic barriers that can be found within the individual, to extrinsic barriers
which refer to factors outside the individual [17]. Some of the most prominent extrinsic barriers
within the South African context include socio-economic barriers, negative attitudes towards
difference and psychiatric disorders, inflexible curricula, inaccessible and unsafe building
environments and schools, inappropriate and inadequate provision of support services, lack
of enabling and protective legislation and policy, lack of parental recognition and involvement,
and lack of human resource development strategies [16]. Some of the most prominent intrinsic
barriers include language and communication difficulties, health difficulties such as HIV and
tuberculosis, sensory impairments, intellectual and learning difficulties, and pervasive
developmental disorders [17].
ADHD would be considered an intrinsic barrier as research has shown that genetic and
biological factors such as an imbalance in the neurotransmitters noradrenalin and dopamine
play an important role in the development of the disorder. It is however important to also take
cognisance of the role that extrinsic barriers such as those noted above, as well as poor socio-
economic circumstances, high crime rates, repeated trauma, parenting styles and parent-child
interactions play in the maintenance and further developmental course of the disorder [15].
4. Teachers: A pivotal part of the eco-system
From an eco-systemic perspective, teachers can act as extrinsic barriers to learning and
development when they act as risk factors in the developmental course of ADHD in particular
learners in their classrooms. Likewise, teachers can also act as protective factors when their
understanding of ADHD and support offered to the learners in their classrooms, positively
impact on the developmental course of the disorder.
Teachers are often the primary source of identification and play a pivotal role in the diagnosis,
management and intervention of ADHD. They have firsthand experience of the learner in the
classroom situation; a setting which requires the learner to sit still, pay attention, adhere to
instructions and interact with peers and adults in an appropriate manner. Teachers’ knowledge
and understanding will determine how they engage with and manage learners experiencing
ADHD. Furthermore, their attitudes towards different forms of ADHD intervention would
affect their support of these treatment methods and the learners in their classrooms. Early
identification and intervention by teachers is vital, especially as a large percentage of individ‐
uals continue to have symptoms in adolescence and adulthood [18], which can impede their
future wellbeing. It is important to take cognisance of the manner in which teachers’ percep‐
tions, knowledge and attitudes are influenced by contextual and socio-cultural factors, as
shown in previous studies [1, 19-20].
It has however been found that teachers’ understanding of ADHD is often based on myths
and false beliefs. It has been reported that some teachers believe that ADHD is a direct cause
of the intake of certain food additives and eating too many sweets [21]. Others are of the idea
that ADHD is mainly as a result of biological abnormalities [11], or as a direct result of bad
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parenting and a lack of parental supervision [22]. It is essential to understand that if teachers
have an incorrect understanding of ADHD and its causes and symptoms, it may lead them to
actually support the presence of behaviours associated with ADHD, which can lead to
inaccurate diagnosis [23].
Over the past decade, many research studies have been done on teachers’ perceptions and
knowledge of ADHD. In the United States, a sample of primary school teachers watched a
video of a student displaying ADHD-like behaviours as well as those behaviours that are
characteristic and unique to Oppositional Defiant Disorder (ODD). When examined, teachers
were accurate in their evaluations of ADHD-like symptoms such as inattention and hyperac‐
tivity. However, when students displayed behaviours that belong solely to the domain of
ODD, such as opposition and non-compliance, teachers automatically assumed that these
behaviours were indicative of ADHD. Thus, teachers mistakenly assumed that children who
displayed only ODD-like behaviours also exhibited ADHD-like behaviours [23]. A study
conducted in Australia likewise revealed that teachers often provide parents and professionals
with incorrect and inappropriate advice and information regarding the child who is displaying
ADHD-like symptoms [21]. A study conducted in South Africa by [24] revealed that teachers
are actually over identifying children with ADHD, as in the study 11.9% of the learners actually
had ADHD, whilst teachers identified 15.4% of the learners to have ADHD. Thus, misunder‐
standings and misperceptions held by teachers may lead to inaccurate information being
passed onto professionals, who carry out the task of making an actual ADHD diagnosis.
In support of these findings, further evidence reveals that teacher knowledge of ADHD tends
to be very narrow and limited and even incorrect [21]. Three studies, as discussed in [21] were
conducted in Australia over the last decade, which explored this area. One of the studies
revealed that the teachers in the selected sample group were able to answer 60.7% of items in
a questionnaire on ADHD. In a different study, the researchers administered the Knowledge
of Attention Deficit Disorders Scale (KADDS) to a group of teachers. The findings of this study
reflected that teachers knew more about the causes of ADHD, but possessed less information
regarding treatment interventions for ADHD [21].
In South Africa, a study conducted in the peripheral areas of the Cape Town Metropole in the
Western Cape, also employed the KADDS to assess 552 teachers’ knowledge of ADHD [2].
Their study revealed that the participants did not have an adequate understanding of ADHD.
An overall score of correct responses of 42,6% was obtained. An overall percentage of 35.4%
was gathered for “don’t know” responses, and 22% for incorrect responses [2].
These above results are consistent with a study conducted by [25]. In this South African study
teachers’ perceptions of their ability to identify and manage learners diagnosed with ADHD
were investigated. Four out of five teachers did not consider themselves able to adequately
manage ADHD symptoms, and some of the teachers misidentified and misunderstood certain
symptoms of this condition. In a further study, [26] revealed that teachers do not have a sound
understanding of the symptoms of ADHD, and the majority of teachers in the sample were
unable to distinguish between inattention and ADHD. According to Venter (2011, as cited in
[27]), teachers from poor black communities that teach at rural South African schools are the
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ones who possess the most limited knowledge on the condition. Consequently, these children
are physically and verbally punished as a result of their ADHD behaviour.
Conversely, a South African study conducted by [28], which included five schools situated in
economically deprived areas and three school situated in economically affluent areas, showed
different results to those yielded by [2]. It was revealed that the majority of teachers in this
sample group in fact had in-depth knowledge and understanding of ADHD, and were acutely
aware of the symptoms of ADHD. The teachers believed that their role in the classroom was
crucial to the management of the condition. Furthermore, teachers in this study were very
eager to learn and gain more information on the condition. However, this study consisted of
a very small sample group and the results garnered appear to be more of an exception and
stronger evidence exists for the fact that teachers generally have a poor understanding and
lack of knowledge on the condition [2].
Research in the past decade, has explored if older teachers and those teachers who have had
more years of teaching experience have better knowledge and understanding of ADHD. An
Australian study conducted by [29], where 120 teachers completed a survey on what they
thought and knew about ADHD, showed that teachers with more years of teaching experience
perceived themselves to have greater knowledge on the condition than the less experienced
teachers. However, the number of years of teaching experience of these teachers was not
related to their actual levels of knowledge. The age of the teachers was also not linked to the
teachers’ level of knowledge and understandings of the condition. These results are confirmed
by the findings by [2].
However, other research [30] reported that in fact younger teachers know more about ADHD
than older ones, a finding which is confirmed by [31]. One explanation for this may be the fact
that younger teachers notice the condition more in their classrooms compared to their older
counterparts who have developed effective classroom behaviour management strategies. One
researcher [32] believes that older teachers are much more rigid and set in their ways as
compared to younger teachers, who are willing to be open, honest and adaptable to the needs
of ADHD learners.
The question arises as to whether a teacher, who has obtained a more advanced level of
education, consequently knows more about ADHD. A study [33] conducted in the United
States, which aimed to investigate preschool teachers’ past educational practices and their
knowledge and understanding of ADHD, revealed that those teachers that obtained higher
levels of academic training, such as a university education, performed on a superior level and
obtained higher scores on the administered questionnaire than those teachers that only
obtained a high school level of education.
The study by [29] also indicated that having taught a student with ADHD is related to that
teacher’s actual knowledge of the condition. Then the question arises as to whether training
and exposure in the area, such as the reading of articles on the topic and the attendance of
workshops, contributes to a teacher’s level of understanding and knowledge on ADHD. A
study by [34], answers this question in the affirmative, and revealed that the attendance of
workshops on ADHD has a positive relationship with teacher knowledge and understanding
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of ADHD. In the study by [2], teachers’ exposure to ADHD, which includes the number of
workshops attended as well as the number of articles read was positively correlated to their
overall knowledge and understanding of the condition.
In the study by [29] older teachers were more likely to attend workshops and engage in ADHD
training than the younger teachers. Teaching experience and exposure to ADHD also increased
the likelihood of teachers attending workshops. The more workshops the teachers attended,
the more knowledge they had on the disorder, compared to the teachers who did not attend
workshops. This was confirmed by the South African study conducted by [2]. Teachers’
confidence levels in their ability to teach and deal with a child with ADHD was positively
related to their overall knowledge of this condition. As every teacher will experience at least
one learner with ADHD per year, it may become essential for teachers to receive pre-service
training in the area of ADHD [35].
5. Knowledge and perceptions of ADHD held by a sample of South African
foundation phase township teachers
Whilst understanding the pivotal role that teachers’ knowledge and perceptions play in the
identification and treatment of ADHD, this chapter aims to integrate the information from the
studies above, with one particular South African study [36] that focussed on the knowledge
and perceptions held by a sample of South African Foundation Phase township teachers.
A range of mainstream and special education schools exist in South Africa, which include
private and government funded schools. Of the government funded schools, formally white
schools were better funded and resourced in comparison to the black township, rural and
informal settlement schools. There is no previous documented research on township teachers’
perceptions of ADHD in South Africa, which prompted the current study. The study was
conducted in Alexandra Township in Gauteng, which is one of the oldest townships in South
Africa. It was proclaimed as a township for black persons in 1912, by the Apartheid regime
which classified South Africans into four racial groups. Alexandra Township, with a popula‐
tion of about 350 000 people, covers an area of over 800 hectares of land. It consists of persons
of different cultures and varying degrees of income and education and has a history of poverty,
overcrowding as well as high levels of unemployment and crime.
5.1. Aim of the study
The overall aim of this study was to explore and assess the knowledge and perceptions of
ADHD held by a sample of Foundation Phase (Reception year to Grade 3) teachers within a
township setting. More specifically, the research aimed at exploring the teachers’ general
knowledge as well as their inadequate knowledge and misconceptions regarding ADHD, with
emphasis paid to its’ associated features, symptoms/diagnosis and treatment. Teachers’
knowledge of ADHD was also investigated in relation to their demographic group.
In fulfilling the aim of the study, the following research questions were posed:
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ones who possess the most limited knowledge on the condition. Consequently, these children
are physically and verbally punished as a result of their ADHD behaviour.
Conversely, a South African study conducted by [28], which included five schools situated in
economically deprived areas and three school situated in economically affluent areas, showed
different results to those yielded by [2]. It was revealed that the majority of teachers in this
sample group in fact had in-depth knowledge and understanding of ADHD, and were acutely
aware of the symptoms of ADHD. The teachers believed that their role in the classroom was
crucial to the management of the condition. Furthermore, teachers in this study were very
eager to learn and gain more information on the condition. However, this study consisted of
a very small sample group and the results garnered appear to be more of an exception and
stronger evidence exists for the fact that teachers generally have a poor understanding and
lack of knowledge on the condition [2].
Research in the past decade, has explored if older teachers and those teachers who have had
more years of teaching experience have better knowledge and understanding of ADHD. An
Australian study conducted by [29], where 120 teachers completed a survey on what they
thought and knew about ADHD, showed that teachers with more years of teaching experience
perceived themselves to have greater knowledge on the condition than the less experienced
teachers. However, the number of years of teaching experience of these teachers was not
related to their actual levels of knowledge. The age of the teachers was also not linked to the
teachers’ level of knowledge and understandings of the condition. These results are confirmed
by the findings by [2].
However, other research [30] reported that in fact younger teachers know more about ADHD
than older ones, a finding which is confirmed by [31]. One explanation for this may be the fact
that younger teachers notice the condition more in their classrooms compared to their older
counterparts who have developed effective classroom behaviour management strategies. One
researcher [32] believes that older teachers are much more rigid and set in their ways as
compared to younger teachers, who are willing to be open, honest and adaptable to the needs
of ADHD learners.
The question arises as to whether a teacher, who has obtained a more advanced level of
education, consequently knows more about ADHD. A study [33] conducted in the United
States, which aimed to investigate preschool teachers’ past educational practices and their
knowledge and understanding of ADHD, revealed that those teachers that obtained higher
levels of academic training, such as a university education, performed on a superior level and
obtained higher scores on the administered questionnaire than those teachers that only
obtained a high school level of education.
The study by [29] also indicated that having taught a student with ADHD is related to that
teacher’s actual knowledge of the condition. Then the question arises as to whether training
and exposure in the area, such as the reading of articles on the topic and the attendance of
workshops, contributes to a teacher’s level of understanding and knowledge on ADHD. A
study by [34], answers this question in the affirmative, and revealed that the attendance of
workshops on ADHD has a positive relationship with teacher knowledge and understanding
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of ADHD. In the study by [2], teachers’ exposure to ADHD, which includes the number of
workshops attended as well as the number of articles read was positively correlated to their
overall knowledge and understanding of the condition.
In the study by [29] older teachers were more likely to attend workshops and engage in ADHD
training than the younger teachers. Teaching experience and exposure to ADHD also increased
the likelihood of teachers attending workshops. The more workshops the teachers attended,
the more knowledge they had on the disorder, compared to the teachers who did not attend
workshops. This was confirmed by the South African study conducted by [2]. Teachers’
confidence levels in their ability to teach and deal with a child with ADHD was positively
related to their overall knowledge of this condition. As every teacher will experience at least
one learner with ADHD per year, it may become essential for teachers to receive pre-service
training in the area of ADHD [35].
5. Knowledge and perceptions of ADHD held by a sample of South African
foundation phase township teachers
Whilst understanding the pivotal role that teachers’ knowledge and perceptions play in the
identification and treatment of ADHD, this chapter aims to integrate the information from the
studies above, with one particular South African study [36] that focussed on the knowledge
and perceptions held by a sample of South African Foundation Phase township teachers.
A range of mainstream and special education schools exist in South Africa, which include
private and government funded schools. Of the government funded schools, formally white
schools were better funded and resourced in comparison to the black township, rural and
informal settlement schools. There is no previous documented research on township teachers’
perceptions of ADHD in South Africa, which prompted the current study. The study was
conducted in Alexandra Township in Gauteng, which is one of the oldest townships in South
Africa. It was proclaimed as a township for black persons in 1912, by the Apartheid regime
which classified South Africans into four racial groups. Alexandra Township, with a popula‐
tion of about 350 000 people, covers an area of over 800 hectares of land. It consists of persons
of different cultures and varying degrees of income and education and has a history of poverty,
overcrowding as well as high levels of unemployment and crime.
5.1. Aim of the study
The overall aim of this study was to explore and assess the knowledge and perceptions of
ADHD held by a sample of Foundation Phase (Reception year to Grade 3) teachers within a
township setting. More specifically, the research aimed at exploring the teachers’ general
knowledge as well as their inadequate knowledge and misconceptions regarding ADHD, with
emphasis paid to its’ associated features, symptoms/diagnosis and treatment. Teachers’
knowledge of ADHD was also investigated in relation to their demographic group.
In fulfilling the aim of the study, the following research questions were posed:
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5.2. Research design and methodology
This research was exploratory in nature as there is very limited documented research on
ADHD in South Africa. The study garnered both qualitative and quantitative material which
was analysed using numerical and descriptive statistics. For logistical and practical reasons,
nine primary schools situated within the Alexandra Township were selected. Non probability,
convenience sampling was employed as participation by the teachers depended on their
availability and willingness to respond. As a result, the final sample of 100 female teachers
who consented to participate in the study was not random in nature [37-38]. Foundation Phase
teachers were chosen as the sample for this study due to the fact that they play an integral and
primary role when it comes to the identification and recognition of ADHD-like symptoms [39].
Permission to undertake the investigation was sought from the Gauteng Department of
Education and the ethics committee at the University of the Witwatersrand. A detailed
information sheet detailing issues of anonymity and confidentiality regarding the particulars
of the study was distributed to the principals of the schools and their teachers.
Clear instructions were given to the respondents during administration of the instrument and
assistance was provided if they did not understand what was required. A questionnaire was
chosen as the preferred instrument as it allowed for administration to a large group of subjects
[38]. The questionnaire which was administered to the 100 participants was threefold in nature.
It included; demographic/biographical questions, the Knowledge of Attention Deficit Disor‐
ders Scale (KADDS), as well as open-ended questions. Permission to use the KADDS measure
was obtained from Professor Mark Sciutto.
In the first section of the questionnaire teachers were asked demographic questions such as
their gender, age, educational level and number of years of teaching experience. Teachers
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were also asked to provide the number of hours of ADHD training that they had received
(if any), as well as the number of evaluations and assessments that they had requested for
children in their  classes that  they thought may have ADHD. Teachers were required to
indicate the number of children that they had taught with a medical diagnosis of ADHD,
how many workshops that they had attended on the topic as well as the number of articles
that they had read on the condition. The teachers were also asked to rate their confidence
levels to teach a child with ADHD. Lastly, teachers were required to indicate whether they
had been asked for feedback by a professional, such as a doctor or psychologist, regarding
a child in their class with ADHD in order to assess the child’s medication. These questions
were based on a questionnaire that was administered in the previously reported South African
study conducted by [2].
The second section of the questionnaire consisted of the Knowledge of Attention Deficit
Disorder Scale (KADDS). This scale was developed by [31] and was previously used in similar
studies in South Africa, see [2] and Australia, see [40]. It was designed and consequently
published to assess teachers’ knowledge, of the symptoms, associated features and treatment
of ADHD. The KADDS is a 39 item rating scale which elicits true and correct answers (T), false,
incorrect and misperceived answers (F) and don’t know answers (DK). Previous research
conducted on the internal consistency of the KADDS total score, based on the original 36 items
that constituted this scale, revealed high internal consistency ranging from.81 to.86 [31,41-42].
A similarly high internal consistency for the KADDS was found in the present study, with the
Cronbach’s alpha for the total score being.88. In terms of validity, KADDS scores are sensitive
to teacher characteristics such as exposure to and interaction with a child with ADHD and
prior training on this condition [31].
The last section of the questionnaire contained open- ended questions, where participants were
given the opportunity to provide any additional comments or ideas that they had regarding
ADHD. This information served to substantiate and support the quantitative results garnered
by the research. In research terms, this method of using multiple sources of data to strengthen
the trustworthiness of the data, is referred to as the triangulation of data [43].
5.3. Data analysis
Descriptive and inferential statistics and graphs were used to describe the sample respondents
and the measurement scales, and to address the aims of the research study. In order to
investigate the areas of inadequate knowledge and misconceptions held by teachers, summary
statistics for the central tendency, variability and shape were computed at the item level of the
KADDS subscales. These results were tabulated using a robot- type colour coding scheme
whereby higher mean scores were shaded in deep green and shades of yellow through to red
were used for relatively lower and low means respectively. Furthermore, the responses to each
item were categorised as “don’t know”, incorrect responses or misconceptions, and correct
responses, thereby enabling the examination of the extent of teachers’ misconceptions versus
poor knowledge at the item level of each of the subscales. This analysis was depicted graphi‐
cally in the form of a stacked bar graph for the items of each subscale of the KADDS. In order
to address the teachers’ general knowledge of ADHD content areas in terms of their demo‐
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5.2. Research design and methodology
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to teacher characteristics such as exposure to and interaction with a child with ADHD and
prior training on this condition [31].
The last section of the questionnaire contained open- ended questions, where participants were
given the opportunity to provide any additional comments or ideas that they had regarding
ADHD. This information served to substantiate and support the quantitative results garnered
by the research. In research terms, this method of using multiple sources of data to strengthen
the trustworthiness of the data, is referred to as the triangulation of data [43].
5.3. Data analysis
Descriptive and inferential statistics and graphs were used to describe the sample respondents
and the measurement scales, and to address the aims of the research study. In order to
investigate the areas of inadequate knowledge and misconceptions held by teachers, summary
statistics for the central tendency, variability and shape were computed at the item level of the
KADDS subscales. These results were tabulated using a robot- type colour coding scheme
whereby higher mean scores were shaded in deep green and shades of yellow through to red
were used for relatively lower and low means respectively. Furthermore, the responses to each
item were categorised as “don’t know”, incorrect responses or misconceptions, and correct
responses, thereby enabling the examination of the extent of teachers’ misconceptions versus
poor knowledge at the item level of each of the subscales. This analysis was depicted graphi‐
cally in the form of a stacked bar graph for the items of each subscale of the KADDS. In order
to address the teachers’ general knowledge of ADHD content areas in terms of their demo‐
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graphic group, a 1-way Analysis of Variance (ANOVA) was used. This was used to compare
the mean responses of the respondents across the levels within each demographic variable on
the three KADDS subscales. Line graphs were used to portray the differences between means
in the case of significant ANOVA comparisons. Furthermore, the post hoc Scheffe test was
used to indicate pairwise significances for significant analyses of demographic variables with
more than two levels. In view of the non-normality of the score distributions, the parametric
ANOVA tests were validated using the non-parametric equivalent Kruskal-Wallis test. Finally,
the Chi squared test was used to compare the demographic characteristics of the respondents
who opted versus those who did not opt for a future workshop on ADHD and profile line
graphs were plotted to describe the two groups of these demographic variables. In addition,
the t-test was used to compare the mean knowledge scores on the three KADDS subscales of
these two groups. These analyses were complemented by the researcher’s thematic analysis
of the qualitative responses.
5.4. Findings
All of the 100 respondents, who agreed to participate in this study, were female. The average
learner to teacher ratio in the schools include in the schools, were 50:1. Almost two-thirds of
the teachers in the sample were older than 40years, with a negligible number of them in the
20-25 year category. Consistent with the age distribution of the teacher respondents,  the
majority (60%) had more than 11 years of teaching experience, 20% had 6-10 years teach‐
ing experience and 20% had 5 years or less. Almost a quarter of the sample had a universi‐
ty level of education, while the remaining individuals had college level training. Over half
of the respondents expressed no confidence in their ability to teach children with ADHD.
Regarding their knowledge of ADHD, two thirds of the teachers had received no ADHD
training. Over half of the respondents (52%) claimed that they had taught children diag‐
nosed with ADHD and had assisted with ADHD evaluations (59%). Almost 40% claimed
that they had been asked for feedback by a doctor regarding a child with ADHD in their
classroom.
The overall results of the KADDS questionnaire revealed that there is a substantial lack of
knowledge about ADHD amongst the participants. Based on the results of Table 1 the overall
percentage of correct responses to the 39 KADDS items was 34.9%. Nine of the 100 educator
respondents scored zero on all 39 items of the scale.






Associated features 30.4% 27.0% 33.8% 31.3% 17.2% -0.21
Symptoms/ Diagnosis 47.9% 43.3% 52.5% 50.0% 23.3% -0.51
Treatment 30.6% 26.5% 34.8% 30.8% 20.9% 0.10
Overall 34.9% 31.3% 38.6% 37.2% 18.2% -0.33
Table 1. Summary descriptive statistics of the three content areas of ADHD
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Regarding the teachers’ knowledge in terms of the Associated Features subscale, a mean score
of 30.4% was garnered which was lower than the overall scale score of 34.9%, and based on
the median score reflected in Table 1, half of the respondents answered fewer than 31.3% of
these items correctly. The minimum scores of zero on the Associated Features subscale show
10 teachers who either did not know and/or who answered all the items of the subscale
incorrectly. Of the three subscales, the highest mean (percentage correctly answered items) is
for Symptoms/Diagnosis (47.9%). Even on this subscale, the average respondent answered
approximately half of the items incorrectly. Nine of the 100 teachers scored zero on this
Symptoms/Diagnosis subscale. The mean score of 30.6% on the Treatment subscale is compa‐
rably low in relation to the mean score on the Associated Features subscale which was lower
than the overall KADDS score of 34.9%. The minimum scores of zero on this subscale show 15
teachers who either did not know and/or who answered all the items of the subscale incor‐
rectly.
In order to determine the specific areas of poor knowledge and misconceptions of the content
areas of ADHD, the scores of the educator respondents were examined at the item level for
the three KADDS subscales. The low internal consistency reliability and low average inter-
item correlation for the Associated Features subscale (Table 2) imply that some items of the
subscale were answered correctly by teachers who answered other items incorrectly, and thus
some items would be expected to have vastly different means from others. To reflect the items
on which low and poor correct responses were obtained, a robot-type colour coding system
was used whereby lower means were shaded red and highest means were shaded dark green
with shades of orange for items in between. Item 1, which suggests that ADHD occurs in
approximately 15% of school age children, item 27, which states that children with ADHD
generally experience more problems in novel situations rather than familiar ones, item 30,
which states that the problem behaviours in children with ADHD are distinctly different from
the behaviours of non-ADHD children and item 39, which states that children with ADHD
display an inflexible adherence to routine, all have very low percentage correct responses with
means between 4% and 12%. These percentages are particularly low compared to items 13,
which states that it is possible for an adult to have ADHD, item 31, which refers to the idea
that children with ADHD are more distinguishable from normal children in a classroom setting
as opposed to a free play situation and item 32, which states that the majority of children with
ADHD evidence some degree of poor school performance during their early school years,
which all have relatively high percentage correct responses with means between 60% and 62%.
Apart from these three items, the mean score on the rest of the items of this subscale were all
below 42%, and thus the standard deviations were low on these items and as a result on the
whole subscale. This low response variability would have impacted negatively on the internal
consistency reliability as Cronbach’s alpha was dependent on the variability in the responses.
In order to investigate the low item scores, a distinction was made between misconceptions,
i.e., incorrect responses, versus “don’t know” responses. This distinction is displayed graph‐
ically for the Associated Features items in Figure 1 where bars shaded in blue indicate the
percentage of misconceptions and bars shaded in red indicate incorrect responses for each
item. Figure 1 shows that teachers have the greatest extent of misconception of ADHD on items
27, 1, 39 and 24, which states that a diagnosis of ADHD by itself makes a child eligible for
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the t-test was used to compare the mean knowledge scores on the three KADDS subscales of
these two groups. These analyses were complemented by the researcher’s thematic analysis
of the qualitative responses.
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All of the 100 respondents, who agreed to participate in this study, were female. The average
learner to teacher ratio in the schools include in the schools, were 50:1. Almost two-thirds of
the teachers in the sample were older than 40years, with a negligible number of them in the
20-25 year category. Consistent with the age distribution of the teacher respondents,  the
majority (60%) had more than 11 years of teaching experience, 20% had 6-10 years teach‐
ing experience and 20% had 5 years or less. Almost a quarter of the sample had a universi‐
ty level of education, while the remaining individuals had college level training. Over half
of the respondents expressed no confidence in their ability to teach children with ADHD.
Regarding their knowledge of ADHD, two thirds of the teachers had received no ADHD
training. Over half of the respondents (52%) claimed that they had taught children diag‐
nosed with ADHD and had assisted with ADHD evaluations (59%). Almost 40% claimed
that they had been asked for feedback by a doctor regarding a child with ADHD in their
classroom.
The overall results of the KADDS questionnaire revealed that there is a substantial lack of
knowledge about ADHD amongst the participants. Based on the results of Table 1 the overall
percentage of correct responses to the 39 KADDS items was 34.9%. Nine of the 100 educator
respondents scored zero on all 39 items of the scale.
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Regarding the teachers’ knowledge in terms of the Associated Features subscale, a mean score
of 30.4% was garnered which was lower than the overall scale score of 34.9%, and based on
the median score reflected in Table 1, half of the respondents answered fewer than 31.3% of
these items correctly. The minimum scores of zero on the Associated Features subscale show
10 teachers who either did not know and/or who answered all the items of the subscale
incorrectly. Of the three subscales, the highest mean (percentage correctly answered items) is
for Symptoms/Diagnosis (47.9%). Even on this subscale, the average respondent answered
approximately half of the items incorrectly. Nine of the 100 teachers scored zero on this
Symptoms/Diagnosis subscale. The mean score of 30.6% on the Treatment subscale is compa‐
rably low in relation to the mean score on the Associated Features subscale which was lower
than the overall KADDS score of 34.9%. The minimum scores of zero on this subscale show 15
teachers who either did not know and/or who answered all the items of the subscale incor‐
rectly.
In order to determine the specific areas of poor knowledge and misconceptions of the content
areas of ADHD, the scores of the educator respondents were examined at the item level for
the three KADDS subscales. The low internal consistency reliability and low average inter-
item correlation for the Associated Features subscale (Table 2) imply that some items of the
subscale were answered correctly by teachers who answered other items incorrectly, and thus
some items would be expected to have vastly different means from others. To reflect the items
on which low and poor correct responses were obtained, a robot-type colour coding system
was used whereby lower means were shaded red and highest means were shaded dark green
with shades of orange for items in between. Item 1, which suggests that ADHD occurs in
approximately 15% of school age children, item 27, which states that children with ADHD
generally experience more problems in novel situations rather than familiar ones, item 30,
which states that the problem behaviours in children with ADHD are distinctly different from
the behaviours of non-ADHD children and item 39, which states that children with ADHD
display an inflexible adherence to routine, all have very low percentage correct responses with
means between 4% and 12%. These percentages are particularly low compared to items 13,
which states that it is possible for an adult to have ADHD, item 31, which refers to the idea
that children with ADHD are more distinguishable from normal children in a classroom setting
as opposed to a free play situation and item 32, which states that the majority of children with
ADHD evidence some degree of poor school performance during their early school years,
which all have relatively high percentage correct responses with means between 60% and 62%.
Apart from these three items, the mean score on the rest of the items of this subscale were all
below 42%, and thus the standard deviations were low on these items and as a result on the
whole subscale. This low response variability would have impacted negatively on the internal
consistency reliability as Cronbach’s alpha was dependent on the variability in the responses.
In order to investigate the low item scores, a distinction was made between misconceptions,
i.e., incorrect responses, versus “don’t know” responses. This distinction is displayed graph‐
ically for the Associated Features items in Figure 1 where bars shaded in blue indicate the
percentage of misconceptions and bars shaded in red indicate incorrect responses for each
item. Figure 1 shows that teachers have the greatest extent of misconception of ADHD on items
27, 1, 39 and 24, which states that a diagnosis of ADHD by itself makes a child eligible for
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placement in special education. These items arranged in decreasing order of incorrect re‐
sponses from 53% to 40% and the least extent on items 31, 13 and 32 (these items similarly









1: Most estimates suggest that ADHD occurs in
approximately 15% of school age children.
4% 0% 20% 17% 23% 4.77
4: ADHD children are typically more compliant with their
fathers than with their mothers.
22% 0% 42% 37% 48% 1.37
6: ADHD is more common in the 1st degree biological
relatives (i.e. mother, father) of children with ADHD than in
the general population.
34% 0% 48% 42% 55% 0.69
13: It is possible for an adult to be diagnosed with ADHD. 62% 100% 49% 43% 57% -0.50
17: Symptoms of depression are found more frequently in
ADHD children than in non- ADHD children.
41% 0% 49% 43% 57% 0.37
19: Most ADHD children "outgrow" their symptoms by the
onset of puberty and subsequently function normally in
adulthood.
25% 0% 44% 38% 51% 1.17
22: If an ADHD child is able to demonstrate sustained
attention to video games or TV for over an hour, that child
is also able to sustain attention for at least an hour of class
or homework.
32% 0% 47% 41% 54% 0.78
24: A diagnosis of ADHD by itself makes a child eligible for
placement in special education.
32% 0% 47% 41% 54% 0.78
27: ADHD children generally experience more problems in
novel situations than in familiar situations.
5% 0% 22% 19% 25% 4.19
28: There are specific physical features which can be
identified by medical doctors (e.g. paediatrician) in making
a definitive diagnosis of ADHD.
20% 0% 40% 35% 47% 1.52
29: In school age children, the prevalence of ADHD in
males and females is equivalent.
33% 0% 47% 41% 55% 0.73
30: In very young children (less than 4 years old), the
problem behaviours of ADHD children are distinctly
different from age-appropriate behaviours of non-ADHD
children.
10% 0% 30% 26% 35% 2.71
31: Children with ADHD are more distinguishable from
normal children in a classroom setting than in a free play
situation.
60% 100% 49% 43% 57% -0.41









32: The majority of ADHD children evidence some degree
of poor school performance in the elementary school
years.
66% 100% 48% 42% 55% -0.69
33: Symptoms of ADHD are often seen in non-ADHD
children who come from inadequate and chaotic home
environments.
28% 0% 45% 40% 52% 0.99
39: Children with ADHD generally display an inflexible
adherence to specific routines or rituals.
12% 0% 33% 29% 38% 2.37
Table 2. Associated Features item statistics39: Children with ADHD generally display an 
inflexible adherence to specific routines or rituals. 12% 0% 33% 29% 38% 2.37 
Associated Features item statistics  
 
Categorised responses to Associated Features items  
In line with the relatively higher mean score of the Symptoms/Diagnosis subscale compared to the other subscales (Table 1), the 
item means presented in Table 3 for this subscale are generally higher than those of the Associated Features subscale. The items 
that the teachers found most difficult were 11, which state that it is common for ADHD children to have an inflated sense of self-
esteem or grandiosity and 38, which states that if a child responds to stimulant medications then they probably have ADHD, as the 
mean correct responses obtained were 18% and 23%, respectively. More than two-thirds of the teachers scored the following items 
correctly: item 3, which states that ADHD children are frequently distracted by extraneous stimuli; item 9, which states that ADHD 
children often fidget or squirm in their seats; item 21, which states that a child must present with symptoms in two or more settings 
to obtain an ADHD diagnosis and item 26 which states that ADHD children often have difficulties organising tasks and activities.  
Once again, in order to investigate the low item scores for Symptoms/Diagnosis, a distinction was made between misconceptions, 
that is, incorrect responses, versus “don’t know” responses. This distinction is displayed graphically for the Symptoms/Diagnosis 
items in Figure 2 where bars shaded in blue indicate the percentage of misconceptions and bars shaded in red indicate incorrect 
responses for each item. The figure shows that teachers have the greatest extent of misconceptions of ADHD Symptoms/ Diagnosis 
on item 7, which states that one of the symptoms displayed by ADHD children is that they are cruel to other people and item 14, 
which states that ADHD children often have a history of stealing or destroying other peoples’ things (48% and 47% misconceptions 
respectively). Figure 2 also shows that teachers have the least extent of misconceptions on items 21 and 16; which states that two 
clusters of symptoms exist for ADHD, and items 3, 9 and 26 have between 9% and 5% misconceptions.  
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Figure 1. Categorised responses to Associated Features items
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placement in special education. These items arranged in decreasing order of incorrect re‐
sponses from 53% to 40% and the least extent on items 31, 13 and 32 (these items similarly
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In line with the relatively higher mean score of the Symptoms/Diagnosis subscale compared
to the other subscales (Table 1), the item means presented in Table 3 for this subscale are
generally higher than those of the Associated Features subscale. The items that the teachers
found most difficult were 11, which state that it is common for ADHD children to have an
inflated sense of self-esteem or grandiosity and 38, which states that if a child responds to
stimulant medications then they probably have ADHD, as the mean correct responses obtained
were 18% and 23%, respectively. More than two-thirds of the teachers scored the following
items correctly: item 3, which states that ADHD children are frequently distracted by extra‐
neous stimuli; item 9, which states that ADHD children often fidget or squirm in their seats;
item 21, which states that a child must present with symptoms in two or more settings to obtain
an ADHD diagnosis and item 26 which states that ADHD children often have difficulties
organising tasks and activities.
Once again, in order to investigate the low item scores for Symptoms/Diagnosis, a distinction
was made between misconceptions, that is, incorrect responses, versus “don’t know” respons‐
es. This distinction is displayed graphically for the Symptoms/Diagnosis items in Figure 2
where bars shaded in blue indicate the percentage of misconceptions and bars shaded in red
indicate incorrect responses for each item. The figure shows that teachers have the greatest
extent of misconceptions of ADHD Symptoms/ Diagnosis on item 7, which states that one of
the symptoms displayed by ADHD children is that they are cruel to other people and item 14,
which states that ADHD children often have a history of stealing or destroying other peoples’
things (48% and 47% misconceptions respectively). Figure 2 also shows that teachers have the
least extent of misconceptions on items 21 and 16; which states that two clusters of symptoms









3: ADHD children are frequently distracted by
extraneous stimuli.
70% 100% 46% 40% 54% -0.89
5: In order to be diagnosed with ADHD, the child's
symptoms must have been present before age 7.
36% 0% 48% 42% 56% 0.59
7: One symptom of ADHD children is that they have
been physically cruel to other people.
31% 0% 46% 41% 54% 0.83
9: ADHD children often fidget or squirm in their seats. 78% 100% 42% 37% 48% -1.37
11: It is common for ADHD children to have an inflated
sense of self-esteem or grandiosity.
18% 0% 39% 34% 45% 1.69
14: ADHD children often have a history of stealing or
destroying other people's things
21% 0% 41% 36% 48% 1.45









16: Current wisdom about ADHD suggests two clusters
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Ritalin), then they probably have ADHD.
23% 0% 42% 37% 49% 1.30
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In line with the relatively higher mean score of the Symptoms/Diagnosis subscale compared
to the other subscales (Table 1), the item means presented in Table 3 for this subscale are
generally higher than those of the Associated Features subscale. The items that the teachers
found most difficult were 11, which state that it is common for ADHD children to have an
inflated sense of self-esteem or grandiosity and 38, which states that if a child responds to
stimulant medications then they probably have ADHD, as the mean correct responses obtained
were 18% and 23%, respectively. More than two-thirds of the teachers scored the following
items correctly: item 3, which states that ADHD children are frequently distracted by extra‐
neous stimuli; item 9, which states that ADHD children often fidget or squirm in their seats;
item 21, which states that a child must present with symptoms in two or more settings to obtain
an ADHD diagnosis and item 26 which states that ADHD children often have difficulties
organising tasks and activities.
Once again, in order to investigate the low item scores for Symptoms/Diagnosis, a distinction
was made between misconceptions, that is, incorrect responses, versus “don’t know” respons‐
es. This distinction is displayed graphically for the Symptoms/Diagnosis items in Figure 2
where bars shaded in blue indicate the percentage of misconceptions and bars shaded in red
indicate incorrect responses for each item. The figure shows that teachers have the greatest
extent of misconceptions of ADHD Symptoms/ Diagnosis on item 7, which states that one of
the symptoms displayed by ADHD children is that they are cruel to other people and item 14,
which states that ADHD children often have a history of stealing or destroying other peoples’
things (48% and 47% misconceptions respectively). Figure 2 also shows that teachers have the
least extent of misconceptions on items 21 and 16; which states that two clusters of symptoms
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As for the Associated Features subscale, the knowledge level on the treatment subscale was poor
(Table 4), with 14% or fewer of the teachers responding correctly to item 23, which states that the
reduction of sugar intake leads to the reduction of ADHD symptoms; item 34, which states that
behavioural interventions for children with ADHD focus primarily on the child’s problems with
inattention; item 35, which states that Electroconvulsive Therapy has been found to be an effective
treatment for severe cases of ADHD and item 37, which states that research has shown that the
prolonged use of medications leads to increased addiction in adulthood. Only on item 10, which
states that parent and teacher training in managing an ADHD child are generally effective when
combined with medication, did the majority of the teachers answer correctly.
Once again, the categorised responses of “don’t know” versus misconceptions and correct
responses are displayed in Figure 3 for Treatment items. This figure shows greatest miscon‐
ceptions for items 23 and 34, which relate to dietary intake and ADHD and behavioural/
psychological interventions for children with ADHD (53% and 47% incorrect responses
respectively), and fewest misconceptions on item 35; which relates to electroconvulsive
therapy as a treatment approach for ADHD and item 20, which states that medication is often









2: Current research suggests that ADHD is largely the
result of ineffective parenting skills.
37% 0% 49% 43% 56% 0.55
8: Antidepressant drugs have been effective in reducing
symptoms for many ADHD
46% 0% 50% 44% 58% 0.16
10: Parent and teacher training in managing an ADHD
child are generally effective when combined with
medication treatment.
65% 100% 48% 42% 56% -0.64
12: When treatment of an ADHD child is terminated, it
is rare for the child's symptoms to return.
26% 0% 44% 39% 51% 1.11
15: Side effects of stimulant drugs used for treatment of
ADHD may include mild insomnia and appetite
reduction.
43% 0% 50% 44% 58% 0.29
18: Individual psychotherapy is usually sufficient for the
treatment of most ADHD children.
19% 0% 39% 35% 46% 1.60
20: In severe cases of ADHD, medication is often used
before other behavior modification techniques are
attempted.
36% 0% 48% 42% 56% 0.59
23: Reducing dietary intake of sugar or food additives is
generally effective in reducing the symptoms of ADHD.
7% 0% 26% 23% 30% 3.42
25: Stimulant drugs are the most common type of drug
used to treat children with ADHD
34% 0% 48% 42% 55% 0.69









34: Behavioral/Psychological interventions for children
with ADHD focus primarily on the child's problems with
inattention.
12% 0% 33% 29% 38% 2.37
35: Electroconvulsive Therapy (i.e. shock treatment) has
been found to be an effective treatment for severe
cases of ADHD.
14% 0% 35% 31% 41% 2.11
36: Treatments for ADHD which focus primarily on
punishment have been found to be the most effective
in reducing the symptoms of ADHD.
47% 0% 50% 44% 58% 0.12
37: Research has shown that prolonged use of
stimulant medications leads to increased addiction (i.e.,
drug, alcohol) in adulthood.
12% 0% 33% 29% 38% 2.37
Table 4. Treatment item statistics
 
Categorised responses to Treatment items 
In order to investigate whether the teachers’ general knowledge of the content areas of ADHD differed in terms of their 
demographic group ,their scores on the three ADHD content areas were compared across the levels of each of the demographic 
variables (Table 5)  using 1- way Analysis of Variance (ANOVA).  















2. Age group 2 2.114   2.126  2.674   
3. Education level 1 15.780 *** 13.919 *** 6.409 * 
4. Number of years of teaching 
experience 
2 1.485   1.174  0.092   
5. Hours of ADHD training 
received 
2 9.035 *** 8.521 *** 15.924 *** 
6. Evaluations/ assessments of 
children you thought may be 
ADHD 
1 0.071   0.432  0.059   
7. Number of children taught 
with a medical diagnosis of 
ADHD 
1 0.347   0.919  1.431   
8. Number of workshops 
attended on ADHD 
1 11.508 ** 13.928 *** 20.087 *** 
9. Number of articles read on 
ADHD 
2 6.538 ** 18.290 *** 20.170 *** 
10. Confidence to teach a child 
with ADHD 
3 3.275 * 8.298 *** 5.629 ** 
11. Teachers asked by a DR to 
assess the medication of a child 
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In order to investigate whether the teachers’ general knowledge of the content areas of ADHD
differed in terms of their demographic group,their scores on the three ADHD content areas
were compared across the levels of each of the demographic variables (Table 5) using 1- way















2. Age group 2 2.114 2.126 2.674
3. Education level 1 15.780 *** 13.919 *** 6.409 *
4. Number of years of teaching
experience
2 1.485 1.174 0.092
5. Hours of ADHD training
received
2 9.035 *** 8.521 *** 15.924 ***
6. Evaluations/ assessments of
children you thought may be
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1 0.071 0.432 0.059
7. Number of children taught
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8. Number of workshops
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1 11.508 ** 13.928 *** 20.087 ***
9. Number of articles read on
ADHD
2 6.538 ** 18.290 *** 20.170 ***
10. Confidence to teach a child
with ADHD
3 3.275 * 8.298 *** 5.629 **
11. Teachers asked by a DR to
assess the medication of a child
with ADHD
1 12.506 *** 21.961 *** 16.809 ***
Table 5. ADHD content areas compared across levels of demographic variables
Education and training is the common theme underlying these items reflecting significant
differences on knowledge levels of the three ADHD content areas. Based on the direction of
the means and the Scheffe post hoc tests for the significant ANOVA comparisons, the general
trend of the means is that the more educated and trained teachers are more knowledgea‐
ble in each of the three ADHD content areas than are the less educated and trained teach‐
ers. Specifically, teachers with a university education score significantly higher than those
with a college education [F (1;93) = 15. 780, p < 0.001; F(1; 93) = 13.919, p < 0.001; and F (1;93)
= 6.409, p < 0.05], teachers with more than ten hours of ADHD training score higher than
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teachers with none or few hours, [(F (1; 93) = 9. 035, p < 0.001; F (1; 93) = 8.521, p< 0.001; and
F (1; 93) = 15. 924, p <0.05]. Those teachers that have attended ADHD workshops score higher
than those who have not [(F (2; 93) = 11. 508, p < 0.001; F (2; 93) = 13. 928, p< 0.001; and F (1;
93) = 20. 087, p <0.05]. Those teachers who have read more than five ADHD articles score
higher than those who have not read any ADHD articles [(F (2; 93) = 6. 538, p < 0.001; F (2;
93) = 18. 290, p< 0.001; and F (2; 93) = 20. 170, p <0.05]. In addition, those teachers who have
been asked by a doctor to assess medication of a child with ADHD, and those who feel more
confident to teach children with ADHD have significantly higher scores on the three ADHD
content areas than other teachers (F (3; 93)= 3.275, p < 0.001; F (3; 93) = 8.298, p < 0.001 and
F(3; 93) = 5.629, p< 0.05) and (F (1; 93)= 12. 506, p < 0.001; F (1; 93) = 21. 961, p < 0.001 and
F(1; 93) = 16. 809, p< 0.05). Finally, it should be noted for all the significant comparisons of
the demographic variables, knowledge levels on the Symptoms/ Diagnosis content area were
significantly  higher  than  on  the  Associated  Features  and  Treatment  content  areas.  The
qualitative results from the questionnaire revealed that teachers are willing and eager to
participate in workshops on ADHD, substantiated by 73% of the sample group indicating
that they were in favour of this. Interestingly, the 27% of teachers who did not opt to attend
the workshop tended to be older, less confident (Pearson Chi-square(3) = 6.41, p<0.10), tended
to have attended fewer ADHD workshops, read fewer ADHD articles and had been less
often  asked by  a  doctor  to  assess  the  medication of  a  child  with  ADHD (Pearson Chi-
square(1) = 5.00, p<0.05). However, although the mean scores on the three content areas of
ADHD of the respondents who opted for the workshops were marginally higher than those
who did not opt to attend, these differences were not significant.
Teachers were given the opportunity to provide additional comments at the end of the
questionnaire. Four teachers commented that there exists a lack of resources at the disposal of
teachers and that schools should have special classes for children with ADHD, and that schools
have a dire need for psychologists to help identify the children who are displaying ADHD -
like symptoms as soon and early on as possible. Some of the teachers explained that there is
often a misdiagnosis of ADHD; and often an over diagnosis made by teachers of this condition.
Teachers expressed that they would like to learn more about the identification, treatment and
possible classroom interventions for learners with ADHD children.
5.5. Discussion
This study sought to investigate the knowledge and perceptions of ADHD held by Foundation
Phase teachers within a township setting in South Africa. The results of the study suggested
that there exists a substantial lack of knowledge about ADHD among this sample group. These
findings are consistent with the body of literature which states that teachers generally lack
knowledge and hold certain misconceptions in the area of ADHD [21]. Teachers in the present
study were the most knowledgeable about the symptoms of ADHD, less knowledgeable about
the associated features and the least knowledgeable about treatment for this condition; which
supported the results reported in an Australian study [21].
Teachers’ generally good understanding of the symptoms of ADHD which was shown in this
research study, is supported by several other South African studies which were conducted
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using a range of different teacher and school samples [2, 26, 28, 44]. Even though teachers in
this study obtained the highest percentage of correct responses for the symptoms/diagnosis
subscale of the KADDS, there were two specific items which resulted in the greatest extent of
teacher misperception. Physical cruelty to other people and a history of stealing and destroying
other people’s things were perceived by the teachers as features of ADHD. The behaviours
included in these two items are those that are characteristic of a Conduct Disorder and
suggestive of an Oppositional Defiant Disorder [45], which the teachers in the present study
may not have been aware of. These findings are consistent with the results of a study that was
conducted in America [23].
In the present study, teachers were less knowledgeable about the associated features of ADHD,
than they were about the symptoms, as half of the respondents answered less than 31% of the
items on this subscale correctly. However, teachers obtained the lowest scores on the treatment
subscale. Teachers in the present study possessed very poor and even incorrect knowledge
regarding the treatment of ADHD. This finding has an important implication for teacher pre-
service and in-service training, as teachers play an important role in the identification,
management and treatment of ADHD [21]. Teachers in this study seemed to possess limited
and even incorrect knowledge on the after effects of medication, and many of them believed
that stimulant medications lead to drug and alcohol addictions in adulthood. Nevertheless,
the majority of the teachers in the current study were aware that parent and teacher training
in managing a child diagnosed with ADHD combined with medical treatment, was generally
an effective and preferable method of treatment for this condition.
In line with the results of a number of other studies [2, 46], a large number of teachers in the
present study incorrectly believed that the alteration of diet and the reduction of sugars and
food additives would lead to the alleviation of ADHD symptoms. Few studies have supported
the idea that the alteration of one’s diet alleviates symptoms of ADHD, and in fact labels this
belief as a common myth [15].
Among the sample group in this study, there existed a clear lack of knowledge on the epi‐
demiology of ADHD, as a very low percentage of correct responses was obtained for the item
which stated that most estimates suggest that ADHD occurs in approximately 15% of school
age children. As pointed out by the study conducted by [23], if teachers are unaware of how
many students in their classrooms have ADHD, it may lead to the condition being overlooked
and unidentified, or conversely, it may lead to the teacher attributing many of a child’s unruly
and uncharacteristic behaviours to ADHD resulting in incorrect referrals [2].
Poor academic performance is often considered as one of the most prominent factors associated
with ADHD, and students with ADHD are at an increased risk for grade retention and school
failure [15]. Teachers in the present study seemed to be aware of this, and results revealed a
large number of correct responses for the questionnaire item which looked at the idea that the
majority of ADHD children evidence some degree of poor school performance in the elemen‐
tary school years.
In this study, while the age of the teachers was unrelated to their overall level of ADHD
knowledge, their educational level was positively related to this variable. The higher their level
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of education, the more knowledge they possessed on ADHD, possibly as a result greater
exposure to this condition. Unlike the findings of [31], teachers’ knowledge of ADHD was
unrelated to their number of years of teaching experience in this study. An important finding
for school administrators is the result that teachers who previously attended training pro‐
grammes and workshops and those that were exposed to ADHD by means of written articles,
all knew more about the condition than those teachers with less training and exposure in the
area. Furthermore, teachers who felt more confident to teach a child with ADHD obtained
higher scores on the KADDS, and thus knew more about the condition. This finding supports
the results of studies conducted by [2, 31], where the more confident teachers had more
knowledge on ADHD.
It was noted in this study, that it was the younger, more confident, more experienced teachers
who wanted to participate in workshops on ADHD. The teachers also suggested that the
workshops include a section on treatment, which is an area where knowledge is seemingly
lacking. The older, more inexperienced teachers were those who were reluctant and disinter‐
ested to partake in workshops. One reason for this may be because the older teachers are more
set in their ways, and are thus more reluctant to engage in and learn new material.
The finding may be related to what Martin Seligman calls learned helplessness. This is once
an “individual learns that he or she is not in control, the motivation to seek control may be
shut down, even when control later becomes possible [47, p.252]. Due to the lack of resources
within the townships in South Africa and the possible lack of options that some of these
teachers are faced with, they may have come to learn that they are not in control of the situation,
and often what they do is to no avail. Thus, when a workshop is offered to them, they may
have learned that they are not in control, and consequently they do not believe that the
workshop will be of assistance and benefit to them.
5.6. Implications of the research
Results of the study imply that South African Foundation Phase teachers do not have adequate
knowledge or sufficient understanding of ADHD. Teachers seem to have some information
on the symptoms of ADHD, and less on the associated features and treatment for the condition.
It is therefore important that training programmes or workshops address these gaps in the
teachers’ knowledge regarding the condition. Overall, the majority of teachers in this study
expressed willingness to participate in workshops and training programmes on ADHD.
Teachers also indicated that there is a lack of resources at the township schools to aid in the
recognition and management of the condition. It is essential that the South African Department
of Education becomes aware of these issues and provides teachers with the necessary training
and ongoing support to facilitate the learning and schooling experience and holistic develop‐
ment of children with ADHD. This is of particular importance if inclusive education is to be
implemented successfully.
5.7. Limitations of the study
The following were some of the limitations of the present research study:
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may not have been aware of. These findings are consistent with the results of a study that was
conducted in America [23].
In the present study, teachers were less knowledgeable about the associated features of ADHD,
than they were about the symptoms, as half of the respondents answered less than 31% of the
items on this subscale correctly. However, teachers obtained the lowest scores on the treatment
subscale. Teachers in the present study possessed very poor and even incorrect knowledge
regarding the treatment of ADHD. This finding has an important implication for teacher pre-
service and in-service training, as teachers play an important role in the identification,
management and treatment of ADHD [21]. Teachers in this study seemed to possess limited
and even incorrect knowledge on the after effects of medication, and many of them believed
that stimulant medications lead to drug and alcohol addictions in adulthood. Nevertheless,
the majority of the teachers in the current study were aware that parent and teacher training
in managing a child diagnosed with ADHD combined with medical treatment, was generally
an effective and preferable method of treatment for this condition.
In line with the results of a number of other studies [2, 46], a large number of teachers in the
present study incorrectly believed that the alteration of diet and the reduction of sugars and
food additives would lead to the alleviation of ADHD symptoms. Few studies have supported
the idea that the alteration of one’s diet alleviates symptoms of ADHD, and in fact labels this
belief as a common myth [15].
Among the sample group in this study, there existed a clear lack of knowledge on the epi‐
demiology of ADHD, as a very low percentage of correct responses was obtained for the item
which stated that most estimates suggest that ADHD occurs in approximately 15% of school
age children. As pointed out by the study conducted by [23], if teachers are unaware of how
many students in their classrooms have ADHD, it may lead to the condition being overlooked
and unidentified, or conversely, it may lead to the teacher attributing many of a child’s unruly
and uncharacteristic behaviours to ADHD resulting in incorrect referrals [2].
Poor academic performance is often considered as one of the most prominent factors associated
with ADHD, and students with ADHD are at an increased risk for grade retention and school
failure [15]. Teachers in the present study seemed to be aware of this, and results revealed a
large number of correct responses for the questionnaire item which looked at the idea that the
majority of ADHD children evidence some degree of poor school performance in the elemen‐
tary school years.
In this study, while the age of the teachers was unrelated to their overall level of ADHD
knowledge, their educational level was positively related to this variable. The higher their level
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of education, the more knowledge they possessed on ADHD, possibly as a result greater
exposure to this condition. Unlike the findings of [31], teachers’ knowledge of ADHD was
unrelated to their number of years of teaching experience in this study. An important finding
for school administrators is the result that teachers who previously attended training pro‐
grammes and workshops and those that were exposed to ADHD by means of written articles,
all knew more about the condition than those teachers with less training and exposure in the
area. Furthermore, teachers who felt more confident to teach a child with ADHD obtained
higher scores on the KADDS, and thus knew more about the condition. This finding supports
the results of studies conducted by [2, 31], where the more confident teachers had more
knowledge on ADHD.
It was noted in this study, that it was the younger, more confident, more experienced teachers
who wanted to participate in workshops on ADHD. The teachers also suggested that the
workshops include a section on treatment, which is an area where knowledge is seemingly
lacking. The older, more inexperienced teachers were those who were reluctant and disinter‐
ested to partake in workshops. One reason for this may be because the older teachers are more
set in their ways, and are thus more reluctant to engage in and learn new material.
The finding may be related to what Martin Seligman calls learned helplessness. This is once
an “individual learns that he or she is not in control, the motivation to seek control may be
shut down, even when control later becomes possible [47, p.252]. Due to the lack of resources
within the townships in South Africa and the possible lack of options that some of these
teachers are faced with, they may have come to learn that they are not in control of the situation,
and often what they do is to no avail. Thus, when a workshop is offered to them, they may
have learned that they are not in control, and consequently they do not believe that the
workshop will be of assistance and benefit to them.
5.6. Implications of the research
Results of the study imply that South African Foundation Phase teachers do not have adequate
knowledge or sufficient understanding of ADHD. Teachers seem to have some information
on the symptoms of ADHD, and less on the associated features and treatment for the condition.
It is therefore important that training programmes or workshops address these gaps in the
teachers’ knowledge regarding the condition. Overall, the majority of teachers in this study
expressed willingness to participate in workshops and training programmes on ADHD.
Teachers also indicated that there is a lack of resources at the township schools to aid in the
recognition and management of the condition. It is essential that the South African Department
of Education becomes aware of these issues and provides teachers with the necessary training
and ongoing support to facilitate the learning and schooling experience and holistic develop‐
ment of children with ADHD. This is of particular importance if inclusive education is to be
implemented successfully.
5.7. Limitations of the study
The following were some of the limitations of the present research study:
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• The sample for the study was obtained on a strict voluntary basis; using a purposive, non
probability sampling method. The current sample is not representative of the entire
population of Foundation Phase township teachers. Responses to the questionnaire were
very much dependent on the teachers’ availability and willingness to participate in the
study. A sample of 100 teachers from a specific geographic location was obtained, and there
were no male participants. Thus, the sample used in the study was small and narrow. For
these reasons, issues with generalisability arose and therefore widespread conclusions from
the results cannot be drawn.
• English is not a first language for many of the teachers that participated in the research
study. It is unknown to what extent the teachers’ responses to the questionnaire were
hampered by language related issues, which similar research studies conducted in the future
would have to consider. The construct validity of the measuring instrument used was
therefore a possible limitation of the study.
• There is limited local literature and research on ADHD. Further work is necessary to develop
and contextualize international developments in relation to the unique South African
context.
5.8. Suggestions for future research
The following suggestions are made for future research:
• The majority of teachers in this study were willing to participate in workshops related to
ADHD training. Future researchers could focus on creating and providing training pro‐
grammes that would bridge the gaps in knowledge about ADHD and its causes, symptoms
and treatment.
• After the implementation of teacher training and workshops, follow up programme
evaluation studies and longitudinal research would be beneficial. This research could serve
as a springboard for future workshops and educational programs to be implemented at
schools at a national level.
• Broader teacher samples from public, private, rural and township schools need to be
considered in future ADHD studies.
• Future research could focus on creating awareness and gathering resources to aid in the
recognition and management of the condition at schools. It is essential that teachers receive
the necessary training and ongoing support to facilitate the learning and schooling experi‐
ence of children with ADHD.
6. Conclusion
This chapter primarily focused on one particular South African study [36] that sought to
investigate the knowledge and perceptions of ADHD held by Foundation Phase teachers in a
township in Gauteng. The results of the study were compared to local and international
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research conducted in the last decade. After an in depth analysis of the results of the study and
other research conducted, the chapter highlighted that the lack of knowledge that teachers has,
as well as the misperceptions they hold regarding ADHD, need to be addressed as teachers
play a vital role in the identification, diagnosis, referral and treatment process of ADHD.
Inaccurate information about ADHD can lead to inaccurate referrals, resulting in the incorrect
information being relayed to parents and doctors, which in itself has negative effects and
consequences for individuals’ diagnosed with the condition. In addition the chapter also noted
the need for more workshops and programmes to become available to teachers to aid them in
the recognition and management of ADHD in their classrooms. Overall, the chapter high‐
lighted the need for more research to be conducted in the area of ADHD in South Africa, in
order for every learner to maximise his or her potential and to succeed within the South African
inclusive education classroom environment.
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• The sample for the study was obtained on a strict voluntary basis; using a purposive, non
probability sampling method. The current sample is not representative of the entire
population of Foundation Phase township teachers. Responses to the questionnaire were
very much dependent on the teachers’ availability and willingness to participate in the
study. A sample of 100 teachers from a specific geographic location was obtained, and there
were no male participants. Thus, the sample used in the study was small and narrow. For
these reasons, issues with generalisability arose and therefore widespread conclusions from
the results cannot be drawn.
• English is not a first language for many of the teachers that participated in the research
study. It is unknown to what extent the teachers’ responses to the questionnaire were
hampered by language related issues, which similar research studies conducted in the future
would have to consider. The construct validity of the measuring instrument used was
therefore a possible limitation of the study.
• There is limited local literature and research on ADHD. Further work is necessary to develop
and contextualize international developments in relation to the unique South African
context.
5.8. Suggestions for future research
The following suggestions are made for future research:
• The majority of teachers in this study were willing to participate in workshops related to
ADHD training. Future researchers could focus on creating and providing training pro‐
grammes that would bridge the gaps in knowledge about ADHD and its causes, symptoms
and treatment.
• After the implementation of teacher training and workshops, follow up programme
evaluation studies and longitudinal research would be beneficial. This research could serve
as a springboard for future workshops and educational programs to be implemented at
schools at a national level.
• Broader teacher samples from public, private, rural and township schools need to be
considered in future ADHD studies.
• Future research could focus on creating awareness and gathering resources to aid in the
recognition and management of the condition at schools. It is essential that teachers receive
the necessary training and ongoing support to facilitate the learning and schooling experi‐
ence of children with ADHD.
6. Conclusion
This chapter primarily focused on one particular South African study [36] that sought to
investigate the knowledge and perceptions of ADHD held by Foundation Phase teachers in a
township in Gauteng. The results of the study were compared to local and international
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research conducted in the last decade. After an in depth analysis of the results of the study and
other research conducted, the chapter highlighted that the lack of knowledge that teachers has,
as well as the misperceptions they hold regarding ADHD, need to be addressed as teachers
play a vital role in the identification, diagnosis, referral and treatment process of ADHD.
Inaccurate information about ADHD can lead to inaccurate referrals, resulting in the incorrect
information being relayed to parents and doctors, which in itself has negative effects and
consequences for individuals’ diagnosed with the condition. In addition the chapter also noted
the need for more workshops and programmes to become available to teachers to aid them in
the recognition and management of ADHD in their classrooms. Overall, the chapter high‐
lighted the need for more research to be conducted in the area of ADHD in South Africa, in
order for every learner to maximise his or her potential and to succeed within the South African
inclusive education classroom environment.
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1. Introduction
Children with ADHD are known to display primary features of impulsivity, inattention
and/or hyperactivity [1]. They also constitute a diverse group, encompassing predominantly
inattentive (ADHD-I), hyperactive/impulsive (ADHD-HI) and combined (ADHD-C) sub‐
types with multiple comorbidities and developmental paths [2]. ADHD children’s cognitive
functioning and outcomes have been investigated extensively. Remarkably, much less re‐
search and prevention efforts have been devoted to their emotional processes and outcomes
[2-4]. Consistent with a surge in research placing emotions at the centre of various psycho‐
pathologies over the past decade, a start has been made toward gaining a more balanced
view of ADHD children’s functioning.
This chapter discusses why emotion research is important for ADHD children (§2), presents
the FACE©-model (Facilitating the Adjustment of Cognition and Emotion, [5, 6]) (§3) as a
comprehensive framework through which to identify the major components and levels of
emotional and associated cognitive functioning covered by the broad concept of emotion
regulation (ER) (§4) and critically reviews which of these issues have been investigated in
the context of ADHD (§5). The chapter pursues with identifying cautions and conditions for
translating research into practice and reformulating these into a resiliency perspective on
ADHD children’s emotional functioning, after which implications are drawn from the evi‐
dence-base to inform intervention and prevention efforts with ADHD youth and their fami‐
lies (§6). The chapter briefly rounds out by outlining a strengths-based perspective on
further emotion-oriented research and practice with ADHD youth (§7).
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terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
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2. Why emotional functioning matters in children with ADHD
ADHD children’s frequent learning and academic difficulties have received ample attention
[1,2]. Programs destined at helping children with ADHD typically focus on alleviating the
behavioural components that contribute to such difficulties in order to facilitate their school
and subsequent professional curriculum. Less extensively investigated yet widely docu‐
mented is ADHD children’s often complicated social, relational and family functioning [7-9].
Children with ADHD are known, for example, to have more negative peer relationships
[10], be subject to bullying [11], engage in risk-taking and antisocial behaviour [12], and ex‐
perience family difficulties [4, 13, 14]. While these risk factors have led to underscoring the
importance of social skills training for children with ADHD, relatively few studies to date
have investigated these issues from an emotion perspective that may shed light on their un‐
derlying mechanisms.
Children with ADHD are also diagnosed more often than not with comorbid disorders [1],
such as conduct disorder (CD) and oppositional defiant disorder (ODD) in 40 to 60% of cas‐
es [15-17], as well as anxiety and depression (including suicide risks) [17-20]. Attachment
problems [21, 22] and posttraumatic stress symptoms/disorder are also frequently associated
with ADHD [12, 23]. Furthermore, Bipolar Disorder (BD) constitutes a major possible co‐
morbidity with emotional implications for ADHD children [5, 24-26]. Pointing to yet another
line of potential deficits in emotion processing, it is also increasingly acknowledged that
children may concurrently present with ADHD and autism spectrum symptoms or disorder
(ASS/D) [27-29].
When evaluating the impact of ADHD on children’s developmental course, research there‐
fore typically grapples with the issue of disentangling to what extent their relational and so‐
cial problems are a mere consequence of their core behaviour regulation difficulties, or
whether and when these problems reflect more fundamental facets of their emotional func‐
tioning. In addition, the pervasiveness of emotion-related difficulties throughout the spec‐
trum of ADHD subtypes and comorbidities questions the extent to which such difficulties
are ADHD (subtype) specific or represent overarching mechanisms of emotional dysregula‐
tion that broadly put children at risk for experiencing clinical problem behaviour.
3. ADHD children’s behaviour in FACE©-perspective: Cognitive and
emotional adjustments within a risk-resiliency context
While diverse areas of research address the above-cited issues separately, there is a need to
move toward a comprehensive, integrated view of ADHD children’s cognitive and emotion‐
al functioning, so as to inform research as well as prevention and intervention efforts in this
context. Stated in a nutshell and schematized in Figure 1, the FACE©-model aims to respond
to this need by focusing on ADHD children’s reciprocal adjustments of cognitive control
and emotion regulation on a micro-level, while accounting for biopsychosocial risk and re‐
siliency dynamics on a macro-level [4-6].
Attention Deficit Hyperactivity Disorder in Children and Adolescents244
Figure 1. ADHD Children’s Functioning in FACE©-perspective, at Cognitive-Emotional Micro-level and at Biopsychoso‐
cial Macro-level
The FACE©-model thus posits that in order to constructively apprehend and act upon
ADHD children’s behavioural and relational challenges, it is necessary to gain insight into
their cognitive-emotional adjustment processes within the ecological context of their experi‐
enced allostatic load [30]. Importantly, systematically accounting for the risk and resiliency
balance operating in the ADHD child’s life should also contribute to a strengths-based ap‐
proach that fosters the ‘positive faces’ of ADHD and thereby pave the way for effective pre‐
vention and intervention programs [4, 31, 32]. Figure 1 illustrates this model at micro-level
[6, 25, 33-35] and at macro-level [4, 6, 30], as discussed hereafter.
3.1. The role of reciprocal cognitive and emotional adjustments on a micro-level
The notion that successful coordination of cognitive control and emotion regulation is pivo‐
tal to adaptive behaviour has been increasingly recognised over the past decade.
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From a predominantly cognitive perspective, ADHD’s cardinal characteristics of impaired
sustained attention and impulsiveness provide grounds per se for expecting so-called top-
down disturbances of emotional functioning. Attentional fluctuations for example may in‐
terfere with how and when the child notices emotional cues, both internal and interpersonal
[36-39]. Similarly, poor behavioural control and planning typical of ADHD are likely to
hamper, amongst others, the child’s ability to postpone emotional responses or to adequate‐
ly modulate their form and intensity [40-43]. High-order cognitive processes such as behav‐
ioural inhibition, sustained attention, attention allocation and cognitive switching indeed
are critical to flexibly responding to emotional interactions in everyday life. Neuroscience
studies have allowed to quite consistently link ADHD children’s problems with these proc‐
esses to distinct underactivation of inferior frontal cortex (IFC) and dorsolateral prefrontal
cortex (DLPFC) circuitries. In comparison, evidence suggests that conduct disordered chil‐
dren display underactivation of paralimbic system areas and bipolar children of ventral
frontostriatal circuitry [44, 45].
Even within this top-down perspective, the reciprocal directions of cognitive and emotional
effects in behavioural (dis)adjustments need to be underscored. For example, in a five-year
follow-up of preadolescent girls with ADHD, the association between childhood executive
functioning skills such as planning and adolescent internalising and externalising comorbid‐
ity was partially mediated by social functioning in adolescence, and vice versa [46]. Studies
in this vein yet still focus on behavioural manifestations of interpersonal functioning rather
than on underlying emotional processes. Moreover, although the above predominant ‘cogni‐
tive-toward-emotional’ pathways have been only partially investigated to date, it has be‐
come apparent that they do not suffice to fully explain the range of emotional dysfunction
and comorbidity in children with ADHD [47, 48].
More recently, ADHD theories have therefore turned to including an emotion-centred per‐
spective. This perspective is supported by brain functioning studies on how underlying
emotional mechanisms may be disrupted in their own right in the context of ADHD [47, 49].
Neuroimaging studies indeed demonstrate the complexity of the neurobiological circuitry of
emotion regulation, which requires continuous adjustments and integration of limbic and
prefrontal brain systems [19, 45, 50, 51]. The dorsolateral, orbitofrontal and anterior cingu‐
late cortex in fact are part of complex interrelated networks that mediate emotional and cog‐
nitive information processing in relation with striatal, cerebellar, and parietal regions along
with the amygdala and hippocampus [44, 45, 48, 51, 52]. More specifically, ADHD disrup‐
tions in IFC and DLPFC regions are found to be associated with prominent structural defi‐
cits in basal ganglia, deficient connectivity with reduced amygdala along with (possibly
compensatory) enlarged hippocampus, all of which mediate emotion processing [44, 49]. Ex‐
pectations of central emotional disruptions in ADHD children’s functioning hereby are fur‐
ther supported by the convergence of certain early-onset ADHD manifestations and the
developmental precedence of the emotional brain systems compared to a comparatively late
maturing cognitive circuitry [37, 44].
In short, from a micro-level perspective, children with ADHD may be vulnerable to emotion
dysregulation through predominant ‘cognitive-toward-emotional’ pathways as well as
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through primary disturbances in an intrinsically integrated ‘emotional-with-cognitive com‐
ponents’ circuitry. This intricacy of reciprocal emotion and cognitive processing provides a
basis for neural understanding of the different emotion regulation levels detailed further on.
3.2. The role of the biopsychosocial risk and resiliency balance on a macro-level
Several fields of study, such as developmental psychopathology, trauma and stress-related
as well as neurobiological investigations, converge to demonstrate that children’s dysfunc‐
tional behaviour, cognition and emotion do not occur in isolation but relative to an immedi‐
ate and larger environment [7, 31, 53]. Children’s direct and long-term outcomes are
determined by a dynamic balance of risks versus resources across several domains through‐
out their development, as illustrated in Figure 1 [6].
Children with ADHD are known to be at increased risk of confronting additional stressors
that even further diminish their perceived resources, notably as regards their parents’ (e.g.
ADHD, substance abuse, stress, anxiety) and siblings’ functioning (e.g. ADHD or behaviou‐
ral problems) [13, 54, 55], along with the quality of their parenting (e.g. harsh or inconsis‐
tent) [56, 57] and family environments (e.g. high levels of negative expressed emotions) [14,
58, 59] as well as school or leisure context (e.g. peer rejection) [10, 11, 60]. In other words,
assessing ADHD children’s emotional functioning without considering the scope of stres‐
sors versus resources operating in their immediate and larger environment will generate on‐
ly a limited understanding of the processes at hand.
Investigating this risk-resiliency load furthermore may be particularly pertinent to under‐
standing  ADHD  children’s  emotional  functioning  given  their  peculiar  arousal  balance.
Children  with  ADHD  are  indeed  documented  to  struggle  simultaneously  with  being
overburdened  and  under-challenged  when  processing  information  [2].  While  these  fea‐
tures  have  been  demonstrated  in  predominantly  cognitive  situations,  and while  clinical
accounts  do  tend  to  reflect  issues  with  emotional  overburdening  in  ADHD  children’s
day-to-day interpersonal functioning [4, 61, 62], there is a need for empirical evidence to
this regard.
In short, ADHD children’s emotion regulation skills may be extra challenged given the po‐
tential level of additional stressors that they tend to face. Their emotional functioning there‐
fore deserves to be examined against the broader backdrop of cumulative risks operating in
their lives. Inversely, assessing the impact of contextual resources on ADHD children’s emo‐
tion regulation skills is likely to provide precious leads for enhancing intervention and pre‐
vention efforts.
Taking into account these conceptual foundations, the FACE©-model hereafter first more
specifically guides our focus on the emotional  and associated cognitive components im‐
plied in the emotion regulation process (§4). The evidence-base with regard to how these
components present in children with ADHD is then primarily discussed on a micro-level
(§5, 5.1-5.3).  Macro-level parenting and family influences on ADHD children’s emotional
functioning  are  briefly  reviewed  in  relation  to  their  cognitive-emotional  adjustments
(§5.4).
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4. Which aspects of emotion regulation merit investigation in ADHD
children and why?
The field of emotion regulation research is unwieldy and potentially confusing as illustrated
hereafter (§4.1). To clarify the evidence-base regarding ADHD children’s emotion regula‐
tion, the next paragraphs first disentangle its major operational components (§4.2) and then
integrate these in the micro-level of the model introduced with Figure 1 (§4.3).
4.1. Investigating ADHD children’s emotion regulation: A complex issue
The adequate recognition and expression of emotions is fundamental to a child's develop‐
ment, and emotion regulation is instrumental to the personal and relational as well as the
cognitive fulfilment of the child [42, 63]. Despite this knowledge, few empirical studies
among children with ADHD (or adults for that matter) are specifically dedicated to their
emotion regulation skills. It has not helped that emotion regulation tends to be approached
in a broad variety of ways, regardless of the investigated population. The focus of ER re‐
search with ADHD children notably ranges from physiological mechanisms and neurobio‐
logical circuits to questionnaire-based and observational behavioural measures; and from
laboratory to ecologically pertinent studies. Furthermore, emotional functioning consists of
autonomic, automated and implicit responses [16, 48, 50] as well as deliberate, effortful reg‐
ulation [20, 37], which adds to the investigation range [42]. In fact, the transient, elusive and
subjective nature of emotions has complicated the process of generating an encompassing
and yet precise definition of emotion since centuries, and has probably contributed to em‐
pirical research shying away from the subject [51, 64]. The conceptualisation history of
ADHD thus has moved away during the second half of the 20th century from emotional fea‐
tures that were previously included in its core descriptions, only to return to addressing
their pervasiveness in the contemporary literature [47]. In recent years, a more pragmatic
approach involves focussing on the typical or core features of ER that allow setting a frame‐
work with working definitions to guide emotion research [63].
4.2. Major operational components and levels of emotion regulation
Three operational specifications of emotion regulation appear particularly pertinent to the
present purpose of clarifying the investigation of emotional processes in children with
ADHD.
First, emotions are bio-psycho-social phenomena that consist of (unconscious, autonomic)
physiological reactions, which are accompanied by subjective experiences and behavioural
expressions within a given context [48, 63, 65]. Emotion research with ADHD children there‐
fore deserves to include at least three levels of interest, namely a biological, an (introspec‐
tive) experiential and a behavioural-interpersonal level.
Second, competent emotional functioning, which appears to be challenged in children with
ADHD, consequently comprises at least three core, interconnected components that merit
examination, namely the adequate appraisal, modulation and expression of emotions [42,
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50, 63, 64, 66]. Cognitive and emotional processes are intricately interwoven in these compo‐
nents. This is the case, for instance, as thoughts and feelings jointly constitute the subjective
experience accompanying a child’s initial physiological reactions (appraisal); or as memory
intervenes along with emotional reactivity in how the child regulates emotional intensity
(modulation); or as attention allocation, planning and attributed feeling reciprocally deter‐
mine the behaviour through which the child exhibits an emotion (expression).
Third and in line with the above, a more detailed working definition of the process of emotion
regulation has been proposed by Eisenberg and Spinrad (2004) as consisting of “initiating,
avoiding, inhibiting, maintaining, or modulating the occurrence, form, intensity, or duration
of internal feeling states, emotion-related physiological, attentional processes, motivational
states, and/or the behavioural concomitants of emotion in the service of accomplishing af‐
fect-related biological or social adaptation or achieving individual goals” [67, p.338]. This
definition further highlights the important range of processes at work in emotion regulation.
Taking into account this working definition, ADHD children’s important levels of external‐
ising (CD, ODD, BD) as well as internalising comorbidity (anxiety, depression, BD) imply
that their emotional arousal, appraisal and expression might carry both ‘hot’ and ‘cold’, as
well as ‘approach’ and ‘avoidance’ features as detailed further on [60].
4.3. ADHD children’s emotion regulation conceptually revisited
Closing in on the micro-level of the FACE©-model allows summarising the aforementioned
multiple facets and levels of emotional, and associated cognitive, functioning covered by the
concept of emotion regulation, as visualised in figure 2.
Figure 2. ADHD children’s cognitive, emotional and behavioural ER components
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4. Which aspects of emotion regulation merit investigation in ADHD
children and why?
The field of emotion regulation research is unwieldy and potentially confusing as illustrated
hereafter (§4.1). To clarify the evidence-base regarding ADHD children’s emotion regula‐
tion, the next paragraphs first disentangle its major operational components (§4.2) and then
integrate these in the micro-level of the model introduced with Figure 1 (§4.3).
4.1. Investigating ADHD children’s emotion regulation: A complex issue
The adequate recognition and expression of emotions is fundamental to a child's develop‐
ment, and emotion regulation is instrumental to the personal and relational as well as the
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pirical research shying away from the subject [51, 64]. The conceptualisation history of
ADHD thus has moved away during the second half of the 20th century from emotional fea‐
tures that were previously included in its core descriptions, only to return to addressing
their pervasiveness in the contemporary literature [47]. In recent years, a more pragmatic
approach involves focussing on the typical or core features of ER that allow setting a frame‐
work with working definitions to guide emotion research [63].
4.2. Major operational components and levels of emotion regulation
Three operational specifications of emotion regulation appear particularly pertinent to the
present purpose of clarifying the investigation of emotional processes in children with
ADHD.
First, emotions are bio-psycho-social phenomena that consist of (unconscious, autonomic)
physiological reactions, which are accompanied by subjective experiences and behavioural
expressions within a given context [48, 63, 65]. Emotion research with ADHD children there‐
fore deserves to include at least three levels of interest, namely a biological, an (introspec‐
tive) experiential and a behavioural-interpersonal level.
Second, competent emotional functioning, which appears to be challenged in children with
ADHD, consequently comprises at least three core, interconnected components that merit
examination, namely the adequate appraisal, modulation and expression of emotions [42,
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(modulation); or as attention allocation, planning and attributed feeling reciprocally deter‐
mine the behaviour through which the child exhibits an emotion (expression).
Third and in line with the above, a more detailed working definition of the process of emotion
regulation has been proposed by Eisenberg and Spinrad (2004) as consisting of “initiating,
avoiding, inhibiting, maintaining, or modulating the occurrence, form, intensity, or duration
of internal feeling states, emotion-related physiological, attentional processes, motivational
states, and/or the behavioural concomitants of emotion in the service of accomplishing af‐
fect-related biological or social adaptation or achieving individual goals” [67, p.338]. This
definition further highlights the important range of processes at work in emotion regulation.
Taking into account this working definition, ADHD children’s important levels of external‐
ising (CD, ODD, BD) as well as internalising comorbidity (anxiety, depression, BD) imply
that their emotional arousal, appraisal and expression might carry both ‘hot’ and ‘cold’, as
well as ‘approach’ and ‘avoidance’ features as detailed further on [60].
4.3. ADHD children’s emotion regulation conceptually revisited
Closing in on the micro-level of the FACE©-model allows summarising the aforementioned
multiple facets and levels of emotional, and associated cognitive, functioning covered by the
concept of emotion regulation, as visualised in figure 2.
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Given this broadness of the emotion regulation concept, it could be argued that much re‐
search has in fact touched upon ADHD children’s emotional functioning in one way or an‐
other. Diverse perspectives, such as parent- and self-reported accounts of affective lability
and comorbidities, social information processing or temperament can be conceived as ques‐
tioning the role of emotions in ADHD children’s outcomes [3, 11, 68]. However, only a limit‐
ed number of studies to date have effectively investigated the emotion-centred theory in
children with ADHD as a means of understanding underlying mechanisms of their behav‐
ioural expressions [69, 70].
In what follows, our focus consequently will be on studies that have explicitly undertaken to
test hypotheses about ADHD children’s functioning through the lens of emotion regulation.
Given our focus, the discussion will more specifically highlight the fields of ADHD chil‐
dren’s emotional functioning that have remained relatively neglected to date, namely their
physiological reactivity, basic and contextual emotional appraisal skills, along with, to a
lesser extent, deliberate emotion regulation efforts.
5. Emotion regulation in ADHD children according to the evidence-base
Consistent with the aforementioned facets of emotion regulation (see figure 2), the review of
the evidence-base hereafter is organised into arousal, basic appraisal and expression re‐
search. Thus, we focus primarily and successively on studies examining how children with
ADHD physiologically regulate emotions (§5.1), how they process basic or contextualised
emotional cues, mainly in facial expressions (§5.2), and how they deliberately modulate
emotional experience and expression (§5.3); this with a priority on recent findings.
5.1. Physiological emotional reactivity and regulation in children with ADHD
Children  with  ADHD’s  hyperactivity  and impulsivity  have  been  posited  from an  emo‐
tion perspective to reflect a basic hyper-arousal tendency, apart from later maturing cog‐
nitive  control  [47].  This  tendency  has  been  called  emotional  impulsiveness,  notably  by
Barkley  (2010),  and considered to  constitute  in  its  own right  a  core  feature  of  children
with ADHD [42, 47, 48]. Emotional impulsiveness is specifically conceived, relative to its
cognitive equivalent, as consisting of heightened emotional reactivity along with lessened
inhibition of  emotional  expression [47,  61].  Children with ADHD thus may be expected
to  show increased  physiological  reactivity  when  confronted  with  affective  stimuli  com‐
pared to non-clinical children. On the other hand, research relative to externalizing disor‐
ders,  which  are  often  concomitant  with  ADHD,  has  suggested  that  children  with  anti-
social,  oppositional-defiant  and  conduct  disordered  behaviour  present  an  underaroused
autonomic nervous system in general baseline [65, 71] as well as in physical or emotion‐
al  change  conditions  [16,  48].  ADHD children’s  emotional  reactivity  may therefore  also
be expected to vary according to the nature of their comorbidities.
On a physiological level, emotional arousal reflects in sympathetic nervous system mobilisa‐
tion, for example through increased heart rate, sweating, muscular tightening and so forth,
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which puts the body in basic ‘approach/fight’ versus ‘avoidance/flight’ readiness. The regu‐
lation of emotional arousal additionally involves activation of the parasympathetic nervous
system, either unconsciously or through deliberate efforts. Emotional reactivity therefore is
often operationalised by confronting children with emotionally evocative material, such as
pictures, stories or movies and measuring their changes from baseline in heart rate (HR),
blood pressure (BP) or skin conductance (SC) levels [48, 65, 71, 72]. Blood pressure and skin
conductance levels hereby provide information about sympathetic activity, whereas heart
rate is linked to both sympathetic arousal and parasympathetic physiological inhibition [65,
71, 72]. Furthermore, to obtain a dynamic assessment of effortful emotion regulation, re‐
search may present children with emotional challenging tasks while measuring their recip‐
rocal adjustments of sympathetic and parasympathetic responses (see below).
Only a handful of studies to date have directly examined the first component of emotional
impulsiveness, namely ADHD children’s autonomic nervous system reactivity [48, 65, 71,
73-76]. Most of these studies, moreover, were not emotion-driven, but pertained to physical
positional changes [76], cognitively challenging tasks [71, 72] or daily routine conditions [74,
75]. Only one published study appears to have addressed the issue in an explicit emotion
regulation context as detailed further on [48].
The findings regarding ADHD children’s autonomic reactivity have remained inconclusive
so far, depending on comorbidity, selected physiological measures and laboratory para‐
digms [74-76]. For instance, a naturalistic study of circadian arousal variations revealed
heightened diurnal and nocturnal heart rate levels in primary school age children with
ADHD compared to non-clinical controls [75]. In contrast, a laboratory study examined
whether school-aged children with ADHD had lower autonomic functioning and reactivity
relative to those with an anxiety disorder. This was tested during and after a cognitively
challenging task requiring mental arithmetic, as indexed by alteration of SC and HR levels
[71]. ADHD children’s skin conductance did not differ from anxious ones in baseline, stress
or recovery conditions. Their heart rate yet showed a decreased response when recovering
after the cognitively challenging task. These findings suggest a relative parasympathetic
dominance in children with ADHD that was even more pronounced in those without co‐
morbid CD or ODD [71].
Moreover, one early study by Beauchaine et al (2001) used a two-phase paradigm with (indi‐
rect) emotional elements, namely a reward and extinction based repetitive response task,
that was followed by the viewing of a two minute video portraying escalating conflict be‐
tween peers [73]. Skin conductance, cardiac pre-ejection periods (PEP) and respiratory sinus
arrhythmia (RSA) were investigated as respective indices of sympathetic and parasympa‐
thetic responses in adolescents aged 12 to 17 with ADHD (n=17) and ADHD with CD (n=20)
compared to non-clinical controls (n=20). Although both ADHD groups displayed lower SC
than controls during baseline, no differences emerged during the reward/extinction condi‐
tion. However, the comorbid ADHD children exhibited more sympathetic reactivity (PEP)
compared to the ADHD and control groups at baseline, and relative to the controls only
during the reward/extinction phase. They also showed lower baseline parasympathetic ac‐
tivity (RSA) relative to the ADHD-only and control children, but the groups did not differ in
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lesser extent, deliberate emotion regulation efforts.
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Consistent with the aforementioned facets of emotion regulation (see figure 2), the review of
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ADHD physiologically regulate emotions (§5.1), how they process basic or contextualised
emotional cues, mainly in facial expressions (§5.2), and how they deliberately modulate
emotional experience and expression (§5.3); this with a priority on recent findings.
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Children  with  ADHD’s  hyperactivity  and impulsivity  have  been  posited  from an  emo‐
tion perspective to reflect a basic hyper-arousal tendency, apart from later maturing cog‐
nitive  control  [47].  This  tendency  has  been  called  emotional  impulsiveness,  notably  by
Barkley  (2010),  and considered to  constitute  in  its  own right  a  core  feature  of  children
with ADHD [42, 47, 48]. Emotional impulsiveness is specifically conceived, relative to its
cognitive equivalent, as consisting of heightened emotional reactivity along with lessened
inhibition of  emotional  expression [47,  61].  Children with ADHD thus may be expected
to  show increased  physiological  reactivity  when  confronted  with  affective  stimuli  com‐
pared to non-clinical children. On the other hand, research relative to externalizing disor‐
ders,  which  are  often  concomitant  with  ADHD,  has  suggested  that  children  with  anti-
social,  oppositional-defiant  and  conduct  disordered  behaviour  present  an  underaroused
autonomic nervous system in general baseline [65, 71] as well as in physical or emotion‐
al  change  conditions  [16,  48].  ADHD children’s  emotional  reactivity  may therefore  also
be expected to vary according to the nature of their comorbidities.
On a physiological level, emotional arousal reflects in sympathetic nervous system mobilisa‐
tion, for example through increased heart rate, sweating, muscular tightening and so forth,
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which puts the body in basic ‘approach/fight’ versus ‘avoidance/flight’ readiness. The regu‐
lation of emotional arousal additionally involves activation of the parasympathetic nervous
system, either unconsciously or through deliberate efforts. Emotional reactivity therefore is
often operationalised by confronting children with emotionally evocative material, such as
pictures, stories or movies and measuring their changes from baseline in heart rate (HR),
blood pressure (BP) or skin conductance (SC) levels [48, 65, 71, 72]. Blood pressure and skin
conductance levels hereby provide information about sympathetic activity, whereas heart
rate is linked to both sympathetic arousal and parasympathetic physiological inhibition [65,
71, 72]. Furthermore, to obtain a dynamic assessment of effortful emotion regulation, re‐
search may present children with emotional challenging tasks while measuring their recip‐
rocal adjustments of sympathetic and parasympathetic responses (see below).
Only a handful of studies to date have directly examined the first component of emotional
impulsiveness, namely ADHD children’s autonomic nervous system reactivity [48, 65, 71,
73-76]. Most of these studies, moreover, were not emotion-driven, but pertained to physical
positional changes [76], cognitively challenging tasks [71, 72] or daily routine conditions [74,
75]. Only one published study appears to have addressed the issue in an explicit emotion
regulation context as detailed further on [48].
The findings regarding ADHD children’s autonomic reactivity have remained inconclusive
so far, depending on comorbidity, selected physiological measures and laboratory para‐
digms [74-76]. For instance, a naturalistic study of circadian arousal variations revealed
heightened diurnal and nocturnal heart rate levels in primary school age children with
ADHD compared to non-clinical controls [75]. In contrast, a laboratory study examined
whether school-aged children with ADHD had lower autonomic functioning and reactivity
relative to those with an anxiety disorder. This was tested during and after a cognitively
challenging task requiring mental arithmetic, as indexed by alteration of SC and HR levels
[71]. ADHD children’s skin conductance did not differ from anxious ones in baseline, stress
or recovery conditions. Their heart rate yet showed a decreased response when recovering
after the cognitively challenging task. These findings suggest a relative parasympathetic
dominance in children with ADHD that was even more pronounced in those without co‐
morbid CD or ODD [71].
Moreover, one early study by Beauchaine et al (2001) used a two-phase paradigm with (indi‐
rect) emotional elements, namely a reward and extinction based repetitive response task,
that was followed by the viewing of a two minute video portraying escalating conflict be‐
tween peers [73]. Skin conductance, cardiac pre-ejection periods (PEP) and respiratory sinus
arrhythmia (RSA) were investigated as respective indices of sympathetic and parasympa‐
thetic responses in adolescents aged 12 to 17 with ADHD (n=17) and ADHD with CD (n=20)
compared to non-clinical controls (n=20). Although both ADHD groups displayed lower SC
than controls during baseline, no differences emerged during the reward/extinction condi‐
tion. However, the comorbid ADHD children exhibited more sympathetic reactivity (PEP)
compared to the ADHD and control groups at baseline, and relative to the controls only
during the reward/extinction phase. They also showed lower baseline parasympathetic ac‐
tivity (RSA) relative to the ADHD-only and control children, but the groups did not differ in
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RSA during the video condition. The SC and PEP findings of this study were essentially re‐
plicated in a more recent investigation with four to six year old preschoolers at risk for hav‐
ing ADHD and ODD (n=18) [77]. Changes in at-risk preschoolers’ heart rate in this study
further pointed to a predominance of parasympathetic mediation of their autonomic re‐
sponses in behavioural reward/extinction conditions.
In all, one published study could be identified that explicitly investigated whether children
with ADHD display a particular sympathetic and/or parasympathetic reactivity in manifest
emotional conditions and whether this differs according to emotions. In a rare laboratory
paradigm using active emotion induction and suppression conditions, Musser et al. (2011)
indeed examined 66, seven to nine-year old, ADHD and non-clinical control children’s auto‐
nomic responses [48]. Children were first instructed to facially mimic emotions of a main
character viewed in a developmentally appropriate film clip (active emotion induction), and
subsequently to imagine the main characters’ feelings yet while not expressing any facial
emotion (active emotion suppression). The children’s sympathetic cardiac PEP and para‐
sympathetic RSA were recorded throughout positive and negative emotion induction and
suppression conditions. ADHD and control children’s autonomic responses did not differ in
baseline or neutral conditions. No significant group differences emerged either in children’s
sympathetic (PEP) responses. However, ADHD children exhibited a slight yet significant
parasympathetic augmentation (RSA), and this inflexibly across all emotional conditions
(positive and negative, induction and suppression). Moreover, when expressing deliberate
positive facial emotion, the ADHD group responded with a more pronounced ineffective
parasympathetic increase in contrast to control children’s RSA decrease, suggesting an ina‐
daptive emotional approach response.
ADHD children’s physiological reactivity has furthermore been investigated along an addi‐
tional line of questioning concerning alterations in their hypothalamic-pituitary-adrenocorti‐
cal (HPA) axis. Consistent with the initially outlined expectations, ADHD children have
been expected to show blunted cortisol responses to stress [78-80]. Again, studies in this re‐
spect have as yet seldom focused specifically on emotional contexts and have yielded mixed
results across ADHD heterogeneity. In essence, predicted blunted cortisol responses are evi‐
denced in children with ADHD and comorbid disruptive behaviour disorders. However,
children with ADHD and comorbid anxiety disorders tend to show increased cortisol reac‐
tivity [78, 79]. Furthermore, one study compared cortisol responses during a public speaking
situation among children with ADHD-C (n=52), ADHD-I (n=23) and non-clinical controls
(n=25) [80]. In this more manifest psychosocial stress condition, ADHD children’s HPA
functioning showed subtype distinctions along similar externalising versus internalising
lines as above, with ADHD-C children displaying blunted and ADHD-I increased cortisol
responses. Finally, one study explicitly examined whether ADHD children’s oppositional
behaviour would be mediated by their cortisol reactivity to expressed emotions during a
family emotion provocation task [58]. High levels of parental negative expressed emotion
were indeed associated with both oppositional behaviour and increased cortisol responses
in children with ADHD. Cortisol reactivity hereby mediated the emotion-to-behaviour path‐
way in all children.
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Taken together, findings remain mixed as regards several aspects of ADHD children’s auto‐
nomic reactivity. The earlier indications of a heightened sympathetic responsiveness in co‐
morbid ADHD and CD children in a reward-based condition contrast with both
underarousal expectations and with ADHD-only children’s similar-to-control sympathetic
reactivity in an active emotion induction/suppression context. A convergent tendency yet
appears to come forward regarding ADHD children’s inadaptive parasympathetic respons‐
es across different investigation contexts (deliberate emotion induction/suppression versus
spontaneous responses to cognitively challenging tasks). This tendency would lend support
to behavioural observations that children with ADHD especially have difficulty adequately
adjusting their emotional responses [42, 61]. Moreover, ADHD children tend to show altered
HPA-functioning, as evidenced in blunted versus intensified cortisol reactivity in respective‐
ly externalising (ADHD-C and conduct disorder comorbidity) and internalising (ADHD-I
and anxious comorbidity) children. Thus, ADHD children’s cortisol reactivity might medi‐
ate their emotional responses in emotionally challenging situations. Evidently, however,
given the scant number of available studies, further specific examination is required of
ADHD children’s physiological arousal in emotional conditions. Variations herein according
to ADHD comorbidities and subtypes merit further clarification, with the latter remaining
largely unaddressed as regards sympathetic and parasympathetic physiological regulation.
5.2. ADHD children’s processing of basic (facial) emotional cues
Emotion research in children with ADHD has emerged in part through a select number of
‘early’ studies examining their facial emotion recognition (FER) skills. Research on FER
questions the ability of the child to adequately process or appraise basic emotional cues, a
skill that is instrumental to its survival and interactions with others [40, 41, 81]. Although
such cues can be verbal as well as non-verbal, especially the latter are recognised to be force‐
ful communication elements and this early-on in development [82]. FER research paradigms
thus generally consist of recording children’s proficiency in labelling facial emotions, which
are either viewed in isolation or within a broader visual or verbal context.
Given the discussion so far, at least four basic questions apply to ADHD children’s FER,
namely 1) are ADHD children’s FER skills compromised compared to those without
ADHD?, 2) if so, for which emotions is this the case?, 3) are ADHD children’s FER skills
linked to their (interpersonal) behavioural functioning?, and 4) which underlying mecha‐
nisms may explain ADHD children’s FER difficulties?
Altogether,  fourteen  published  studies  were  identified  from  1998  on  in  Pubmed  and
through further reviewing of references that have directly addressed (facial) emotion rec‐
ognition and understanding in children diagnosed with ADHD, besides one study on ‘at-
risk’  children  [83]  and  an  ongoing  study  by  our  FACE©-ADHD  program  [30,  84].  As
summarised in Table 1 and discussed in paragraph 5.2.1,  two-third of these studies [28,
36,  39,  40,  85-89]  have focused on simple  FER and mostly  pointed toward ADHD chil‐
dren  experiencing  significantly  more  FER  difficulties  compared  to  non-clinical  controls.
The investigated samples  however  remain relatively small  and diverse  in  terms of  con‐
text  and  comorbidity.  Furthermore,  precise  indications  regarding  which  facial  emotions
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RSA during the video condition. The SC and PEP findings of this study were essentially re‐
plicated in a more recent investigation with four to six year old preschoolers at risk for hav‐
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In all, one published study could be identified that explicitly investigated whether children
with ADHD display a particular sympathetic and/or parasympathetic reactivity in manifest
emotional conditions and whether this differs according to emotions. In a rare laboratory
paradigm using active emotion induction and suppression conditions, Musser et al. (2011)
indeed examined 66, seven to nine-year old, ADHD and non-clinical control children’s auto‐
nomic responses [48]. Children were first instructed to facially mimic emotions of a main
character viewed in a developmentally appropriate film clip (active emotion induction), and
subsequently to imagine the main characters’ feelings yet while not expressing any facial
emotion (active emotion suppression). The children’s sympathetic cardiac PEP and para‐
sympathetic RSA were recorded throughout positive and negative emotion induction and
suppression conditions. ADHD and control children’s autonomic responses did not differ in
baseline or neutral conditions. No significant group differences emerged either in children’s
sympathetic (PEP) responses. However, ADHD children exhibited a slight yet significant
parasympathetic augmentation (RSA), and this inflexibly across all emotional conditions
(positive and negative, induction and suppression). Moreover, when expressing deliberate
positive facial emotion, the ADHD group responded with a more pronounced ineffective
parasympathetic increase in contrast to control children’s RSA decrease, suggesting an ina‐
daptive emotional approach response.
ADHD children’s physiological reactivity has furthermore been investigated along an addi‐
tional line of questioning concerning alterations in their hypothalamic-pituitary-adrenocorti‐
cal (HPA) axis. Consistent with the initially outlined expectations, ADHD children have
been expected to show blunted cortisol responses to stress [78-80]. Again, studies in this re‐
spect have as yet seldom focused specifically on emotional contexts and have yielded mixed
results across ADHD heterogeneity. In essence, predicted blunted cortisol responses are evi‐
denced in children with ADHD and comorbid disruptive behaviour disorders. However,
children with ADHD and comorbid anxiety disorders tend to show increased cortisol reac‐
tivity [78, 79]. Furthermore, one study compared cortisol responses during a public speaking
situation among children with ADHD-C (n=52), ADHD-I (n=23) and non-clinical controls
(n=25) [80]. In this more manifest psychosocial stress condition, ADHD children’s HPA
functioning showed subtype distinctions along similar externalising versus internalising
lines as above, with ADHD-C children displaying blunted and ADHD-I increased cortisol
responses. Finally, one study explicitly examined whether ADHD children’s oppositional
behaviour would be mediated by their cortisol reactivity to expressed emotions during a
family emotion provocation task [58]. High levels of parental negative expressed emotion
were indeed associated with both oppositional behaviour and increased cortisol responses
in children with ADHD. Cortisol reactivity hereby mediated the emotion-to-behaviour path‐
way in all children.
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to behavioural observations that children with ADHD especially have difficulty adequately
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HPA-functioning, as evidenced in blunted versus intensified cortisol reactivity in respective‐
ly externalising (ADHD-C and conduct disorder comorbidity) and internalising (ADHD-I
and anxious comorbidity) children. Thus, ADHD children’s cortisol reactivity might medi‐
ate their emotional responses in emotionally challenging situations. Evidently, however,
given the scant number of available studies, further specific examination is required of
ADHD children’s physiological arousal in emotional conditions. Variations herein according
to ADHD comorbidities and subtypes merit further clarification, with the latter remaining
largely unaddressed as regards sympathetic and parasympathetic physiological regulation.
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Emotion research in children with ADHD has emerged in part through a select number of
‘early’ studies examining their facial emotion recognition (FER) skills. Research on FER
questions the ability of the child to adequately process or appraise basic emotional cues, a
skill that is instrumental to its survival and interactions with others [40, 41, 81]. Although
such cues can be verbal as well as non-verbal, especially the latter are recognised to be force‐
ful communication elements and this early-on in development [82]. FER research paradigms
thus generally consist of recording children’s proficiency in labelling facial emotions, which
are either viewed in isolation or within a broader visual or verbal context.
Given the discussion so far, at least four basic questions apply to ADHD children’s FER,
namely 1) are ADHD children’s FER skills compromised compared to those without
ADHD?, 2) if so, for which emotions is this the case?, 3) are ADHD children’s FER skills
linked to their (interpersonal) behavioural functioning?, and 4) which underlying mecha‐
nisms may explain ADHD children’s FER difficulties?
Altogether,  fourteen  published  studies  were  identified  from  1998  on  in  Pubmed  and
through further reviewing of references that have directly addressed (facial) emotion rec‐
ognition and understanding in children diagnosed with ADHD, besides one study on ‘at-
risk’  children  [83]  and  an  ongoing  study  by  our  FACE©-ADHD  program  [30,  84].  As
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are more challenging for ADHD children to process remain inconsistent. As reviewed in
Table  2  and  discussed  in  paragraph  5.2.2,  six  studies  also  focused  on  emotion  under‐
standing  in  context  and/or  simultaneously  compared  ADHD  children’s  simple  versus
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5.2.1. ADHD children’s simple facial emotion recognition skills
Children generally are able to identify basic facial emotions (happiness, anger, sadness and
fear) by early childhood and gain in accuracy to accomplish fuller emotion classification by
middle childhood [86]. In children with ADHD, brain imaging studies have documented
(posterior) right hemispheric specificities, such as an enlarged right hemisphere structure
and hypofused functioning, along with possibly reduced amygdala and compensatory en‐
larged hippocampus [44, 49]. Since such deficits are profoundly linked to impairments in
evaluating emotional stimuli, children with ADHD may be expected to have difficulties in
adequately perceiving or processing emotions at an appraisal level [41]. Additionally,
ADHD children’s fluctuating attentional deployment raises questions as to whether im‐
paired sustained attention also contributes to difficulties in processing affective cues [83].
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More precise expectations about differential emotion recognition difficulties have been diffi‐
cult to formulate. For instance, joy and surprise tend to be more easily recognised by chil‐
dren overall compared to fear, sadness and disgust [86]. Yet, negative facial expressions
compared to neutral ones are also documented to mobilise typically developing children’s
attention; a tendency that is understood as an adaptive response toward potential danger
[36, 15]. Children with CD/ODD, which are frequent ADHD comorbidities, for their part
seem to display a marked increased bias toward processing negative emotional information
in social situations. At the same time, CD/ODD children also appear less aroused by nega‐
tive emotional stimuli [15, 85]. Thus, detailed expectations about ADHD children’s FER
skills may depend on their clinical constellation including their comorbidities.
Overall, the reviewed studies point to statistically significant differences in basic FER skills
between children with ADHD and non-clinical controls or other clinical groups, as illustrat‐
ed in Table 1 (question 1). However, depending on comorbidity and comparison groups, dif‐
ferences are not necessarily to the disadvantage of the ADHD population and/or tend to
vary widely as regards which emotions elicit more recognition difficulties (question 2). More‐
over, whenever performance percentages are specified, a majority of ADHD children (60%
and up) still appear to exhibit accurate FER.
Thus, the right hemisphere hypothesis has been supported at least partially as several stud‐
ies document children with ADHD to be less efficient at identifying negative facial cues com‐
pared to non-clinical controls [36, 40, 83, 84, 88, 89]. Specific negative FER difficulties,
however, vary across studies and children’s clinical status, with no clear pattern coming for‐
ward. For example, an expected dampened detection of anger and fear was found compared
to non-clinical controls in a sample of 51 adolescent boys with ADHD and associated oppo‐
sitional behaviour along with depressed and anxious mood [89]. This was also the case for
anger and sadness, but not for fear, in a sample of hyperactive/impulsive ADHD children
without comorbidities [88].
These findings partially converge with pilot results from an ongoing multi-method, multi-
informant research that operationalises the above FACE©-model. In this research, a natural‐
istic group of medicated ADHD children in a special school setting is compared with
gender- and age-matched non-referred children (ages 7-12, mean age 10, 80% boys) on corre‐
lates of emotion regulation [30, 84]. On a micro-level, children are examined on emotional
components of ER (basic FER, emotion recognition in context, and self-reported experience)
along with cognitive (Theory-Of-Mind), attentional (simple and modified emotional Simon
tasks), and behavioural ones (multi-informant reports of problem behaviour including ag‐
gression and anxiety). Children’s developmental risk-resiliency load is furthermore regis‐
tered on a macro-level. Compared to controls (n=13), a preliminary sample of ADHD
children (n=15) with comorbid learning problems and autism spectrum symptoms (ASS) (re‐
spectively 66% and 33%) made significantly more FER errors than controls (t (26) = -2,578, p
= 0,016) and doubted more their choices (t (26) = -2,147, p = 0,041). These comorbid ADHD
children were in particular marginally less efficient at identifying happiness and anger. A
second subsample of ADHD children (n=20), also with mainly learning problems but no
ASS, did not differ in basic FER compared to controls (n=20) but was less efficient in contex‐
Attention Deficit Hyperactivity Disorder in Children and Adolescents258
tualising emotions, especially anxiety, during a verbal recognition task, as well as in Theory
of Mind (also see §5.2.2). For all children, happiness was best recognised facially, followed
by anger, and fear (sample 1) or sadness (sample 2) [4, 5, 30, 84].
The aforementioned less expected difficulties with the recognition of the positive emotion
happiness were also found in children with ADHD and comorbid CD [86], as well as in a
comparison among children (ages 6-18) with autism, autism and ADHD, and ADHD-only
[28] (see Table 1). In the latter study, both groups with ADHD, namely ADHD-only and co‐
morbid autism and ADHD, were less proficient in recognising happiness as well as surprise
on faces and on eye pairs, relative to autism-only and non-clinical children [28].
In contrast, ADHD appears to be associated with more successful FER in some instances, as
comes forward from a detailed analysis of studies examining whether FER patterns are dis‐
tinct or cut across clinical conditions. This was the case, for example, in a rare study compar‐
ing FER among children and adolescents with BD, severe mood dysregulation (SMD),
ADHD and/or CD, anxiety and/or depression and controls [86]. Markedly, the ADHD with
CD group appeared to make least errors in angry, sad and fearful FER compared to all other
groups, including non-clinical controls. Similarly, another study compared FER among chil‐
dren with ADHD, ADHD with conduct problems (CP) or CP (all with comorbid ODD), and
controls. Along with controls, the comorbid ADHD with CP children also exhibited least er‐
rors except for sadness, while ADHD-only children mostly displayed random errors.
Findings tend to be clearer regarding the behavioural and relational impact of children’s FER
skills (question 3). When this is examined, studies indeed report significant associations be‐
tween ADHD children’s FER skills and daily-life outcomes. For instance, in the pilot study
of the FACE©-research, ADHD children’s FER skills were inversely proportional to parent
and teacher rated ADHD-specific (hyperactivity, inattention, impulsivity) and non-specific
(oppositional and aggressive) problem behaviour [30, 84]. Similarly, the above-cited hyper‐
active/impulsive ADHD children without comorbidities investigated by Pelc et al. (2006)
who made more FER errors also exhibited higher interpersonal problems [88].
Finally, some studies attempted to shed light on the neural basis of ADHD children’s FER
skills (question 4) (see table 2). One study examined contrasted amygdala responses when
rating emotional cues (fear and hostility) versus non-emotional ones (nose-width) in happy,
angry, fearful or neutral faces, and this among youth with BD, SMD, ADHD and non-clini‐
cal controls [85]. Interestingly, although ADHD youth did not differ from the other groups
in fear, hostility or nose-width ratings, they manifested left-amygdala hyperactivation in
fear – nose-width contrasts compared to healthy controls, bipolar and SMD children. Anoth‐
er study, by Williams et al. (2008), recorded ADHD youth’s event-related potentials during a
second presentation of facial emotion labelling, before and after methylphenidate (MPH)
treatment in an open label trial spanning four weeks [89]. ADHD boys showed a pattern of
reduced occipital activity during initial perceptual analysis that was associated with their
disrupted FER and mood. This was followed by flow-on difficulties in emotion processing,
such as an exaggerated structural encoding activity and finally reduced temporal contextual
activity. In short, these findings lend further support to possible (compensatory) amygdala
responses and specific temporal-occipital pathways in mood processing linked to ADHD.
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5.2.2. Understanding of emotions in context by children with ADHD
While identifying simple facial emotions represents the most basic form of emotion recogni‐
tion, real-life communication seldom consists of isolated facial expressions. Facial expres‐
sions are mostly if not always situationally embedded. From their earliest interactions,
children learn to modulate their appraisal of facial emotions according to the context [66].
As experience develops, this skill increasingly involves (episodic) memory and associated
hippocampal functions through which emotional stimuli are linked to (the remembrance of)
contextual cues. Specifically, given disruptions in right hemispheric functioning and in the
IFC/DLPFC to amygdala circuitry reported for children with ADHD, they may be expected
to display difficulties in contextualising emotions over and above their simple FER difficul‐
ties [44, 49]. A next level in emotional assessment therefore consists of examining the child’s
ability to appropriately link facial expressions and (social) situations or to understand emo‐
tional cues in their context (e.g. in stories) [42, 64].
All six reviewed published studies (see Table 2) provide evidence that children with ADHD
are less successful in reciprocally matching (facial) emotions and interpersonal situations
than non-clinical controls (question 1) [39, 41, 81, 90-92]. Furthermore, as mentioned above
(§5.2.1), the subsample of ADHD children with learning problems of the ongoing FACE©-
ADHD research was significantly less efficient than non-clinical controls in identifying emo‐
tions in verbally presented stories [84]. Along the same line of thought, an early study by
Braaten et al. (2000) stands somewhat apart by addressing a more sophisticated level of
emotional understanding. Here, children’s ER was further probed by assessing their ability
to recognise characters’ emotions in a story and to relate these to their own feelings [90].
Children with ADHD were less likely than controls to match their own feelings with those
of the child in the story and to interpret the latter according to the characters’ context.
Again, however, no clear pattern emerges as to whether ADHD children have more difficul‐
ty contextualising specific emotions (question 2). For example, an early study with five to 13-
year old ADHD boys and girls enrolled in a summer camp, using Ekman’s facial affect
pictures, suggested a mixed pattern of negative emotions as well as surprise to elicit more
contextualisation errors than happiness [81]. Another mixed pattern of better contextualis‐
ing of happy and angry, than fearful and sad feelings occurred for both ADHD-combined
subtype and control children when asked to link symbolic facial expressions (Smiley’s) to
masked faces of people in popular magazine pictures [91].
Apparently, few of these studies furthermore examined the link between ADHD children’s
contextualised emotion recognition and their behavioural outcomes (question 3). In our on‐
going research, children’s emotion recognition (and Theory-of-Mind) were found to be in‐
versely related to reports of their externalizing and internalizing problem behaviour in both
subsamples regardless of type of ADHD comorbidity [30, 84].
Some studies finally addressed possible underlying mechanisms of ADHD children’s diffi‐
culties in contextualising emotions (question 4). For instance, Da Fonseca et al’s (2008) study
also included the matching of objects to situational magazine pictures. In contrast to the
emotional matching, ADHD children displayed no significant difficulties in replacing ob‐
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jects in their context, confirming an emotional rather than solely perceptual nature of their
matching errors [91]. A study addressing the link between ADHD boys’ continuous atten‐
tional performance furthermore found only omission errors to account significantly for
ADHD children’s matching of facial emotional expressions to situational cartoons [39]. Also,
in an early yet thorough study involving FER, along with prosody, verbal and nonverbal
impulse inhibition and attention tasks, ADHD children’s significantly poorer performances
on all tasks relative to controls where explained for 85% by their FER skills [41].
Still, findings on ADHD children’s contextual emotion recognition seem to remain quite task
and/or stimulus dependent. For instance, one study involved the matching of facial expres‐
sions to specifically designed emotion-situation sentences, and object pictures to non-emo‐
tional sentences [92]. In this case, ADHD boys exhibited exceptionally poor performances
with only 20 to 40% of correct emotional and 40 to 50% non-emotional matchings. Control
children, in turn, achieved 79 to 100% correct matchings across conditions. These findings
contrast with a sensibly higher overall mean of 74% of correct contextual emotion identifica‐
tion by ADHD children documented in Singh’s early study [81]. In the same line of stimu‐
lus-dependent ER variations, a condition of contextualised emotion recognition in verbal
material yielded anger to be least well identified by both control and ADHD children, as op‐
posed to being second-best recognised in a condition of FER [84].
Of note, studies comparing contextual emotion recognition among children with ADHD and
other clinical conditions or different subtypes are still lacking. Simple or contextualised proc‐
essing of prosody also has hardly been investigated in children with ADHD [15, 93]. In
adults, emotional semantic processing has been found to be enhanced compared to controls,
possibly through compensatory mobilisation of cognitive resources [94]. Similar investiga‐
tions are needed in children with ADHD.
5.2.3. Summary
Overall, ADHD children as a group do appear to display specificities in FER skills that tend
to set them apart from non-referred controls and children with other clinical conditions. In
addition, the ADHD child and adolescent population also does seem to exhibit more diffi‐
culties in matching facial emotions to contextual clues, or recognising emotions in verbal
context, compared to non-clinical controls.
The pattern of these basic and contextualised (facial) emotion recognition specificities yet re‐
mains unclear to date. ADHD children with or without comorbidities are diversely found to
be less efficient in recognising simple negative as well as positive facial emotions compared
to non-clinical controls and possibly also to children with different clinical conditions. How‐
ever, the opposite occurs in some instances, with some large comparison studies document‐
ing better FER skills in (comorbid) ADHD children relative to other clinical and non-clinical
groups. Comorbidity or medication statuses do not appear to provide sufficient leads for ex‐
plaining these contrasting outcomes. Potential influences of maturation (age) and ADHD
heterogeneity (subtypes) still require further clarification given that half of the studies span
child through adolescent populations, and that the majority leaves ADHD subtypes unspe‐
cified. Also needed are studies that address potential gender effects on simple or contextual‐
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5.2.2. Understanding of emotions in context by children with ADHD
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jects in their context, confirming an emotional rather than solely perceptual nature of their
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adults, emotional semantic processing has been found to be enhanced compared to controls,
possibly through compensatory mobilisation of cognitive resources [94]. Similar investiga‐
tions are needed in children with ADHD.
5.2.3. Summary
Overall, ADHD children as a group do appear to display specificities in FER skills that tend
to set them apart from non-referred controls and children with other clinical conditions. In
addition, the ADHD child and adolescent population also does seem to exhibit more diffi‐
culties in matching facial emotions to contextual clues, or recognising emotions in verbal
context, compared to non-clinical controls.
The pattern of these basic and contextualised (facial) emotion recognition specificities yet re‐
mains unclear to date. ADHD children with or without comorbidities are diversely found to
be less efficient in recognising simple negative as well as positive facial emotions compared
to non-clinical controls and possibly also to children with different clinical conditions. How‐
ever, the opposite occurs in some instances, with some large comparison studies document‐
ing better FER skills in (comorbid) ADHD children relative to other clinical and non-clinical
groups. Comorbidity or medication statuses do not appear to provide sufficient leads for ex‐
plaining these contrasting outcomes. Potential influences of maturation (age) and ADHD
heterogeneity (subtypes) still require further clarification given that half of the studies span
child through adolescent populations, and that the majority leaves ADHD subtypes unspe‐
cified. Also needed are studies that address potential gender effects on simple or contextual‐
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ised emotion recognition with sufficient participation of girls with ADHD. The effects of
verbal versus non-verbal stimulus modes as yet remain underexplored too.
Furthermore, when FER difficulties are documented in ADHD children, these appear to be
linked to adverse behavioural and interpersonal outcomes. Similar links remain to be fur‐
ther established for ADHD children’s contextual emotion recognition.
Finally, there are some indications that ADHD children’s basic and contextual emotion rec‐
ognition skills are related to specificities in right hemispheric emotion-processing and (left)
amygdala hyperactivity, while attentional impacts remain less well established. The intrica‐
cy of cognitive and emotional systems hereby points to the need of considering multiple
pathways of underlying mechanisms instead of mutually exclusive ones, whereby probable
compensatory functioning may contribute to explaining the absence of observed emotion
processing deficits in some instances.
In sum, the heterogeneity of the population of youth with ADHD, the relative scarcity of
current studies directly addressing their emotion recognition skills, and the contrasting out‐
comes so far all call for a research agenda that would more systematically examine the ex‐
tent to which gender, age, ADHD subtypes, comorbidities and stimulus type account for
variability in ADHD children’s basic and contextualised emotion recognition skills.
5.3. How do children with ADHD (deliberately) modulate subjective experiences and
behavioural expressions of emotional reactivity?
As defined previously, emotional impulsiveness consists of diminished inhibition of emo‐
tional expression besides heightened emotional reactivity (cf.§5.1) [47, 61]. ADHD children’s
difficulties with modulating their emotional expressions have been mostly documented in‐
directly through a vast literature attesting to their externalising problem behaviour. Specific
examination of the behavioural component of ADHD children’s emotional impulsiveness to
date has mainly concerned their management of frustration, and this principally in cognitive
task-interference contexts [61, 83].
On a behavioural level, children with ADHD are inclined to favour situations that provide
immediate reward. They also tend to have difficulty persisting when gratification is de‐
layed. This tendency has been described under the delay-aversion hypothesis [66]. Still, the
question arises what makes it more difficult for children with ADHD than for their peers to
delay reward and persist when positive reinforcement remains uncertain? From an emotion-
centred perspective, ADHD children’s difficulties with persisting under delayed reward
conditions are thought to be mediated by the challenge of regulating negative emotions, and
especially frustration.
Several studies have therefore explicitly investigated how children with ADHD modulate
their emotional experience and expression in constrained task conditions that elicit frustra‐
tion. Frustration is defined here as the emotion resulting from an absence of reward when
such reward is expected [82]. Persistence can thus be conceived as the ability to adjust or
modulate frustration perception so as to maintain task-oriented behavioural continuity.
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Study paradigms consequently generally consist of manipulating children’s reward expect‐
ancy and registering their self-reported and/or behaviourally observed emotional responses.
Most studies have confirmed children with ADHD to experience heightened frustration lev‐
els in association with persistence and behavioural control problems, this both in cognitive
task conditions [66, 95, 82] and in less investigated emotional contexts [9]. Detailed accounts
of their task-related emotional experiences however provide important nuance regarding
ADHD children’s emotional understanding and process insight [66, 82].
For instance, an early study compared how seven to nine year old, clinically-referred ADHD
children (n=22) and non-referred controls (n=20) compared on performance, study-time, self-
rated persistence (namely how much did the child feel like continuing), and facially record‐
ed frustration levels during a nonsense word learning task [82]. Children were assigned to
either a predetermined continuous reinforcement (CRF) or partial reinforcement (PRF) con‐
dition. The CRF and PRF conditions both consist of an acquisition phase followed by a non-
reward extinction phase, yet PRF involves random instead of continuous reward during
acquisition. Importantly, reinforcement pertained to persistence rather than task correctness
in this study. As expected, learning occurred in both phases for both groups. Children with
ADHD yet made more errors, expressed more frustration and felt less like persisting overall.
Interestingly, especially the random reward (PRF) condition yielded three-fold frustration
levels in ADHD children during the acquisition phase along with a persistence deficit. In
turn, only children with ADHD (and not controls) in the CRF condition spent more study-
time over the acquisition course [82]. Thus, children with ADHD displayed a marked diffi‐
culty habituating to initial frustration, while investing considerable effort in a consistent
reward condition.
In the same vein, self-reported frustration was studied in medicated children with ADHD
(n=21; mostly combined subtype) compared to non-clinical controls (n=43) using a blindfold‐
ed puzzle task [66]. This study moreover recorded detailed accounts of children’s emotions,
such as their self-reported mood after the task, general persistence and frustration tendency
(likeliness of quitting and getting frustrated compared to peers), insight in the accompany‐
ing physical, emotional, or cognitive sensations of their frustration and how they dealt with
it. Children additionally completed a structured emotional competence self-report measure,
along with a mathematics task. Consistent with the previous findings, the present ADHD
children were less persistent overall but invested as much time as control children in the
tasks. This yielded them mixed results: they were more likely to quit the puzzle task and
completed less mathematic problems than their peers, but the ones they completed were ac‐
curate. Of special interest for the present focus, the children with ADHD were likelier to re‐
port suffering frustration and give up compared to other children, were able to identify
signs of their frustration and knew about ways of dealing with it. However, they were sig‐
nificantly less effective at acting upon this emotional understanding than controls.
Children with ADHD have also been demonstrated to have difficulty deliberately masking
their emotions in an elicited frustration situation [95]. One study for instance examined
ADHD boys’ (n=26, ages 6 to 11) observed emotion regulation compared to that of controls
(n=23), by explicitly asking them to hide their feelings even if they became upset during a
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tional expression besides heightened emotional reactivity (cf.§5.1) [47, 61]. ADHD children’s
difficulties with modulating their emotional expressions have been mostly documented in‐
directly through a vast literature attesting to their externalising problem behaviour. Specific
examination of the behavioural component of ADHD children’s emotional impulsiveness to
date has mainly concerned their management of frustration, and this principally in cognitive
task-interference contexts [61, 83].
On a behavioural level, children with ADHD are inclined to favour situations that provide
immediate reward. They also tend to have difficulty persisting when gratification is de‐
layed. This tendency has been described under the delay-aversion hypothesis [66]. Still, the
question arises what makes it more difficult for children with ADHD than for their peers to
delay reward and persist when positive reinforcement remains uncertain? From an emotion-
centred perspective, ADHD children’s difficulties with persisting under delayed reward
conditions are thought to be mediated by the challenge of regulating negative emotions, and
especially frustration.
Several studies have therefore explicitly investigated how children with ADHD modulate
their emotional experience and expression in constrained task conditions that elicit frustra‐
tion. Frustration is defined here as the emotion resulting from an absence of reward when
such reward is expected [82]. Persistence can thus be conceived as the ability to adjust or
modulate frustration perception so as to maintain task-oriented behavioural continuity.
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Study paradigms consequently generally consist of manipulating children’s reward expect‐
ancy and registering their self-reported and/or behaviourally observed emotional responses.
Most studies have confirmed children with ADHD to experience heightened frustration lev‐
els in association with persistence and behavioural control problems, this both in cognitive
task conditions [66, 95, 82] and in less investigated emotional contexts [9]. Detailed accounts
of their task-related emotional experiences however provide important nuance regarding
ADHD children’s emotional understanding and process insight [66, 82].
For instance, an early study compared how seven to nine year old, clinically-referred ADHD
children (n=22) and non-referred controls (n=20) compared on performance, study-time, self-
rated persistence (namely how much did the child feel like continuing), and facially record‐
ed frustration levels during a nonsense word learning task [82]. Children were assigned to
either a predetermined continuous reinforcement (CRF) or partial reinforcement (PRF) con‐
dition. The CRF and PRF conditions both consist of an acquisition phase followed by a non-
reward extinction phase, yet PRF involves random instead of continuous reward during
acquisition. Importantly, reinforcement pertained to persistence rather than task correctness
in this study. As expected, learning occurred in both phases for both groups. Children with
ADHD yet made more errors, expressed more frustration and felt less like persisting overall.
Interestingly, especially the random reward (PRF) condition yielded three-fold frustration
levels in ADHD children during the acquisition phase along with a persistence deficit. In
turn, only children with ADHD (and not controls) in the CRF condition spent more study-
time over the acquisition course [82]. Thus, children with ADHD displayed a marked diffi‐
culty habituating to initial frustration, while investing considerable effort in a consistent
reward condition.
In the same vein, self-reported frustration was studied in medicated children with ADHD
(n=21; mostly combined subtype) compared to non-clinical controls (n=43) using a blindfold‐
ed puzzle task [66]. This study moreover recorded detailed accounts of children’s emotions,
such as their self-reported mood after the task, general persistence and frustration tendency
(likeliness of quitting and getting frustrated compared to peers), insight in the accompany‐
ing physical, emotional, or cognitive sensations of their frustration and how they dealt with
it. Children additionally completed a structured emotional competence self-report measure,
along with a mathematics task. Consistent with the previous findings, the present ADHD
children were less persistent overall but invested as much time as control children in the
tasks. This yielded them mixed results: they were more likely to quit the puzzle task and
completed less mathematic problems than their peers, but the ones they completed were ac‐
curate. Of special interest for the present focus, the children with ADHD were likelier to re‐
port suffering frustration and give up compared to other children, were able to identify
signs of their frustration and knew about ways of dealing with it. However, they were sig‐
nificantly less effective at acting upon this emotional understanding than controls.
Children with ADHD have also been demonstrated to have difficulty deliberately masking
their emotions in an elicited frustration situation [95]. One study for instance examined
ADHD boys’ (n=26, ages 6 to 11) observed emotion regulation compared to that of controls
(n=23), by explicitly asking them to hide their feelings even if they became upset during a
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competitive Stop Signal Task with peers. The boys with ADHD not only had more difficulty
with regulating their emotions compared to their non-clinical peers, they were also less suc‐
cessful at hiding their emotions despite knowing that they were expected to do so [95].
Of note, the previous studies examined ADHD children’s emotional expression in cognitive‐
ly challenging contexts. Two other studies did so too in more explicitly emotion-related in‐
terpersonal contexts. One study used a prize paradigm with 8 to 11-year-old medicated
children with ADHD-combined (ADHD-C, n=16) and inattentive (ADHD-I, n=14) subtypes
(12 boys, 9 girls) compared to controls (n=17) [9]. Children’s emotional responses were re‐
corded in disappointing versus non-disappointing conditions, namely receiving an unwant‐
ed versus a desired prize, after they had been asked to rank prizes in order of desirability
and told they would receive prizes for helping another examiner. Emotion-focused meas‐
ures included children’s facial and non-verbal reactions (classified as positive, negative, so‐
cial monitoring or tension behaviour), along with self-rated affect (how they felt about the
prize, how frustrated they felt and how they liked the prize). As expected, all children gen‐
erally displayed condition-congruent behaviour, along with more intense self-reported af‐
fect following disappointment and more interest and effective ER in the non-disappointing
condition. Children with ADHD-C additionally showed a trend toward more negatively be‐
having after disappointment, experiencing more prize interest and affect intensity as well as
poorer ER than inattentive and control peers. Remarkably, children with ADHD-C also
showed significantly more positive behaviour overall (regardless of condition) than their in‐
attentive and control peers [9]. These findings concord with evidence stemming from phys‐
iological reactivity research (cf. §5.1), suggesting that children with ADHD, and among
them mainly those with the combined subtype, experience difficulties in adjusting their
emotions and related behaviours across shifting situational demands.
A study by Melnick & Hinshaw (2000) employed a more ecologically valid approach by us‐
ing a videotaped frustrating family task to examine emotional reactivity and regulation
among six to twelve year old, low aggressive (n=23) and high aggressive (n=25) ADHD boys
compared to non-clinical controls and their parents (see §5.4 for the latter) [60]. Frustration,
or negative emotion, was elicited by asking the child to complete a construction model with
parental help while two building pieces were lacking. Children’s behaviour was coded as
regards the intensity of their emotional ventilation (or reactivity) and the appropriateness of
their emotion modulation strategies (such as problem solving, seeking help, accommodat‐
ing, negative focussing or shutting down). Interestingly, no generalised ER difficulty could
be demonstrated for these ADHD children. Observer-rated aggression was also not related
to children’s emotion regulation strategies overall, nor was emotional reactivity a significant
predictor of their behavioural and social (peer) outcomes in this study. However, within-
population distinctions emerged whereby high-aggressive ADHD boys exhibited expected
overreactive emotions and impaired problem solving, whereas low-aggressive ADHD boys
showed either normal range or underresponsive emotional reactions [60].
It should be noted that, similar to (facial) emotion recognition evidence, findings on ADHD
children’s emotional intensity and behaviour may present measure-dependent variations.
For instance, the early empathy study by Braaten et al. (2000) cited in paragraph 5.2.2 addi‐
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tionally assessed children’s emotional behaviours, intensity and reactions to contingencies
using reported responses to hypothetical reward and punishment situations instead of live
laboratory paradigms [90]. The use of these formats yielded parent-reports of more manifest
signs of sadness, anger and guilt in ADHD boys but no self-reported differences in emotion‐
al intensity or reactivity compared to controls.
Finally, the chronic and pervasive impact of emotional impulsiveness is documented in a
rare longitudinal study that followed up on hyperactive (n=158) and community control
(n=81) children, currently 27 years of age [47]. Participants reported on emotional impulsive‐
ness (such as impatient, irascible, easily excited, frustrated, annoyed and emotionally over‐
reactive behaviour) and were interviewed on multiple domains of functioning (e.g., home
life and responsibilities, marital life, social interactions and leisure activities, occupation,
and so forth). Emotional impulsiveness was highly correlated with the interrelated dimen‐
sions of inattention and hyperactivity-impulsivity in participants with persistent ADHD.
The severity of emotional impulsiveness furthermore contributed uniquely to participants’
overall impairment and multiple domain-specific adverse outcomes.
Taken together, these studies’ findings lend credence to the emotion-centred expectations that
ADHD children’s (cognitive) abilities may become masked, not only by task modalities, but
significantly so too by difficulties in modulating their emotional responses across tasks and
situational demands. They also indicate that children with ADHD may especially benefit
from support in translating mood- and mood-repair-knowledge into action. Still, there is
ample room for further investigation of ADHD children’s deliberate modulation of emotion‐
al responses in emotional contexts. The small number of studies and limited investigation
scope leave more open questions than answers for the time being, notably regarding wheth‐
er and to what extent children with ADHD experience differential emotion regulation diffi‐
culties depending on the type of emotions, their intensity, the interaction styles and the
involved relational contexts, to name but a few. The longitudinal findings on the unique life‐
long impact of emotional impulsiveness underline the importance of uncovering early inter‐
vention leads for supporting youth with ADHD to behaviourally modulate their emotions.
5.4. ADHD children’s emotion regulation in the context of parenting and family risks and
resources
The reviewed evidence-base suggests that children with ADHD differ from other children in
their processing of facial affective clues, are less effective at matching (facial) affect and con‐
text, experience higher frustration levels in (cognitively) challenging situations and experi‐
ence more difficulty habituating to negative feelings and/or modulating these by acting
upon mood-repair techniques, despite some degree of insight into internal emotion-related
signals. Importantly, these difficulties occur even though children with ADHD appear to in‐
vest considerable effort into ‘doing well’ and complying with external instructions.
From a theoretical viewpoint (see paragraph 3.2), these observations raise questions about
contextual effects, and especially parenting and family ones, on ADHD children’s emotion
regulation skills. Several macro-level pathways may indeed influence the development of
ER skills in children with ADHD, both directly and indirectly, as illustrated by the arrows in
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iological reactivity research (cf. §5.1), suggesting that children with ADHD, and among
them mainly those with the combined subtype, experience difficulties in adjusting their
emotions and related behaviours across shifting situational demands.
A study by Melnick & Hinshaw (2000) employed a more ecologically valid approach by us‐
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their emotion modulation strategies (such as problem solving, seeking help, accommodat‐
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be demonstrated for these ADHD children. Observer-rated aggression was also not related
to children’s emotion regulation strategies overall, nor was emotional reactivity a significant
predictor of their behavioural and social (peer) outcomes in this study. However, within-
population distinctions emerged whereby high-aggressive ADHD boys exhibited expected
overreactive emotions and impaired problem solving, whereas low-aggressive ADHD boys
showed either normal range or underresponsive emotional reactions [60].
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ness (such as impatient, irascible, easily excited, frustrated, annoyed and emotionally over‐
reactive behaviour) and were interviewed on multiple domains of functioning (e.g., home
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and so forth). Emotional impulsiveness was highly correlated with the interrelated dimen‐
sions of inattention and hyperactivity-impulsivity in participants with persistent ADHD.
The severity of emotional impulsiveness furthermore contributed uniquely to participants’
overall impairment and multiple domain-specific adverse outcomes.
Taken together, these studies’ findings lend credence to the emotion-centred expectations that
ADHD children’s (cognitive) abilities may become masked, not only by task modalities, but
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situational demands. They also indicate that children with ADHD may especially benefit
from support in translating mood- and mood-repair-knowledge into action. Still, there is
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al responses in emotional contexts. The small number of studies and limited investigation
scope leave more open questions than answers for the time being, notably regarding wheth‐
er and to what extent children with ADHD experience differential emotion regulation diffi‐
culties depending on the type of emotions, their intensity, the interaction styles and the
involved relational contexts, to name but a few. The longitudinal findings on the unique life‐
long impact of emotional impulsiveness underline the importance of uncovering early inter‐
vention leads for supporting youth with ADHD to behaviourally modulate their emotions.
5.4. ADHD children’s emotion regulation in the context of parenting and family risks and
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The reviewed evidence-base suggests that children with ADHD differ from other children in
their processing of facial affective clues, are less effective at matching (facial) affect and con‐
text, experience higher frustration levels in (cognitively) challenging situations and experi‐
ence more difficulty habituating to negative feelings and/or modulating these by acting
upon mood-repair techniques, despite some degree of insight into internal emotion-related
signals. Importantly, these difficulties occur even though children with ADHD appear to in‐
vest considerable effort into ‘doing well’ and complying with external instructions.
From a theoretical viewpoint (see paragraph 3.2), these observations raise questions about
contextual effects, and especially parenting and family ones, on ADHD children’s emotion
regulation skills. Several macro-level pathways may indeed influence the development of
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Figure 1. Exploring these contextual pathways seems all the more pertinent given the ob‐
served discrepancies of ER findings within the ADHD youth population and apparently in‐
sufficient explanatory value of subtype, comorbidity or medication-statuses.
The most direct contextual effects on ADHD children’s ER skills concern the way in which
parents raise their children and run the family as regards these skills. Mediating and moder‐
ating effects of, for instance, parental depression, marital conflict, and critical and harsh pa‐
renting indeed already have been documented in general developmental studies and in
research regarding predictors of early-onset conduct problems [53, 96, 97]. With the in‐
creased recognition of adult persistence of ADHD, many children with ADHD are acknowl‐
edged to grow up in families with at least one parent with ADHD [8, 43] and possibly
siblings too [55, 96]. Emotional impairments in children with ADHD therefore are expected
to be reciprocally shaped by their personal neurobiological predispositions and parenting-
and family-related disruptions in emotion regulation [8, 14, 43, 57, 97, 98]. ER disruptions
also involve less direct effects, such as ADHD children’s observational, modelled learning of
emotion expression through their parents and possibly siblings. Moreover, structural and
functional contextual risks and resources are known to operate through cumulative and rela‐
tive principles, also described as psychological allostatic load [7, 13, 30, 35, 53]. For example,
an accumulation of family members with ADHD, internalising or externalising comorbidity,
family conflict and an adverse school climate would expectedly culminate in mutually un‐
dermining effects on the ADHD child’s ER skills. Conversely, the presence, for example, of
family members with strong emotion regulation skills and a supportive school climate
would constitute cumulative resources that stimulate the ADHD child’s emotion regulation
skills, or at least counterbalance its personal liabilities to this regard.
Unfortunately, to what extent parental, parenting and family ER difficulties affect specific
ER components in ADHD offspring has hardly been empirically examined. A Pubmed
search with the key-words ‘ADHD’, ‘emotion regulation’ and ‘parenting’ yields a mere five
published articles, among which only the above-cited study of Melnick et al. (2000) directly
tackled the subject (see §5.3) [60]. In this previously described videotaped frustrating family
task, asides from child ER, parental behaviour was also observed as regards positive versus
negative parenting (e.g. situational advice, warmth, structuring and empathy versus nega‐
tivity, intrusiveness, withdrawal), along with personal (global) emotion regulation (e.g.
anxiety, maintenance of focus on and interaction with the child). Mean levels of parenting
behaviour did not differ significantly among the ADHD (sub)groups and control children.
However, parental anxiety/nervousness and mother’s negativity were significantly associat‐
ed with child global emotion regulation difficulties overall; whereas father’s global ER and
advice-giving were marginally linked with child positive coping behaviour.
These findings are consonant with several other research reports linking parental negativity,
sometimes in association with parental ADHD, to (self-reported) adverse outcomes on emo‐
tion regulation in ADHD offspring and this throughout the life span [21, 47, 99].
For instance, in the broader literature children with ADHD have been described to resort to
overestimation of their social, behavioural or family-related self-perceptions, probably as a
compensation mechanism for excessive emotionally negative interactions [98, 99]. This phe‐
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nomenon, described as the positive illusory bias, was investigated in one study as regards
its link with parental emotional expression among families with seven to ten year old chil‐
dren with ADHD compared to controls (N=56) [99]. Parental criticism was indeed associated
with greater positive illusory bias, and parental warmth with lower bias regarding social
functioning in children with ADHD. Such findings call for the investigation of comparable
parenting effects on ER aspects such as ADHD children’s physiological reactivity, basic or
contextualised emotion appraisal and behavioural modulation.
Regarding behavioural modulation, a retrospective study for instance examined whether re‐
called parental ADHD and parenting behaviour related to current emotion regulation
among adults with persistent ADHD (n=73, mean age 40, half combined/half inattentive
subtypes) [21]. The ADHD adults whose mother possibly had ADHD recalled more mater‐
nal rejection and punishment, less paternal rejection and punishment, along with more emo‐
tional warmth. These retrospectively identified maternal parenting characteristics, as well as
recalled maternal ADHD symptoms, were linked to current insecure emotional functioning
and interpersonal relationships. ADHD adults’ current attachment and emotion processing
patterns were not similarly linked to recalled paternal ADHD and fathering characteristics.
To conclude on potential contextual influences on ADHD children’s emotion regulation, it is
noteworthy that the cultural component hereof has drawn little attention so far. While basic
FER is considered to be relatively universal, this assumption is far less evident for the con‐
textual embedment of emotions and for their behavioural correlates. One study for instance
found parenting strategies among children with ADHD to differ by ethnicity, although this
did not moderate treatment outcomes [100]. Potential effects of ethnicity and culture on
ADHD children’s appraisal and expression of emotions thus deserve examination.
In  sum,  the  frequent  cumulative  presence  of  ADHD  among  family  members  by  itself
forms  a  considerable  risk  burden  that  may  increase  emotion  dysregulation  in  children
with ADHD or constitute critical obstacles toward their learning of effective emotion reg‐
ulation. While these risks of parental ADHD, negative parenting and family interactions
are easily conceived, there is a lack of empirical research that investigates when and how
such cumulative risks versus resources specifically operate in the ADHD child’s acquisi‐
tion of emotion regulation skills.
5.5. Summary
Behavioural observations, neurobiological and brain imaging data have led to postulate that
children with ADHD may experience disrupted emotion regulation. More specifically,
ADHD children are expected to exhibit right hemispheric- and attention-related emotion
recognition difficulties along with emotional impulsiveness, including heightened physio‐
logical reactivity and lessened control of behavioural emotional expression, as synthesised
at micro-level of the FACE-model. ADHD children’s emotion regulation consequently mer‐
its investigation as regards their physiological arousal levels, basic and contextualised ap‐
praisal of (facial) emotional cues and modulation of emotional behaviour.
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Our review of the current evidence-base concerning ADHD children’s emotion regulation
reveals a still emerging field that involves a wide scope of ER components and operationali‐
sations, which have only been investigated to a limited extent to date. This state-of-the-art
prohibits drawing definite conclusions on the extent to which the ADHD youth population
exhibits the expected ER difficulties, and the degree to which these apply to its heterogene‐
ous subgroups as regards subtypes and comorbidities. Further empirical evidence is re‐
quired too regarding how, precisely, parental, parenting and family dynamics hamper
versus foster specific aspects of ADHD children’s emotion regulation.
Taken together, the available studies nevertheless suggest that children with ADHD tend to
differ from other children in their processing of facial affective clues and are at-risk for being
less effective at adequately adapting their physiological arousal to situational demands, and
at matching (facial) affect and context. Children with ADHD also appear vulnerable to expe‐
riencing higher frustration levels in (cognitively) challenging situations, and having more
difficulties with behaviourally habituating to negative feelings and modulating these by act‐
ing upon mood-repair techniques. This happens despite indications that children with
ADHD do demonstrate some degree of insight into internal emotion-related signals. Per‐
haps even more importantly, it appears that children with ADHD invest considerable effort
into ‘doing well’ and attempting to control their negative emotions when requested to do so,
yet these efforts are seldom acknowledged and/or accompanied by the expected results. The
prevention and intervention implications hereof are discussed hereafter.
6. From studying to facilitating ADHD children’s emotion regulation
Translating research into practice remains an important challenge for designing, implement‐
ing and evaluating ADHD prevention and intervention programs [6, 18, 57, 101]. Several
characteristics of the extant ER research yet call for caution when attempting to move from
the evidence-base toward one-on-one practice with ADHD children. We therefore first ana‐
lyse conditions for a cautious interpretation of the evidence-base that also foster a strengths-
based approach, this along three related lines pertaining to the individual, the proportional
and the clinical relevance of the empirical findings (§6.1). Several potential implications of
the ER evidence-base for emotion-oriented intervention with ADHD children and their fam‐
ilies are considered subsequently (§6.2).
6.1. Cautions and conditions for an evidence-based, resiliency-oriented practice
A first and fundamental challenge when relying on the evidence-base for practice consists of
deciphering its potential relevance for the individual child with ADHD and its family. Em‐
pirical research indeed mostly reports on statistically significant differences between groups
of children with and without ADHD; or on group-level correlations between the ADHD sta‐
tus and several emotion regulation aspects. Such mean differences or group-wise correla‐
tions evidently do not concern all investigated ADHD children. Most of the current research
data thus critically leave open questions as to which children within the investigated ADHD
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groups are more particularly concerned by specific ER difficulties [ 19, 28, 37, 46]. Moreover,
cross-sectional research, which is currently dominant, informs little to none about children’s
personal trajectories, while understanding these trajectories is crucial to guiding prevention
and intervention efforts with individual ADHD children and their families.
A second, related challenge consists of clarifying the proportions of children with ADHD
who are vulnerable to exhibiting ER difficulties. Percentages of ADHD versus control chil‐
dren concerned by the observed ER differences indeed are not systematically provided in
many studies. A clear view of the proportion of the investigated ADHD children facing
emotion regulation challenges consequently does not automatically emerge from the evi‐
dence-base. Closer analysis nevertheless reveals that oftentimes only a minority or a sub‐
group among the children with ADHD presents deficits in the investigated emotion
regulation components, while a majority successfully accomplishes the tasks at hand. Prac‐
tice relevance would consequently be enhanced if empirical research were oriented to a larg‐
er extent on identifying the subsets of ADHD children who account for the differences in
emotion regulation observed between investigated groups.
A third challenge concerns the clinical relevance of statistical findings. Group-level statistical‐
ly significant differences or correlations do not naturally equal clinically significant levels of
emotion dysregulation in (all) children with ADHD [6]. When studies report statistical ER
differences between groups of controls and children with ADHD, it therefore still remains to
be specified to what extent these differences correspond to clinically relevant functional im‐
pairments in the latter. This challenge is compounded by the inherent chiasm between, on
the one hand, striving toward as ‘pure’ as possible research conditions, and on the other
hand, obtaining ecologically valid insights of how ADHD children’s emotion regulation ef‐
forts unfold when cognitive, emotional and behavioural stimulus input and output occur si‐
multaneously in a continuous loop of adjustment processes.
Additionally, and contrasting with a voluminous parenting literature and demand, very lit‐
tle empirical research has been devoted to the potential emotional strengths that may come
with ADHD [13]. A growing resiliency-oriented literature yet suggests that the aim of help‐
ing ADHD children better deal with their personal and interpersonal challenges may be
more difficult to attain when weighing in on ‘what goes wrong’ without simultaneously try‐
ing to understand ‘what goes right’ [102]. The macro-level of the FACE-model indeed re‐
minds that solely assessing ADHD children’s emotion-related problems does not provide a
valid view of day-to-day dynamics. Importantly, it creates the risk of overlooking child- and
family strengths that contribute to compensating, alleviating or avoiding negative emotional
outcomes in the ADHD child’s development [31]. This omission of strengths, or of at least a
balanced risk-resiliency assessment, may contribute to accounting, for instance, for the pro‐
portions of children with diagnosed ADHD in which no significant emotion regulation defi‐
cits are found in the discussed studies.
Altogether these factors add to necessary caution when linking empirical data to real-life im‐
plications for ADHD children and their families. Given a generalised tendency to overgener‐
alisation, evidence-based practice would benefit from studies adding more ecologically
valid indices in their conclusions regarding the profiles of ADHD children to which ob‐
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served emotion processing and regulation characteristics apply, and to which degree these
correspond to clinically relevant impairments [6, 19]. Even when considering that emotion
regulation training probably constitutes a valuable asset to any prevention and intervention
effort, the main preoccupation for children with ADHD still consists of tailoring such efforts
as closely as possible to their particular ER challenges. The current knowledgebase hereby
points to potentially relevant prevention/intervention avenues that merit individual tailor‐
ing when addressing ADHD children’s emotional functioning in practice.
6.2. How to face emotion regulation in children with ADHD and their families:
Prevention and intervention keys
Bearing the discussed cautions in mind, an integrated theory-grounded, evidence-based and
strengths-oriented approach offers several instrumental leads for accompanying children
and their parents towards facing emotionally disruptive facets of ADHD and equipping
them with emotion regulation strengths.
On a micro-level, it appears key to help at-risk ADHD children with adjusting their emotion‐
al reactivity, with appraising how emotions relate to particular contexts, with recognising
negative emotions, and with acquiring problem solving, mood-adjustment knowledge and
techniques to act upon this knowledge.
On a macro-level, parents with ADHD are likely to find solace in the same focuses, while pa‐
rents of ADHD children in general may benefit from psychoeducation about the aforemen‐
tioned ER specificities in their children (and partners) and from tailoring emotion regulation
and problem solving techniques to these specificities.
Given the most directly influential impact of parenting on the child’s life, it appears particu‐
larly important for practice to identify parental ADHD as well as parental emotional resour‐
ces. Indeed, adults who suffer emotional disruptions themselves confront a significant
parenting burden when rearing one or more children with ADHD. Parents with ADHD, but
also with other affective issues such as depression, may be particularly vulnerable toward
disrupted emotion regulation [43]. Conversely, since not all parents of ADHD children
present with ADHD and not all ADHD parents suffer (the same extent of) emotional impair‐
ments, recognising ER resources in parents represents a valuable asset for building resilien‐
cy in their children. Identifying the ER strategies acquired by parents with ADHD hereby
especially offers added value because this simultaneously allows drawing on experience-
tested insights, promoting empathy with the ADHD child and engaging in uncovering exist‐
ing strengths in the family.
An illustration of these principles can be found and is currently evaluated in the ongoing
FACE©-ADHD program, which consists of thirteen weekly, 2-hour sessions combining child
and parent intervention [4, 5, 30]. Sessions evolve from psychoeducation through problem-
solving activities and cognitive-oriented parenting support, toward more specific targeting
of (negative) emotions, building emotional skills and training in emotion regulation so as to
reduce negative and increase positive experiences and interactions by and among ADHD
children and their parents. In a preliminary evaluation, this approach yielded significant
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pre- versus posttest improvements in child- and parent-reported experiential and behaviou‐
ral outcomes after program completion [4, 5, 30]. The FACE©-program hereby also involves
stimulating the transfer of clinic-based activities through home activities during which pa‐
rents and children use self-report versions of the FACE’ogram© illustrated in Figure 1 to
map perceived stressors and resources. Micro-challenges in daily adjustments are also moni‐
tored through the use of a cognitive-emotional diary (FACE©-CEM) [6]. Similar diary meth‐
ods have been found useful for identifying ADHD families’ daily challenges [103].
Despite a growing range of evidence-based interventions for ADHD children and their fami‐
lies, emotion-centred insights yet still remain sparsely applied in this context [104]. To date,
many of these interventions also have more broadly concerned children with oppositional
behaviour and conduct problems, whereby ADHD symptoms may be involved but not nec‐
essarily amount to formal ADHD diagnoses. Most interventions thus still tend to focus pri‐
marily on behavioural and/or cognitive modification techniques, even if emotion-related
management is more or less implicitly involved in parent-training intervention components
[56, 104-106]. A recent meta-analysis of 40 ADHD-oriented parent-intervention studies here‐
by showed parenting competence to be the only parent-intervention outcome with a large-
to-moderate effect from immediate assessment to follow-up, among otherwise generally
moderate-to-small outcome effects [104]. Training outcomes seem to follow comparable tra‐
jectories for mothers and fathers, consisting of immediate efficacy followed by limited gen‐
eralisation and waning longer term effects, although it should be noted that fathers typically
have been less implicated and thus less investigated [106].
Interestingly, two interventions that do include a more explicit emotion-centred focus, one
of which was aimed at ADHD children, are reported to yield firmer long-term outcomes.
Thus, one study assessed whether limiting negative emotional control through the training
of parental positive behaviour in a family-centred intervention would amend the growth of
children’s early behaviour problems [107]. An effortful increase in proactive parenting was
indeed significantly associated with lower levels of toddlers’ general behavioural problems
through age two to four. Another study more specifically evaluated the efficacy of the In‐
credible Years (IY) interventions for children with a primary ADHD diagnosis [108]. The IY
interventions involve emotion-focused techniques, besides more traditional child and parent
behaviour modification and parenting support, and have been found effective in reducing
negative parenting and externalising behaviour among children with ODD and CD in a ser‐
ies of randomized control group studies [96, 108]. An updated program version was used to
more precisely examine IY efficacy with four to six-year-old ADHD children (n=49) and
their parents who participated in six intervention months. Emotion-focused targets included
emotional coaching and teaching of ER strategies, reducing parental depression and anger
and increasing family support. Statistically and clinically significant post-treatment effects
were found for most outcome variables; including parent-reported and observed parenting,
child social, externalising and ADHD-specific behaviours. Significantly, ADHD children’s
treatment progress was maintained after one year [108].
Finally and for the sake of exhaustiveness, it deserves to be noted that, given space-con‐
straints, the present discussion did not extensively review medication effects on ADHD chil‐
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emotional coaching and teaching of ER strategies, reducing parental depression and anger
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were found for most outcome variables; including parent-reported and observed parenting,
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Finally and for the sake of exhaustiveness, it deserves to be noted that, given space-con‐
straints, the present discussion did not extensively review medication effects on ADHD chil‐
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dren’s emotion regulation. Briefly considered, the additive value of combining medication
and psychosocial treatments has been demonstrated especially for children with intense
ADHD symptomatology [2, 105, 108]. It is therefore likely that medication may benefit the
efficacy of emotion-focused interventions with these children too, albeit because a normali‐
sation of behavioural activity levels is expected to improve learning conditions and family
communication [38]. For instance, a study on 43 elementary-school-age children with
ADHD documents the positive impact of amphetamine medication on child and family dy‐
namics [59]. Furthermore, Williams’ et al.’s study (2008) on youth’s event-related potentials
before and after MPH treatment [89], evoked in paragraph 5.2.1, specifically showed that
improved brain activity after MPH treatment predicted diminution of emotional lability al‐
though not of negative mood. Medication has however also been reported to result in blunt‐
ed, flattened, restricted and dysphoric emotional expression along with passive and even
submissive behaviour among children with ADHD [109]. Optimising medication doses may
therefore be crucial, as evidenced by one study reporting curvilinear MPH dose effects on
ADHD children’s visual focusing and variability of facially expressed emotions [38]. Subop‐
timal medication protocols might in turn interfere with the process of training ADHD chil‐
dren’s emotion regulation skills. Investigating the impact of ADHD medication on emotion-
centred intervention outcomes and its differential effects according to symptom intensity,
comorbidity and medication dosage is therefore recommended.
Taken together, an integration of the nascent empirical evidence-base with the outlined con‐
ceptual foundations suggests the importance of incorporating techniques for adjusting emo‐
tional reactivity, appraisal and behavioural modulation of emotions when intervening with
children with ADHD and their parents, whereby relative focuses merit to be tailored to the
specificities of the individual family’s risk-resiliency balance and challenges. Research-wise
there still is a critical need for prospective, follow-up as well as qualitative studies to move
towards more fine-grained evidence-based insights into how and under which conditions
emotion regulation training with ADHD children and their parents bears fruit.
7. Conclusion
Drawing on the FACE©-model, this chapter has examined ADHD children’s emotion regula‐
tion skills on a cognitive-emotional adjustment and behavioural expression micro-level,
along with parenting and family risks and resources herein on a contextual macro-level.
Emotion regulation hereby was operationally conceived as the autonomic and effortful
modulation of the transient physiological reactions, the basic and contextualised appraisal,
the subjective experience and the overt behavioural expressions involved in emotions.
As far as the extant evidence-base allows concluding, children with ADHD appear vulnera‐
ble to some extent to difficulties in modulating each of these emotion regulation compo‐
nents, from adaptively accommodating physiological reactivity through adequately
appraising emotions in their context to flexibly modulating experience and behavioural ex‐
pression of emotions. At the least, children with ADHD as a group seem inclined to process
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emotions differently compared to peers so that they are in need of extra support in the skill
of emotionally adjusting to habitual contextual demands. Throughout the diverse outcomes
for this heterogeneous population, it seems that especially children with an externalising
pattern of functioning, namely those with the combined ADHD subtype and/or comorbid
conduct problems, are most at-risk for demonstrating emotion regulation difficulties at
physiological, experiential and behavioural levels. Although as yet scarcely investigated, pa‐
rental expressed negativity furthermore appears to adversely weigh in on ADHD children’s
emotion regulation skills at parenting and family-functioning levels.
Given that the research to date predominantly has investigated ADHD children’s emotion
regulation in cognitive (challenging) situations, findings hereby primarily underscore the
importance of considering the impact of ADHD children’s emotional functioning on (cogni‐
tive) task accomplishments and of acknowledging their non-apparent regulation efforts.
These insights call for incorporating mood-management support for children with ADHD in
learning conditions. They also call for a paradigm shift so as to value ADHD children’s ef‐
forts instead of sole outcomes to a much larger extent than is generally the case in academic
contexts.
Importantly, the observation that large proportions of investigated children with ADHD do
not exhibit the expected emotion regulation difficulties still tends to go unnoticed. This
leaves unexploited critical leads for gaining a refined understanding of the impact of ADHD
on a child’s life and of the resources that may be more or less naturally present in some fam‐
ilies to mend its expected adverse effects. Emerging intervention-outcome evidence also
points to promising resiliency-building opportunities through the integration of emotion
regulation, problem solving, behaviour modification and positive parenting training for
those children with ADHD and their parents who confront emotion dysregulation.
The complex field of ADHD children’s emotion regulation thus still remains under-explored
empirically on several aspects with practical relevance. Children’s physiological reactivity,
appraisal of emotional cues and modulation of emotional experience and expression hardly
have been examined in inherently emotion-driven contexts, such as during parent-child and
family interactions. More ecologically valid indices are therefore needed as to which emo‐
tion regulation processes underlie ADHD children’s observed emotional disruptions in the
daily life situations where they matter most in their early years.
In a theory-grounded research utopia, each of the emotion regulation components specified
at the micro-level of the FACE©-model would be investigated longitudinally as they develop
in children with ADHD while taking into account probable mediating and moderating ef‐
fects of their macro-level risk and resiliency balance, especially as regards their parenting
and family environment. As an added value, ADHD children’s emotion regulation trajecto‐
ries would be compared with those of children with other clinical conditions.
In an evidence-based practice utopia, research would systematically inform about the pro‐
portions and specificities of children with ADHD concerned by clinically relevant emotion
dysregulation processes. Even more fundamentally, empirical findings would predictively
outline the constellation of cognitive-emotional (micro-level) and family environmental
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(macro-level) characteristics of those ADHD children who are most at-risk for emotion dys‐
regulation so as to direct prevention or intervention efforts toward these children.
While patiently building the empirical evidence-base and advocating shifts toward sus‐
tained research policies that stimulate large-scale longitudinal investigations, remembering
the final aim of ADHD emotion research may facilitate moving toward the outlined practice
utopia. This aim would expectedly consist of significantly contributing to ameliorating
ADHD children’s outcomes. A strengths-oriented evidence-base consequently deserves to
integrate research that also focuses on gaining an understanding of the conditions under
which children with ADHD do manage to regulate their emotions in functional ways. The
current chapter allows concluding that combining the search for dysfunctional emotion
areas with the discovery of individual and contextual characteristics of children with ADHD
who fare best emotionally despite their vulnerabilities, offers the strongest leads for durably
building ADHD children’s resilience.
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1. Introduction
Attention Deficit and Hyperactivity Disorder (ADHD) comprises a disorder which is charac‐
terized with inattention, hyperactivity and impulsivity, seen in 3-7% of school-age children
Boys are two to nine times more often affected than girls [1]. Twin, adoption, and molecular
genetic studies show ADHD to be highly heritable. Evidence from animal and human studies
implicates the dysregulation of frontal-subcortical-cerebellar catecholaminergic circuits in the
pathophysiology of ADHD. Imaging studies suggest that abnormalities of the dopaminergic
and adrenergic transmitter systems lead to impaired neurotransmission [2]
The  main  course  of  ADHD  is  a  persistent  pattern  of  inattention  and/or  hyperactivity-
impulsivity  that  may be  seen more  frequently  and/or  severely  compared to  individuals
with  the  same  level  of  development.  Its  pathophysiology  appears  to  involve  different
alterations in dopaminergic  and noradrenergic  pathways related to  the control  of  atten‐
tion and impulsivity [1,3,4].
ADHD is associated with important deterioration at numerous fields such as developmental,
cognitive, emotional, social and academical, and also associated with personal time for parents
because of affecting several health risks and academic performance. Deterioration in these
fields based on basic sypmtoms of ADHD: hyperactivity, inattention and impulsivity [5]. In
case of ADHD, as a result of inadequacies any time in the life of the child, reduction in self-
confidence, misery, failure and thus reduced quality of life; deterioration of interpersonal and
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intra-family relations, being affected adversely of psychological well-being could be seen.
Therefore, it is reported that “psychosocial dimension” gains importance gradually besides
clinical parameters in multidimensional monitoring of disease and adequacy and inadequacy
in this dimension could be explained with “life quality” concept [6]. Because of difficulties in
academical, social and emotional fields, the effects of deterioration over life quality came into
discussion in the context of the recent literature [7,8,9]. This level of interest is not surprising
due to the complexity of the relationships; QoL(Quality of life) is not only influenced by the
disorder itself, but also by many proximal (i.e. family, friendship) and distal (socioeconomic
and cultural) factors. In addition to its core symptoms of attention deficit, hyperactivity and
impulsivity, ADHD is associated with numerous developmental, cognitive, emotional, social
and academic impairments [10,11].
The psychostimulants (e.g., methylphenidate) are considered the first-line of therapy for
ADHD, relieving symptoms by increasing intrasynaptic dopamine, norepinephrine, and
serotonin [12]. Nevertheless, some patients fail to respond to stimulants or are unable to
tolerate them, and the stimulants such as methylphenidate are contraindicated for some
children and adolescents including those with Tourette’s disorder. Nonstimulant agents used
in ADHD include tricyclic antidepressants, bupropion, clonidine, guanfacine, selective
serotonin reuptake inhibitors, and newer atypical antidepressants [13,14]. But their current use
is limited, because these agents do not improve impulsive behavior and cognitive impairments
and also they have serious adverse effects [15].
On the other hand, atomoxetine, a highly selective inhibitor of the noradrenergic transporter,
is the first non-psychostimulant agent approved by the Food and Drug Administration (FDA)
for ADHD. Compared to its effect on the norepinephrine transporter, atomoxetine has very
little affinity for the dopamine or serotonin transpoter. As a result of the central role of CYP2D6
in metabolism of atomoxetine, the activity of this enzyme plays a significant role in its
pharmachokinetics. The majority of people ([90%), who metabolise atomoxetine and other
CYP2D6 substrates relatively rapidly, are designed as CYP2D6 extensive metaboliser. Its
efficacy in children with ADHD has been demonstrated in three double-blind, placebo-
controlled trials [16].
Commonly used drugs for ADHD are shown in table 1.
Drug Dosage Dosage range
Time of Maximum plasma
concentraiton (hour)
FDA approval year
Concerta 18,27,36,54,72 18-72 8 2000
Metadate CD 10,20,30 20-60 5 2001
Ritalin LA 10,20,30,40 20-60 5 2002
Adderall XR 10,20,30 10-40 1-4 2001
Ritalin 5,10,20 10-60 0.3-4 2000
Atomoksetin 10,18,25,40,60 10-60 1-2,3-4 2002
Table 1. Commonly used drugs for ADHD
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Consequently, methylphenidate for stimulant group and atomoxetine for nonstimulant group
are in primer use for ADHD treatment. The use of these medications becomes widespread
gradually. It is reported that both medications are effective on treatment of ADHD’s basic
symptoms in children and adolescents. Thus, significant improvement could be seen in life
quality [9,17,18]. When comparing with normal population, difficulties in academical, social
and emotional fields could be developed more frequently.
The side effects on weight and height of these medications which are used considerably in
child psychiatry are in discussion over a long time. Although a few studies defend inefficiency
over weight and height, some studies show arrest in height development and shortness in
ultimate height [19]. Current studies in this content on children and adolescents are subjects
of only a few studies specially in our country [20].
In our study, we aimed to compare the effect of long acting methylphenidatefor and/or
atomoxetine usage due to ADHD, weight-height measurements, and comparison of life quality
between children and adolescents, and healthy population.
2. Material and methods
This study was conducted in Department of Child and Adolescent Pscyhiatry, Erciyes
University Faculty of Medicine in the period from September 2011 to May 2012. Study
population consists of 52 patients with ADHD based on DSM-IV and these patients were
pharmacologically treated for at least 12 months and sypmtom severity is consistent with
Scanning and Evaluation Scale based on DSM-IV for Behavioral Disorders in Children and
Adolescents. Coexisting psychiatric disorders were accepted as exclusion criteria. Children
with no previous history of psychopharmalogical treatment except ADHD and simultaneously
no previous history of epilepsy and other medical disease was examined. Control group was
selected randomly between patients of social pediatric clinical and specified as 25 healthy
children in physical and psychological way. Smilarity between control and patient group from
the point of gender and age avaragewas noticed. Parents of children with ADHD filled
sociodemographic data form, The Pediatric Quality of Life Inventory(PedsQL), Atilla Turgay
Scanning and Evaluation Scale based on DSM-IV for Behavioral Disorders in Children and
Adolescents. Weight and height measurements were performed by our nurse specialist.
Parents of control group also filled the same tests. Parents of both group signed informed
consent and ethics committee approval was obtained.
3. Scales used in this study
The Pediatric Quality of Life Inventory(PedsQL): Developed for psychosocial and physcial life
quality measurement of children and adolescent between 2-18 age interval by Varni and et all.
and adapted into Turkish for 8-18 age interval was carried out by Çakın Memik et al. [21,22].
It is obtained that Cronbach Alfa coefficients vary between 0.80 and 0.88. PedsQL between the
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ages of 8-18 children / adolescents, there are forms for both self-report and parent and consists
of 23 articles. The scale of physical health, emotional functioning, social functioning, and school
functioning challenged areas. Scoring, scale total score (CAP), physical health score (FSTP),
emotional, social and school functioning scores evaluating the substance of the calculation of
the total score of psychosocial health (PSTP) to be carried out in three areas. This is the last
month of children and adolescents with the scale in question. Substances "never", "rarely",
"sometimes", "often" or "always" in the form of, and in turn responded, 100, 75, 50, 25, 0 points
are given. Points total score is obtained by dividing the number of items collected and
replenished. As a result the higher the PedsQL total score, the better the perceived health-
related quality of life [20].
Thus fields of physical health, emotional functioning, social functioning and shcool function‐
ing as features of well-being, identified by WHO, was examined.
Turgay DSM-IV Based Child and Adolescent Behavior Disorders Screening and Rating Scale:
This scale was developed by Turgay [23], based on DSM-IV diagnosis criteria. This scale
consists of 41 questions; 9 of them for attention deficit, 9 of them for mobility and impulsivity,
8 of them for comorbid oppositional defiant disorder (ODD), and 15 of them for behavioral
disorder. Each question has 4 choices: 0 for strongly disagree, 1 for somewhat, 2 for agree, 3
for strongly agree. For ADHD diagnosis, min 6 of 9 questions that examine attention deficit
should have 2 or 3 scoring, min 6 of 9 questions that examine hyperactivity or impulsivity
should have 2 or 3 scoring. For ODD, min 4 of 8 questions should have 2 or 3 scoring; for BD
diagnosis, min 2 of 25 questions should exist for 6 months or 1 year. Confidence validity test
was conducted by Ercan et al. in Turkey [24].
4. Statistical evaluation
The statistics software SPSS 17.0 is utilized in this study. The data obtained through measure‐
ment is indicated as arithmetic mean (X) and standard deviation (SD); the data obtained
through census is indicated as percentages (%).The significance level in the evaluations is
determined as p<0.05. One- Sample Kolmogorov- Smirnov Test is used for control if variables
are normal distribution or not. The grading differences between the groups (children-
adolescents with ADHD diagnoses and healthy children-adolescents) are compared by using
the “Student t test” for the measuremental variables that conform to the normal distribution
and “Mann Whitney-U test” for the measuremental variables that do not conform to the normal
distribution. Tukey and Dunnett post hoc tests are also used for varyans analyze. Sperman
correlation test is used for showing correlations.
5. Results
Fourty two of patients who admitted into study were men (80.8%) and ten were women
(19.2%). The avarage age of children was 10.42 ±2.136. Control group was smilar to patient
Attention Deficit Hyperactivity Disorder in Children and Adolescents288
group in terms of avarage age and sex ratio. Socio- demographic characteristics of the group
with ADHD and the control group are shown in tables (Table 2 and table 3). Socio-demographic
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Table 3. Socio-demographic characteristics of the control group
33 of patients (63.5%) were under long acting methylphenidate (OROS-MPH) therapy and 19
(36.5%) were under atomoxetine therapy. The medication use duration of first group was
18.54±15.43 months and second group was 18.3±14.8 months. No significant difference was
found between these two groups in terms of duration (p=0,958, t=0,52).
Dose rate for OROS-MPH was averagely 29,4±7,88 mg and for atomexetine was averagely
45,42±12,36 mg.
Height average in patient group was 141,4±13,8 cm, weight average was 37,07±11,17 kg and
height average for control group was 145,6±17,9cm, weight average was41,1±15,5 kg (p=0,251).
In terms of weight and height, there is no significant difference between atomexetine users,
MPH-OROS users and control group (Table 4 and 5).
When considered sub-group of life quality scale in patient group, phsycal sub-group was
found as 80,8 ±15,27, while emotianol sub-group was 66,05±18,26, life quality social was
76,15±22,28 and sub-group associated with school was 66,25±18,86. In control group, physcal
sub-group was found as 96,37±7,02, while emotional sub-group was 90,2±13,5, life quality
social 97,4±7,92 and sub-group associated with school was 91,6±10,19. There is significant
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difference between all fields of life quality in both groups (p<0.001*). When comparing life
quality of atomexetine and MPH users, no significant difference was found. But when
comparing long acting MPH users and atomexetine users with control group individually,
significant difference was examined in life quality sub-groups between control group and
other two groups (Table 4).
Patient group Control group Comparement of groups
Mean of ages 10,42 ±2,136 10,4±2,66
p= 0,970
t= 0,041
Mean of height 141,63 ±14,19 145,6±17,9
p= 0,296
t= 1,051
Mean of weight 37,07±11,17 41,12±15,5
p= 0,251
t= 1,166





















Table 4. Comparement of Socialdemographic datas and life quality
In OROS-MPH user group, while score between age and life quality in school field was found
significantly correlated; (p<0.05*, r=0.443) in atomexetine user group, no correlation was found.
When considering changes in hand-writing and drug use, 20 patients of 52 parents showed
recovery in hand writing after drug intake.
26 patients (50%) were applied before any other treatment of ADHD. However, several side
effects, and due to non compliance of previously treatment patients couldn’t maintain previous
treatment is observed. 16 patients of the 26 patients, (20.8%), inability to benefit from treatment,
2 patients (2.6%), insomnia, and 2 (2.6%), loss of appetite, and 2 (2.6%), nervousness, 1 'patients
(1.3%) hyperactivity, and 1 (1.3%), treatment noncompliance, and 1 (1.3%) increase in anxiety,
and 1 (1.3%) were somnolence. The relationship between these side effects, drugs, the treat‐
ment of patients do not benefit from atomoxetine before 4 out, 11 patients are used long-or
short-acting MPH, that 1 learned that used risperidone treatment. Insomnia, loss of appetite,
and nervousness side effects was seen with all the OROS MPH. Increase in hyperactivity and
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anxiety side effects could be showed with the use of OROS MPH. The side effects of somnolence
and non-compliance with the development of atomoxetine (Table 6).
Reason of finishing first treatment /
First treatment
MPH Atomoxetine Risperidone
Non effective 11 4 1
Insomnia 2 - -
Loss of appetite 2 - -
Nervoussness 2 - -
Non compliance of treatment - 1 -
Hyperactivity 1 - -
Increase in anxiety 1 - -
Somnolence - 1 -












Mean of ages p= 0,586 p= 0,933 p= 0,806
Mean of height p= 0,294 p= 0,336 p= 1,00
Mean of weight p= 0,475 p= 0,225 p= 0,937
Mean of physical health field in
PedsQL
p= 0,991 p<0,001* p<0,005*
MMean of emotional functioning
field in PPedsQL
p= 1,00 p<0,001* p<0,001*
MMean of , social functioning field in
PedsQL
p= 0,821 p<0,001* p<0,005*
MMean of shcool functioning field in
PedsQL
p= 0,683 p<0,001* p<0,001*
(p<0,05*)
Table 5. Comparement of patients under OROS-MPH, atomoxetine treatment with each others and control group
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6. Discussion — conclusions
Life quality measurement is a method that gains gradually importance in children and
adolescent, mental health surveys and clinical practice. Investigators and practioners sup‐
posed that important deterioration in psychosocial fields associated with ADHD based on
basic symptoms of ADHD.
Children and adolescent with ADHD are at increased risk of academic failure, dropping out
of school or college, teenage pregnancy, alcohol and substance use and criminal behaviour.
Driving poses an additional risk. The emotional impairments of children and adolescents with
ADHD may include poor self-regulation of emotion, greater excessive emotional expression,
especially anger and aggression, greater problems coping with frustration, reduced empathy,
and decreased arousal to stimulation [25]. Children and adolescents with ADHD have
problems with peer relationships lack friendships, or have limitations in their activities with
friends if they do have friends. More than half of these children and adolescents have serious
problems with peer relationships [26]. Relationships and activities within the family can be
impaired and in some cases family relationships can break down, bringing additional social
and financial difficulties causing children to feel sad or show oppositional or aggressive
behavior [27].
Specific academic difficulties noted in children with ADHD include slower reading fluency
weaker reading comprehension (Ghelani and poor penmanship. Mastery of academic skills
can also be hampered by the secondary effects (impulsivity, inattention, and disorganization)
that ADHD can have upon a child’s ability to practice newly learned skills or study recently
presented material in the homework setting [28,29].
ADHD affects not only on the child, but also on parents and siblings, causing disturbances to
family and marital functioning, increased healthcare costs for patients and their family.
Children and their families changes from the preschool years to primary school and adoles‐
cence, with varying aspects of the disorder being more prominent at different stages. Also,
ADHD had more parent-reported problems in terms of emotional-behavioral role function,
behavior, mental health, and self-esteem. In addition, the problems of children with ADHD
had a significant impact on the parents' emotional health and parents' time to meet their own
needs, and they interfered with family activities and family cohesion[30].
ADHD is one of the most common psychiatric conditions estimated to affect 5-10% of all
children and ADHD predisposes children to impaired academic, familial, social, vocational
and emotional functioning if untreated. ADHD does not remit with the onset of puberty alone
and teenagers and adults continue to have symptoms of the disorder that cause significant
problems in their lives[31].
Children with attention-deficit and disruptive behavior disorder had, according to parent
ratings, a better emotional functioning score than children with anxiety disorders. Their
academic performance was significantly lower than for children with anxiety disorders and
other disorders, but school functioning was reported as equal. Clinicians reported more
problems in behavior toward others for this group compared to children with anxiety and
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mood disorders. Comorbidity of attention-deficit disorder or disruptive behavior disorder
with other psychiatric diagnoses did not influence overall Quality of Life. Also ıt had been
found that children with ADHD were more limited in schoolwork and social functioning[32].
Danckaerts M. et al. showed that a robust negative effect on QoL was reported by the parents
of children with ADHD across a broad range of psychopathology symptoms [33].
Because of difficulties in academical, social and emotional fields, the adverse effect of ADHD
on life quality is in evidence in current studies. Numerous studies have shown significant
recovery in life quality with medication use in case of ADHD [6,7,8]. The results of studies
carried out in this content showed adverse effect on all fields of children with ADHD diagnosis
and therapy requirement. Also, it is suggested that recovery attempts for children with ADHD
diagnosis should include all fields of life [34]. In line with previous studies, our study showed
that there is significantly difference in all sub-fields of life quality scale between control group
and under ADHD treatment [6,7,8]. Among this, when comparing all sub-fields of life quality
scale, there is no significant difference between atomexetine and OROS-MPH users. This result
is consistent with Leo Bastiaens’s study [35] conducted in 75 children between 6-12 age interval,
comparing the effects of atomexetine and stimulant therapy over life quality, and there are
further studies that suggests efficiency of OROS-MPH on life quality [36]. Also in another study
of Leo Bastiaens, 84 patients (atomoxetine n = 39/stimulants n = 45), between the ages of 5
and18, were treated for approximately 8 months. At end point, there were no significant
differences in improvements of quality of life between the two groups [37].
However an interesting study is that; 977 Male and female patients aged 6-17 years seeking
treatment for symptoms of ADHD were assessed,they were grouped according to wheth‐
er  they  were  prescribed  psycho-  and/or  pharmacotherapy  (treatment)  or  not  (no/‘other’
treatment)  Although  both  treatment  and  no/‘other’  treatment  cohorts  showed  improve‐
ments in mean Quality of Life over 12 months, the difference was small and not statistical‐
ly significant [38].
In our study, we found that confounding result, although patients with ADHD tent to show
a decrease in school success with increase in age, patients who take OROS-MPH treatment
show an increase in life quality school sub-score. This increase could be due to enhancement
in OROS-MPH usage dose with age. Higher dose levels in OROS-MPH could be asserted as
more effective for increase in academical success. Compared with the control group, decrease
of life quality sub-areas is supported the view of pharmacotherapy alone not enough. How‐
ever, further studies are needed to obtain certain data.
İn this point; V A Harpin showed that the primary school children with ADHD frequently
begins to be seen as being different as classmates start to develop the skills and maturity that
enable them to learn successfully in school. ADHD to succeed, more frequently the child
experiences academic failure, rejection by peers, and low self esteem. And This study sug‐
gested that assessment by an educational psychologist may help to unravel learning strengths
and difficulties, and advise on necessary support in the classroom [39].
50 children and adolescents with ADHD diagnosis, 30 control group and both of their parents
are examined. Rosenberg Self-Esteem Scale and Children’s Quality of Life Scale are used. The
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results of this study suggest that self-esteem in the children and adolescents with ADHD is
not significantly high and that their quality of life is significantly low. This is noticeable for it
draws attention to the psycho-social dimension in the clinical evaluation of the children with
ADHD [40]. İn this way, social support and motivational therapy may needed.
From anoher study Figure 1 shows benefit (dark green bars) or no benefit (light green bars) by
outcome group in treated participants with attention deficit hyperactivity disorder (ADHD)
versus untreated ADHD. Improvement was reported most often in studies of driving and
obesity outcomes (left side), with a greater proportion of outcomes reported to exhibit no
benefit following treatment compared with no treatment in studies of occupation (right side).
An intermediate proportion of studies of self-esteem, social function, academic, drug use/
addictive behavior,antisocial behavior, and services use outcomes reported benefit with
treatment [41].
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Figure 1. Benefit and no benefit with treatment by outcome group
Treatment with OROS-MPH and atomoxsetine also have side effects. Evidence shows that
ADHD medications are safe and effective for children ages 6 and older. For children over
the age of 6, long-term effectiveness and adverse effects are not well studied. More studies
showed  that  psychostimulants  and  atomoxetine  may  cause  insomnia,  appetite  loss,
tiredness, social withdrawal, and abdominal pain. Psychostimulants and atomoxetine may
also cause a modest  increase in average blood pressure and average heart  rate in some
children and adolescents. Children or adolescents taking atomoxetine may be more likely
to think about suicide than children who do not take it. More adverse effects were report‐
ed in preschoolers than in elementary school children. Moodiness and irritability often led
to discontinuation of treatment with MPH. [42] In our study; 26 patients were applied before
any other treatment of ADHD. However, several side effects, and due to non compliance
of previously treatment patients couldn’t maintain previous treatment is observed. İnsom‐
nia, loss of appetite, nervousness, hyperactivity, increase in anxiety, and somnolence areside
effect which cause to stop first treatment. Insomnia, loss of appetite, and nervousness side
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effects was seen with all the OROS MPH. Increase in hyperactivity and anxiety side effects
could be showed with the use of OROS MPH. The side effects of somnolence and non-
compliance with the development of atomoxetine. But our datas are limited about relation‐
ship of side effects and life quality. Further studies are needed side effects of OROS-MPH
and atomoxetine on life quality.
Long-term effects of methylphenidate and atomoxsetine on growth rates of children with
ADHD are the other size of the treatment which also effect the Quality of life. The effect
of OROS-MPH and atomoxsetine over weight and height is  still  a  subject  of  discussion.
The final results, as to children with attention deficit who take stimulant medication grow
slower than children with no treatment, verify the results of previous studies in 1972-1973.
Recent study showed a decrease in expected weight and height growing in children who
take  stimulant  therapy.  In  treatments  continuing  2-3  years,  the  growing  speed  shows
normalization tendency [43,44].
İn the one of the review about effects of stimulants on height and weight; the quantitative
analyses showed that treatment with stimulant medication led to statistically significant delays
in height and weight. Treatment with stimulants in childhood reduced expected height and
weight. This review also found statistically significant evidence of attenuation of these deficits
over time. The qualitative review suggested that growth deficits may be dose dependent. Some
data suggest that ultimate adult growth parameters are not affected [45].
Prolonged medication (data evaluated at 6 months - 5 years) with short-acting MPH has shown
to have minimal impact on height only at the first 6 months; however, catch up growth was
detected during adolescent period in 96 cases wo were treated with short-acting MPH 0.41-0.49
mg/kg/day [46]. İn another research about the potential negative influence of methylphenidate
on growth; mean value of height was lower than expected mean height for age by 0.42 cm at
diagnosis. This difference increased to 2.69 cm (at 30 months of treatment), but it subsequently
decreased to 0.83 cm (at 48 months of treatment). The relationship between nutritional status
and the negative effects on the height curve in those patients would require nutritional
optimization to return anthropometric variables to normal [47].
Two new researches was performed on the effect of amoxetine on growing patients with 5
year follow-up and long- time efficiency and reliability of atomoxetine. After a 5 year follow-
up, it is suggested that while atomoxetine has no or a little effect on growing, in some cases
could cause reduction in growing. Especially in 18 months, growing could be affected a
little, however normal development could proceed in a period of 2-3 years [43,44]. Spenc‐
er et al present findings from an ongoing 5-year study of the efficacy and safety of treatment
with atomoxetine. After 1 month's treatment,they found patients weighed less than expected
from their starting percentiles relative to population norms, with a maximum shortfall at
15 months and a return to expected weight by 36 months. Patients were slightly shorter
than expected after 12 months, reaching a maximum shortfall at 18 months and returning
to expected height by 24 months. Patients in the top quartile for body mass index (BMI) or
weight at baseline, and those in the third quartile for height, showed 5-year decreases from
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results of this study suggest that self-esteem in the children and adolescents with ADHD is
not significantly high and that their quality of life is significantly low. This is noticeable for it
draws attention to the psycho-social dimension in the clinical evaluation of the children with
ADHD [40]. İn this way, social support and motivational therapy may needed.
From anoher study Figure 1 shows benefit (dark green bars) or no benefit (light green bars) by
outcome group in treated participants with attention deficit hyperactivity disorder (ADHD)
versus untreated ADHD. Improvement was reported most often in studies of driving and
obesity outcomes (left side), with a greater proportion of outcomes reported to exhibit no
benefit following treatment compared with no treatment in studies of occupation (right side).
An intermediate proportion of studies of self-esteem, social function, academic, drug use/
addictive behavior,antisocial behavior, and services use outcomes reported benefit with
treatment [41].
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Figure 1. Benefit and no benefit with treatment by outcome group
Treatment with OROS-MPH and atomoxsetine also have side effects. Evidence shows that
ADHD medications are safe and effective for children ages 6 and older. For children over
the age of 6, long-term effectiveness and adverse effects are not well studied. More studies
showed  that  psychostimulants  and  atomoxetine  may  cause  insomnia,  appetite  loss,
tiredness, social withdrawal, and abdominal pain. Psychostimulants and atomoxetine may
also cause a modest  increase in average blood pressure and average heart  rate in some
children and adolescents. Children or adolescents taking atomoxetine may be more likely
to think about suicide than children who do not take it. More adverse effects were report‐
ed in preschoolers than in elementary school children. Moodiness and irritability often led
to discontinuation of treatment with MPH. [42] In our study; 26 patients were applied before
any other treatment of ADHD. However, several side effects, and due to non compliance
of previously treatment patients couldn’t maintain previous treatment is observed. İnsom‐
nia, loss of appetite, nervousness, hyperactivity, increase in anxiety, and somnolence areside
effect which cause to stop first treatment. Insomnia, loss of appetite, and nervousness side
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effects was seen with all the OROS MPH. Increase in hyperactivity and anxiety side effects
could be showed with the use of OROS MPH. The side effects of somnolence and non-
compliance with the development of atomoxetine. But our datas are limited about relation‐
ship of side effects and life quality. Further studies are needed side effects of OROS-MPH
and atomoxetine on life quality.
Long-term effects of methylphenidate and atomoxsetine on growth rates of children with
ADHD are the other size of the treatment which also effect the Quality of life. The effect
of OROS-MPH and atomoxsetine over weight and height is  still  a  subject  of  discussion.
The final results, as to children with attention deficit who take stimulant medication grow
slower than children with no treatment, verify the results of previous studies in 1972-1973.
Recent study showed a decrease in expected weight and height growing in children who
take  stimulant  therapy.  In  treatments  continuing  2-3  years,  the  growing  speed  shows
normalization tendency [43,44].
İn the one of the review about effects of stimulants on height and weight; the quantitative
analyses showed that treatment with stimulant medication led to statistically significant delays
in height and weight. Treatment with stimulants in childhood reduced expected height and
weight. This review also found statistically significant evidence of attenuation of these deficits
over time. The qualitative review suggested that growth deficits may be dose dependent. Some
data suggest that ultimate adult growth parameters are not affected [45].
Prolonged medication (data evaluated at 6 months - 5 years) with short-acting MPH has shown
to have minimal impact on height only at the first 6 months; however, catch up growth was
detected during adolescent period in 96 cases wo were treated with short-acting MPH 0.41-0.49
mg/kg/day [46]. İn another research about the potential negative influence of methylphenidate
on growth; mean value of height was lower than expected mean height for age by 0.42 cm at
diagnosis. This difference increased to 2.69 cm (at 30 months of treatment), but it subsequently
decreased to 0.83 cm (at 48 months of treatment). The relationship between nutritional status
and the negative effects on the height curve in those patients would require nutritional
optimization to return anthropometric variables to normal [47].
Two new researches was performed on the effect of amoxetine on growing patients with 5
year follow-up and long- time efficiency and reliability of atomoxetine. After a 5 year follow-
up, it is suggested that while atomoxetine has no or a little effect on growing, in some cases
could cause reduction in growing. Especially in 18 months, growing could be affected a
little, however normal development could proceed in a period of 2-3 years [43,44]. Spenc‐
er et al present findings from an ongoing 5-year study of the efficacy and safety of treatment
with atomoxetine. After 1 month's treatment,they found patients weighed less than expected
from their starting percentiles relative to population norms, with a maximum shortfall at
15 months and a return to expected weight by 36 months. Patients were slightly shorter
than expected after 12 months, reaching a maximum shortfall at 18 months and returning
to expected height by 24 months. Patients in the top quartile for body mass index (BMI) or
weight at baseline, and those in the third quartile for height, showed 5-year decreases from
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expected  values.  Those  below  median  height  at  baseline  showed  increases  relative  to
expected values.[43]
In our study, we found no significant difference between both control group of OROS-MHP
and atomoxetine in terms of weight and height. And also no significant difference were
between treatment under OROS-MHP and atomoxetine. This result could be associated with
time limitation. Further studies are needed if there are difference effects of between OROS-
MPH and atomoxetine treatment on weight-height.
Although one of the research children with ADHD who performed poorly on the neuropsy‐
chological battery had greater BMI z-scores, and were more likely to be classified as over‐
weight/obese compared with children with ADHD who performed better on the
neuropsychological battery. In addition, children with ADHD who were taking a stimulant
medication had significantly lower BMI z-scores compared with children with ADHD who
were not taking medication or who were taking a non-stimulant medication. They claimed
that EF (Executive Function) is more impaired among children with ADHD and co-occurring
weight problems, highlighting the importance of self-regulation as a link between pediatric
obesity and ADHD [48].
An intresting point is that last studies reported an association between overweight and ADHD.
Although a higher prevalence of overweight/obesity was reported in clinical samples of
patients with ADHD, longitudinal studies are needed to better understand the mechanisms
underlying the association between ADHD and overweight/obesity [49].
Current data suggests an association between growing and medical effect of stimulants. Also
normal growing speeds have been shown in children who take no treatment with attention
deficit hyperactivity disorder. Therefore, further studies should focus on fields as detailed
definition of growing and development effects of stimulants in children with different ages,
determining the growing deficiency mechanism up to stimulant [50].
Gender differences is another variability that may affect the quality of life. Children with high
levels of ADHD symptoms have many associated behaviour problems, even in pre-school
years, and boys with high levels of ADHD symptoms are more severely affected compared
with girls. Datas of researches are not enough in this field.
Data from 5 clinical atomoxetine trials (4 from Europe and 1 from Canada) with similar
inclusion  and  exclusion  criteria  and  similar  durations  (8-  to  12-week  follow-up)  were
included in  the  pooled analysis.  136  girls  and 658 boys were  treated with atomoxetine.
Atomoxetine was effective in improving some aspects of health-related quality of life (HR-
QoL) in both genders without any significant differences across genders.Also, ıt was found
that correlations between core symptoms of ADHD and HR-QoL were low to moderate in
both boys and girls [51].
Also 6-17 aged of patients were treated with atomoxetine in two studies. ADHD-related
difficulties were assessed after 8 and 24 weeks using the Global Impression of Perceived
Difficulties (GIPD) instrument, which can be taken to reflect the patient's QoL from the three
perspectives. The GIPD scores over time suggest that patients' QoL, as reflected by perceived
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ADHD-related difficulties, improved with time on atomoxetine The sexes did not differ
significantly in mean GIPD total scores.and also improvement in ADHD-related difficulties
did not differ significantly between boys and girls [52]. In the second step of our study; we
aimed to compare effects of sex differences on response of treatment with both atomoxetine
and OROS-MPH, also correlation with life quality, ıt is our limitation of this study.
Consequently, ADHD, which is a chronic neuropsychiatric disorder, is known as negative‐
ly  effective  on life  quality  perception in  reports  about  children and it  is  suggested that
evaluation of  life  quality  in  follow-up and treatment  stages  of  ADHD and efficiency of
pharmacological treatment on life quality of this patients could be a guide for determin‐
ing  the  fields  that  children  have  difficulty  on.  Besides,  when  comparing  with  normal
population, the difficulties in academical, social and emotional fields could be seen more
frequently.  Medical treatment of attention deficit  and hyperactivity disorder alone could
cause  increasing  in  conseptualization  tendency  of  problems  and  nondevelopment  on
problem solving skills. Therefore, it is suggested that recovery attempts for children with
ADHD diagnosis should include all fields of life. Karabekiroğlu K. et al found that more
than half of the teachers denoted that the medication used for ADHD would have serious
side  effects  and  even  with  treatment  ADHD  would  not  sufficiently  improve,  and  the
children diagnosed with ADHD or autism should be trained at separate classes.  So that
the parents and teachers may benefit from structured educative programs inorder to get
rid of wrong assumptions and stigma [53].
One of the importent point is that further study is needed to understand the social and
psychological processes that underlie stigmatization, how parents balance perceived benefits
of treatment with mental health stigma concerns, and to determine how stigmatization effects
quality of life children with ADHD.
Although in our study, patients with ADHD tent to show a decrease in school success with
increase in age, patients who take OROS-MPH treatment show an increase in life quality school
sub-score. This information could be a guide for examining of detailed determining of OROS-
MPH effects.
Limitaton of our study are number of patients and time of treatments. Our datas are not enough
effects of socio-demographic differences, side effects, gender and stigma on life quality.
Measurement of quality of life in attention-deficit-hyperactivity disorder (ADHD) gives a more
complete picture of day-to-day functioning and treatment effects than behavioural rating
alone. Quality of life is effected from numerous factors so that new measurement parameters
should be developed.
In conclusion; there is significantly difference in all sub-fields of life quality scale between
control group and under ADHD treatment. Tretment is increase life quality of ADHD patients
but only medical treatment is not enought.There is no significant difference between weight
and height when comparing between control groups of OROS-MPH and atomexetine. Further
studies are needed to support the effects of OROS-MPH and atomoxetine on life quality and
weight-height.
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expected  values.  Those  below  median  height  at  baseline  showed  increases  relative  to
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and atomoxetine in terms of weight and height. And also no significant difference were
between treatment under OROS-MHP and atomoxetine. This result could be associated with
time limitation. Further studies are needed if there are difference effects of between OROS-
MPH and atomoxetine treatment on weight-height.
Although one of the research children with ADHD who performed poorly on the neuropsy‐
chological battery had greater BMI z-scores, and were more likely to be classified as over‐
weight/obese compared with children with ADHD who performed better on the
neuropsychological battery. In addition, children with ADHD who were taking a stimulant
medication had significantly lower BMI z-scores compared with children with ADHD who
were not taking medication or who were taking a non-stimulant medication. They claimed
that EF (Executive Function) is more impaired among children with ADHD and co-occurring
weight problems, highlighting the importance of self-regulation as a link between pediatric
obesity and ADHD [48].
An intresting point is that last studies reported an association between overweight and ADHD.
Although a higher prevalence of overweight/obesity was reported in clinical samples of
patients with ADHD, longitudinal studies are needed to better understand the mechanisms
underlying the association between ADHD and overweight/obesity [49].
Current data suggests an association between growing and medical effect of stimulants. Also
normal growing speeds have been shown in children who take no treatment with attention
deficit hyperactivity disorder. Therefore, further studies should focus on fields as detailed
definition of growing and development effects of stimulants in children with different ages,
determining the growing deficiency mechanism up to stimulant [50].
Gender differences is another variability that may affect the quality of life. Children with high
levels of ADHD symptoms have many associated behaviour problems, even in pre-school
years, and boys with high levels of ADHD symptoms are more severely affected compared
with girls. Datas of researches are not enough in this field.
Data from 5 clinical atomoxetine trials (4 from Europe and 1 from Canada) with similar
inclusion  and  exclusion  criteria  and  similar  durations  (8-  to  12-week  follow-up)  were
included in  the  pooled analysis.  136  girls  and 658 boys were  treated with atomoxetine.
Atomoxetine was effective in improving some aspects of health-related quality of life (HR-
QoL) in both genders without any significant differences across genders.Also, ıt was found
that correlations between core symptoms of ADHD and HR-QoL were low to moderate in
both boys and girls [51].
Also 6-17 aged of patients were treated with atomoxetine in two studies. ADHD-related
difficulties were assessed after 8 and 24 weeks using the Global Impression of Perceived
Difficulties (GIPD) instrument, which can be taken to reflect the patient's QoL from the three
perspectives. The GIPD scores over time suggest that patients' QoL, as reflected by perceived
Attention Deficit Hyperactivity Disorder in Children and Adolescents298
ADHD-related difficulties, improved with time on atomoxetine The sexes did not differ
significantly in mean GIPD total scores.and also improvement in ADHD-related difficulties
did not differ significantly between boys and girls [52]. In the second step of our study; we
aimed to compare effects of sex differences on response of treatment with both atomoxetine
and OROS-MPH, also correlation with life quality, ıt is our limitation of this study.
Consequently, ADHD, which is a chronic neuropsychiatric disorder, is known as negative‐
ly  effective  on life  quality  perception in  reports  about  children and it  is  suggested that
evaluation of  life  quality  in  follow-up and treatment  stages  of  ADHD and efficiency of
pharmacological treatment on life quality of this patients could be a guide for determin‐
ing  the  fields  that  children  have  difficulty  on.  Besides,  when  comparing  with  normal
population, the difficulties in academical, social and emotional fields could be seen more
frequently.  Medical treatment of attention deficit  and hyperactivity disorder alone could
cause  increasing  in  conseptualization  tendency  of  problems  and  nondevelopment  on
problem solving skills. Therefore, it is suggested that recovery attempts for children with
ADHD diagnosis should include all fields of life. Karabekiroğlu K. et al found that more
than half of the teachers denoted that the medication used for ADHD would have serious
side  effects  and  even  with  treatment  ADHD  would  not  sufficiently  improve,  and  the
children diagnosed with ADHD or autism should be trained at separate classes.  So that
the parents and teachers may benefit from structured educative programs inorder to get
rid of wrong assumptions and stigma [53].
One of the importent point is that further study is needed to understand the social and
psychological processes that underlie stigmatization, how parents balance perceived benefits
of treatment with mental health stigma concerns, and to determine how stigmatization effects
quality of life children with ADHD.
Although in our study, patients with ADHD tent to show a decrease in school success with
increase in age, patients who take OROS-MPH treatment show an increase in life quality school
sub-score. This information could be a guide for examining of detailed determining of OROS-
MPH effects.
Limitaton of our study are number of patients and time of treatments. Our datas are not enough
effects of socio-demographic differences, side effects, gender and stigma on life quality.
Measurement of quality of life in attention-deficit-hyperactivity disorder (ADHD) gives a more
complete picture of day-to-day functioning and treatment effects than behavioural rating
alone. Quality of life is effected from numerous factors so that new measurement parameters
should be developed.
In conclusion; there is significantly difference in all sub-fields of life quality scale between
control group and under ADHD treatment. Tretment is increase life quality of ADHD patients
but only medical treatment is not enought.There is no significant difference between weight
and height when comparing between control groups of OROS-MPH and atomexetine. Further
studies are needed to support the effects of OROS-MPH and atomoxetine on life quality and
weight-height.
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1. Introduction
Take a moment to consider how individuals with Attention Deficit Hyperactivity Disorder
(ADHD) are described. When people talked about these individuals what do they say about
their behaviors, bodies, and minds? Do these descriptions vary across individuals, contexts,
and time? Now compare your reflections as to how individuals with ADHD are often descri‐
bed. In today’s world ADHD is described as a:
• disorder/dysfunction.
• heterogeneous developmental disorder.
• chronic condition with life-span implications.
• brain difference.
• delay or deterioration in their cognitive, social, and emotional functioning.
• universal condition transcending culture, socio-economic, and race.
• social and emotional burden.
These descriptions are common and, as a matter of fact, most of them were drawn from
chapters in this book.
My point for using this activity to open this chapter is to make you aware of your personal
theories and how the symptoms of ADHD, who has it, and what happens as a result is
influenced by our perspectives. Let me clarify what I mean a bit more with a boy name Michael
and a role-play for you. Imagine that you are a teacher and Michael is a student in your
classroom. You enjoy Michael’s humor but he is showing uneven academic progress and is
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constantly fidgety and out of his seat. Take a few minutes to answer these questions: From
where is Michael’s lack of progress stemming? Why is he so fidgety and out of his seat? What
would you do to help Michael?
Now, let’s consider some common answers. If you thought Michael’s uneven progress and
fidgetiness stemmed from his family’s lack of discipline you would likely direct Michael and
his family to a counselor, who in turn might place them in some sort of counseling or therapy.
If you thought Michael’s uneven progress and fidgetiness came from a brain difference you
would likely refer Michael to the school psychologist, who in turn might refer him to a
physician, who might place Michael on medication. If you thought Michael’s uneven progress
and fidgetiness stemmed from his environment (your classroom) you might decide to
differentiate his instruction and restructure the activities he was given so he could get up and
move. Three varied perspectives of Michael with three different outcomes. No perspective was
neutral and each set Michael on a different path.
To take the idea of teachers’ perspectives about boys like Michael one step further let me
explain a study conducted by two colleagues and myself (Zambo, Zambo & Sidlik) in 2009.
We wanted to understand what teachers thought about individuals with ADHD and if
neuroscience was useful to them so we based on the work of McCabe and Castel (2008) and
Weisberg, Keil, Goodstein, Rawson, and Gray (2008). These researchers manipulated infor‐
mation and used an fMRI image, a graph, or no image to understand if neuroscience was
persuasive and they found it was both persuasive and misleading. These researchers conclud‐
ed that fMRI images were persuasive because they appealed to their participants’ intuitive
reductionist notions of learning and confirmed theories and biases they already possessed
(learning boils down to brightly lit areas captured in fMRIs). Instead of thinking of learning
as a complex process unable to be reduced to biological functions alone, participants believed
colorful images proved learning had occurred.
Based on this work, we set out to understand what a group of preservice teachers knew about
ADHD, where they learned this information, and what they thought about medical science
and neuroscience being useful to them to educate students with attention challenges. We used
a general questionnaire but manipulated the type of information participants received. Half
of our participants saw an fMRI image and read about ADHD from a neuroscience perspective
(e.g., caused by faulty neuroreceptors responding to the neurotransmitter dopamine) and the
other half saw an image of a premature infant and read about ADHD from a medical per‐
spective (e.g., infants being born prematurely and weighing less than 3.3 pounds often develop
ADHD).
We found that the participants in both groups knew a lot about the behaviors of students with
ADHD. They knew, or at had theories that, students with ADHD were hyperactive, excitable,
impulsive, irritable, and seldom tired. They also believed that these characteristics inhibit
students’ learning and social life. They believed that children with attention challenges were
distractible, struggle with concentration, get off task easily, and have social and family
problems. When asked where they learned this information they said they had friends or
family members with it, heard celebrities on television talk about it, and discussed it in their
courses (especially special education courses).
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Data from the two conditions (neuroscience and medical science) showed some differences.
Participants who saw the fMRI image and read information suggesting ADHD was a biological
disorder believed that neuroscience would be useful to them. These participants believed
information from neuroscience would help them identify students with ADHD, understand
how their brain works, and understand why they behave in certain ways. Participants in the
neuroscience condition also thought neuroscience would help them teach these students. They
thought neuroscience would show them how to create learning environments and lessons
conducive to these students’ needs.
In comparison, participants in the medical science condition, who saw the image of the
premature infant and read information from medical science also saw it as useful but had
different theories about its use. Participants in this group thought medical science would help
them understand the cause, signs, and symptoms of ADHD, the importance of medication,
and how to manage students’ behaviors. Different conditions lead to different perspectives of
students with ADHD.
I hope these results help you realize that each of us operates from our own vantage point, or
the theories that we construct as we go about our daily lives. The theories we build, in this
sense, are not like the grand ideas tested by researchers (e.g., behaviorism, information
processing, psychoanalysis) but the mental models or internal maps we use to navigate and
make sense of our world and the things and individuals in it. We each construct our own
theories based on our observations, but we also build theories based on what we hear or read.
Social relationships matter and through dialogue and other means collective theories get built,
spread, and get used to determine good and bad and normal and abnormal (Gergen, 2009).
Collective theories gain momentum when they are turned into the stories that we tell. Stories
become cultural artifacts and when they are repeated they become the norm and influence our
values and behaviors. This includes our perceptions of disorders, who has them, and what this
means. Consider the following example in which another culture, in this case the Maori of
New Zealand, were seen as different simply because of their culture and its’ traditions.
Psychology…has created the mass abnormalization of the Maori people by virtue of the fact
the Maori people have been…recipients of defined labels and treatments…Clinical psychology
is a form of social control…and offers no more “truth” about the realities of the Maori people’s
lives than a regular reading of a horoscope page in the local newspaper (Lawson-Te, Ano, 1993)
Foucault (1978; 1979) a proponent of helping people to understand their subjugation revealed
the power of taken for granted practices. To Foucault, power is a coordinated cluster of
relations and the specialized language a discipline develops creates binaries and divides.
Instead of being seen as an individual we get placed into categories such as normal or
abnormal. Disciplines also produce certain research procedures that privilege certain kinds of
methodologies and scrutinize and classify us along their disciplinary lines. In other words, we
become the labels that get assigned to us and the labels we acquire are used to control us.
Disciplines gain power and influence public policy. Given this, let’s look at mental disorders,
like ADHD from a historical perspective.
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Data from the two conditions (neuroscience and medical science) showed some differences.
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sense, are not like the grand ideas tested by researchers (e.g., behaviorism, information
processing, psychoanalysis) but the mental models or internal maps we use to navigate and
make sense of our world and the things and individuals in it. We each construct our own
theories based on our observations, but we also build theories based on what we hear or read.
Social relationships matter and through dialogue and other means collective theories get built,
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New Zealand, were seen as different simply because of their culture and its’ traditions.
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Foucault (1978; 1979) a proponent of helping people to understand their subjugation revealed
the power of taken for granted practices. To Foucault, power is a coordinated cluster of
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become the labels that get assigned to us and the labels we acquire are used to control us.
Disciplines gain power and influence public policy. Given this, let’s look at mental disorders,
like ADHD from a historical perspective.
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In the United States, the first classification of a mental disorder occurred in 1840 and given its
newness there were only a handful of distinctions. In 1930 psychiatry emerged and the
perceptions of mental disorders began to grow. By 1938 the number of disturbances rose to
approximately forty and since then, the number of disorders has risen to over three hundred
and drug treatments have grown into a multi-billion dollar industry. If an individual has
ADHD symptoms it is likely that he/she will be offered medication (Gergen, 2009).
Psychiatry has influence but another discipline neuroscience, has also come into play. In
today’s disorder-focused society neuroscience is influencing perspectives and this trend is
likely to continue to grow (Maxwell, 2004). The past fifty years has seen an explosion of
information about the brain offered to laypersons (Stamm, 2007; Stein, della Chiesa, Hin‐
ton, & Fischer, 2010). More findings are leading to more interest, more treatments, and as
these get normalized and incorporated into policies and beliefs,  fewer calls for restraint.
When it comes to a disorder like ADHD more findings from are leading to more biologi‐
cal  theories of  it  and more standardized treatments aimed at  this  cause.  Neuroscientists
are  helping  us  understand  how the  brain  of  individuals  with  ADHD function  but  like
McCabe  and  Castel  (2008)  and  Weisberg,  Keil,  Goodstein,  Rawson,  and  Gray  (2008)
showed these findings can be persuasive and misleading because they are new, diminu‐
tive,  and  alluring  even  though  much  of  it  is  being  overextended,  misinterpreted,  and
simplified. If interpreted literally, and in isolation, findings from neuroscience will reduce
learning, behavior, and emotions to biological processes alone. There are treatments, cur‐
ricula,  and  products  that  purport  to  utilize  findings  from  neuroscience  to  promote  the
learning and behavior of individuals with ADHD without any scientific backing.
Neuroscience is providing new and important information but if we are not careful it can also
produce simplified and detached views of individuals, including those with ADHD. A
Pygmalion Effect, or self-fulfilling prophecy is a groundless expectation that leads to behaviors
that the make the original expectation come true (Merton, 1948). In other words, we see what
we expect and expect what we want to see. Remember the opening exercise where you recalled
various perspectives of individuals with ADHD and the Maori people who were perceived to
be abnormal and defined and perceived as such. Just because a characterization, or label
becomes common does not mean it is right, fair, ethical, or just.
2. The ethics of ADHD
Considering ethical questions that arise when an individual is labeled ADHD is important
because five million children (most of whom are boys) between the ages of 3 and 17 years and
8 million adults are diagnosed with it and this number is growing each year (U.S. Department
of Health and Human Services, 2010). Thanks to better diagnosis and the spread of information,
more and more children, adolescents, and adults are being diagnosed and as a result of
identification more and more are being treated with pharmaceutical, social, and behavioral
interventions (Barkley, 2005). Unfortunately, and too often, medication is often the only
treatment many individuals receive. Medications like methyphenidate (Ritalin) and amphet‐
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amine (Adderall) slow the reuptake of dopamine in the brain and decrease the impulsivity
and agitation of ADHD in 70-90% of cases. This quick and easy removal of symptoms is leading
to more and more children at younger ages, and more and more adolescents and adults to be
prescribed medication. But too often, medication is the only treatment many individuals
receive despite the fact that absolute proof of its benefits is not available and little is known
about its long-term effects (Farah, 2005). While there is no doubt medication helps many
individuals with ADHD there is also no doubt that, for some, there are unintended conse‐
quences and side effects like weight loss, sleeplessness, and cloudy minds (Chau, 2007).
Neuroscientists, physicians, psychiatrists, psychologists, and social workers warn that
medication needs to be coupled with behavioral, social, and emotional support because alone
it is not enough. In other words, medicine is a part of the puzzle but it is not a panacea. Locating
an attention problem solely in an individual’s brain and treating her/his brain with medication
gets results but it does not offer a cure or help an individual truly understand him/herself.
Medication focuses on changing behaviors. It does not increase self-awareness or heal a body
or mind (Farah, 2005; Morse, 2006; Stein, della Chiesa, Hinton, & Fischer, 2010).
Medicating children can also lead to misuse of medication if they are not instructed as to
its proper use. Current sales figures indicate that Ritalin and Adderall are not only being
used by individuals  with ADHD but by high school  and college students without it.  A
survey by McCabe,  Knight,  Teter,  and Wechsler (2005)  discovered that  as many as 10%
of high school students and 20% of college students say that they have used prescription
stimulant medications to increase their performance on a test and this use varies by eth‐
nicity,  gender,  achievement,  and location. White males who receive low grades,  and are
going to Ivy League colleges in the northeast with high standards, are the most likely to
abuse  stimulant  medication.  Interestingly,  the  stimulants  they  abuse  often  come  from
their  peers  who  have  been  diagnosed  with  ADHD.  Purchasing  Ritalin  is  so  prevalent
among young adults it  is  referred as “ kiddy coke” and “study buddies.” While my in‐
tent is not to criticize or condone the use of medication, I realize medication helps many
individuals,  but  I  want  to  once  again  point  out  that  of  we  do  not  slow  our  thinking
down and become aware of our beliefs we will miss ethical questions like:
• How might the use of this stimulant cause psychological harm (e.g., lower esteem and
motivation)? Will an individual on medication be robbed of his/her identity?
• When it comes to medication, what responsibilities are there and who is accountable for
these?
• Does the label of ADHD promote standardized, quick and easy treatments?
• Is the label of ADHD promoting biases and stereotypes?
• How can we better the lives and learning of individuals with ADHD?
• How can individuals with ADHD be supported so they know how to compensate, navigate,
and fit into the world?
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• Do individuals with ADHD really need to change? How can characteristics and relational
styles be respected rather than modified? How can individuals with ADHD become their
own advocates?
Habermas (2003) notes that the careless use of biomedical advances can undermine the
behaviors and passions of individuals, or change individuals so much they lose the ability to
understand and take responsibility for their own lives. In the wake of neuroscience and
biotechnologies it is important to step back, reflect, make good ethical decisions, and take
action to ensure that individuals with ADHD are allowed to be themselves and have a voice
in their development and lives (Stein, della Chiesa, Hinton, & Fischer, 2010).
3. Making ethical decisions
Now, the Star-Bell Sneetches had bellies with stars.
The Plain-Belly Sneetches had none upon thars.
Those stars weren’t so big. They were really so small.
You might think such a thing wouldn’t matter at all.
But, because they had stars, all the Star-Belly Sneetches
Would brag, “We’re the best kind of Sneetch on the beaches.”
With their snoots in the air, they would sniff and they’d snort
“We’ll have nothing to do with the Plain-Belly sort!”
And, whenever they met some, when they were out walking,
They’d hike right on past them without even talking.
Dr. Seuss (1961)
The quote from The Sneeches by Dr. Seuss (1961) was written to oppose anti-Semitism and
remind us about discrimination. As science moves forward the ethical challenges we will face
will continue to grow and change. Neuroscience is seeping into all of our lives and changing
what we know and think, including what we think about ADHD. However, making ethical
decisions is often perplexing and sometimes stars on bellies become so common we fail to see
them. When it comes to neuroscience how do we decide what to believe? How do we know
what is right and wrong, what is just and unfair? Where can we find reliable information?
Who’s ideas matter? Neuroethics brings questions like these into focus and this is important
because of the power of our beliefs. Neuroethics sits at the intersection between neuroscience
and the ethical, legal and social implications it brings. To Racine and Illes (2006), neuroethics
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focuses on the right and wrong, good and bad treatment of, perfection of, or unwelcome
invasion of and worrisome manipulation of the human brain. Gazzaniga (2005, 2011) furthered
this idea to include "the examination of how we as humans, want to deal with the social issues
of disease, normality, mortality, lifestyle, and the philosophy of living informed by our
understanding of underlying brain mechanisms." To Gazzaniga, neuroscience should help
everyone develop a brain-based philosophy of life. But this is not easy because we tend to focus
on ideas that align with our beliefs and allow our beliefs and emotions to cloud our judgment.
To develop a brain-based philosophy we will need valid information and time for deep and
reflective thought. Beliefs are not easy to change and neuroscience and ethics do not mix easily.
Some findings from neuroscience are difficult to understand because they make us question
the very fabric of who we are, who we can become, and how is best to live our lives. Moral
questions have been around for centuries and after years of debate a human rights approach
focuses on ensuring that everyone, including individuals with ADHD receive truthful
information, a voice in their lives, the right not to be harmed, and the right to develop and
grow. Now look back at the questions posed in the previous section and consider how these
positions relate to individuals with ADHD.
In closing. I hope this chapter has made you reflect on your beliefs and ask questions as to how
findings from neuroscience, medical science, psychiatry, and all of the other disciplines used
to influence the lives of individuals with ADHD can be used fairly, for their good, and for the
betterment of individuals with ADHD. Reason (1988) used the term “critical subjectivity” to
explain the balance we should strive to achieve. To him we should critically reflect on what
we learn and disregard what seems harmful and unjust. Gergan (2009) makes a similar point
and reminds us to consider how beliefs stem from dominant disciplines, become obvious,
bestow power, and cause some voices to be silenced. Kahneman (2011) notes the importance
of slowing down and reflecting on our thinking and how information we focus on influences
our thoughts and behaviors. Realizing that neuroscience can be persuasive and influence our
beliefs opens the door for us to re-interpret and re-envision our perspectives of it. Moral
questions arise when science’s findings are applied to lives and we need to examine and change
our theories, methodologies, and beliefs if they are wrong (Gopnik, 2009).
Questioning, of course, does not always provide automatic answers to moral issues but it does
bring into focus the need to seek valid information and keep a critical eye on the facts we
receive and trust. Findings and treatments from neuroscience can have positive or negative
effects. Interventions can help individuals focus and behave. But if we are not careful they can
also place stars on their bellies and rob individuals of their identities (Racine & Illes, 2006). The
limits of methodology and the complexity of relations between research and practice take
center stage in the challenges we face (Stein, della Chiesa, Hinton, & Fischer, 2010).
Progress is being made as the many chapters in this volume note, but we have much work
ahead. To use neuroscience appropriately a causal chain of evidence needs to be clear and it
is important to realize that when it comes to labeling, treating, and caring for individuals with
ADHD we must realize:
• The best information from neuroscience is gathered with reliable and valid tools, replicated,
and combined with personal insights.
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• We need to become better consumers of information from neuroscience.
• We need to understand that the tools neuroscientists use are new, popular, rapidly chang‐
ing, and persuasive. We need to understand these tools, the level of analysis they are able
to perform, the reliability/validity of results, and what this all means to us in understandable
and useable terms.
• Neuroscience cannot tell us how to treat individuals. However, it can be used to confirm,
enrich, and refine theories and models of learning and behavior. Different vantage points
or a consilience of disciplines (e.g., human development, cognitive science, neuroscience,
behavioral science) are best (Wilson, 1998). A multi-voiced perspective leads to interven‐
tions that work.
• Even though information from neuroscience has grown, given insight, and become part of
daily conversations we must not lose sight of the fact that it is an evolving and quickly
changing field. We need to be fascinated but remain skeptical at the same time.
This chapter is full of questions, perhaps more than answers, but this is where I see us. Gains
are being made and beliefs are being formed. Fortunately the Sneetches came to realize they
were wrong.
But Mc Bean was quite wrong. I’m quite happy to say That the Sneetches got really quite smart on that day, The day they decided
that Sneetches are Sneetches.
And no kind of Sneetch is best on the beaches, that day all the Sneetches forgot about the stars.




Mary Lou Fulton Teachers College, Arizona State University, Phoenix
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tional neuroscience: Raising children in a brave new world (p 1-32). Boston, Oxford
University Press.
[19] U.S. Department of Health and Human Services, (2010). Summary health statistics for
U.S. children: National health interview survey. Washington, DC: U.S. Government
Printing Office.
[20] Weisberg, D.S., Keil, F.C., Goodstein, E.R., Rawson, & Gray, J.R. (2008). The seductive
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• We need to become better consumers of information from neuroscience.
• We need to understand that the tools neuroscientists use are new, popular, rapidly chang‐
ing, and persuasive. We need to understand these tools, the level of analysis they are able
to perform, the reliability/validity of results, and what this all means to us in understandable
and useable terms.
• Neuroscience cannot tell us how to treat individuals. However, it can be used to confirm,
enrich, and refine theories and models of learning and behavior. Different vantage points
or a consilience of disciplines (e.g., human development, cognitive science, neuroscience,
behavioral science) are best (Wilson, 1998). A multi-voiced perspective leads to interven‐
tions that work.
• Even though information from neuroscience has grown, given insight, and become part of
daily conversations we must not lose sight of the fact that it is an evolving and quickly
changing field. We need to be fascinated but remain skeptical at the same time.
This chapter is full of questions, perhaps more than answers, but this is where I see us. Gains
are being made and beliefs are being formed. Fortunately the Sneetches came to realize they
were wrong.
But Mc Bean was quite wrong. I’m quite happy to say That the Sneetches got really quite smart on that day, The day they decided
that Sneetches are Sneetches.
And no kind of Sneetch is best on the beaches, that day all the Sneetches forgot about the stars.




Mary Lou Fulton Teachers College, Arizona State University, Phoenix
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ADHD in children and adolescents is a neurodevelopmental disorder, which is 
recognized by the clinicians all over the world. ADHD is a clinical diagnosis based 
on reliable history, reports from home and school and a physical examination to rule 
out any other underlying medical conditions. ADHD can cause low self-esteem in the 
child and impair quality of life for the child and the family. It is known that ADHD is 
a chronic illness and that clinicians needed to use chronic illness principles in treating 
it. The last 10 years have seen an increase in the number of medications that have been 
approved for the treatment of ADHD. This book has tried to address some of the issues 
in ADHD.
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